PT J
AU Alston, CL
   Lowe, J
   Turnbull, DM
   Maddison, P
   Taylor, RW
AF Alston, Charlotte L.
   Lowe, James
   Turnbull, Douglass M.
   Maddison, Paul
   Taylor, Robert W.
TI A novel mitochondrial tRNA<SUP>Glu</SUP> (<i>MTTE</i>) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial DNA; Chronic progressive external ophthalmoplegia; tRNA(Glu); Single fibre studies; Pathogenicity
ID glutamic-acid gene; diabetes-mellitus; skeletal-muscle; point mutations; dna mutations; mtdna; myopathy; cells; encephalomyopathy; population
AB Mitochondrial respiratory chain defects are associated with diverse clinical phenotypes in both adults and children, and may be caused by mutations in either nuclear or mitochondrial DNA (mtDNA). We report the molecular genetic investigations of a patient with chronic progressive external ophthalmoplegia (CPEO) and myopathy where muscle biopsies taken 11 years apart revealed a progressive increase in the proportion of cytochrome c oxidase (COX)-deficient fibres. Mitochondrial genetic analysis of the early biopsy had seemingly excluded both mtDNA rearrangements and mtDNA point mutations. Sequencing mtDNA from individual COX-deficient muscle fibres in the second biopsy, however, identified an unreported m.14723 T>C substitution within the mitochondrial tRNA(Glu) (MTTE) gene, which fulfilled all canonical criteria for pathogenicity. The m.14723 T>C mutation was absent from several tissues, including muscle, from maternal relatives suggesting a de novo event, whilst quantitative analysis of the first muscle biopsy confirmed a very low level of the mutation (7% mutated mtDNA), highlighting a potential problem whereby pathogenic mtDNA mutations may remain undetected using established screening methodologies. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Alston, Charlotte L.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lowe, James] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England.
   [Maddison, Paul] Nottingham Univ Hosp NHS Trust, Dept Clin Neurol, Nottingham, England.
C3 Newcastle University - UK; University of Nottingham; Nottingham University Hospital NHS Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Wellcome Trust [074454/Z/04/Z]; UK National Commissioning Group; MRC [G0800674, G0601943] Funding Source: UKRI
CR Al-Dosary M, 2009, NEUROMUSCULAR DISORD, V19, P841, DOI 10.1016/j.nmd.2009.10.001
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kondrashov FA, 2005, HUM MOL GENET, V14, P2415, DOI 10.1093/hmg/ddi243
   Mayr JA, 2006, NEUROMUSCULAR DISORD, V16, P874, DOI 10.1016/j.nmd.2006.08.010
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pancrudo J, 2007, J CHILD NEUROL, V22, P858, DOI 10.1177/0883073807304199
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Weber K, 1997, AM J HUM GENET, V60, P373
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
NR 26
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD NOV 15
PY 2010
VL 298
IS 1-2
BP 140
EP 144
DI 10.1016/j.jns.2010.08.014
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 682ZJ
UT WOS:000284441200029
PM 20810132
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Lodi, T
AF Baruffini, Enrico
   Lodi, Tiziana
TI Construction and validation of a yeast model system for studying <i>in vivo</i> the susceptibility to nucleoside analogues of DNA polymerase gamma allelic variants
SO MITOCHONDRION
LA English
DT Article
DE Yeast model system; NRTIs/stavudine toxicity; DNA polymerase gamma; MIPI; POLG mutations/SNPs; Pharmacogenetics
ID progressive external ophthalmoplegia; saccharomyces-cerevisiae; mitochondrial toxicity; mutation; defects; polg; phenotype
AB Mitochondrial dysfunctions have been observed in subjects treated with antiretroviral nucleoside analogues, such as stavudine, as they can interfere with the activity of DNA polymerase gamma. Recently. stavudine-induced mitochondrial toxicity was associated to POLG mutations R964C and E1143G. A yeast model system useful to evaluate the association between D4T toxicity and mutations in MIP1, the yeast ortholog of POLG, was constructed and validated as a tool for pharmacogenetics research. We showed that mutant Mip1p(R964C) and possibly Mip1p(E1143G) are more sensitive to stavudine, and that stavudine has the potential to cause mitochondrial toxicity in heterozygous subjects harboring recessive mutations. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Baruffini, Enrico; Lodi, Tiziana] Univ Parma, Dept Genet, I-43124 Parma, Italy.
C3 University of Parma
RP Baruffini, E (corresponding author), Univ Parma, Dept Genet, Viale Usberti 11-A, I-43124 Parma, Italy.
EM enrico.baruffini@nemo.unipr.it
FU Fondazione Telethon-Italy [GGP07019]
CR Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223
   Lewis W, 2007, J INFECT DIS, V195, P1399, DOI 10.1086/513879
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vernis L, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng121
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 20
TC 14
Z9 15
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2010
VL 10
IS 2
BP 183
EP 187
DI 10.1016/j.mito.2009.10.002
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 561PC
UT WOS:000274989300013
PM 19887119
DA 2024-11-01
ER

PT J
AU Van Hove, JLK
   Saenz, MS
   Thomas, JA
   Gallagher, RC
   Lovell, MA
   Fenton, LZ
   Shanske, S
   Myers, SM
   Wanders, RJA
   Ruiter, J
   Turkenburg, M
   Waterham, HR
AF Van Hove, Johan L. K.
   Saenz, Margarita S.
   Thomas, Janet A.
   Gallagher, Renata C.
   Lovell, Mark A.
   Fenton, Laura Z.
   Shanske, Sarah
   Myers, Sommer M.
   Wanders, Ronald J. A.
   Ruiter, Jos
   Turkenburg, Marjolein
   Waterham, Hans R.
TI Succinyl-CoA Ligase Deficiency: A Mitochondrial Hepatoencephalomyopathy
SO PEDIATRIC RESEARCH
LA English
DT Article
ID encephalomyopathy; synthetases; nonsense; expression; mutations; decay
AB This patient presented on the first day of life with pronounced lactic acidosis with an elevated lactate/pyruvate ratio. Urine organic acids showed Krebs cycle metabolites and mildly elevated methylmalonate and methylcitrate. The acylcarnitine profile showed elevated propionylcarnitine and succinylcarnitine. Amino acids showed elevated glutamic acid, glutamine, proline, and alanine. From the age 2 of mo on, she had elevated transaminases and intermittent episodes of liver failure. Liver biopsy showed steatosis and a decrease of mitochondrial DNA to 50% of control. She had bilateral sensorineural hearing loss. Over the course of the first 2 y of life, she developed a progressively severe myopathy with pronounced muscle weakness eventually leading to respiratory failure, Leigh disease, and recurrent hepatic failure. The hepatic symptoms and the metabolic parameters temporarily improved on treatment with aspartate, but neither muscle symptoms nor brain lesions improved. Laboratory testing revealed a deficiency of succinyl-CoA ligase enzyme activity and protein in fibroblasts because of a novel homozygous mutation in the SUCLG1 gene: c.40A>T (p.M14L). Functional analysis suggests that this methionine is more likely to function as the translation initiator methionine, explaining the pathogenic nature of the mutation. Succinyl-CoA ligase deficiency due to an SUCLG1 mutation is a new cause for mitochondrial hepatoencephalomyopathy. (Pediatr Res 68: 159-164, 2010)
C1 [Van Hove, Johan L. K.] Univ Colorado Denver, Dept Pediat, Sect Clin Genet & Metab, Aurora, CO 80045 USA.
   [Lovell, Mark A.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA.
   [Fenton, Laura Z.] Childrens Hosp, Dept Radiol, Aurora, CO 80045 USA.
   [Shanske, Sarah] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Wanders, Ronald J. A.; Ruiter, Jos; Turkenburg, Marjolein; Waterham, Hans R.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metabol Dis, NL-1100 DD Amsterdam, Netherlands.
C3 Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Columbia University; University of Amsterdam; Academic Medical Center Amsterdam
RP Van Hove, JLK (corresponding author), Univ Colorado Denver, Dept Pediat, Sect Clin Genet & Metab, Educ 2 S,L28-4122,13121 E 17th Ave, Aurora, CO 80045 USA.
EM Vanhove.Johan@tchden.org
FU National Institutes of Health (Cholestatic Liver Disease Consortium) [U54 DK078377]; National Institutes of Health (Cholestatic Liver Disease Research and Education Network) [U01 DK062453]
CR Ahmad A, 1999, AM J MED GENET, V87, P331, DOI 10.1002/(SICI)1096-8628(19991203)87:4<331::AID-AJMG10>3.0.CO;2-K
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Amrani N, 2006, BIOCHEM SOC T, V34, P39, DOI 10.1042/BST0340039
   Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Naini A, 2007, METHOD CELL BIOL, V80, P437, DOI 10.1016/S0091-679X(06)80022-1
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Welch EM, 1999, EMBO J, V18, P6134, DOI 10.1093/emboj/18.21.6134
NR 19
TC 58
Z9 59
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD AUG 15
PY 2010
VL 68
IS 2
BP 159
EP 164
DI 10.1203/PDR.0b013e3181e5c3a4
PG 6
WC Pediatrics
SC Pediatrics
GA 629PJ
UT WOS:000280211900014
PM 20453710
DA 2024-11-01
ER

PT J
AU Fratter, C
   Gorman, GS
   Stewart, JD
   Buddles, M
   Smith, C
   Evans, J
   Seller, A
   Poulton, J
   Roberts, M
   Hanna, MG
   Rahman, S
   Omer, SE
   Klopstock, T
   Schoser, B
   Kornblum, C
   Czermin, B
   Lecky, B
   Blakely, EL
   Craig, K
   Chinnery, PF
   Turnbull, DM
   Horvath, R
   Taylor, RW
AF Fratter, C.
   Gorman, G. S.
   Stewart, J. D.
   Buddles, M.
   Smith, C.
   Evans, J.
   Seller, A.
   Poulton, J.
   Roberts, M.
   Hanna, M. G.
   Rahman, S.
   Omer, S. E.
   Klopstock, T.
   Schoser, B.
   Kornblum, C.
   Czermin, B.
   Lecky, B.
   Blakely, E. L.
   Craig, K.
   Chinnery, P. F.
   Turnbull, D. M.
   Horvath, R.
   Taylor, R. W.
TI The clinical, histochemical, and molecular spectrum of <i>PEO1</i> (Twinkle)-linked adPEO
SO NEUROLOGY
LA English
DT Article
ID progressive external ophthalmoplegia; dna-polymerase-gamma; recessive twinkle mutations; mitochondrial-dna; multiple deletions; gene mutation; phenotypic spectrum; optic atrophy; parkinsonism; ant1
AB Background: Mutations in the Twinkle (PEO1) gene are a recognized cause of autosomal dominant progressive external ophthalmoplegia (adPEO), resulting in the accumulation of multiple mitochondrial DNA (mtDNA) deletions and cytochrome c oxidase (COX)-deficient fibers in skeletal muscle secondary to a disorder of mtDNA maintenance. Patients typically present with isolated extraocular muscle involvement, with little apparent evidence of the clinical heterogeneity documented in other mtDNA maintenance disorders, in particular POLG-related disease. Methods: We reviewed the clinical, histochemical, and molecular genetics analysis of 33 unreported patients from 26 families together with all previous cases described in the literature to define the clinical phenotype associated with PEO1 mutations. Results: Ptosis and ophthalmoparesis were almost universal clinical features among this cohort, with 52%(17/33) reporting fatigue and 33%(11/33) having mild proximal myopathy. Features consistent with CNS involvement were rarely described; however, in 24% (8/33) of the patients, cardiac abnormalities were reported. Mitochondrial histochemical changes observed in muscle showed remarkable variability, as did the secondary mtDNA deletions, which in some patients were only detected by PCR-based assays and not Southern blotting. Moreover, we report 7 novel PEO1 variants. Conclusions: Our data suggest a shared clinical phenotype with variable mild multiorgan involvement, and that the contribution of PEO1 mutations as a cause of adPEO may well be underestimated. Direct sequencing of the PEO1 gene should be considered in adPEO patients prior to muscle biopsy. Neurology (R) 2010; 74: 1619-1626
C1 [Taylor, R. W.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Fratter, C.; Smith, C.; Evans, J.; Seller, A.] Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LJ, England.
   [Roberts, M.] Hope Hosp, Dept Neurol, Salford M6 8HD, Lancs, England.
   [Poulton, J.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Hanna, M. G.] Inst Neurol, UCL MRC Ctr Neuromuscular Dis, Dept Mol Neurosci, London WC1N 3BG, England.
   [Rahman, S.] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
   [Omer, S. E.] Univ London St Georges Hosp, Dept Neurol, London, England.
   [Klopstock, T.; Schoser, B.] LMU, Dept Neurol, Friedrich Baur Inst, Munich, Germany.
   [Czermin, B.] Ctr Med Genet, Munich, Germany.
   [Kornblum, C.] Univ Hosp Bonn, Dept Neurol, Munich, Germany.
   [Lecky, B.] Walton Ctr Neurol & Neurosurg NHS Trust, Liverpool, Merseyside, England.
C3 Newcastle University - UK; University of Oxford; University of Oxford; University of London; University College London; University of London; University College London; City St Georges, University of London; University of Munich; Walton Centre
RP Taylor, RW (corresponding author), Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU National Commissioning Group; UK NIHR Biomedical Research Centre for Aging; MRC [G0601943, G0800674, G0200335, G0500695] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   [Anonymous], 2002, STATISTICAL METHODS IN MEDICAL RESEARCH, V0, P0
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265
   Liu ZR, 2008, MOL VIS, V14, P1995
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Negro R, 2009, NEUROMUSCULAR DISORD, V19, P423, DOI 10.1016/j.nmd.2009.04.008
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 64
Z9 68
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 18
PY 2010
VL 74
IS 20
BP 1619
EP 1626
DI 10.1212/WNL.0b013e3181df099f
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 597OG
UT WOS:000277767000010
PM 20479361
DA 2024-11-01
ER

PT J
AU Bisceglia, L
   Zoccolella, S
   Torraco, A
   Piemontese, MR
   Dell'Aglio, R
   Amati, A
   De Bonis, P
   Artuso, L
   Copetti, M
   Santorelli, FM
   Serlenga, L
   Zelante, L
   Bertini, E
   Petruzzella, V
AF Bisceglia, Luigi
   Zoccolella, Stefano
   Torraco, Alessandra
   Piemontese, Maria Rosaria
   Dell'Aglio, Rosa
   Amati, Angela
   De Bonis, Patrizia
   Artuso, Lucia
   Copetti, Massimiliano
   Santorelli, Filippo Maria
   Serlenga, Luigi
   Zelante, Leopoldo
   Bertini, Enrico
   Petruzzella, Vittoria
TI A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE autosomal-dominant limb-girdle muscular dystrophy; multiple mtDNA deletions; linkage analysis; chromosome 3
ID identification; mutations; linkage; deletions; descent; maps
AB Limb-girdle muscular dystrophies (LGMDs) are a genetically heterogeneous group of neuromuscular disorders with a selective or predominant involvement of shoulder and pelvic girdles. We clinically examined 19 members in a four-generation Italian family with autosomal-dominant LGMD. A total of 11 subjects were affected. Clinical findings showed variable expressivity in terms of age at onset and disease severity. Five subjects presented with a slowly progressive proximal muscle weakness, in both upper and lower limbs, with onset during the fourth-fifth decade of life, which fulfilled the consensus diagnostic criteria for LGMD. Earlier onset of the disease was observed in a group of patients presenting with muscle weakness and/or calf hypertrophy, and/or occasionally high CK and lactate serum levels. Two muscle biopsies showed morphological findings compatible with MD associated with subsarcolemmal accumulation of mitochondria and the presence of multiple mitochondrial DNA deletions. A genome-wide scan performed using microsatellite markers mapped the disease on chromosome 3p23-p25.1 locus in a 25-cM region between markers D3S1263 and D3S3685. The highest two-point LOD score was 3.26 (theta=0) at marker D3S1286 and D3S3613, whereas non-parametric analysis reached a P-value=0.0004. Four candidate genes within the refined region were analysed but did not reveal any mutations. Our findings further expand the clinical and genetic heterogeneity of LGMDs. European Journal of Human Genetics (2010) 18, 636-641; doi: 10.1038/ejhg.2009.235; published online 13 January 2010
C1 [Torraco, Alessandra; Dell'Aglio, Rosa; Artuso, Lucia; Petruzzella, Vittoria] Univ Bari, Dept Med Biochem Biol & Phys, I-00165 Bari, Italy.
   [Bisceglia, Luigi; Piemontese, Maria Rosaria; De Bonis, Patrizia; Zelante, Leopoldo] IRCCS Osped Casa Sollievo Sofferenza, Med Genet Unit, Dept Evolut Age, Foggia, Italy.
   [Zoccolella, Stefano] Osped Riuniti Foggia, Clin Nervous Syst Dis, Foggia, Italy.
   [Torraco, Alessandra; Santorelli, Filippo Maria; Bertini, Enrico] IRCCS Osped Bambino Gesu, Rome, Italy.
   [Amati, Angela] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy.
   [Copetti, Massimiliano] IRCCS Osped Casa Sollievo Sofferenza, Biostat Unit, Foggia, Italy.
   [Serlenga, Luigi] L Bonomo Hosp, Operat Unit Neurol, Andria, Italy.
   [Petruzzella, Vittoria] CNR, Inst Biomembranes & Bioenerget, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; IRCCS Bambino Gesu; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Consiglio Nazionale delle Ricerche (CNR)
RP Petruzzella, V (corresponding author), Univ Bari, Dept Med Biochem Biol & Phys, Piazza Giulio Cesare 11, I-00165 Bari, Italy.
EM v.petruzzella@biochem.uniba.it
FU Italian Ministry of Health; MIUR-PRIN [2005052128_001]; Research Foundation Cassa di Risparmio di Puglia
CR Beckmann J S, 1999, NEUROMUSCUL DISORD, V9, P436, DOI 10.1016/S0960-8966(99)00064-4
   Bisceglia L, 2009, INVEST OPHTH VIS SCI, V50, P1081, DOI 10.1167/iovs.08-2382
   BUSHBY KMD, 1997, DIAGNOSTIC CRITERIA, V0, P17
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Futai E, 2001, BBA-GENE STRUCT EXPR, V1517, P316, DOI 10.1016/S0167-4781(00)00256-6
   Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450
   Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2
   Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Jung-Ching Lin Jim, 2005, J MED SCI, V25, P215
   Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896
   Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175
   Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Sobel E, 1996, AM J HUM GENET, V58, P1323
   Speer MC, 1999, AM J HUM GENET, V64, P556, DOI 10.1086/302252
   Starling A, 2004, EUR J HUM GENET, V12, P1033, DOI 10.1038/sj.ejhg.5201289
   vanderKooi AJ, 1997, AM J HUM GENET, V60, P891
   Weeks DE, 1990, AM J HUM GENET, V47, P0
   WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
NR 24
TC 17
Z9 19
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUN 15
PY 2010
VL 18
IS 6
BP 636
EP 641
DI 10.1038/ejhg.2009.235
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 599DR
UT WOS:000277890900003
PM 20068593
DA 2024-11-01
ER

PT J
AU Abramov, AY
   Smulders-Srinivasan, TK
   Kirby, DM
   Acin-Perez, R
   Enriquez, JA
   Lightowlers, RN
   Duchen, MR
   Turnbull, DM
AF Abramov, Andrey Y.
   Smulders-Srinivasan, Tora K.
   Kirby, Denise M.
   Acin-Perez, Rebeca
   Antonio Enriquez, Jose
   Lightowlers, Robert N.
   Duchen, Michael R.
   Turnbull, Douglass M.
TI Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations
SO BRAIN
LA English
DT Article
DE mitochondrial diseases; oxidative stress; calcium signalling; neuronal degeneration; neuronal loss
ID substantia-nigra neurons; cell-death; 1555a-greater-than-g mutation; mtdna mutations; human-disease; calcium; glutathione; prevalence; deletions; brain
AB Mutations of mitochondrial DNA are associated with a wide spectrum of disorders, primarily affecting the central nervous system and muscle function. The specific consequences of mitochondrial DNA mutations for neuronal pathophysiology are not understood. In order to explore the impact of mitochondrial mutations on neuronal biochemistry and physiology, we have used fluorescence imaging techniques to examine changes in mitochondrial function in neurons differentiated from mouse embryonic stem-cell cybrids containing mitochondrial DNA polymorphic variants or mutations. Surprisingly, in neurons carrying a severe mutation in respiratory complex I (< 10% residual complex I activity) the mitochondrial membrane potential was significantly increased, but collapsed in response to oligomycin, suggesting that the mitochondrial membrane potential was maintained by the F(1)F(o) ATPase operating in 'reverse' mode. In cells with a mutation in complex IV causing similar to 40% residual complex IV activity, the mitochondrial membrane potential was not significantly different from controls. The rate of generation of mitochondrial reactive oxygen species, measured using hydroethidium and signals from the mitochondrially targeted hydroethidine, was increased in neurons with both the complex I and complex IV mutations. Glutathione was depleted, suggesting significant oxidative stress in neurons with a complex I deficiency, but not in those with a complex IV defect. In the neurons with complex I deficiency but not the complex IV defect, neuronal death was increased and was attenuated by reactive oxygen species scavengers. Thus, in neurons with a severe mutation of complex I, the maintenance of a high potential by F(1)F(o) ATPase activity combined with an impaired respiratory chain causes oxidative stress which promotes cell death.
C1 [Abramov, Andrey Y.] UCL, Dept Mol Neurosci, Inst Neurol, London WC1N 3BG, England.
   [Smulders-Srinivasan, Tora K.; Kirby, Denise M.; Lightowlers, Robert N.; Turnbull, Douglass M.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Kirby, Denise M.] Royal Childrens Hosp, Mitochondrial & Metab Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Acin-Perez, Rebeca; Antonio Enriquez, Jose] Univ Zaragoza, Dept Bioquim, Zaragoza, Spain.
   [Acin-Perez, Rebeca; Antonio Enriquez, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.
   [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.
C3 University of London; University College London; Newcastle University - UK; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Zaragoza; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of London; University College London
RP Abramov, AY (corresponding author), UCL, Dept Mol Neurosci, Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM a.abramov@ucl.ac.uk
FU Wellcome Trust; UK NIHR Biomedical Research Centre for Ageing and Age- related disease; BBSRC; EPSRC; ESRC; MRC; NRSA (NINDS, NIH, USA); National Health and Medical Research Council of AUSTRALIA (NHMRC); MRC [G0700718, G0601943] Funding Source: UKRI
CR Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017
   Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795
   CARAFOLI E, 1964, J BIOL CHEM, V239, P3055
   CROMPTON M, 1978, EUR J BIOCHEM, V91, P599, DOI 10.1111/j.1432-1033.1978.tb12713.x
   Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059
   Duchen MR, 2003, METHOD ENZYMOL, V361, P353
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085
   Kirby DM, 2009, CELL PROLIFERAT, V42, P413, DOI 10.1111/j.1365-2184.2009.00612.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SNYDER CD, 1983, J NEUROCHEM, V40, P1178, DOI 10.1111/j.1471-4159.1983.tb08111.x
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   VASINGTON FD, 1962, J BIOL CHEM, V237, P2670
   Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200
   WERTH JL, 1994, J NEUROSCI, V14, P348
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
NR 35
TC 99
Z9 107
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 
J9 BRAIN
JI Brain
PD MAR 15
PY 2010
VL 133
IS 
BP 797
EP 807
DI 10.1093/brain/awq015
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 575DI
UT WOS:000276046000015
PM 20157008
DA 2024-11-01
ER

PT J
AU Suen, DF
   Narendra, DP
   Tanaka, A
   Manfredi, G
   Youle, RJ
AF Suen, Der-Fen
   Narendra, Derek P.
   Tanaka, Atsushi
   Manfredi, Giovanni
   Youle, Richard J.
TI Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE autophagy; neurodegeneration; Parkinson disease; PINK1; mitochondria
ID mitochondrial-dna deletions; substantia-nigra neurons; helicase twinkle; gene-product; disease; mitophagy; mutants; drosophila-pink1; complementation; degeneration
AB Mitochondrial genomes with deleterious mutations can replicate in cells along with wild-type genomes in a state of heteroplasmy, and are a cause of severe inherited syndromes, such as mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS), neuropathy, ataxia, retinitis pigmentosa-maternally inherited Leigh syndrome (NARP-MILS), and Leber's hereditary optic neuropathy (LHON). The cytosolic E3 ligase, Parkin, commonly mutated in recessive familial parkinsonism, translocates to depolarized mitochondria and induces their autophagic elimination, suggesting that Parkin may signal the selective removal of defective mitochondria within the cell. We report that long-term overexpression of Parkin can eliminate mitochondria with deleterious COXI mutations in heteroplasmic cybrid cells, thereby enriching cells for wild-type mtDNA and restoring cytochrome c oxidase activity. After relieving cybrid cells of Parkin overexpression, a more favorable wild-type to mutant mitochondrial genome ratio is stably maintained. These data support the model that Parkin functions in a mitochondrial quality control pathway. Additionally, they suggest that transiently increasing levels of Parkin expression might ameliorate certain mitochondrial diseases.
C1 [Suen, Der-Fen; Narendra, Derek P.; Tanaka, Atsushi; Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
   [Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Cornell University; Weill Cornell Medicine
RP Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
EM youler@ninds.nih.gov
FU National Institute of Neurological Disorders and Stroke at the National Institutes of Health
CR Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   McCormick AL, 2003, J VIROL, V77, P631, DOI 10.1128/JVI.77.1.631-641.2003
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   SHOUBRIDGE EA, 1995, BIOCHEM BIOPH RES CO, V213, P189, DOI 10.1006/bbrc.1995.2115
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
NR 34
TC 254
Z9 298
U1 2
U2 20
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 29
PY 2010
VL 107
IS 26
BP 11835
EP 11840
DI 10.1073/pnas.0914569107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 618DT
UT WOS:000279332300034
PM 20547844
DA 2024-11-01
ER

PT J
AU Babusikova, E
   Jesenak, M
AF Babusikova, Eva
   Jesenak, Milos
TI MITOCHONDRIA AND AGEING: DO MITOCHONDRIA PLAY A (KEY) ROLE?
SO MITOCHONDRIA: STRUCTURE, FUNCTIONS AND DYSFUNCTIONS
LA English
DT Article; Book Chapter
ID nitric-oxide-synthase; free-radical theory; hydrogen-peroxide production; membrane-lipid-peroxidation; oxidative stress; alzheimers-disease; protein oxidation; dna deletions; skeletal-muscle; degenerative diseases
AB Ageing is a fascinating topic that engaged philosophers and scientists for centuries. Nevertheless, it is very difficult to define precisely the term "ageing". There is no simple definition, which would be universally accepted. Ageing is inevitable, a complex biological process which can be characterized as a progressive deterioration of physiological functions and metabolic processes after the reproductive phase of life. In the process of ageing is the gradual accumulation of changes with time, which are connected or responsible for the ever-increasing susceptibility to disease and death with increasing age. One of theory which tries to explain senescence is free radical theory of ageing or oxidative damage theory of ageing. There is an increase level of reactive oxygen species and sequential accumulation of oxidative damage of biomolecules during ageing. This damage may by the most important contribution to ageing and ageing-related diseases. All organisms live in an environment containing reactive oxygen species and mitochondrial respiratory chain which generate reactive species. Mitochondrial theory of ageing, a hypothesis of free radical theory of ageing, suggests that accumulation of mitochondrial oxidative damage leads to human and animal ageing because mitochondria are the main source and target of reactive oxygen species. There is increasing evidence that bioenergetic function of mitochondria and mitochondrial antioxidant pool decrease with advancing of age in several tissues. Literature is full of controversy results. Oxidative modification of proteins, saccharides, nucleic acid (nuclear and mitochondria!) and lipid peroxidation were observed in different tissues, cells, compartments, including mitochondria with advancing of age. On the other hand also no significant changes in level of oxidative damage products were observed during ageing. We observed different kind of mitochondrial oxidative changes in the brain and in the heart during ageing. Our understanding of the role played by reactive oxygen species and by mitochondria in disease pathology and ageing is still insufficient. Little is known about mechanisms responsible for the deleterious changes seen during both normal ageing and diseases. Mitochondrial changes, oxidative damages in mitochondria with advancing age and mitochondrial dysfunction in cardiovascular and neurodegenerative diseases will be discussed in this chapter.
C1 [Babusikova, Eva] Comenius Univ, Dept Med Biochem, Jessenius Fac Med Martin, Martin 03601, Slovakia.
   [Jesenak, Milos] Comenius Univ, Dept Paediat, Jessenius Fac Med Martin, Martin 03601, Slovakia.
C3 Comenius University Bratislava; Comenius University Bratislava
RP Babusikova, E (corresponding author), Comenius Univ, Dept Med Biochem, Jessenius Fac Med Martin, Mala Flora 4, Martin 03601, Slovakia.
EM babusikova@jfmed.uniba.sk
CR Agarwal S, 1995, MECH AGEING DEV, V85, P55, DOI 10.1016/0047-6374(95)01655-4
   Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X
   AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ATAKA K, 1992, CIRCULATION, V86, P371
   Babusikova E, 2008, GEN PHYSIOL BIOPHYS, V27, P115
   Babusikova E, 2007, NEUROCHEM RES, V32, P1351, DOI 10.1007/s11064-007-9314-0
   Babusíková E, 2004, GEN PHYSIOL BIOPHYS, V23, P327
   Babusíková E, 2008, PHYSIOL RES, V57, PS49, DOI 10.33549/physiolres.931551
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839
   Bauer V, 1994, BRATISL LEK LISTY, V95, P243
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERGENDI L, 1999, BIOCHEM BIOPH RES CO, V186, P782
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BURDON RH, 1989, FREE RADICAL RES COM, V6, P345, DOI 10.3109/10715768909087918
   Byrne E, 2002, J CLIN NEUROSCI, V9, P497, DOI 10.1054/jocn.2001.0991
   Çakatay U, 2001, EXP GERONTOL, V36, P221, DOI 10.1016/S0531-5565(00)00197-2
   Cash AD, 2002, NEUROSCIENTIST, V8, P489, DOI 10.1177/107385802236968
   Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002
   CHEN JJ, 1995, FREE RADICAL BIO MED, V19, P583, DOI 10.1016/0891-5849(95)00066-7
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007
   CITRON M, 1940, P NATL ACAD SCI USA, V93, P13170
   COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0
   David H, 1981, EXP PATHOL SUPPL (1981), V7, P1
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302
   Dean RT, 1997, BIOCHEM J, V324, P1
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002
   Dhalla NS, 1999, CAN J CARDIOL, V15, P587
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DREW B, 2002, ANN NY ACAD SCI, V659, P66
   Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497
   DUPUY C, 1991, J BIOL CHEM, V266, P3739
   DUTHIE GG, 1991, AM J CLIN NUTR, V53, PS1061, DOI 10.1093/ajcn/53.4.1061S
   ERMINI M, 1976, GERONTOLOGY, V22, P301, DOI 10.1159/000212145
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Fu S, 1998, MOL BIOL FREE RADICA, V0, P29
   Fukagawa NK, 2000, ANTIOXID REDOX SIGN, V2, P379, DOI 10.1089/15230860050192152
   Fukagawa NK, 1999, P SOC EXP BIOL MED, V222, P293, DOI 10.1046/j.1525-1373.1999.d01-146.x
   Gao J, 1998, BIOCHEMISTRY-US, V37, P9536, DOI 10.1021/bi9803877
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   Girotti AW, 1998, J LIPID RES, V39, P1529
   GIULIVI C, 1994, METHOD ENZYMOL, V233, P363
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006
   GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913
   HALLIWELL B, 1989, FREE RADICAL RES COM, V5, P315, DOI 10.3109/10715768909073413
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   Halliwell B, 1999, FREE RADICAL BIOL ME, V0, P0
   Hanafy K A, 2001, MED SCI MONIT, V7, P801
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   Hayashi H, 1998, EUR J PHARMACOL, V349, P133, DOI 10.1016/S0014-2999(98)00266-0
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270
   Hernanz A, 2000, LIFE SCI, V67, P1317, DOI 10.1016/S0024-3205(00)00722-0
   HIRSCH EC, 1993, EUR NEUROL, V33, P52, DOI 10.1159/000118538
   Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i
   James T N, 1994, TRANS AM CLIN CLIMATOL ASSOC, V105, P145
   Jenner P, 2003, ANN NEUROL, V53, PS26, DOI 10.1002/ana.10483
   Jourdheuil D, 2001, J BIOL CHEM, V276, P28799, DOI 10.1074/jbc.M102341200
   KANUNGO MS, 1975, J THEOR BIOL, V53, P253, DOI 10.1016/S0022-5193(75)80002-6
   Kaplan P, 2007, MOL CELL BIOCHEM, V301, P219, DOI 10.1007/s11010-007-9414-9
   Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616
   KAUL N, 1993, J PHARMACOL TOX MET, V30, P55, DOI 10.1016/1056-8719(93)90008-3
   Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200
   Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1
   Kelley EE, 1999, ARCH BIOCHEM BIOPHYS, V370, P97, DOI 10.1006/abbi.1999.1386
   KING PA, 1992, J AM CHEM SOC, V114, P5430, DOI 10.1021/ja00039a068
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Knight JA, 1998, ANN CLIN LAB SCI, V28, P331
   KOSHLAND DE, 1992, SCIENCE, V258, P1861, DOI 10.1126/science.1470903
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kröncke KD, 2001, FASEB J, V15, P2503, DOI 10.1096/fj.01-0240hyp
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Kumaran S, 2004, CHEM-BIOL INTERACT, V148, P11, DOI 10.1016/j.cbi.2003.10.010
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LAKATTA EG, 1990, EUR HEART J, V11, P22, DOI 10.1093/eurheartj/11.suppl_C.22
   Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Lamperti C, 2009, ACTA MYOL, V28, P2
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   LESNEFSKY EJ, 1991, CIRC RES, V68, P605, DOI 10.1161/01.RES.68.2.605
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu CY, 2009, J FORMOS MED ASSOC, V108, P599, DOI 10.1016/S0929-6646(09)60380-6
   Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510
   Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689
   LUCKING CB, 1995, BIOCHEM BIOPH RES CO, V211, P700, DOI 10.1006/bbrc.1995.1868
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004
   Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   Müller-Strahl G, 2000, J PHYSIOL-LONDON, V522, P311, DOI 10.1111/j.1469-7793.2000.00311.x
   NATHAN C, 1994, J BIOL CHEM, V269, P13725
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, PR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, PR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, PC670, DOI 10.1152/ajpcell.00213.2006
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6
   Parks JK, 2001, J NEUROCHEM, V76, P1050, DOI 10.1046/j.1471-4159.2001.00112.x
   Perry G, 2002, COMP BIOCHEM PHYS C, V133, P507, DOI 10.1016/S1532-0456(02)00119-9
   Phillips JP, 2000, EXP GERONTOL, V35, P1157, DOI 10.1016/S0531-5565(00)00117-0
   Pignatelli B, 2001, CANCER RES, V61, P778
   PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x
   Pollack ML, 1999, HANDBOOK OF OXIDANTS AND ANTIOXIDANTS IN EXERCISE, V0, P0
   Probst A, 1991, BRAIN PATHOL, V1, P229, DOI 10.1111/j.1750-3639.1991.tb00666.x
   RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7
   RADI R, 1991, J BIOL CHEM, V266, P4244
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Robert M, 2007, NEUROL INDIA, V55, P11, DOI 10.4103/0028-3886.30420
   SACHS HG, 1977, AM J ANAT, V150, P63, DOI 10.1002/aja.1001500105
   Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8
   Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200
   Sastre J, 2000, IUBMB LIFE, V49, P427
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHECTMAN G, 1991, AM J CLIN NUTR, V53, P1466, DOI 10.1093/ajcn/53.6.1466
   Schon Eric A, 1998, BIOFACTORS, V7, P191
   Schöneich C, 1999, EXP GERONTOL, V34, P19, DOI 10.1016/S0531-5565(98)00066-7
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Semsei I, 2000, MECH AGEING DEV, V117, P93, DOI 10.1016/S0047-6374(00)00147-0
   Shacter E, 2000, METHOD ENZYMOL, V319, P428
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Shoffner JM, 2001, SEMIN NEUROL, V21, P237, DOI 10.1055/s-2001-17941
   Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9
   Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002
   Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   Sohal RS, 1997, FASEB J, V11, P1269, DOI 10.1096/fasebj.11.14.9409545
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   Sohal RS, 1995, LIFE SCI R, V56, P109
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   Sorescu Dan, 2002, CONGEST HEART FAIL, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r
   STEIN G, 1948, NATURE, V161, P650, DOI 10.1038/161650a0
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044
   Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1
   Valdez Laura B, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P49, DOI 10.1016/j.mam.2004.02.008
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wei Y H, 2001, ZHONGHUA YI XUE ZA ZHI (TAIPEI), V64, P259
   Wei YH, 1996, ANN NY ACAD SCI, V786, P24, DOI 10.1111/j.1749-6632.1996.tb39049.x
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6
   Wink DA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P802
   WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813
   Xiong K, 2007, EXP BRAIN RES, V181, P435, DOI 10.1007/s00221-007-0943-y
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yang ZW, 1997, BIOSCIENCE REP, V17, P557, DOI 10.1023/A:1027316424985
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   Yu BP, 1996, ANN NY ACAD SCI, V786, P44, DOI 10.1111/j.1749-6632.1996.tb39050.x
NR 207
TC 0
Z9 0
U1 0
U2 6
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
SN 
EI 
J9 CELL BIO RES PROG
PD JUN 15
PY 2010
VL 0
IS 
BP 377
EP 410
DI 
PG 34
WC Cell Biology
SC Cell Biology
GA BTG89
UT WOS:000286916800007
DA 2024-11-01
ER

PT J
AU He, ZW
   Zhang, CD
AF He, Zhenwei
   Zhang, Chaodong
TI Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes correlates with heteroplasmic mutations of mitochondrial DNA 3243 <i>A single-case genealogy analysis</i>
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE MELAS syndrome; mitochondrial mutation; heteroplasmic level; clinical behavior
ID a3243g mutation; melas; encephalopathy; quantification; management; diagnosis; phenotype; myopathy; features
AB BACKGROUND: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a common syndrome of mitochondrial diseases caused primarily by a mutation from adenine to guanine at mitochondrial DNA 3243. However, the correlation between heteroplasmic mutations and clinical characteristics of hereditary MELAS syndrome is unclear. OBJECTIVE: To survey the clinical behaviors, biochemical outcomes, and imaging data in a patient with suspected MELAS syndrome by maternal inheritance, and to investigate the correlation with heteroplasmic mutations of hemocyte mitochondrial DNA. DESIGN, TIME AND SETTING: A case analysis based on hereditary family surgery was performed in the Enliang Hospital of Anshan, Taian County, and biochemical tests and gene diagnosis were performed at the Department of Laboratory and Institute of Neurology, the First Affiliated Hospital of China Medical University, between March and September 2009. PARTICIPANTS: A 22-year-old female patient with MELAS syndrome was diagnosed in the First Affiliated Hospital of China Medical University in January, 2009. She had five males and seven females in her maternal family. METHODS: We obtained stroke and convulsion history in the patient and her family, as well as performing routine blood tests, plasma lactic acid levels before and after movement, and magnetic resonance of the head. A mutation at m.3243A > G was verified using polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing, and quantitated using real-time polymerase chain reaction. MAIN OUTCOME MEASURES: Correlation of clinical behaviors and biochemical outcomes, as well as imaging data with heteroplasmic mutations in family members with typical and atypical MELAS syndrome. RESULTS: Some family members had typical symptoms of convulsion, stroke, and MELAS syndrome, as well as atypical symptoms of microsomia, movement intolerance, febrile, and migraine. Magnetic resonance of the head was consistent with typical imaging data of MELAS syndrome during attacks, and family members showed cerebellar atrophy. A heteroplasmic mutation of mitochondrial DNA 3243 occurred in all family members, although higher levels caused severe typical symptoms. The age of first-onset convulsion was negatively correlated with level of heteroplasmic mutation (r = -0.852, P < 0.05), but lactic acid was positively correlated with mutation levels (before movement, r = 0.945, P < 0.001; after movement, r = 0.945, P < 0.001). CONCLUSION: MELAS syndrome was diagnosed in this family by maternal inheritance, and the etiological factor was a mutation of mitochondrial A3243G. The level of heteroplasmic mutation correlated with anticipated convulsion and lactic acid levels.
C1 [He, Zhenwei; Zhang, Chaodong] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Liaoning Prov, Peoples R China.
C3 China Medical University
RP Zhang, CD (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Liaoning Prov, Peoples R China.
EM xcdzhang@163.com
CR Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chou HF, 2008, PEDIATR NEUROL, V38, P143, DOI 10.1016/j.pediatrneurol.2007.09.015
   da Rocha AJ, 2008, J NEUROIMAGING, V18, P1, DOI 10.1111/j.1552-6569.2007.00205.x
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kang CS, 2008, NEURAL REGEN RES, V3, P652
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Lau KK, 2007, INT UROL NEPHROL, V39, P941, DOI 10.1007/s11255-006-9172-8
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Mizrachi IB, 2006, J NEURO-OPHTHALMOL, V26, P38, DOI 10.1097/01.wno.0000204662.25935.8b
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Strand H, 2008, CLIN CHIM ACTA, V390, P126, DOI 10.1016/j.cca.2008.01.010
   Tierney MC, 1997, ARCH NEUROL-CHICAGO, V54, P713, DOI 10.1001/archneur.1997.00550180035009
   VANADEL BA, 2009, CLIN NEUROMUSCL DIS, V10, P97
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Zhang Shi, 2009, CHINESE MEDICAL SCIENCES JOURNAL, V24, P20
NR 30
TC 0
Z9 0
U1 1
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD FEB 15
PY 2010
VL 5
IS 4
BP 295
EP 300
DI 10.3969/j.issn.1673-5374.2010.04.010
PG 6
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 573PB
UT WOS:000275925500010
DA 2024-11-01
ER

PT J
AU Borlado, MCG
   Lastres, DM
   Hoyuela, MG
   Moran, M
   Blazquez, A
   Pello, R
   Buera, LM
   Gabaldon, T
   Peñas, JJG
   Martín, MA
   Arenas, J
   Ugalde, C
AF Gil Borlado, Mari Carmen
   Moreno Lastres, David
   Gonzalez Hoyuela, Maritza
   Moran, Maria
   Blazquez, Alberto
   Pello, Rosa
   Marin Buera, Lorena
   Gabaldon, Toni
   Garcia Penas, Juan Jose
   Martin, Miguel A.
   Arenas, Joaquin
   Ugalde, Cristina
TI Impact of the Mitochondrial Genetic Background in Complex III Deficiency
SO PLOS ONE
LA English
DT Article
ID cytochrome-b gene; missense mutation; sequence; model; mtdna
AB Background: In recent years clinical evidence has emphasized the importance of the mtDNA genetic background that hosts a primary pathogenic mutation in the clinical expression of mitochondrial disorders, but little experimental confirmation has been provided. We have analyzed the pathogenic role of a novel homoplasmic mutation (m. 15533 A>G) in the cytochrome b (MT-CYB) gene in a patient presenting with lactic acidosis, seizures, mild mental delay, and behaviour abnormalities. Methodology: Spectrophotometric analyses of the respiratory chain enzyme activities were performed in different tissues, the whole muscle mitochondrial DNA of the patient was sequenced, and the novel mutation was confirmed by PCR-RFLP. Transmitochondrial cybrids were constructed to confirm the pathogenicity of the mutation, and assembly/stability studies were carried out in fibroblasts and cybrids by means of mitochondrial translation inhibition in combination with blue native gel electrophoresis. Principal Findings: Biochemical analyses revealed a decrease in respiratory chain complex III activity in patient's skeletal muscle, and a combined enzyme defect of complexes III and IV in fibroblasts. Mutant transmitochondrial cybrids restored normal enzyme activities and steady-state protein levels, the mutation was mildly conserved along evolution, and the proband's mother and maternal aunt, both clinically unaffected, also harboured the homoplasmic mutation. These data suggested a nuclear genetic origin of the disease. However, by forcing the de novo functioning of the OXPHOS system, a severe delay in the biogenesis of the respiratory chain complexes was observed in the mutants, which demonstrated a direct functional effect of the mitochondrial genetic background. Conclusions: Our results point to possible pitfalls in the detection of pathogenic mitochondrial mutations, and highlight the role of the genetic mtDNA background in the development of mitochondrial disorders.
C1 [Gil Borlado, Mari Carmen; Moreno Lastres, David; Gonzalez Hoyuela, Maritza; Moran, Maria; Blazquez, Alberto; Pello, Rosa; Marin Buera, Lorena; Martin, Miguel A.; Arenas, Joaquin; Ugalde, Cristina] Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain.
   [Moreno Lastres, David; Moran, Maria; Blazquez, Alberto; Marin Buera, Lorena; Martin, Miguel A.; Arenas, Joaquin; Ugalde, Cristina] CIBERER, U723, Madrid, Spain.
   [Gabaldon, Toni] CRG, Barcelona, Spain.
   [Garcia Penas, Juan Jose] Hosp Univ Nino Jesus, Serv Neurol, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)
RP Borlado, MCG (corresponding author), Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain.
EM cugalde@h12o.es
FU Fundacion de Investigacion Biomedica del Hospital Universitario 12 de Octubre/Agencia Pedro Lain Entralgo; Instituto de Salud Carlos III (ISCIII) [PI05-0379, PI08-0021, PI09-01359, PI060213]; Spanish Ministry of Science (MICINN) [BFU2009-09168]
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Apweiler R, 2010, NUCLEIC ACIDS RES, V38, PD142, DOI 10.1093/nar/gkp846
   BAUM H, 1967, P NATL ACAD SCI USA, V57, P798, DOI 10.1073/pnas.57.3.798
   Bénit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004
   BROWN MD, 1992, GENETICS, V130, P163
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Fuku N, 2002, BIOCHEM BIOPH RES CO, V290, P1199, DOI 10.1006/bbrc.2002.6330
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Martinez B, 2001, J NEUROCHEM, V78, P1054, DOI 10.1046/j.1471-4159.2001.00487.x
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Suissa S, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000474
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Wang LM, 2001, J MATER SCI TECHNOL, V17, P263
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60
NR 31
TC 29
Z9 29
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD SEP 17
PY 2010
VL 5
IS 9
BP 
EP 
DI 10.1371/journal.pone.0012801
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 651XL
UT WOS:000281960800014
PM 20862300
DA 2024-11-01
ER

PT J
AU Quiles, JL
   Pamplona, R
   Ramirez-Tortosa, MC
   Naudí, A
   Portero-Otin, M
   Araujo-Nepomuceno, E
   López-Frías, M
   Battino, M
   Ochoa, JJ
AF Quiles, Jose L.
   Pamplona, Reinald
   Carmen Ramirez-Tortosa, M.
   Naudi, Alba
   Portero-Otin, Manuel
   Araujo-Nepomuceno, Eduardo
   Lopez-Frias, Magdalena
   Battino, Maurizio
   Ochoa, Julio J.
TI Coenzyme Q addition to an n-6 PUFA-rich diet resembles benefits on age-related mitochondrial DNA deletion and oxidative stress of a MUFA-rich diet in rat heart
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AIF; Carbonyls; Cytochrome c oxidase; Sunflower oil; Ubiquinone; Virgin olive oil
ID apoptosis-inducing factor; electron-transport chain; acid (pufa)-rich diet; double-strand-breaks; life-span; caloric restriction; lipid-peroxidation; skeletal-muscle; aging heart; fat type
AB Age-related changes in cardiomyocytes reduce the capacity to recover from acute injury or to adapt during chronic disease in advanced age N-6 polyunsaturated fatty acids (n-6PUFA) lead to higher lipid peroxidation during aging than the less oxidizable monosaturated fatty acids (MUFA); and coenzyme Q(CoQ)-supplemented n-6PUFA lengthens the lifespan and reduces peroxidation in comparison to non-supplemented n-6PUFA Here, lifelong feeding on MUFA, n-6PUFA, and n-6 PUFA + CoQ was compared regarding age-related alterations in rat heart. Less mitochondrial area and perimeter were reported for aged n-6 PUFA-fed animals while MUFA led to a higher density of mitochondrial cristae. Mitochondrial complexes and cyrochrome c oxidase activity decreased with aging (except complex I and cytochrome c oxidase in n-6 PUFA + CoQ), while increased apoptosis-inducing factor was found with aging MUFA led to lower mitochondrial DNA-deletion frequency.The lowest hydroperoxide levels for aged animals were found for n-6 PUFA + CoQ, which also showed lower concentrations than did n-6 PUFA. For protein oxidation, specific carbonyl compounds were lower in aged animals; meanwhile lipoxidation-derived protein-oxidation markers were higher The results suggest that MUFA can protect mitochondria from age-related changes, and that CoQ supplementation to n-6 PUFA partially resembles MUFA benefits. Moreover, under our experimental conditions, lipid-derived oxidative damage appears to be more important than the pure protein-derived oxidative damage during aging (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Quiles, Jose L.; Carmen Ramirez-Tortosa, M.; Araujo-Nepomuceno, Eduardo; Lopez-Frias, Magdalena; Ochoa, Julio J.] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, E-18071 Granada, Spain.
   [Quiles, Jose L.; Lopez-Frias, Magdalena; Ochoa, Julio J.] Univ Granada, Dept Physiol, E-18071 Granada, Spain.
   [Pamplona, Reinald; Naudi, Alba; Portero-Otin, Manuel] Univ Lleida, Dept Expt Med, Lleida, Spain.
   [Carmen Ramirez-Tortosa, M.] Univ Granada, Dept Biochem & Mol Biol 2, E-18071 Granada, Spain.
   [Battino, Maurizio] Polytech Univ Marche, Inst Biochem, Fac Med, Granada, Spain.
C3 University of Granada; University of Granada; Universitat de Lleida; University of Granada
RP Quiles, JL (corresponding author), Univ Granada, Inst Nutr & Tecnol Alimentos Jose Mataix Verdu, Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Lab 120,Ave Conocimi, E-18071 Granada, Spain.
CR *AHA, 2007, HEART STROK STAT UPD, V0, P0
   AMICI A, 1989, J BIOL CHEM, V264, P3341
   [Anonymous], 2005, DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   BATTINO M, 1986, FEBS LETT, V199, P155, DOI 10.1016/0014-5793(86)80470-7
   Battino M, 2002, J BIOENERG BIOMEMBR, V34, P127, DOI 10.1023/A:1015128009826
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Fleischer S, 1979, METHODS ENZYMOL, V55, P32
   Genova ML, 1999, BIOFACTORS, V9, P345, DOI 10.1002/biof.5520090234
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hsu CP, 2008, BIOL CHEM, V389, P221, DOI 10.1515/BC.2008.032
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, PC1983, DOI 10.1152/ajpcell.00285.2006
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, PH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   Lakatta E G, 2001, NOVARTIS FOUND SYMP, V235, P172
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358
   Miles MV, 2004, CLIN CHIM ACTA, V347, P139, DOI 10.1016/j.cccn.2004.04.003
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   MUSCARI C, 1993, MECH AGEING DEV, V67, P1, DOI 10.1016/0047-6374(93)90107-3
   NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357
   Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Perez-Jimenez F, 2005, EUR J CLIN INVEST, V35, P421, DOI 10.1111/j.1365-2362.2005.01516.x
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, PR423, DOI 10.1152/ajpregu.00296.2001
   Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Quiles JL, 2005, BIOFACTORS, V25, P73, DOI 10.1002/biof.5520250109
   Rasband WS, 2008, IMAGEJ, V0, P0
   Reeves P G, 1997, J NUTR, V127, P838S, DOI 10.1093/jn/127.5.838S
   Rosamond W, 2008, CIRCULATION, V117, PE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Sohal RS, 2007, MITOCHONDRION, V7, PS103, DOI 10.1016/j.mito.2007.03.006
   Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
   VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4
   Wessells RJ, 2007, SEMIN CELL DEV BIOL, V18, P111, DOI 10.1016/j.semcdb.2006.12.011
   Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002
NR 66
TC 41
Z9 42
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0047-6374
EI 
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN 15
PY 2010
VL 131
IS 1
BP 38
EP 47
DI 10.1016/j.mad.2009.11.004
PG 10
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 560ZU
UT WOS:000274945300006
PM 19948181
DA 2024-11-01
ER

PT J
AU Berardo, A
   DiMauro, S
   Hirano, M
AF Berardo, Andres
   DiMauro, Salvatore
   Hirano, Michio
TI A Diagnostic Algorithm for Metabolic Myopathies
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Metabolic myopathies; Glycogenosis; Fatty acid; Mitochondrial diseases
ID mitochondrial-dna; coenzyme-q10 deficiency; exercise intolerance; a3243g mutation; gene; disorders; disease; form; tolerance
AB Metabolic myopathies comprise a clinically and etiologically diverse group of disorders caused by defects in cellular energy metabolism, including the breakdown of carbohydrates and fatty acids to generate adenosine triphosphate, predominantly through mitochondrial oxidative phosphorylation. Accordingly, the three main categories of metabolic myopathies are glycogen storage diseases, fatty acid oxidation defects, and mitochondrial disorders due to respiratory chain impairment. The wide clinical spectrum of metabolic myopathies ranges from severe infantile-onset multisystemic diseases to adult-onset isolated myopathies with exertional cramps. Diagnosing these diverse disorders often is challenging because clinical features such as recurrent myoglobinuria and exercise intolerance are common to all three types of metabolic myopathy. Nevertheless, distinct clinical manifestations are important to recognize as they can guide diagnostic testing and lead to the correct diagnosis. This article briefly reviews general clinical aspects of metabolic myopathies and highlights approaches to diagnosing the relatively more frequent subtypes (Fig. 1).
C1 [Berardo, Andres; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 630 W 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NICHD NIH HHS [R01 HD057543, R01 HD057543-03] Funding Source: Medline
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Bruno C, 2008, CURR OPIN NEUROL, V21, P601, DOI 10.1097/WCO.0b013e32830dd5a6
   Curcoy A, 2003, MOL GENET METAB, V78, P247, DOI 10.1016/S1096-7192(03)00024-6
   Darras BT, 2000, PEDIATR NEUROL, V22, P87, DOI 10.1016/S0887-8994(99)00133-2
   Deschauer M, 2005, ARCH NEUROL-CHICAGO, V62, P37, DOI 10.1001/archneur.62.1.37
   DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929
   DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185
   Eymard B, 2001, REV MED INTERNE, V22, P0
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haller RG, 2000, ARCH NEUROL-CHICAGO, V57, P923, DOI 10.1001/archneur.57.7.923
   Haller RG, 2004, NEUROLOGY, V62, P82, DOI 10.1212/WNL.62.1.82
   Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395
   Hamano Hitoshi, 2003, RINSHO SHINKEIGAKU, V43, P253
   Hirano M, 2007, NEUROBIOLOGY OF DISEASE, V0, PP947, DOI 10.1016/B978-012088592-3/50088-8
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Klein CJ, 2004, MUSCLE NERVE, V29, P323, DOI 10.1002/mus.10520
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Noel N, 2006, BRIT J HAEMATOL, V132, P523, DOI 10.1111/j.1365-2141.2005.05882.x
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   Orngreen MC, 2008, NEUROLOGY, V70, P1876, DOI 10.1212/01.wnl.0000289190.66955.67
   Orngreen MC, 2005, ANN NEUROL, V57, P60, DOI 10.1002/ana.20320
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shen JJ, 1996, J CLIN INVEST, V98, P352, DOI 10.1172/JCI118799
   Spiegel R, 2009, NEUROMUSCULAR DISORD, V19, P207, DOI 10.1016/j.nmd.2008.12.004
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tein I, 1999, SEMIN PERINATOL, V23, P125, DOI 10.1016/S0146-0005(99)80046-9
   Toscano A, 2007, ACTA MYOL, V26, P105
   Tsujino S, 2000, NEUROL CLIN, V18, P125, DOI 10.1016/S0733-8619(05)70181-X
   van Adel Brian A, 2009, J CLIN NEUROMUSCUL DIS, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Vissing J, 2005, ARCH NEUROL-CHICAGO, V62, P1440, DOI 10.1001/archneur.62.9.1440
   Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 53
TC 86
Z9 96
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1528-4042
EI 1534-6293
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD MAR 15
PY 2010
VL 10
IS 2
BP 118
EP 126
DI 10.1007/s11910-010-0096-4
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 571WH
UT WOS:000275786100006
PM 20425236
DA 2024-11-01
ER

PT J
AU Bass, MG
   Sokolova, VA
   Kustova, ME
   Kidgotko, OV
   Zakharova, FM
   Vasilyev, VB
AF Bass, Mikhail G.
   Sokolova, Vassilina A.
   Kustova, Maria E.
   Kidgotko, Oksana V.
   Zakharova, Faina M.
   Vasilyev, Vadim B.
TI TRANSMITOCHONDRIAL MICE IN STUDYING MTDNA DISTRIBUTION AND TRANSMISSION
SO HORIZONS IN DNA RESEARCH, VOL 1
LA English
DT Article; Book Chapter
ID human mitochondrial-dna; rapid segregation; missense mutation; protein opa1; organization; disease; inheritance; dynamin; nucleoids; oocytes
AB Obtaining reliable animal models of human OXPHOS (oxidative phosphorylation) diseases caused by accumulation of mutant mtDNA in cells of certain tissues might be a noticeable step towards understanding their pathogenesis. Despite some attempts, so far no successful approach to the targeted delivery of mutant mtDNA to certain tissues/organs has been elaborated in experiments on animals. We have elaborated a model that allows studying some features of foreign mtDNA distribution at different stages of embryonic development and in organs of transmitochondrial mice developed from zygotes injected with human mitochondria. All pre-implantation embryos and some neonate animals were carrying copies of human mitochondrial genome along with murine mtDNA, which is an indication of artificial heteroplasmy. This feature persisted in the progeny of transmitochondrial animals obtained from injected zygotes i.e. among the mice in generations F-1-F-3 at least 14% were human mtDNA-carriers inheriting foreign genome along the maternal lineage. Only some transmitochondrial embryos had human mtDNA in all the blastomeres. Likewise it was found only in some organs of transmitochondrial mice. Statistical elaboration and Monte Carlo simulation taking into account Markovian process showed, firstly, that human mtDNA was unevenly distributed in zygotic cytoplasm within the time between the injection of human mitochondria and the first cleavage; secondly, that the number of mtDNA segregation units in the entire amount of mitochondria injected (ca. 5.10(2)) is about ten. Analysis of human mtDNA distribution among the organs of transmitochondrial animals showed that skeletal muscles, liver and gonads are the targets frequently hit.
C1 [Bass, Mikhail G.; Sokolova, Vassilina A.; Kustova, Maria E.; Kidgotko, Oksana V.; Zakharova, Faina M.; Vasilyev, Vadim B.] Russian Acad Med Sci, Expt Med Res Inst, St Petersburg, Russia.
C3 Russian Academy of Medical Sciences; Institute of Experimental Medicine
RP Bass, MG (corresponding author), Russian Acad Med Sci, Expt Med Res Inst, St Petersburg, Russia.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   Bass MG, 2006, BBA-BIOENERGETICS, V1757, P679, DOI 10.1016/j.bbabio.2006.05.021
   BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Borovkov AA, 1986, PROBABILITY THEORY, V0, P0
   Brewer LR, 2003, BIOPHYS J, V85, P2519, DOI 10.1016/S0006-3495(03)74674-8
   Carlson BM, 1981, PATTENS FOUNDATIONS OF EMBRYOLOGY, V0, P0
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   de Magalhaes JP, 2005, J MOL EVOL, V61, P491, DOI 10.1007/s00239-004-0258-6
   DEBRITO OM, 2007, ANTIOXIDANTS REDOX S, V10, P2008, DOI 10.1089/ARS.1934
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DVOIRIN VV, 1985, METHODS CONTROLLED C, V0, P0
   Friddle RW, 2004, BIOPHYS J, V86, P1632, DOI 10.1016/S0006-3495(04)74231-9
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Glantz S, 1994, PRIMER OF BIOSTATISTICS, V0, P0
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141
   Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 1996, AM J HUM GENET, V59, P501
   Howell N, 1999, INT REV CYTOL, V186, P49
   Inoue K, 2004, GENESIS, V39, P79, DOI 10.1002/gene.20029
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kaufman BA, 2003, J CELL BIOL, V163, P457, DOI 10.1083/jcb.200306132
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, PC658, DOI 10.1152/ajpcell.00224.2006
   Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605
   KUSTOVA ME, 2008, CELL TISSUE BIOL, V2, P609
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   Nagao Yasumitsu, 1998, JOURNAL OF REPRODUCTION AND DEVELOPMENT, V44, P129, DOI 10.1262/jrd.44.129
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NOGAWA T, 1988, J MORPHOL, V195, P225, DOI 10.1002/jmor.1051950208
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   PENMAN S, 1995, P NATL ACAD SCI USA, V92, P5251, DOI 10.1073/pnas.92.12.5251
   Poulton J, 1996, PRENATAL DIAG, V16, P1247, DOI 10.1002/(SICI)1097-0223(199612)16:13<1247::AID-PD99>3.0.CO;2-P
   Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751
   Sambrook J, 1989, MOL CLONING, V2, P9
   SMITH LC, 1993, J REPROD FERTIL, V0, P31
   Sokolova VA, 2004, MOL REPROD DEV, V68, P299, DOI 10.1002/mrd.20075
   TORRONI A, 1992, GENETICS, V130, P153
   TOURTE M, 1991, MOL REPROD DEV, V30, P353, DOI 10.1002/mrd.1080300410
   Van Blerkom J, 2000, HUM REPROD, V15, P2621, DOI 10.1093/humrep/15.12.2621
   Van Blerkom J, 1998, HUM REPROD, V13, P2857, DOI 10.1093/humrep/13.10.2857
   van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1
   Vasilyev VB, 1999, ZYGOTE, V7, P279, DOI 10.1017/S0967199499000672
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133
NR 55
TC 1
Z9 1
U1 0
U2 3
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
SN 
EI 
J9 HORIZ DNA RES
PD JUN 15
PY 2010
VL 1
IS 
BP 151
EP 170
DI 
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA BPT61
UT WOS:000279873200006
DA 2024-11-01
ER

PT J
AU Bartesaghi, S
   Betts-Henderson, J
   Cain, K
   Dinsdale, D
   Zhou, XS
   Karlsson, A
   Salomoni, P
   Nicotera, P
AF Bartesaghi, Stefano
   Betts-Henderson, Joanne
   Cain, Kelvin
   Dinsdale, David
   Zhou, Xiaoshan
   Karlsson, Anna
   Salomoni, Paolo
   Nicotera, Pierluigi
TI Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID mitochondrial-dna depletion; deoxyguanosine kinase; mtdna depletion; mutations; encephalomyopathy; metabolism; expression; level; gene
AB Mutations of thymidine kinase 2 (TK2), an essential component of the mitochondrial nucleotide salvage pathway, can give rise to mitochondrial DNA (mtDNA) depletion syndromes (MDS). These clinically heterogeneous disorders are characterized by severe reduction in mtDNA copy number in affected tissues and are associated with progressive myopathy, hepatopathy and/or encephalopathy, depending in part on the underlying nuclear genetic defect. Mutations of TK2 have previously been associated with an isolated myopathic form of MDS (OMIM 609560). However, more recently, neurological phenotypes have been demonstrated in patients carrying TK2 mutations, thus suggesting that loss of TK2 results in neuronal dysfunction. Here, we directly address the role of TK2 in neuronal homeostasis using a knockout mouse model. We demonstrate that in vivo loss of TK2 activity leads to a severe ataxic phenotype, accompanied by reduced mtDNA copy number and decreased steady-state levels of electron transport chain proteins in the brain. In TK2-deficient cerebellar neurons, these abnormalities are associated with impaired mitochondrial bioenergetic function, aberrant mitochondrial ultrastructure and degeneration of selected neuronal types. Overall, our findings demonstrate that TK2 deficiency leads to neuronal dysfunction in vivo, and have important implications for understanding the mechanisms of neurological impairment in MDS.
C1 [Bartesaghi, Stefano; Betts-Henderson, Joanne; Cain, Kelvin; Dinsdale, David; Salomoni, Paolo; Nicotera, Pierluigi] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
   [Zhou, Xiaoshan; Karlsson, Anna] Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden.
   [Nicotera, Pierluigi] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany.
C3 University of Leicester; Karolinska Institutet; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)
RP Nicotera, P (corresponding author), Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
EM pierluigi.nicotera@dzne.de
FU Medical Research Council (MRC); Samantha Dickson Brain Tumour Trust; Wellcome Trust; MRC [MC_U132670601, MC_U132664972] Funding Source: UKRI
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384
   Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200
   Kukat A, 2008, NUCLEIC ACIDS RES, V36, P0, DOI 10.1093/nar/gkn124
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wu M, 2007, AM J PHYSIOL-CELL PH, V292, PC125, DOI 10.1152/ajpcell.00247.2006
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 26
TC 31
Z9 37
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2010
VL 19
IS 9
BP 1669
EP 1677
DI 10.1093/hmg/ddq043
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 581MF
UT WOS:000276526700003
PM 20123860
DA 2024-11-01
ER

PT J
AU Çoku, J
   Shanske, S
   Mehrazin, M
   Tanji, K
   Naini, A
   Emmanuele, V
   Patterson, M
   Hirano, M
   DiMauro, S
AF Coku, Jorida
   Shanske, Sara
   Mehrazin, Mahsa
   Tanji, Kurenai
   Naini, Ali
   Emmanuele, Valentina
   Patterson, Marc
   Hirano, Michio
   DiMauro, Salvatore
TI Slowly progressive encephalopathy with hearing loss due to a mutation in the mtDNA tRNA<SUP>Leu(CUN)</SUP> gene
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial DNA; tRNALeu(UCN); Ataxia; Dementia; Hearing loss
ID mitochondrial-dna; sporadic patient; skeletal-muscle; ophthalmoplegia
AB Pathogenic mutations in the tRNA(Leu(UCN)) gene of mitochondrial DNA (mtDNA) have been invariably accompanied by skeletal myopathy with or without chronic progressive external ophthalmoplegia (CPEO). We report a young woman with a heteroplasmic m.12276G>A mutation in tRNA(Leu(UCN)), who had childhood-onset and slowly progressive encephalopathy with ataxia, cognitive impairment, and hearing loss. Sequencing of the 22 tRNA mitochondrial genes is indicated in all unusual neurological syndromes, even in the absence of maternal inheritance. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Coku, Jorida; Shanske, Sara; Mehrazin, Mahsa; Naini, Ali; Emmanuele, Valentina; Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Tanji, Kurenai] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA.
   [Patterson, Marc] Mayo Clin, Div Child & Adolescent Neurol, Rochester, MN USA.
C3 Columbia University; Columbia University; Mayo Clinic
RP DiMauro, S (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, P&S Bldg,4th Floor,POB 31, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NIH [HD 32062]; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF)
CR Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Di Mauro S, 2008, MOL GENETIC BASIS NE, V0, P169
   Filosto M, 2008, NEUROMUSCULAR DISORD, V18, P204, DOI 10.1016/j.nmd.2007.12.005
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Hirano M, 2006, MITOCHONDRIAL MEDICINE, V0, P27
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Weber K, 1997, AM J HUM GENET, V60, P373
   Zsurka G, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2004.022566
NR 12
TC 3
Z9 3
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2010
VL 290
IS 1-2
BP 166
EP 168
DI 10.1016/j.jns.2009.12.001
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 561OK
UT WOS:000274987200036
PM 20022607
DA 2024-11-01
ER

PT J
AU Shchelochkov, OA
   Li, FY
   Wang, J
   Zhan, HL
   Towbin, JA
   Jefferies, JL
   Wong, LJ
   Scaglia, F
AF Shchelochkov, Oleg A.
   Li, Fang-Yuan
   Wang, Jing
   Zhan, Hongli
   Towbin, Jeffrey A.
   Jefferies, John Lynn
   Wong, Lee-Jun
   Scaglia, Fernando
TI Milder clinical course of Type IV 3-methylglutaconic aciduria due to a novel mutation in <i>TMEM70</i>
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE TMEM70 Type IV 3-methylglutaconic aciduria; Hypertrophic cardiomyopathy; Reye-like syndrome; Hyperammonemia; ATP synthase; ATP5J; Respiratory complex V; Mitochondrial disorders; Case report
ID atp synthase deficiency; mitochondrial; protein
AB Mitochondrial disorders are a large and genetically heterogeneous group of disorders posing a significant diagnostic challenge. Only approximately 10-20% of patients have identifiable alterations in their mitochondrial DNA (mtDNA). The remaining similar to 80-90% of affected patients likely harbor mutations in nuclear genes, most of which are still poorly characterized, and therefore not amenable to efficient screening using currently available molecular methods. Here we present a patient, who has been followed since birth after presenting with neonatal hyperammonemia, lactic acidosis, Reye-like syndrome episodes, and ventricular tachyarrhythmia. Initial biochemical work-up revealed hyperalaninemia, normal plasma glutamine, mild orotic aciduria and significant amounts of urinary 3-methylglutaconic (3-MGC) and 3-methylglutaric (3-MGA) acids. Muscle biopsy demonstrated the presence of ragged-red fibers and non-specific structural abnormalities of mitochondria. The activities of respiratory chain enzymes (complexes I-IV) showed no deficiency. Mutational analysis of the entire mitochondrial genome did not reveal deleterious point mutations or large deletions. Long-term follow-up was significant for a later-onset hypertrophic cardiomyopathy, muscle weakness, and exercise intolerance. Although she had frequent episodes of Reye-like episodes in infancy and early childhood, mostly triggered by illnesses, these symptoms improved significantly with the onset of puberty. In the light of recent reports linking cases of type IV 3-methylglutaconic aciduria (3-MGCA) and hypertrophic cardiomyopathy to mutations in TMEM70, we proceeded with sequencing analysis of this gene. We identified one previously reported splice site mutation, c.317-2A>G and a novel mutation c.494G>A ( p.G165D) in an evolutionarily conserved region predicted to be deleterious. This variant was not identified in 100 chromosomes of healthy control subjects and 200 chromosomes of patients with cardiomyopathies. Western blotting using a polyclonal antibody against ATP5J, subunit F6 of ATP synthase, on patient's skin fibroblasts showed undetectable amount of the ATP5J protein. In comparison to the previously reported cases, we note that our patient had normal growth parameters and cognitive development, absence of structural heart and urinary tract defects, no dysmorphic features, improvement of symptoms with age, and persistence of hypertrophic cardiomyopathy. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Shchelochkov, Oleg A.; Li, Fang-Yuan; Wang, Jing; Zhan, Hongli; Wong, Lee-Jun; Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Towbin, Jeffrey A.] Cincinnati Childrens Hosp, Med Ctr, Inst Heart, Cincinnati, OH USA.
   [Jefferies, John Lynn] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; Baylor College of Medicine
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
EM fscaglia@bcm.tmc.edu
FU NIH [NIH NHLBI R01 HL-53392, NIH NHLBI R01 HL-087000]
CR Cízková A, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-38
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Houstek J, 2009, BBA-BIOENERGETICS, V1787, P529, DOI 10.1016/j.bbabio.2008.11.013
   King TE, 1967, METHODS ENZYMOLOGY, V10, P322, DOI 10.1016/0076-6879(67)10061-X
   King TE, 1967, PREPARATION PROPERTI, VVolume 10, P275
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Philpa AR, 2009, HUM MUTAT, V30, P1183, DOI 10.1002/humu.21033
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Scaglia Fernando, 2002, BMC PEDIATR, V2, P12, DOI 10.1186/1471-2431-2-12
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Srere PA, 1969, METHOD ENZYMOL, V13, P3, DOI 10.1016/0076-6879(69)13005-0
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Wong LJC, 2004, ELECTROPHORESIS, V25, P2602, DOI 10.1002/elps.200406016
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yonetan T, 1967, METHODS ENZYMOL, V0, P332
NR 18
TC 20
Z9 26
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD OCT-NOV 15
PY 2010
VL 101
IS 2-3
BP 282
EP 285
DI 10.1016/j.ymgme.2010.07.012
PG 4
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 672TK
UT WOS:000283609600032
PM 20728387
DA 2024-11-01
ER

PT J
AU Chen, HC
   Vermulst, M
   Wang, YE
   Chomyn, A
   Prolla, TA
   McCaffery, JM
   Chan, DC
AF Chen, Hsiuchen
   Vermulst, Marc
   Wang, Yun E.
   Chomyn, Anne
   Prolla, Tomas A.
   McCaffery, J. Michael
   Chan, David C.
TI Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle and Tolerance of mtDNA Mutations
SO CELL
LA English
DT Article
ID dominant optic atrophy; dynamin-related gtpase; substantia-nigra neurons; dna deletions; functional mitochondria; membrane fusion; mice; disease; fibers; opa1
AB Mitochondria are highly mobile and dynamic organelles that continually fuse and divide. These processes allow mitochondria to exchange contents, including mitochondrial DNA (mtDNA). Here we examine the functions of mitochondrial fusion in differentiated skeletal muscle through conditional deletion of the mitofusins Mfn1 and Mfn2, mitochondrial GTPases essential for fusion. Loss of the mitofusins causes severe mitochondrial dysfunction, compensatory mitochondrial proliferation, and muscle atrophy. Mutant mice have severe mtDNA depletion in muscle that precedes physiological abnormalities. Moreover, the mitochondrial genomes of the mutant muscle rapidly accumulate point mutations and deletions. In a related experiment, we find that disruption of mitochondrial fusion strongly increases mitochondrial dysfunction and lethality in a mouse model with high levels of mtDNA mutations. With its dual function in safeguarding mtDNA integrity and preserving mtDNA function in the face of mutations, mitochondrial fusion is likely to be a protective factor in human disorders associated with mtDNA mutations.
C1 [Chen, Hsiuchen; Vermulst, Marc; Wang, Yun E.; Chomyn, Anne; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA.
   [Chomyn, Anne; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
   [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA.
C3 California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University
RP Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.
EM dchan@caltech.edu
FU Ellison Medical Foundation; NCRR [1 S10 RR023454-01];  [R01 GM062967]
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P743, DOI 10.1006/bbrc.2001.5838
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Ogata T, 1997, ANAT REC, V248, P214
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 48
TC 892
Z9 1025
U1 3
U2 88
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 
J9 CELL
JI Cell
PD APR 16
PY 2010
VL 141
IS 2
BP 280
EP 289
DI 10.1016/j.cell.2010.02.026
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 584GF
UT WOS:000276738400018
PM 20403324
DA 2024-11-01
ER

PT J
AU Kasiviswanathan, R
   Longley, MJ
   Young, MJ
   Copeland, WC
AF Kasiviswanathan, Rajesh
   Longley, Matthew J.
   Young, Matthew J.
   Copeland, William C.
TI Purification and functional characterization of human mitochondrial DNA polymerase gamma harboring disease mutations
SO METHODS
LA English
DT Article
DE Mitochondrial DNA; DNA polymerase gamma; p55 accessory subunit; Alpers syndrome; Progressive external ophthalmoplegia
ID progressive external ophthalmoplegia; accessory subunit; w748s mutation; replication; defects
AB More than 150 different point mutations in POLG, the gene encoding the human mitochondrial DNA polymerase gamma (pol gamma), cause a broad spectrum of childhood and adult onset diseases like Alpers syndrome, ataxia-neuropathy syndrome and progressive external ophthalmoplegia. These disease mutations can affect the pot gamma enzyme's properties in numerous ways, thus potentially influencing the severity of the disease. Hence, a detailed characterization of disease mutants will greatly assist researchers and clinicians to develop a clear understanding of the functional defects caused by these mutant enzymes. Experimental approaches for characterizing the wild-type (WT) and mutant pot gamma enzymes are extensively described in this manuscript. The methods start with construction and purification of the recombinant wild-type and mutant forms of pot gamma protein, followed by assays to determine its structural integrity and thermal stability. Next, the biochemical characterization of these enzymes is described in detail, which includes measuring the purified enzyme's catalytic activity, its steady-state kinetic parameters and DNA binding activity, and determining the physical and functional interaction of these pot gamma proteins with the p55 accessory subunit. Published by Elsevier Inc.
C1 [Kasiviswanathan, Rajesh; Longley, Matthew J.; Young, Matthew J.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU NIEHS
CR Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, METHODS MOL BIOL, V554, P59, DOI 10.1007/978-1-59745-521-3_4
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 19
TC 19
Z9 21
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG 15
PY 2010
VL 51
IS 4
BP 379
EP 384
DI 10.1016/j.ymeth.2010.02.015
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 640KK
UT WOS:000281049900004
PM 20176107
DA 2024-11-01
ER

PT J
AU Lang, T
   Laver, N
   Strominger, MB
   Witking, A
   Pfannl, R
   Alroy, J
AF Lang, Tee
   Laver, Nora
   Strominger, Mitchell B.
   Witking, Andre
   Pfannl, Rolf
   Alroy, Joseph
TI Morphological Findings of Extraocular Myopathy with Chronic Progressive External Ophthalmoplegia
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE CPEO; mitochondria; ultrastructure
ID kearns-sayre-syndrome; mitochondrial; diagnosis; muscle; pathology; biopsy
AB Mitochondrial diseases are a large group of disorders resulting from mutations of nuclear DNA (nDNA) and mitochondrial DNA (mtDNA). Patients present clinically with multiple manifestations, including myopathies and multiple system disorders. Establishing a specific diagnosis often requires extensive clinical and laboratory evaluation. In this study of 2 adult patients with presumptive mitochondrial disease, the authors have identified distinctive morphological changes in medial rectus muscle biopsies that confirm the diagnosis of chronic progressive external ophthalmoplegia (CPEO). These findings demonstrate the usefulness of electron microscopy using medial rectus muscle in the diagnosis of adult patients with a slowly progressive course of mild skeletal weakness and CPEO.</.
C1 [Lang, Tee; Laver, Nora; Pfannl, Rolf; Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.
   [Lang, Tee; Laver, Nora; Strominger, Mitchell B.; Witking, Andre; Pfannl, Rolf; Alroy, Joseph] Tufts Med Ctr, Boston, MA USA.
   [Alroy, Joseph] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, Grafton, MA USA.
   [Strominger, Mitchell B.; Witking, Andre] Tufts Univ, Sch Med, New England Eye Ctr, Boston, MA 02111 USA.
C3 Tufts University; Tufts Medical Center; Tufts University; Tufts University
RP Alroy, J (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.
EM joseph.alroy@tufts.edu
CR BRIL V, 1984, CAN J NEUROL SCI, V11, P390, DOI 10.1017/S0317167100045789
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Carta A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1441
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Di Mauro S, 2004, MYOLOGY PHILADELPHIA, V0, P1623
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Kyriacou K, 1999, ULTRASTRUCT PATHOL, V23, P163
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Lloreta-Trull J, 1998, ULTRASTRUCT PATHOL, V22, P357, DOI 10.3109/01913129809103357
   Munnich A, 2001, METABOLIC MOL BASES, V0, P2261
   REICHMANN H, 1993, ACTA NEUROPATHOL, V85, P679, DOI 10.1007/BF00334681
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHWARTZKOPFF B, 1988, J AM COLL CARDIOL, V12, P1522, DOI 10.1016/S0735-1097(88)80020-2
   Shoffner JM, 2001, METABOLIC MOL BASES, V0, P2367
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Wabbels B, 2008, OPHTHALMOLOGE, V105, P550, DOI 10.1007/s00347-007-1643-5
   Wallace DC, 2001, THE METABOLIC AND MOLECULAR BASIS OF INHERITED DISEASE, V0, P2425
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
NR 21
TC 1
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0191-3123
EI 1521-0758
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PD APR 15
PY 2010
VL 34
IS 2
BP 78
EP 81
DI 10.3109/01913121003624684
PG 4
WC Microscopy; Pathology
SC Microscopy; Pathology
GA 562QF
UT WOS:000275067000005
PM 20192704
DA 2024-11-01
ER

PT J
AU Ohno, A
   Mori, A
   Doi, R
   Yonenaga, Y
   Asano, N
   Uemoto, S
AF Ohno, Ayami
   Mori, Akira
   Doi, Ryuichiro
   Yonenaga, Yoshikuni
   Asano, Noboru
   Uemoto, Shinji
TI Successful left hemihepatectomy and perioperative management of a patient with biliary cystadenocarcinoma, complicated with MELAS syndrome: Report of a case
SO SURGERY TODAY
LA English
DT Article
DE MELAS; Hepatectomy; Biliary cystadenocarcinoma; F-18-Fluorodeoxyglucose positron emission tomography
ID stroke-like episodes; human pancreatic tumors; lactic-acidosis; mitochondrial myopathy; anesthetic management; encephalopathy; glucose; liver; population; prevalence
AB Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like syndrome (MELAS) is a rare, fetal disease caused by a mutation in mitochondrial DNA that leads to impaired oxidative metabolism in skeletal muscle, the central nervous system, and liver function. This report presents the case of a 50-year-old woman with biliary cystadenocarcinoma complicated by MELAS who underwent a successful left hemihepatectomy. In this case, the diagnostic key for the malignant tumor was an F-18-fluorodeoxyglucose positron emission tomography study, which was useful even in a patient with MELAS, which causes abnormal glucose metabolism. The perioperative management of such patients includes special precautions to prevent lactic acidosis and deterioration of the reserved liver function after a hepatectomy, since the mitochondrial function in MELAS patients is abnormal. The patient in this report has remained free of liver dysfunctions and cancer recurrence for 2 years following the hepatectomy. This is the first report of a successful major hepatectomy for a patient with MELAS.
C1 [Ohno, Ayami; Mori, Akira; Doi, Ryuichiro; Yonenaga, Yoshikuni; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg & Transplantat, Dept Surg,Sakyo Ku, Kyoto 6068507, Japan.
   [Ohno, Ayami] Kyoto Med Ctr, Dept Radiol, Natl Hosp Org, Kyoto, Japan.
   [Asano, Noboru] Minami Kyoto Hosp, Dept Surg, Natl Hosp Org, Kyoto, Japan.
C3 Kyoto University
RP Mori, A (corresponding author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg & Transplantat, Dept Surg,Sakyo Ku, 54 Shogoin,Kawahara Cho, Kyoto 6068507, Japan.
CR Chioléro R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009
   Del Poggio P, 2008, WORLD J GASTROENTERO, V14, P3616, DOI 10.3748/wjg.14.3616
   Furukawa H, 2008, EUR RADIOL, V18, P2841, DOI 10.1007/s00330-008-1062-2
   Higashi T, 1997, J NUCL MED, V38, P1337
   Higashi T, 1998, J NUCL MED, V39, P1727
   Läuffer JM, 1998, EUR J CANCER, V34, P1845
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marko P, 2004, J CLIN ANESTH, V16, P389, DOI 10.1016/j.jclinane.2003.09.012
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   Pojchamarnwiputh S, 2008, SINGAP MED J, V49, P392
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Sasano N, 2007, J ANESTH, V21, P72, DOI 10.1007/s00540-006-0449-y
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
NR 17
TC 7
Z9 7
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD SEP 15
PY 2010
VL 40
IS 9
BP 878
EP 882
DI 10.1007/s00595-009-4145-z
PG 5
WC Surgery
SC Surgery
GA 643XH
UT WOS:000281333300014
PM 20740354
DA 2024-11-01
ER

PT J
AU Robberecht, K
   Decock, C
   Stevens, A
   Seneca, S
   De Bleecker, J
   Leroy, BP
AF Robberecht, Kirsten
   Decock, Christian
   Stevens, Annemie
   Seneca, Sara
   De Bleecker, Jan
   Leroy, Bart P.
TI Ptosis as an associated finding in maternally inherited diabetes and deafness
SO OPHTHALMIC GENETICS
LA English
DT Article
DE Maternally inherited diabetes and deafness; MIDD; Ptosis; mtDNA; m.3243A > G
AB Purpose: To report ptosis as an associated finding in 2 patients with maternally inherited diabetes and deafness (MIDD). Methods: Two unrelated female patients with genetically proven MIDD are described. A complete ophthalmological examination included evaluation of levator muscle function, vertical fissure height and upper lid crease position measurements, the ice pack test and extensive imaging. In addition, pathology of the levator muscle was performed in 1 patient. Results: The first patient had an asymmetric ptosis at presentation. Levator muscle function was initially normal and decreased 3 years after, suggestive of a myogenic ptosis. Fundus examination revealed a macular pattern dystrophy. The second MIDD patient was referred for bilateral pigment alterations at the posterior pole. Gradually bilateral ptosis developed over a 3-year period. In both patients, ocular motility testing revealed a reduced upgaze. Conclusions: Myogenic ptosis has been described in association with several of the phenotypes caused by the m.3243A > G mutation, but up to now it had not been described as a finding in MIDD. MIDD has pleomorphic manifestations, and myogenic ptosis should be added to the list of associated clinical features. The additional symmetric elevation deficit in both patients may be an early sign of chronic progressive external ophthalmoplegia (CPEO). The results provide further evidence to suggest that MIDD represents only a part of a continuous spectrum of disease related to the m.3243A > G point mutation in the tRNA<SULeu</SU gene.
C1 [Leroy, Bart P.] Ghent Univ Hosp, Unit Ophthalm Genet & Visual Electrophysiol, Dept Ophthalmol, B-9000 Ghent, Belgium.
   [Seneca, Sara] Brussels Univ Hosp, Ctr Med Genet, Brussels, Belgium.
   [De Bleecker, Jan] Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium.
   [Leroy, Bart P.] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.
C3 Ghent University; Ghent University Hospital; University Hospital Brussels; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital
RP Leroy, BP (corresponding author), Ghent Univ Hosp, Unit Ophthalm Genet & Visual Electrophysiol, Dept Ophthalmol, De Pintelaan 185, B-9000 Ghent, Belgium.
EM bart.leroy@ugent.be
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ENGEL AG, 2004, MYOLOGY, V0, P681
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 6
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1381-6810
EI 1744-5094
J9 OPHTHALMIC GENET
JI Ophthalmic Genet.
PD DEC 15
PY 2010
VL 31
IS 4
BP 240
EP 243
DI 10.3109/13816810.2010.520297
PG 4
WC Genetics & Heredity; Ophthalmology
SC Genetics & Heredity; Ophthalmology
GA 678WZ
UT WOS:000284115400016
PM 21067488
DA 2024-11-01
ER

PT J
AU Yan, NH
   Cai, SP
   Guo, B
   Mou, Y
   Zhu, J
   Chen, J
   Zhang, T
   Li, RH
   Liu, XY
AF Yan, Naihong
   Cai, Shuping
   Guo, Bo
   Mou, Yi
   Zhu, Jing
   Chen, Jun
   Zhang, Ting
   Li, Ronghua
   Liu, Xuyang
TI A novel mitochondrial tRNA<SUP>Val</SUP> T1658C mutation identified in a CPEO family
SO MOLECULAR VISION
LA English
DT Article
ID progressive external ophthalmoplegia; transfer-rna genes; point mutation; dna; disease; sequence; melas; trna(asn); myopathy; patient
AB Purpose: To analyze mitochondrial DNA (mt DNA) gene mutations in a 19-year-old female patient, who presented with chronic progressive external ophthalmoplegia (CPEO), together with her mother and younger sister. Methods: The diagnosis of mitochondrial myopathy was made based on clinical and biologic analysis. Histochemical methods were used to detect ragged-red fibers (RRFs) and ragged-blue fibers (RBFs) on a muscle biopsy of the patient. All mitochondrial gene DNA fragments of the patient, her mother, and younger sister were amplified by polymerase chain reaction. The products were sequenced and compared with reference databases. Results: A novel T1658C mutation and a known A10006G mutation were identified in the mitochondrial tRNA(Val) gene and the tRNA(Gly) gene, respectively, in the patient, her mother, and younger sister. The T1658C mutation changes the T loop structure of mitochondrial tRNA(Val) and the A10006G mutation disturbs the D loop of mitochondrial tRNA(Gly). Conclusions: The T1658C and A10006G mutations of mtDNA may be responsible for the pathogenesis of the patient with CPEO.
C1 [Yan, Naihong; Cai, Shuping; Guo, Bo; Mou, Yi; Zhu, Jing; Chen, Jun; Zhang, Ting; Liu, Xuyang] Sichuan Univ, W China Hosp, Ophthalm Labs, Chengdu 610041, Peoples R China.
   [Yan, Naihong; Cai, Shuping; Guo, Bo; Mou, Yi; Zhu, Jing; Chen, Jun; Zhang, Ting; Liu, Xuyang] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu 610041, Peoples R China.
   [Li, Ronghua] Sichuan Univ, W China Hosp, Dept Med Genet, Chengdu 610064, Sichuan, Peoples R China.
C3 Sichuan University; Sichuan University; Sichuan University
RP Liu, XY (corresponding author), Sichuan Univ, W China Hosp, Ophthalm Labs, Chengdu 610041, Peoples R China.
EM xliu1213@yahoo.com.cn
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   HATTORI Y, 1994, J NEUROL SCI, V125, P50, DOI 10.1016/0022-510X(94)90241-0
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   MARZUKI S, 1991, HUM GENET, V88, P139
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   NOER AS, 1991, AM J HUM GENET, V49, P715
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   SANDIFER PH, 1946, J NEUROL NEUROSUR PS, V9, P81, DOI 10.1136/jnnp.9.3.81
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Schaefer AM, 2005, MUSCLE NERVE, V32, P104, DOI 10.1002/mus.20319
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
NR 31
TC 10
Z9 11
U1 0
U2 2
PU MOLECULAR VISION
PI ATLANTA
PA C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA
SN 1090-0535
EI 
J9 MOL VIS
JI Mol. Vis.
PD AUG 25
PY 2010
VL 16
IS 187-89
BP 1736
EP 1742
DI 
PG 7
WC Biochemistry & Molecular Biology; Ophthalmology
SC Biochemistry & Molecular Biology; Ophthalmology
GA 643ZY
UT WOS:000281341400002
PM 20806033
DA 2024-11-01
ER

PT J
AU Marín-García, J
AF Marin-Garcia, Jose
TI Thyroid hormone and myocardial mitochondrial biogenesis
SO VASCULAR PHARMACOLOGY
LA English
DT Review
DE Mitochondria; Thyroid hormone; Biogenesis; Myocardial hypertrophy; Signaling pathways
ID transcription termination factor; activated receptor-alpha; human skeletal-muscle; messenger-rna; gene-expression; cardiac-hypertrophy; protein-composition; heart-mitochondria; sequence-analysis; dna-polymerase
AB Mitochondria have been central in the development of some of the most important ideas in modern biology. Since the discovery that mitochondria have its own DNA and specific mutations and deletions were found in association with neuromuscular and heart diseases, as well as in aging, an extraordinary number of publications have followed, and the term mitochondrial medicine was coined. Recently, it has been found that thyroid hormone (TH) stimulates cardiac mitochondrial biogenesis increasing myocardial mitochondrial mass, mitochondrial respiration, oxidative phosphorylation (OXPHOS), enzyme activities, mitochondrial protein synthesis (by stimulation in a T3-dependent manner), cytochrome, phospholipid and mtDNA content. Also, TH therapy may modulate cardiac mitochondrial protein-import apparatus. To identify the sequence of events, molecules and signaling pathways that is activated by TH affecting mitochondrial structure, biogenesis and function further research is warranted. (C) 2009 Elsevier Inc. All rights reserved.
C1 Mol Cardiol & Neuromuscular Inst, Highland Pk, NJ 08904 USA.
RP Marín-García, J (corresponding author), Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
EM tmci@att.net
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, PE748, DOI 10.1152/ajpendo.00311.2006
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANNEX BH, 1990, MOL CELL BIOL, V10, P5671, DOI 10.1128/MCB.10.11.5671
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Barbe P, 2001, FASEB J, V15, P13
   Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056
   Bigard Andre-Xavier, 2008, JOURNAL DE LA SOCIETE DE BIOLOGIE, V202, P93, DOI 10.1051/jbio:2008011
   Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, PH977, DOI 10.1152/ajpheart.2001.280.3.H977
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Cahill A, 2000, ELECTROPHORESIS, V21, P3420, DOI 10.1002/1522-2683(20001001)21:16<3420::AID-ELPS3420>3.0.CO;2-Q
   Cai Y, 1996, ARCH BIOCHEM BIOPHYS, V325, P107, DOI 10.1006/abbi.1996.0013
   Casas F, 1999, MOL CELL BIOL, V19, P7913
   CASSARMALEK I, 1994, ONCOGENE, V9, P2197
   CASTORA FJ, 1985, BIOCHEM BIOPH RES CO, V130, P854, DOI 10.1016/0006-291X(85)90495-4
   Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006
   Civitarese AE, 2007, CURR OPIN CLIN NUTR, V10, P679, DOI 10.1097/MCO.0b013e3282f0ecd2
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   Craig EE, 1998, AM J PHYSIOL-CELL PH, V275, PC1508, DOI 10.1152/ajpcell.1998.275.6.C1508
   DAGA A, 1993, J BIOL CHEM, V268, P8123
   DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W
   Enríquez JA, 1999, MOL CELL BIOL, V19, P657
   Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x
   Enríquez JA, 1999, BIOL CHEM, V380, P737, DOI 10.1515/BC.1999.094
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   GAINES G, 1987, J BIOL CHEM, V262, P1907
   Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536
   GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497
   Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C
   Goldenthal MJ, 2004, MOL CELL BIOCHEM, V265, P97, DOI 10.1023/B:MCBI.0000044321.17680.a2
   GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Hernández JM, 1999, GENE, V239, P283, DOI 10.1016/S0378-1119(99)00409-6
   Hertz R, 1996, BIOCHEM J, V319, P241, DOI 10.1042/bj3190241
   HILLAR M, 1979, ARCH INT PHYSIOL BIO, V87, P29
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622
   KING MP, 1993, J BIOL CHEM, V268, P10228
   Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebuffe G, 2003, AM J PHYSIOL-HEART C, V284, PH299, DOI 10.1152/ajpheart.00706.2002
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534
   MA JH, 1995, BBA-GENE STRUCT EXPR, V1261, P321, DOI 10.1016/0167-4781(95)00041-E
   MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162
   Marín-García J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774
   Martí R, 2003, CLIN CHEM LAB MED, V41, P845, DOI 10.1515/CCLM.2003.128
   MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788
   Meisinger C, 1999, CELL MOL LIFE SCI, V56, P817, DOI 10.1007/s000180050028
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   NELSON BD, 1995, BBA-MOL BASIS DIS, V1271, P85, DOI 10.1016/0925-4439(95)00014-U
   OBrien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3
   Pantos C, 2006, HORM METAB RES, V38, P308, DOI 10.1055/s-2006-925404
   Pantos C, 2008, PHARMACOL THERAPEUT, V118, P277, DOI 10.1016/j.pharmthera.2008.02.011
   PARADIES G, 1994, BBA-MOL BASIS DIS, V1225, P165, DOI 10.1016/0925-4439(94)90074-4
   Portman MA, 2002, CLIN EXP PHARMACOL P, V29, P334, DOI 10.1046/j.1440-1681.2002.03654.x
   Prieto-Martín A, 2004, NUCLEIC ACIDS RES, V32, P2059, DOI 10.1093/nar/gkh528
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846
   Scheller K, 2000, EUR J CELL BIOL, V79, P299, DOI 10.1078/S0171-9335(04)70033-3
   SCHIEBER GL, 1985, J BIOL CHEM, V260, P6367
   Schleiff E, 1999, ARCH BIOCHEM BIOPHYS, V367, P95, DOI 10.1006/abbi.1999.1240
   Schönfeld P, 2000, FEBS LETT, V471, P108, DOI 10.1016/S0014-5793(00)01376-4
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   SEIDEN D, 1988, J MOL CELL CARDIOL, V20, P917, DOI 10.1016/S0022-2828(88)80146-9
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spirina O, 2000, GENE, V261, P229, DOI 10.1016/S0378-1119(00)00504-7
   SUZUKI H, 1995, BIOCHEM BIOPH RES CO, V213, P204, DOI 10.1006/bbrc.1995.2117
   Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17
   TANAKA T, 1985, BASIC RES CARDIOL, V80, P165, DOI 10.1007/BF01910464
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   WIESNER RJ, 1994, AM J PHYSIOL, V267, PC229, DOI 10.1152/ajpcell.1994.267.1.C229
   WIESNER RJ, 1992, MOL ENDOCRINOL, V6, P1458, DOI 10.1210/me.6.9.1458
   WONG TW, 1985, J BIOL CHEM, V260, P1530
   Woriax VL, 1995, BBA-GENE STRUCT EXPR, V1264, P347, DOI 10.1016/0167-4781(95)00176-X
   WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347
   Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067
   Wrutniak-Cabello Chantal, 2008, JOURNAL DE LA SOCIETE DE BIOLOGIE, V202, P83, DOI 10.1051/jbio:2008010
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com
   ZAK R, 1980, BASIC RES CARDIOL, V75, P171, DOI 10.1007/BF02001410
   Zhang CY, 2000, EUR J NEUROSCI, V12, P1013, DOI 10.1046/j.1460-9568.2000.00997.x
NR 97
TC 37
Z9 40
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1537-1891
EI 1879-3649
J9 VASC PHARMACOL
JI Vasc. Pharmacol.
PD MAR-APR 15
PY 2010
VL 52
IS 3-4
BP 120
EP 130
DI 10.1016/j.vph.2009.10.008
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 566TI
UT WOS:000275395700004
PM 19857604
DA 2024-11-01
ER

PT J
AU Rötig, A
AF Roetig, Agnes
TI Genetic bases of mitochondrial respiratory chain disorders
SO DIABETES & METABOLISM
LA English
DT Review
DE Genetics; Mitochondria; Respiratory chain; Review
ID cytochrome-c-oxidase; complex-iii deficiency; progressive external ophthalmoplegia; dna depletion; leigh-syndrome; diabetes-mellitus; oxidative-phosphorylation; succinate-dehydrogenase; thymidine kinase; lactic-acidosis
AB Oxidative phosphorylation ATP synthesis by the oxygen-consuming respiratory chain (RC) supplies most organs and tissues with a readily usable energy source, and is already fully functioning at birth. This means that, in theory. RC deficiency can give rise to any symptom in any organ or tissue at any age and with any mode of inheritance, due to the two-fold genetic origin of RC components (nuclear DNA and mitochondrial DNA). It has long been erroneously believed that RC disorders originate from mutations of mtDNA as, for some time, only mutations or deletions of mtDNA could be identified. However, the number of disease-causing mutations in nuclear genes is now steadily growing. These genes not only encode the various subunits of each complex, but also the ancillary proteins involved in the different stages of holoenzyme biogenesis, including transcription, translation, chaperoning, addition of prosthetic groups and assembly of proteins, as well as the various enzymes involved in mtDNA metabolism. (c) 2010 Elsevier Masson SAS. All rights reserved.
C1 Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Rötig, A (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.
EM agnes.Rotig@inserm.fr
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   BOUCHET C, 2006, J MED GENET, V0, P0
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bugiani M, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.029926
   BUNDSCHUH FA, 2009, J BIOL CHEM, V0, P0
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Ghezzi D, 2009, NAT GENET, V0, P0
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Grivell LA, 1999, FEBS LETT, V452, P57, DOI 10.1016/S0014-5793(99)00532-3
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Oquendo CE, 2004, J MED GENET, V41, P540, DOI 10.1136/jmg.2003.017426
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paquis-Flucklinger V, 1998, DIABETOLOGIA, V41, P740, DOI 10.1007/s001250050978
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rötig A, 2007, MITOCHONDRION, V7, PS112, DOI 10.1016/j.mito.2007.02.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SARZI E, 1931, J PEDIAT, V150, P0
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 103
TC 29
Z9 32
U1 0
U2 9
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
EI 
J9 DIABETES METAB
JI Diabetes Metab.
PD APR 15
PY 2010
VL 36
IS 2
BP 97
EP 107
DI 10.1016/j.diabet.2009.11.002
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 598KN
UT WOS:000277835800002
PM 20093061
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Yu-Wai-Man, P
   Blakely, EL
   Krishnan, KJ
   Beadle, NE
   Kerin, J
   Barron, MJ
   Griffiths, PG
   Dickinson, AJ
   Turnbull, DM
   Taylor, RW
AF Greaves, Laura C.
   Yu-Wai-Man, Patrick
   Blakely, Emma L.
   Krishnan, Kim J.
   Beadle, Nina E.
   Kerin, Jamie
   Barron, Martin J.
   Griffiths, Philip G.
   Dickinson, Alison J.
   Turnbull, Douglass M.
   Taylor, Robert W.
TI Mitochondrial DNA Defects and Selective Extraocular Muscle Involvement in CPEO
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID progressive external ophthalmoplegia; cytochrome-c-oxidase; human skeletal-muscle; real-time pcr; wild-type; individual cells; point mutation; nigra neurons; deletions; disease
AB PURPOSE. Chronic progressive external ophthalmoplegia (CPEO) is a prominent, and often the only, presentation among patients with mitochondrial diseases. The mechanisms underlying the preferential involvement of extraocular muscles (EOMs) in CPEO were explored in a comprehensive histologic and molecular genetic study, to define the extent of mitochondrial dysfunction in EOMs compared with that in skeletal muscle from the same patient. METHODS. A well-characterized cohort of 13 CPEO patients harboring a variety of primary and secondary mitochondrial (mt)DNA defects was studied. Mitochondrial enzyme function was determined in EOM and quadriceps muscle sections with cytochrome c oxidase (COX)/succinate dehydrogenase (SDH) histochemistry, and the mutation load in single muscle fibers was quantified by real-time PCR and PCR-RFLP assays. RESULTS. CPEO patients with mtDNA deletions had more COX-deficient fibers in EOM (41.6%) than in skeletal muscle (13.7%, P > 0.0001), and single-fiber analysis revealed a lower mutational threshold for COX deficiency in EOM. Patients with mtDNA point mutations had a less severe ocular phenotype, and there was no significant difference in the absolute level of COX deficiency or mutational threshold between these two muscle groups. CONCLUSIONS. The more pronounced mitochondrial biochemical defect and lower mutational threshold in EOM compared with skeletal muscle fibers provide an explanation of the selective muscle involvement in CPEO. The data also suggest that tissue-specific mechanisms are involved in the clonal expansion and expression of secondary mtDNA deletions in CPEO patients with nuclear genetic defects. (Invest Ophthalmol Vis Sci. 2010; 51: 3340-3346) DOI:10.1167/iovs.09-4659
C1 [Taylor, Robert W.] Med Sch Newcastle Upon Tyne, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick; Griffiths, Philip G.; Dickinson, Alison J.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Taylor, RW (corresponding author), Med Sch Newcastle Upon Tyne, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Newcastle University Centre; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); MRC (Medical Research Council); Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; U.K. National Commissioning Group; MRC [G0800674, G0601943, G0701386] Funding Source: UKRI
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   FUCHS AF, 1983, J NEUROPHYSIOL, V49, P28, DOI 10.1152/jn.1983.49.1.28
   Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Scott AB, 2007, BRIT J OPHTHALMOL, V91, P146, DOI 10.1136/bjo.2006.110619
   Sevel D, 1986, TRANS AM OPHTHALMOL SOC, V84, P488
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spencer R F, 1988, REV OCULOMOT RES, V2, P33
   Taherian K, 2007, EYE, V21, P639, DOI 10.1038/sj.eye.6702296
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   VIVIAN AJ, 1993, EYE, V7, P565, DOI 10.1038/eye.1993.123
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 40
TC 43
Z9 45
U1 0
U2 4
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL 15
PY 2010
VL 51
IS 7
BP 3340
EP 3346
DI 10.1167/iovs.09-4659
PG 7
WC Ophthalmology
SC Ophthalmology
GA 614HX
UT WOS:000279047500003
PM 20164463
DA 2024-11-01
ER

PT J
AU Nishri, D
   Blumkin, L
   Lev, D
   Leshinsky-Silver, E
   Abu-Rashid, M
   Birch, R
   Zuberi, SM
   Lerman-Sagie, T
AF Nishri, Daniella
   Blumkin, Lubov
   Lev, Dorit
   Leshinsky-Silver, Esther
   Abu-Rashid, Mohammad
   Birch, Rachael
   Zuberi, Sameer M.
   Lerman-Sagie, Tally
TI Hepatic coma culminating in severe brain damage in a child with a SCN1A mutation
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE SCN1A; Severe myoclonic epilepsy of infancy; Alpers-Huttenlocher disease; Mitochondrial dysfunction; Liver failure; Valproic acid
ID severe myoclonic epilepsy
AB An 11 months old boy, developed liver failure after febrile status epilepticus while being treated with valproic acid for myoclonic epilepsy and recurrent partial and generalized seizures. The diagnosis of Alpers-Huttenlocher disease was considered. A muscle biopsy showed mitochondrial dysfunction. Mitochondrial DNA depletion was ruled out. Sequencing of the polymerase gamma gene (POLG1) did not detect any mutations. Sequencing of the alpha-1 subunit gene of the voltage-gated neuronal sodium channel (SCN1A) revealed a novel, de novo amino acid change p.Val 1637 Glu. This case expands the spectrum of clinical presentations related to mutations in SCN1A. We warn that children with SCN1A mutations may be at risk for developing liver failure following status epilepticus, due to mitochondrial dysfunction. (C) 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Nishri, Daniella; Blumkin, Lubov; Abu-Rashid, Mohammad; Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, IL-58100 Holon, Israel.
   [Nishri, Daniella; Blumkin, Lubov; Lev, Dorit; Leshinsky-Silver, Esther; Abu-Rashid, Mohammad; Lerman-Sagie, Tally] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
   [Nishri, Daniella; Blumkin, Lubov; Lev, Dorit; Abu-Rashid, Mohammad; Lerman-Sagie, Tally] Wolfson Med Ctr, Metab Neurogenet Serv, IL-58100 Holon, Israel.
   [Lev, Dorit; Leshinsky-Silver, Esther] Wolfson Med Ctr, Inst Med Genet, IL-58100 Holon, Israel.
   [Leshinsky-Silver, Esther] Wolfson Med Ctr, Mol Genet Lab, IL-58100 Holon, Israel.
   [Birch, Rachael] Royal Hosp Sick Children, Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland.
   [Zuberi, Sameer M.] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland.
C3 Tel Aviv University; University of Glasgow; University of Glasgow
RP Lerman-Sagie, T (corresponding author), Wolfson Med Ctr, Pediat Neurol Unit, IL-58100 Holon, Israel.
EM asagie@post.tau.ac.il
CR Castro-Gago M, 1997, CHILD NERV SYST, V13, P570, DOI 10.1007/s003810050141
   CASTROGAGO M, 1995, CHILD NERV SYST, V11, P630, DOI 10.1007/BF00300719
   Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3
   Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323
   Dravet C, 2002, CURR PROB E, V17, P81
   Fernandez-Jaen A, 1998, REV NEUROLOGIA, V26, P759, DOI 10.33588/rn.26153.981007
   Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002
   Kassaï B, 2008, EPILEPSIA, V49, P343, DOI 10.1111/j.1528-1167.2007.01423.x
   Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011
   Michelson-Kerman M, 2003, J CHILD NEUROL, V18, P876, DOI 10.1177/088307380301801208
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nicolai J, 2008, SEIZURE-EUR J EPILEP, V17, P92, DOI 10.1016/j.seizure.2007.07.003
NR 12
TC 8
Z9 9
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD SEP 15
PY 2010
VL 14
IS 5
BP 456
EP 459
DI 10.1016/j.ejpn.2010.03.002
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 649FB
UT WOS:000281752100013
PM 20392657
DA 2024-11-01
ER

PT J
AU Grönlund, MA
   Honarvar, AKS
   Andersson, S
   Moslemi, AR
   Oldfors, A
   Holme, E
   Tulinius, M
   Darin, N
AF Gronlund, M. A.
   Honarvar, A. K. Seyedi
   Andersson, S.
   Moslemi, A. R.
   Oldfors, A.
   Holme, E.
   Tulinius, M.
   Darin, N.
TI Ophthalmological findings in children and young adults with genetically verified mitochondrial disease
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID clinical spectrum; light; encephalomyopathy; death
AB Aim: To describe ophthalmological phenotypes in patients with mitochondrial disease and known genotypes. Methods: A retrospective study was performed on 59 patients (29 male, 30 female) with a mean age of 11.8 years who had mitochondrial disease with known DNA mutations. Fifty-seven of the 59 subjects underwent a detailed ophthalmological examination including visual acuity (VA), eye motility, refraction, slit-lamp examination, ophthalmoscopy and, in almost one-half of the cases, a full-field electroretinogram (ERG). Results: Forty-six (81%) of the patients had one or more ophthalmological findings such as ptosis (n = 16), reduced eye motility (n = 22) including severe external ophthalmoplegia (n = 9), strabismus (n = 4), nystagmus (n = 9), low VA (n = 21), refractive errors (n = 26), photophobia (n = 4), and partial or total optic atrophy (n = 25). Pigmentation in the macula and/or periphery was noted in 16 patients. In 10/27 investigated individuals with full field ERG, retinal dystrophy was recorded in six different genotypes representing Kearns-Sayre syndrome (n = 5), Leigh syndrome (n = 1), Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (n = 1), Myoclonus epilepsy with red ragged fibres (MERRF) (n = 1), Leber hereditary optic neuropathy (n = 1) and mitochondrial myopathy (n = 1). Conclusion: The results show that a majority of patients with mitochondrial disorders have ophthalmological abnormalities. We recommend that an ophthalmological examination, including ERG, be performed on all children and adolescents who are suspected of having a mitochondrial disease.
C1 [Gronlund, M. A.; Honarvar, A. K. Seyedi; Andersson, S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol Ophthalmol, Gothenburg, Sweden.
   [Moslemi, A. R.; Oldfors, A.] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden.
   [Holme, E.] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden.
   [Tulinius, M.; Darin, N.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg
RP Grönlund, MA (corresponding author), Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Paediat Ophthalmol, SE-41685 Gothenburg, Sweden.
EM marita.gronlund@neuro.gu.se
FU Goteborg Medical Society; W & M Lundgrens Vetenskapsfond II; Petter Silfverskolds Minnesfond; Vastra Gotaland ALF
CR AMBROSIO G, 1995, DOC OPHTHALMOL, V89, P211, DOI 10.1007/BF01203374
   Andreasson S, 1997, AM J OPHTHALMOL, V124, P95
   Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Cooper LL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1055
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Grönlund MA, 2006, ACTA OPHTHALMOL SCAN, V84, P169, DOI 10.1111/j.1600-0420.2005.00615.x
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Marmor MF, 1999, DOC OPHTHALMOL, V97, P143
   Moslemi AR, 2007, MITOCHONDRION, V7, P241, DOI 10.1016/j.mito.2007.02.002
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x
   Osborne NN, 2006, BRIT J OPHTHALMOL, V90, P237, DOI 10.1136/bjo.2005.082230
   Phillips P, 1997, J AAPOS, V2, P115
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Staudt S, 2003, OPHTHALMOLOGE, V100, P234, DOI 10.1007/s00347-002-0662-5
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wallace Douglas C, 1998, BIOFACTORS, V7, P187
NR 24
TC 55
Z9 61
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD JAN 15
PY 2010
VL 94
IS 1
BP 121
EP 127
DI 10.1136/bjo.2008.154187
PG 7
WC Ophthalmology
SC Ophthalmology
GA 544IW
UT WOS:000273650300024
PM 20385529
DA 2024-11-01
ER

PT J
AU El Sabbagh, S
   Lebre, AS
   Bahi-Buisson, N
   Delonlay, P
   Soufflet, C
   Boddaert, N
   Rio, M
   Rötig, A
   Dulac, O
   Munnich, A
   Desguerre, I
AF El Sabbagh, Sandra
   Lebre, Anne-Sophie
   Bahi-Buisson, Nadia
   Delonlay, Pascale
   Soufflet, Christine
   Boddaert, Nathalie
   Rio, Marlene
   Roetig, Agnes
   Dulac, Olivier
   Munnich, Arnold
   Desguerre, Isabelle
TI Epileptic phenotypes in children with respiratory chain disorders
SO EPILEPSIA
LA English
DT Article
DE Mitochondriopathy; Epilepsy-NARP; MELAS; POLG1; mtDNA depletion; Myoclonic epilepsy; Neonatal myoclonic encephalopathy; Infantile spasms; Status epilepticus; Epilepsia partialis continua
ID progressive neuronal degeneration; mitochondrial disorders; alpers-disease; mutations; mri; encephalopathy; deficiency; childhood; myopathy; spectrum
AB P>Purpose: Epilepsy is a commonly reported but rarely described clinical hallmark of mitochondrial respiratory chain defects (RCDs) with encephalopathy. Methods: From 1990-2006 we collected data about 56 children with RCD (single, n = 24 or multiple, n = 20 mitochondrial complex deficiencies; mtDNA mutation, n = 11; mtDNA depletion n = 10 of 21; and nuclear gene mutation n = 11). Epileptic features were reviewed retrospectively. Results: First seizures were frequently (47 patients, 82.5%) preceded by failure to thrive, psychomotor delay, ataxia, or multisystemic dysfunction. Sixty percent of the patients had several seizure types. Six age-related epilepsy phenotypes could be identified: status epilepticus complicating neonatal multivisceral deficiency (2 patients), neonatal myoclonic encephalopathy (3 patients), infantile spasms (8 patients), refractory or recurrent status epilepticus (21 patients), epilepsia partialis continua (4 patients), and myoclonic epilepsy (18 patients). Except for infantile spasms, epilepsy was difficult to control in most patients (95%). Valproate was administered to 25 patients, one of whom developed acute liver failure 6 days later. Twenty-two patients (45%) died, half of them within 9 months from the onset of epilepsy. Discussion: In RCD, epilepsy is not only difficult to control but its occurrence often indicates a severe turn in the course of the disease. For one-third of the patients, classical biochemical measures failed to reveal any abnormality and RCD could be detected in the liver only.
C1 [El Sabbagh, Sandra; Lebre, Anne-Sophie; Bahi-Buisson, Nadia; Boddaert, Nathalie; Rio, Marlene; Dulac, Olivier; Munnich, Arnold; Desguerre, Isabelle] Hop Necker Enfants Malad, AP HP, F-75450 Paris 15, France.
   [Bahi-Buisson, Nadia; Delonlay, Pascale; Boddaert, Nathalie; Dulac, Olivier; Munnich, Arnold] Univ Paris 05, Paris, France.
   [Delonlay, Pascale] Hop Necker Enfants Malad, AP HP, Metab Clin, F-75450 Paris 15, France.
   [Soufflet, Christine] Necker, Neurophysiol, Paris, France.
   [Roetig, Agnes; Munnich, Arnold] INSERM, U781, Paris, France.
   INSERM, U663, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Desguerre, I (corresponding author), Hop Necker Enfants Malad, AP HP, 149 Rue Sevres, F-75450 Paris 15, France.
EM isabelle.desguerre@nck.aphp.fr
CR [Anonymous], 1981, EPILEPSIA, V22, P489
   Bahi-Buisson N, 2006, EPILEPSIA, V47, P380, DOI 10.1111/j.1528-1167.2006.00432.x
   Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Desguerre I, 2003, NEUROPEDIATRICS, V34, P265
   Folbergrová J, 2007, EXP NEUROL, V204, P597, DOI 10.1016/j.expneurol.2006.12.010
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kann O, 2007, AM J PHYSIOL-CELL PH, V292, PC641, DOI 10.1152/ajpcell.00222.2006
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7
   Leary LD, 2003, EPILEPSIA, V44, P701, DOI 10.1046/j.1528-1157.2003.05302.x
   Lee YC, 2008, PHYTOCHEM LETT, V1, P6, DOI 10.1016/j.phytol.2007.11.002
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mascalchi M, 2002, NEUROLOGY, V58, P1686, DOI 10.1212/WNL.58.11.1686
   Mikaeloff Y, 2006, EPILEPSY RES, V69, P67, DOI 10.1016/j.eplepsyres.2006.01.002
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Nabbout R, 1999, ARCH DIS CHILD-FETAL, V81, PF125, DOI 10.1136/fn.81.2.F125
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Riquet A, 2008, EPILEPSY RES, V78, P1, DOI 10.1016/j.eplepsyres.2007.10.001
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   RYDING E, 1988, J CEREBR BLOOD F MET, V8, PS95, DOI 10.1038/jcbfm.1988.38
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Shah NS, 2002, J CHILD NEUROL, V17, P369, DOI 10.1177/088307380201700511
   Striano P, 2007, EPILEPSY BEHAV, V10, P187, DOI 10.1016/j.yebeh.2006.10.009
   Stromberger C, 2003, J INHERIT METAB DIS, V26, P299, DOI 10.1023/A:1024453704800
   TADA K, 1993, J INHERIT METAB DIS, V16, P691, DOI 10.1007/BF00711901
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Villanueva V, 2006, EPILEPSIA, V47, P788, DOI 10.1111/j.1528-1167.2006.00526.x
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
NR 39
TC 80
Z9 83
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD JUL 15
PY 2010
VL 51
IS 7
BP 1225
EP 1235
DI 10.1111/j.1528-1167.2009.02504.x
PG 11
WC Clinical Neurology
SC Neurosciences & Neurology
GA 619PG
UT WOS:000279441500017
PM 20196775
DA 2024-11-01
ER

PT J
AU Batabyal, D
   McKenzie, JL
   Johnson, KA
AF Batabyal, Dipanwita
   McKenzie, Jessica L.
   Johnson, Kenneth A.
TI Role of Histidine 932 of the Human Mitochondrial DNA Polymerase in Nucleotide Discrimination and Inherited Disease
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID progressive external ophthalmoplegia; hiv reverse-transcriptase; nucleoside analogs; crystal-structure; alpers-syndrome; kinetic-data; induced-fit; replication; mutations; fidelity
AB The human mitochondrial DNA polymerase (pol gamma) is nuclearly encoded and is solely responsible for the replication and repair of the mitochondrial genome. The progressive accumulation of mutations within the mitochondrial genome is thought to be related to aging, and mutations in the pol gamma gene are responsible for numerous heritable disorders including progressive external opthalmoplegia, Alpers syndrome, and parkinsonism. Here we investigate the kinetic effect of H932Y, a mutation associated with opthalmoplegia. Mutations H932Y and H932A reduce the specificity constant governing correct nucleotide incorporation 150- and 70-fold, respectively, without significantly affecting fidelity of incorporation or the maximum rate of incorporation. However, this leads to only a 2-fold reduction in rate of incorporation at a physiological nucleotide concentration (similar to 100 mu M). Surprisingly, incorporation of T: T or C: T mismatches catalyzed by either H932Y or H932A mutants was followed by slow pyrophosphate release (or fast pyrophosphate rebinding). Also, H932Y readily catalyzed incorporation of multiple mismatches, which may have a profound physiological impact over time. His-932 is thought to contact the beta-phosphate of the incoming nucleotide, so it is perhaps surprising that H932Y appears to slow rather than accelerate pyrophosphate release.
C1 [Batabyal, Dipanwita; McKenzie, Jessica L.; Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.
C3 University of Texas System; University of Texas Austin
RP Johnson, KA (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.
EM kajohnson@mail.utexas.edu
FU National Institutes of Health [R01 GM 044613]; Welch Foundation [F-1604]
CR Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Doublié S, 1999, STRUCTURE, V7, PR31, DOI 10.1016/S0969-2126(99)80017-3
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695
   Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345
   Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200
   Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006
   Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025
   Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024
   Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029
   Roitberg AE, 2007, J PHYS CHEM B, V111, P2415, DOI 10.1021/jp068335b
   STEITZ TA, 1993, COLD SPRING HARB SYM, V58, P495, DOI 10.1101/SQB.1993.058.01.056
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339
   Truniger V, 2002, NUCLEIC ACIDS RES, V30, P1483, DOI 10.1093/nar/30.7.1483
   Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z
   WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 35
TC 12
Z9 14
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 29
PY 2010
VL 285
IS 44
BP 34191
EP 34201
DI 10.1074/jbc.M110.156182
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 669MD
UT WOS:000283354000064
PM 20685647
DA 2024-11-01
ER

PT J
AU Hirano, M
AF Hirano, M.
TI Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa (NARP)
SO ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 2: H-P
LA English
DT Article; Book Chapter
ID mitochondrial-dna; prenatal-diagnosis; t8993c mutation; leighs syndrome; disease; mtdna; gene
C1 Columbia Univ, Med Ctr, New York, NY 10027 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.
CR Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Fujii T, 2002, PEDIATR NEUROL, V27, P58, DOI 10.1016/S0887-8994(02)00378-8
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pettman R, 2007, J INHERIT METAB DIS, V30, P404, DOI 10.1007/s10545-007-0460-y
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 
EI 
J9 
PD JUN 15
PY 2010
VL 0
IS 
BP 270
EP 272
DI 
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA BA3XC
UT WOS:000335076600086
DA 2024-11-01
ER

PT J
AU Ghezzi, D
   Sevrioukova, I
   Invernizzi, F
   Lamperti, C
   Mora, M
   D'Adamo, P
   Novara, F
   Zuffardi, O
   Uziel, G
   Zeviani, M
AF Ghezzi, Daniele
   Sevrioukova, Irina
   Invernizzi, Federica
   Lamperti, Costanza
   Mora, Marina
   D'Adamo, Pio
   Novara, Francesca
   Zuffardi, Orsetta
   Uziel, Graziella
   Zeviani, Massimo
TI Severe X-Linked Mitochondrial Encephalomyopathy Associated with a Mutation in Apoptosis-Inducing Factor
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID oxidative-phosphorylation; aif; release; atrophy
AB We investigated two male infant patients who were given a diagnosis of progressive mitochondrial encephalomyopathy on the basis of clinical, biochemical, and morphological features. These patients were born from monozygotic twin sisters and unrelated fathers, suggesting an X-linked trait. Fibroblasts from both showed reduction of respiratory chain (RC) cIII and cIV, but not of cl activities. We found a disease-segregating mutation in the X-linked AIFM1 gene, encoding the Apoptosis-Inducing Factor (AIF) mitochondrion-associated 1 precursor that deletes arginine 201 (R201 del). Under normal conditions, mature AIF is a FAD-dependent NADH oxidase of unknown function and is targeted to the mitochondrial intermembrane space (this form is called AIF(mit)). Upon apoptogenic stimuli, a soluble form (AIF(sol)) is released by proteolytic cleavage and migrates to the nucleus, where it induces "parthanatos," i.e., caspase-independent fragmentation of chromosomal DNA. In vitro, the AIF(R201) (del) mutation decreases stability of both AIF(mit), and AIF(sol) and increases the AIF(sol) DNA binding affinity, a prerequisite for nuclear apoptosis. In AIF(R201) (del) fibroblasts, staurosporine-induced parthanatos was markedly increased, whereas re-expression of AIF(wt) induced recovery of RC activities. Numerous TUNEL-positive, caspase 3-negative nuclei were visualized in patient #1's muscle, again indicating markedly increased parthanatos in the AIF(R201 del) critical tissues. We conclude that AIF(R201) (del) is an unstable mutant variant associated with increased parthanatos-linked cell death. Our data suggest a role for AIF in RC integrity and mtDNA maintenance, at least in some tissues. Interestingly, riboflavin supplementation was associated with prolonged improvement of patient #1's neurological conditions, as well as correction of RC defects in mutant fibroblasts, suggesting that stabilization of the FAD binding in AIF(mit) is beneficial.
C1 [Ghezzi, Daniele; Invernizzi, Federica; Lamperti, Costanza; Zeviani, Massimo] Ist Ricovero & Cura Carattere Sci, Div Mol Neurogenet, Carlo Besta Neurol Inst Fdn, I-20126 Milan, Italy.
   [Sevrioukova, Irina] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.
   [Mora, Marina] Ist Ricovero & Cura Carattere Sci, Neuromuscular Dis & Neuroimmunol Unit, Carlo Besta Neurol Inst Fdn, I-20126 Milan, Italy.
   [D'Adamo, Pio] Univ Trieste, Div Med Genet, Ist Ricovero & Cura Carattere Sci, I-34137 Trieste, Italy.
   [Novara, Francesca; Zuffardi, Orsetta] Univ Pavia, Dept Human End Hereditary Pathol, Med Genet Sect, I-27100 Pavia, Italy.
   [Uziel, Graziella] Ist Ricovero & Cura Carattere Sci, Div Child Neurol, Carlo Besta Neurol Inst Fdn, I-20133 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of California System; University of California Irvine; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Trieste; University of Pavia; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Zeviani, M (corresponding author), Ist Ricovero & Cura Carattere Sci, Div Mol Neurogenet, Carlo Besta Neurol Inst Fdn, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
FU Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy [GGP07019]; Italian Ministry of Health [RF-INN-2007-634163]
CR ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014
   Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071
   Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, PC1031, DOI 10.1152/ajpcell.00420.2001
   Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276
   Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x
   Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034
   Maté MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008
   Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614
   Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200
   Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Sevrioukova IF, 2009, J MOL BIOL, V390, P924, DOI 10.1016/j.jmb.2009.05.013
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020
   Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
   Yu SW, 2009, ASN NEURO, V1, P0, DOI 10.1042/AN20090046
   Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
NR 28
TC 171
Z9 180
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD APR 9
PY 2010
VL 86
IS 4
BP 639
EP 649
DI 10.1016/j.ajhg.2010.03.002
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA 583YP
UT WOS:000276716800016
PM 20362274
DA 2024-11-01
ER

PT J
AU Weakley, SM
   Jiang, J
   Kougias, P
   Lin, PH
   Yao, QZ
   Brunicardi, FC
   Gibbs, RA
   Chen, CY
AF Weakley, Sarah M.
   Jiang, Jun
   Kougias, Panagiotis
   Lin, Peter H.
   Yao, Qizhi
   Brunicardi, F. Charles
   Gibbs, Richard A.
   Chen, Changyi
TI Role of somatic mutations in vascular disease formation
SO EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
LA English
DT Review
DE atherosclerosis; human genome project; mitochondrial DNA; pulmonary artery hypertension; somatic mutation
ID smooth-muscle-cells; growth-factor-beta; mitochondria dna deletions; atherosclerotic lesions; brain microvessels; microsatellite instability; pulmonary-hypertension; cellular senescence; endothelial-cells; oxidative stress
AB Coronary artery disease, cerebrovascular disease, pulmonary artery hypertension and Alzheimer's disease all lead to substantial morbidity and mortality, and we currently lack effective treatments for these vascular diseases. Since the discovery, decades ago, that atherosclerotic lesions display clonal growth, atherosclerosis and other vascular diseases have been postulated to be neoplastic processes, arising through a series of critical somatic mutations. There is conflicting evidence supporting this but studies of DNA damage and mutagenesis, both genomic and mitochondrial, in atherosclerotic and vascular lesions, have yielded evidence that somatic mutations are involved in atherogenesis and vascular disease development. The roles of mitochondrial DNA damage, oxidative stress and signaling by members of the TGF-beta receptor family are implicated. With the increasing convenience and cost-effectiveness of genome sequencing, it is feasible to continue to seek specific genetic targets in the pathogenesis of these devastating diseases, with the hope of developing personalized genomic medicine in the future.
C1 [Chen, Changyi] Baylor Coll Med, Michael E DeBakey Dept Surg R413, Houston, TX 77030 USA.
   [Jiang, Jun; Kougias, Panagiotis; Lin, Peter H.; Yao, Qizhi; Chen, Changyi] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Weakley, Sarah M.; Jiang, Jun; Kougias, Panagiotis; Lin, Peter H.; Yao, Qizhi; Brunicardi, F. Charles] Baylor Coll Med, Michael E DeBakey Dept Surg, Mol Surg Res Ctr, Houston, TX 77030 USA.
   [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Chen, CY (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg R413, 1 Baylor Plaza,Mail Stop BCM391, Houston, TX 77030 USA.
EM jchen@bcm.tmc.edu
FU NIH [R01HL083471, T32HL083774, K08HL076345]; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA
CR Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x
   Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040
   Anderson Jeffrey L, 2007, CURR ATHEROSCLER REP, V9, P179, DOI 10.1007/s11883-007-0017-4
   Andreassi MG, 2008, J MOL MED, V86, P1033, DOI 10.1007/s00109-008-0358-7
   Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018
   Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Bartsch H, 2004, CANCER DETECT PREV, V28, P385, DOI 10.1016/j.cdp.2004.07.004
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Binková B, 2001, INT J HYG ENVIR HEAL, V204, P49, DOI 10.1078/1438-4639-00072
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Botto N, 2002, CORONARY ARTERY DIS, V13, P269, DOI 10.1097/00019501-200208000-00004
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Brunicardi FC, 2009, WORLD J SURG, V33, P612, DOI 10.1007/s00268-008-9861-9
   Cakir Y, 2007, FREE RADICAL BIO MED, V43, P1279, DOI 10.1016/j.freeradbiomed.2007.07.015
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chung IM, 1998, AM J PATHOL, V152, P913
   Clark KJ, 2001, ARTERIOSCL THROM VAS, V21, P555, DOI 10.1161/01.ATV.21.4.555
   Costopouzos C, 2008, BIOCHEM PHARMACOL, V75, P1251, DOI 10.1016/j.bcp.2007.10.006
   Curfs DMJ, 2005, FASEB J, V19, P1290, DOI 10.1096/fj.04-2269fje
   Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X
   Dandona Sonny, 2009, CURR CARDIOL REP, V11, P282
   Dandona S, 2009, CURR ATHEROSCLER REP, V11, P175, DOI 10.1007/s11883-009-0028-4
   David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978
   Daw EW, 2007, HUM MOL GENET, V16, P2463, DOI 10.1093/hmg/ddm202
   de la Chapelle A, 2003, NEW ENGL J MED, V349, P209, DOI 10.1056/NEJMp038099
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Federici C, 2008, AM J CARDIOL, V102, P1296, DOI 10.1016/j.amjcard.2008.07.024
   Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101
   Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074
   Godschalk R, 2003, FREE RADICAL RES, V37, P1299, DOI 10.1080/10715760310001621333
   Godschalk RWL, 2007, MUTAT RES-FUND MOL M, V621, P87, DOI 10.1016/j.mrfmmm.2007.02.012
   Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729
   Gorgoulis VG, 2005, LAB INVEST, V85, P502, DOI 10.1038/labinvest.3700241
   Hamsten A, 2008, J INTERN MED, V263, P538, DOI 10.1111/j.1365-2796.2008.01958.x
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Hezel AF, 2005, CURR MOL MED, V5, P145, DOI 10.2174/1566524053586563
   Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801
   Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V658, P215, DOI 10.1016/j.mrrev.2007.10.001
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Laghi L, 2008, ONCOGENE, V27, P6313, DOI 10.1038/onc.2008.217
   Lavezzi AM, 2005, APMIS, V113, P112, DOI 10.1111/j.1600-0463.2005.apm1130204.x
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272
   Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1
   Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F
   Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285
   Machado RD, 2005, CIRCULATION, V111, P607, DOI 10.1161/01.CIR.0000154543.07679.08
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, PL548, DOI 10.1152/ajplung.00428.2006
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Matturri L, 2003, J THROMB HAEMOST, V1, P2234, DOI 10.1046/j.1538-7836.2003.00409.x
   Matturri L, 2001, ATHEROSCLEROSIS, V154, P755, DOI 10.1016/S0021-9150(00)00488-3
   McCaffrey TA, 1997, J CLIN INVEST, V100, P2182, DOI 10.1172/JCI119754
   McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203
   Milei J, 2008, CAN J CARDIOL, V24, P137, DOI 10.1016/S0828-282X(08)70570-1
   Minamino T, 2008, NAT CLIN PRACT CARD, V5, P637, DOI 10.1038/ncpcardio1324
   Mishima T, 2008, INT J MOL MED, V21, P181
   Mulvihill ER, 2004, ARTERIOSCL THROM VAS, V24, P1283, DOI 10.1161/01.ATV.0000132401.12275.0c
   Naira J, 2007, MUTAT RES-FUND MOL M, V621, P95, DOI 10.1016/j.mrfmmm.2007.02.013
   Napoli C, 2002, NEOPLASIA, V4, P185, DOI 10.1038/sj.neo.7900232
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   PARKES JL, 1991, AM J PATHOL, V138, P765
   PENN A, 1986, P NATL ACAD SCI USA, V83, P7951, DOI 10.1073/pnas.83.20.7951
   Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796
   Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP
   Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC
   Roberts R, 2008, CURR OPIN CARDIOL, V23, P629, DOI 10.1097/HCO.0b013e32830e6b4e
   Roy H, 2009, HUM GENET, V125, P467, DOI 10.1007/s00439-009-0654-5
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Schwartz SM, 1998, ANNU REV MED, V49, P437
   Simonneau G, 2013, J AM COLL CARDIOL, V62, PD34, DOI 10.1016/j.jacc.2013.10.029
   Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002
   Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177
   Takeshita J, 2006, J BIOL CHEM, V281, P3096, DOI 10.1074/jbc.M509236200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuder RM, 1998, AM J RESP CRIT CARE, V158, P1999, DOI 10.1164/ajrccm.158.6.9805002
   Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X
   Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb
   Yeager ME, 2001, CIRC RES, V88, P0
   Yuan JXJ, 2005, CIRCULATION, V111, P534, DOI 10.1161/01.CIR.0000156326.48823.55
   Zaiman A, 2005, AM J RESP CELL MOL, V33, P425, DOI 10.1165/rcmb.F307
NR 99
TC 26
Z9 33
U1 0
U2 12
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 1473-7159
EI 1744-8352
J9 EXPERT REV MOL DIAGN
JI Expert Rev. Mol. Diagn.
PD MAR 15
PY 2010
VL 10
IS 2
BP 173
EP 185
DI 10.1586/ERM.10.1
PG 13
WC Pathology
SC Pathology
GA 571VQ
UT WOS:000275784400005
PM 20214536
DA 2024-11-01
ER

PT J
AU Ghatak, A
   Faheem, O
   Thompson, PD
AF Ghatak, Abhijit
   Faheem, Osman
   Thompson, Paul D.
TI The genetics of statin-induced myopathy
SO ATHEROSCLEROSIS
LA English
DT Review
DE Genetics; Organic anion transporter; Inherited
ID coa reductase inhibitors; rippling muscle disease; malignant-hyperthermia susceptibility; myoadenylate deaminase deficiency; skeletal-muscle; slco1b1 polymorphism; mitochondrial-dna; sarcoplasmic-reticulum; lactic-acidosis; episodes melas
AB Objective: Our goal was to use genetic variants to identify factors contributing to the muscular side effects of statins. Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are usually well tolerated medications, but muscle symptoms, ranging from mild myalgia to clinically important rhabdomyolysis are an important side effect of these drugs and a leading cause of noncompliance. Recent results suggest that genetic factors increase the risk of statin-related muscle complaints. We performed a systematic review of the medical literature to determine genetic factors associated with statin myopathy. Methods: We identified English language articles relating statin myopathy and genetic diseases and gene variants via a PubMed search. Articles pertinent to the topic were reviewed in detail. Results/Conclusions: Our review suggests that some patients are susceptible to statin myopathy because of pre-existing subclinical inherited muscular disorders, or genetic variation in statin uptake proteins encoded by SLCO1B1 or the cytochrome P enzyme system. Variations in genes affecting pain perception and polymorphism in vascular receptors may also contribute to statin myopathy. None of the variants identified in this review suggested novel metabolic mechanisms leading to statin myopathy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Faheem, Osman; Thompson, Paul D.] Hartford Hosp, Div Cardiol, Henry Low Heart Ctr, Hartford, CT 06102 USA.
   [Ghatak, Abhijit] Univ Connecticut, Dept Internal Med, Farmington, CT 06032 USA.
C3 Hartford Hospital; University of Connecticut
RP Thompson, PD (corresponding author), Hartford Hosp, Div Cardiol, Henry Low Heart Ctr, 80 Seymour St,POB 5037, Hartford, CT 06102 USA.
EM pthomps@harthosp.org
FU GlaxoSmithKline; Merck; Roche; Pfizer; Astra Zeneca B. Braun; Genomas
CR Ansevin CF, 1996, ARCH NEUROL-CHICAGO, V53, P197, DOI 10.1001/archneur.1996.00550020113023
   Baker SK, 2001, CLIN INVEST MED, V24, P258
   Baker SK, 2006, MUSCLE NERVE, V34, P478, DOI 10.1002/mus.20575
   Barth JH, 2003, ANN CLIN BIOCHEM, V40, P576, DOI 10.1258/000456303322326542
   Bhuiyan J, 1996, LIPIDS, V31, P867, DOI 10.1007/BF02522982
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   Bolego C, 2002, CARDIOVASC DRUG THER, V16, P251, DOI 10.1023/A:1020656607497
   Bonnefont Jean-Paul, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P495, DOI 10.1016/j.mam.2004.06.004
   Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938
   Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z
   Bullen WW, 1999, J AM SOC MASS SPECTR, V10, P55, DOI 10.1016/S1044-0305(98)00118-4
   BURNS RJ, 1994, J NEUROL NEUROSUR PS, V57, P344, DOI 10.1136/jnnp.57.3.344
   BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003
   Carswell CI, 2002, DRUGS, V62, P2075, DOI 10.2165/00003495-200262140-00008
   CHARIOT P, 1993, AM J MED, V94, P109, DOI 10.1016/0002-9343(93)90129-D
   Chen CP, 2008, DRUG METAB DISPOS, V36, P1840, DOI 10.1124/dmd.108.020594
   Corti S, 2008, J NEUROL SCI, V266, P97, DOI 10.1016/j.jns.2007.09.015
   DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516
   Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018
   GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486
   Gray DF, 2000, CARDIOVASC RES, V47, P329, DOI 10.1016/S0008-6363(00)00106-1
   Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490
   Guis S, 2006, ARTHRIT RHEUM-ARTHR, V55, P551, DOI 10.1002/art.22100
   Heydemann A, 2009, J CLIN INVEST, V119, P448, DOI 10.1172/JCI38618
   Ikemoto T, 2001, BRIT J PHARMACOL, V134, P719, DOI 10.1038/sj.bjp.0704306
   Inoue R, 2003, J PHARMACOL SCI, V93, P279, DOI 10.1254/jphs.93.279
   Ishikawa C, 2004, J HUM GENET, V49, P582, DOI 10.1007/s10038-004-0188-6
   Jacobson TA, 2006, AM J CARDIOL, V97, P44C, DOI 10.1016/j.amjcard.2005.12.009
   JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825
   KALOW W, 1979, INTERNATIONAL ANESTHESIOLOGY CLINICS, V17, P119, DOI 10.1097/00004311-197917040-00008
   Kameyama Y, 2005, PHARMACOGENET GENOM, V15, P513, DOI 10.1097/01.fpc.0000170913.73780.5f
   Kim K, 2004, J CLIN PHARMACOL, V44, P1083, DOI 10.1177/0091270004268128
   Koeppe C, 2004, SCAND J RHEUMATOL, V33, P24, DOI 10.1080/03009740410006989
   König J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y
   Krivosic-Horber R, 2004, EUR J ANAESTH, V21, P572, DOI 10.1017/S0265021504227120
   Kubisch C, 2005, ANN NEUROL, V57, P303, DOI 10.1002/ana.20350
   Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
   Livingstone C, 2004, ANN CLIN BIOCHEM, V41, P338, DOI 10.1258/0004563041201554
   Lorenzoni PJ, 2007, ARQ NEURO-PSIQUIAT, V65, P834, DOI 10.1590/S0004-282X2007000500020
   Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049
   Marez D, 1997, PHARMACOGENETICS, V7, P193, DOI 10.1097/00008571-199706000-00004
   McClure DL, 2007, J CLIN EPIDEMIOL, V60, P812, DOI 10.1016/j.jclinepi.2006.11.006
   Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365
   Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454
   Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5
   Morimoto Kaori, 2004, DRUG METAB PHARMACOKINET, V19, P453, DOI 10.2133/dmpk.19.453
   MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457
   Mosieniak G, 1997, J NEUROCHEM, V68, P1142
   Mulder AB, 2001, CLIN PHARMACOL THER, V70, P546, DOI 10.1067/mcp.2001.120251
   NAKAHARA K, 1994, BIOCHEM BIOPH RES CO, V202, P1579, DOI 10.1006/bbrc.1994.2112
   Niemi M, 2004, PHARMACOGENETICS, V14, P429, DOI 10.1097/01.fpc.0000114750.08559.32
   Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Nordin C, 1997, LANCET, V350, P29, DOI 10.1016/S0140-6736(05)66238-1
   Oh J, 2007, LIPIDS HEALTH DIS, V6, P0, DOI 10.1186/1476-511X-6-7
   Päivä H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006
   Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220
   Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90
   Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2
   Phillips Paul S, 2008, EXPERT REV CARDIOVASC THER, V6, P971, DOI 10.1586/14779072.6.7.971
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033
   Ruaño G, 2005, PHARMACOGENOMICS, V6, P865, DOI 10.2217/14622416.6.8.865
   Ruaño G, 2007, MUSCLE NERVE, V36, P329, DOI 10.1002/mus.20871
   Sailler L, 2008, ANN RHEUM DIS, V67, P614, DOI 10.1136/ard.2007.075523
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x
   Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721
   Stephan DA, 1999, GENOMICS, V55, P268, DOI 10.1006/geno.1998.5689
   Tarnopolsky MA, 2001, J PHYSIOL-LONDON, V533, P881, DOI 10.1111/j.1469-7793.2001.t01-1-00881.x
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Thomas JE, 2007, EUR NEUROL, V57, P232, DOI 10.1159/000101287
   Thompson PD, 2006, AM J CARDIOL, V97, P69C, DOI 10.1016/j.amjcard.2005.12.013
   Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681
   Torbergsen T, 2002, MUSCLE NERVE, V0, PPS103, DOI 10.1002/mus.10156
   TORBERGSEN T, 1975, ACTA NEUROL SCAND, V51, P225, DOI 10.1111/j.1600-0404.1975.tb07603.x
   Transon C, 1996, EUR J CLIN PHARMACOL, V50, P209, DOI 10.1007/s002280050094
   Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71
   Urwyler A, 2001, BRIT J ANAESTH, V86, P283, DOI 10.1093/bja/86.2.283
   Venero CV, 2009, ENDOCRIN METAB CLIN, V38, P121, DOI 10.1016/j.ecl.2008.11.002
   Verzijl HTFM, 1998, ANN NEUROL, V44, P140, DOI 10.1002/ana.410440124
   VLADITU G, 2004, AM COLL RHEUM 2004 M, V0, P0
   Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567
   Voermans NC, 2005, J INTERN MED, V258, P196, DOI 10.1111/j.1365-2796.2005.01515.x
   Voora D, 2009, J AM COLL CARDIOL, V54, P1609, DOI 10.1016/j.jacc.2009.04.053
   Wilke RA, 2005, PHARMACOGENET GENOM, V15, P415, DOI 10.1097/01213011-200506000-00007
   Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003
   Wolfe GI, 2000, MUSCLE NERVE, V23, P641, DOI 10.1002/(SICI)1097-4598(200004)23:4<641::AID-MUS25>3.0.CO;2-M
   Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200
   Zuccaro P, 2007, PHARMACOL RES, V55, P310, DOI 10.1016/j.phrs.2006.12.009
NR 96
TC 93
Z9 101
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JUN 15
PY 2010
VL 210
IS 2
BP 337
EP 343
DI 10.1016/j.atherosclerosis.2009.11.033
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 601CY
UT WOS:000278036800002
PM 20042189
DA 2024-11-01
ER

PT J
AU Hong, DJ
   Bi, HY
   Yao, S
   Wang, ZX
   Yuan, Y
AF Hong, Daojun
   Bi, Hongyan
   Yao, Sheng
   Wang, Zhaoxia
   Yuan, Yun
TI CLINICAL PHENOTYPE OF AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA IN A FAMILY WITH A NOVEL MUTATION IN THE C10orf2 GENE
SO MUSCLE & NERVE
LA English
DT Article
DE progressive external ophthalmoplegia; mitochondrion; C10orf2 gene; autosomal dominant; cardiac abnormality
ID mitochondrial-dna deletions; twinkle gene; multiple deletions; helicase twinkle; mtdna deletions; swiss-model; protein; region; polg; features
AB Autosomal dominant progressive external ophthalmoplegia (adPEO) is a mitochondrial disorder caused by mutations in nuclear genes. Here we report the clinical and genetic features of adPEO in a Chinese family. All patients had gradual onset of ptosis, with or without ophthalmoplegia, around age 30. Thirteen patients had limb weakness around age 40. Eight patients developed dysphagia around age 50. Four patients died of cardiac abnormalities around age 60. Muscle biopsy of the proband indicated mitochondrial myopathy characterized by ragged-red fibers, cytochrome c oxidase-negative fibers, and multiple deletions of mitochondrial DNA. A heterozygous missense mutation of c.1342A>G in the C10orf2 gene resulting in the p.448N>D mutation in the protein was found in the proband and four other affected family members. In summary, we identified an adPEO family with a novel C10orf2 gene mutation that manifested an age-dependent phenotype. It suggests that greater attention must be paid to cardiac abnormalities in the late stages of this disease. Muscle Nerve 41: 92-99, 2010
C1 [Hong, Daojun; Yao, Sheng; Wang, Zhaoxia; Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
   [Bi, Hongyan] Capital Med Univ, Dept Neurol, Friendship Hosp, Beijing, Peoples R China.
C3 Peking University; Capital Medical University
RP Yuan, Y (corresponding author), Peking Univ, Hosp 1, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
EM yuanyun2002@sohu.com
FU National Science Foundation of China [30870864]
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Carrozzo R, 1999, J NEUROL SCI, V170, P24, DOI 10.1016/S0022-510X(99)00193-8
   Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, PD230, DOI 10.1093/nar/gkh008
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
NR 29
TC 7
Z9 7
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JAN 15
PY 2010
VL 41
IS 1
BP 92
EP 99
DI 10.1002/mus.21439
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 540FB
UT WOS:000273315600011
PM 19705478
DA 2024-11-01
ER

PT J
AU Kaufman, KR
   Zuber, N
   Rueda-Lara, MA
   Tobia, A
AF Kaufman, Kenneth R.
   Zuber, Nicole
   Rueda-Lara, Maria A.
   Tobia, Anthony
TI MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: Case analysis with literature review
SO EPILEPSY & BEHAVIOR
LA English
DT Article
DE Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS); Mitochondrial encephalopathy; Complex partial seizures; Nonconvulsive status epilepticus; Aggression; Psychosis, hallucinations; Paranoid delusions; Video/EEG monitoring; Oxidative stress; Valproate; Levocarnitine; Vitamin E; Coenzyme Q10; Treatment; Education
ID stroke-like episodes; convulsive status epilepticus; lactic-acidosis; mitochondrial myopathy; a3243g mutation; 3243a-greater-than-g mutation; l-carnitine; encephalopathy; olanzapine; disorders
AB Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS) is a progressive neurodegenerative disorder associated with polygenetic, maternally inherited, mitochondrial DNA mutations. MELAS has multisystem presentation including neurological, muscular, endocrine, auditory, visual, cardiac, psychiatric, renal, gastrointestinal and dermatological symptoms. Clinical course and prognosis are variable, often leading to cognitive decline, disability, and premature death. Both convulsive status epilepticus (CSE) and nonconvulsive status epilepticus (NCSE) are reported with MELAS. This report illustrates a case of MELAS with recurrent complex partial seizures, NCSE, confusion, aggressive behaviors, hallucinations, and paranoid delusions. Rapid video/EEG confirmation of diagnosis and aggressive antiepileptic drug intervention are required. Further education of medical professionals regarding this disorder, its appropriate management, and the significance of NCSE is indicated to avoid delay of treatment. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Kaufman, Kenneth R.; Zuber, Nicole; Rueda-Lara, Maria A.; Tobia, Anthony] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, New Brunswick, NJ 08901 USA.
   [Kaufman, Kenneth R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA.
   [Kaufman, Kenneth R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Anesthesiol, New Brunswick, NJ 08901 USA.
   [Tobia, Anthony] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences
RP Kaufman, KR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, 125 Paterson St,Suite 2200, New Brunswick, NJ 08901 USA.
EM kaufmakr@umdnj.edu
CR Alemdar M, 2007, J NEUROPSYCH CLIN N, V19, P482, DOI 10.1176/appi.neuropsych.19.4.482
   Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023
   [Anonymous], 2000, DIAGN STAT MAN MENT, V0, P0
   BARAK Y, 1995, ISRAEL J MED SCI, V31, P224
   Berbel-Garcia A, 2004, CLIN NEUROPHARMACOL, V27, P187, DOI 10.1097/01.wnf.0000137862.67131.bf
   Bhuvaneswar Chaya G, 2008, PRIM CARE COMPANION J CLIN PSYCHIATRY, V10, P237
   Binienda Z, 2005, ANN NY ACAD SCI, V1053, P174, DOI 10.1196/annals.1344.015
   Camacho A, 2005, CLIN NEUROPHARMACOL, V28, P145, DOI 10.1097/01.wnf.0000165351.10841.fa
   Cock H, 2007, EPILEPSIA, V48, P24, DOI 10.1111/j.1528-1167.2007.01341.x
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   DELGADOESCUETA AV, 1981, NEW ENGL J MED, V305, P711, DOI 10.1056/NEJM198109173051231
   Eriksson K, 2005, NEUROLOGY, V65, P1316, DOI 10.1212/01.wnl.0000180959.31355.92
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Higashikata T, 2001, INTERNAL MED, V40, P405, DOI 10.2169/internalmedicine.40.405
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kanner AM, 2004, EPILEPSIA, V45, P22, DOI 10.1111/j.0013-9580.2004.452004.x
   Kaplan PW, 2005, NEUROLOGIST, V11, P348, DOI 10.1097/01.nrl.0000162954.76053.d2
   Kaplan PW, 2003, NEUROLOGY, V61, P1035, DOI 10.1212/WNL.61.8.1035
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Korff CM, 2007, NAT CLIN PRACT NEURO, V3, P505, DOI 10.1038/ncpneuro0605
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Misra UK, 2006, NEUROLOGY, V67, P340, DOI 10.1212/01.wnl.0000224880.35053.26
   Neargarder SA, 2007, COGN BEHAV NEUROL, V20, P83, DOI 10.1097/WNN.0b013e3180335faf
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Riggio S, 2006, MT SINAI J MED, V73, P960
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Russell S, 2007, CURR OPIN PEDIATR, V19, P206, DOI 10.1097/MOP.0b013e32805e879a
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sezen O, 2008, NEUROSURG REV, V31, P205, DOI 10.1007/s10143-007-0118-0
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tan TMM, 2009, CLIN ENDOCRINOL, V70, P340, DOI 10.1111/j.1365-2265.2008.03341.x
   Treiman DM, 2008, LANCET NEUROL, V7, P667, DOI 10.1016/S1474-4422(08)70142-X
   Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wheless JW, 2008, EPILEPSIA, V49, P74, DOI 10.1111/j.1528-1167.2008.01929.x
   Woolley J, 2001, BRIT J PSYCHIAT, V178, P85, DOI 10.1192/bjp.178.1.85-a
   Wyderski RJ, 1999, ANN PHARMACOTHER, V33, P787, DOI 10.1345/aph.18399
   Zaja-Milatovic S, 2008, NEUROTOXICOLOGY, V29, P621, DOI 10.1016/j.neuro.2008.04.009
NR 46
TC 37
Z9 42
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-5050
EI 1525-5069
J9 EPILEPSY BEHAV
JI Epilepsy Behav.
PD AUG 15
PY 2010
VL 18
IS 4
BP 494
EP 497
DI 10.1016/j.yebeh.2010.05.020
PG 4
WC Behavioral Sciences; Clinical Neurology; Psychiatry
SC Behavioral Sciences; Neurosciences & Neurology; Psychiatry
GA 643ON
UT WOS:000281306600026
PM 20580320
DA 2024-11-01
ER

PT J
AU Yano, T
   Tanaka, M
   Fukuda, N
   Ueda, T
   Nagase, H
AF Yano, Takamitsu
   Tanaka, Masashi
   Fukuda, Noboru
   Ueda, Takuya
   Nagase, Hiroki
TI Loss of mutant mitochondrial DNA harboring the MELAS A3243G mutation in human cybrid cells after cell-cell fusion with normal tissue-derived fibroblast cells
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE Mitochondrial DNA; cybrid cells; A3243G mutation; cell fusion; osteosarcoma; non-tumorigenic fibroblast cell; mitochondrial myopathy; encephalomyopathy; lactic acidosis; stroke-like episodes
ID transfer rnaleu(uur) gene; stroke-like episodes; point mutation; transcription termination; lactic-acidosis; protein-synthesis; encephalopathy; myopathy; mtdna; encephalomyopathy
AB Mutant mitochondrial (mt) DNA variants are related to human disease and have been investigated using cytoplasmic hybrid (cybrid) cells generated from human tumor cells in which mutant nit maintenance depends on the cell line. It is, however, unclear whether human intercellular fusion of non-tumorous cells influences the maintenance of disease-related mutant mt. A preliminary experiment of cell-cell fusion between a human skin fibroblast cell line from a Lesch-Nyhan syndrome patient and an osteosarcoma cybrid cell line harboring the mitochondrial tRNA(Leu(UUR))A3243G mutation showed a decrease of A3243G mutant mtDNA in fused cells during passages. In order to confirm the decrease of mutant mtDNA, we performed cell-cell fusion experiments using another human lung fibroblastic cell line. When the hygromycin-resistant osteosarcoma cybrid cell line was fused with the fibroblasts without any A3243G mtDNA mutations, the proportion of A3243G mutant mtDNA in the hybrid cells gradually decreased during cell culture and almost completely disappeared in all hybrid clones at the end of 15 passages. These results indicated that A3243G mutant specific mtDNA decreases in the hybrid background when normal fibroblast-derived cell contents, including the nucleus and mt, were introduced. Thus, we are hypothesizing that the non-tumorigenic fibroblast cellular components induce a difference in replication efficacy between the mtDNAs with and without the A3243G mutant sequence, which may be related to the decrease of disease-related mutant mtDNA in the hybrid cells.
C1 [Nagase, Hiroki] Nihon Univ, Div Canc Genet, Dept Adv Med Sci, Sch Med,Itabashi Ku, Tokyo 1738610, Japan.
   [Yano, Takamitsu; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
   [Fukuda, Noboru; Nagase, Hiroki] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo 1738610, Japan.
   [Nagase, Hiroki] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.
C3 Nihon University; University of Tokyo; Tokyo Metropolitan Institute of Gerontology; Nihon University; Roswell Park Comprehensive Cancer Center
RP Nagase, H (corresponding author), Nihon Univ, Div Canc Genet, Dept Adv Med Sci, Sch Med,Itabashi Ku, 30-1 Ooyaguchi Kamicho, Tokyo 1738610, Japan.
EM nagase.hiroki@nihon-u.ac.jp
FU academic frontier project; Grants-in-Aid for Scientific Research [21590411] Funding Source: KAKEN
CR Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHOUBRIDGE EA, 1995, BIOCHEM BIOPH RES CO, V213, P189, DOI 10.1006/bbrc.1995.2115
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 22
TC 2
Z9 2
U1 0
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD JAN 15
PY 2010
VL 25
IS 1
BP 153
EP 158
DI 10.3892/ijmm_00000325
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 635WQ
UT WOS:000280688500020
PM 19956914
DA 2024-11-01
ER

PT J
AU Bratic, I
   Trifunovic, A
AF Bratic, Ivana
   Trifunovic, Aleksandra
TI Mitochondrial energy metabolism and ageing
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
DE Mitochondrial respiratory chain; The mitochondrial theory of ageing; Uncoupling to survive; The rate of living hypothesis
ID systematic rnai screen; increased life-span; caenorhabditis-elegans; skeletal-muscle; calorie restriction; drosophila-melanogaster; oxidative stress; insulin-receptor; c-elegans; uncoupling protein-2
AB Ageing can be defined as "a progressive, generalized impairment of function, resulting in an increased vulnerability to environmental challenge and a growing risk of disease and death". Ageing is likely a multifactorial process caused by accumulated damage to a variety of cellular components. During the last 20 years, gerontological studies have revealed different molecular pathways involved in the ageing process and pointed out mitochondria as one of the key regulators of longevity. Increasing age in mammals correlates with increased levels of mitochondrial DNA (mtDNA) mutations and a deteriorating respiratory chain function. Experimental evidence in the mouse has linked increased levels of somatic mtDNA mutations to a variety of ageing phenotypes, such as osteoporosis, hair loss, graying of the hair, weight reduction and decreased fertility. A mosaic respiratory chain deficiency in a subset of cells in various tissues, such as heart, skeletal muscle, colonic crypts and neurons, is typically found in aged humans. It has been known for a long time that respiratory chain-deficient cells are more prone to undergo apoptosis and an increased cell loss is therefore likely of importance in the age-associated mitochondrial dysfunction. In this review, we would like to point out the link between the mitochondrial energy balance and ageing, as well as a possible connection between the mitochondrial metabolism and molecular pathways important for the lifespan extension. (C) 2010 Elsevier B.V. All rights reserved.
C1 Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany.
   Karolinska Inst, Dept Lab Med, Div Metab Dis, S-14186 Stockholm, Sweden.
C3 University of Cologne; Karolinska Institutet
RP Trifunovic, A (corresponding author), Univ Cologne, CECAD Cologne Excellent Ageing Res, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.
EM aleksandra.trifunovic@ki.se
CR Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x
   Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102
   Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191
   Cottrell D A, 2000, CURR OPIN CLIN NUTR METAB CARE, V3, P473, DOI 10.1097/00075197-200011000-00009
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5
   FRENZEL H, 1984, MECH AGEING DEV, V27, P29, DOI 10.1016/0047-6374(84)90080-0
   FRIEDMAN DB, 1988, GENETICS, V118, P75
   Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200
   Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9
   Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006
   Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200
   Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069
   Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296
   Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x
   Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200
   Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009
   Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, PE448, DOI 10.1152/ajpendo.1992.263.3.E448
   MCCAY CM, 1989, NUTRITION, V5, P155
   Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200
   Mozo J, 2005, BIOSCIENCE REP, V25, P227, DOI 10.1007/s10540-005-2887-4
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, PR985, DOI 10.1152/ajpregu.00537.2001
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, PC670, DOI 10.1152/ajpcell.00213.2006
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Pearl R, 1928, RATE LIVING BEING AC, V0, P0
   Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563
   Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9
   Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259
   Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015
   REID RA, 1966, NATURE, V212, P257, DOI 10.1038/212257a0
   Rousset S, 2004, DIABETES, V53, PS130, DOI 10.2337/diabetes.53.2007.S130
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x
   Stuart JA, 1999, BBA-BIOENERGETICS, V1413, P50, DOI 10.1016/S0005-2728(99)00081-X
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399
   Van Voorhies WA, 2003, J APPL PHYSIOL, V95, P2605, DOI 10.1152/japplphysiol.00448.2003
   Voet D, 2004, BIOCHEMISTRY, V3rd, P0
   Wallace D C, 2001, NOVARTIS FOUND SYMP, V235, P247
   Wieckowski MR, 1997, BIOCHEM BIOPH RES CO, V232, P414
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yu XX, 2001, BIOCHEM J, V353, P369, DOI 10.1042/bj3530369
   Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072
NR 72
TC 192
Z9 233
U1 0
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUN-JUL 15
PY 2010
VL 1797
IS 6-7
BP 961
EP 967
DI 10.1016/j.bbabio.2010.01.004
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 622KV
UT WOS:000279663200043
PM 20064485
DA 2024-11-01
ER

PT J
AU Hadzsiev, K
   Maasz, A
   Kisfali, P
   Kalman, E
   Gomori, E
   Pal, E
   Berenyi, E
   Komlosi, K
   Melegh, B
AF Hadzsiev, Kinga
   Maasz, Anita
   Kisfali, Peter
   Kalman, Endre
   Gomori, Eva
   Pal, Endre
   Berenyi, Ervin
   Komlosi, Katalin
   Melegh, Bela
TI Mitochondrial DNA 11777C&gt;A Mutation Associated Leigh Syndrome: Case Report with a Review of the Previously Described Pedigrees
SO NEUROMOLECULAR MEDICINE
LA English
DT Article
DE Leigh syndrome; Mitochondrial DNA; mtDNA 11777C > A; Mitochondrial mutation
ID cytochrome-c-oxidase; complex-i deficiency; c11777a mutation; common-cause; disease; nadh; encephalopathy; identification; subunits; children
AB Here, we present a male infant with clinical signs of typical Leigh syndrome. The first symptom, myoclonus was presented already on the 5th day of life; at 7 months of age limb convulsions and cerebral paresis with hypotonia were developed. At the age of 11 months, MRI verified increased signal intensity in the entire mesencephalon and medulla oblongata; while gray matter proton spectroscopy revealed presence of lactate increase in the brain. At age of 17 months, the child died in cardiorespiratory arrest. After autopsy, the diagnosis of Leigh syndrome was established; using DNA isolated from skeletal muscle and liver, heteroplasmic (> 50%) mitochondrial 11777C > A was detected in the fourth subunit of NADH dehydrogenase enzyme (MTND4) encoding gene, which causes Arg -> Ser replacement. The mutation was also detected in low copy number in blood of mother. Albeit this mutation type is well recognized as a typical mtDNA mutation, according the reports available on the PubMed, this mutation was described only in four patients with wide phenotypic variations; here, we reviewed the characteristic clinical features of them. Taken together, the earliest onset of symptoms, the nature of the first presentation signs, the most rapid progression, the character of minor additional symptoms, and the early fatal outcome differentiate the phenotypic variant of the proband presented here from cases reported so far by others.
C1 [Hadzsiev, Kinga; Maasz, Anita; Kisfali, Peter; Komlosi, Katalin; Melegh, Bela] Univ Pecs, Dept Med Genet, Pecs, Hungary.
   [Kalman, Endre; Gomori, Eva] Univ Pecs, Dept Pathol, Pecs, Hungary.
   [Pal, Endre] Univ Pecs, Dept Neurol, Pecs, Hungary.
   [Berenyi, Ervin] Ctr Med & Hlth Sci, Debrecen, Hungary.
C3 University of Pecs; University of Pecs; University of Pecs
RP Melegh, B (corresponding author), Univ Pecs, Dept Med Genet, Pecs, Hungary.
EM bela.melegh@aok.pte.hu
FU Hungarian Scientific Research Foundation [OTKA T 73430]; Hungarian Ministry of Health [ETT 243/2009]
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Deschauer M, 2003, NEUROLOGY, V60, P1357, DOI 10.1212/01.WNL.0000055869.99975.4B
   DI DS, 2009, J NEUROL, V256, P693
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Edmond Jane C, 2009, INT OPHTHALMOL CLIN, V49, P27, DOI 10.1097/IIO.0b013e3181a8de58
   FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   HOMMES FA, 1968, ARCH DIS CHILD, V43, P423, DOI 10.1136/adc.43.230.423
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maász A, 2008, CURR MED CHEM, V15, P1257, DOI 10.2174/092986708784534910
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224
   SUMEGI B, 1990, CLIN CHIM ACTA, V192, P9, DOI 10.1016/0009-8981(90)90266-U
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Ton C, 1997, BIOCHEM BIOPH RES CO, V241, P589, DOI 10.1006/bbrc.1997.7707
   Torroni A, 1996, GENETICS, V144, P1835
   WORSLEY HE, 1965, ARCH DIS CHILD, V40, P492, DOI 10.1136/adc.40.213.492
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 32
TC 10
Z9 11
U1 0
U2 7
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1535-1084
EI 1559-1174
J9 NEUROMOL MED
JI Neuromol. Med.
PD SEP 15
PY 2010
VL 12
IS 3
BP 277
EP 284
DI 10.1007/s12017-010-8115-9
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 642YZ
UT WOS:000281259200010
PM 20502985
DA 2024-11-01
ER

PT J
AU Copeland, WC
AF Copeland, William C.
TI The Mitochondrial DNA Polymerase in Health and Disease
SO GENOME STABILITY AND HUMAN DISEASES
LA English
DT Article; Book Chapter
DE DNA polymerase gamma; Mitochondrial disease; Mitochondrial DNA replication; Mitochondrial DNA repair; Nucleoside analogs
ID base excision-repair; progressive external ophthalmoplegia; virus reverse-transcriptase; antiviral nucleoside analogs; anti-hiv deoxynucleotides; p55 accessory subunit; selective action; polg mutations; w748s mutation; in-vitro
AB Since mutations in mitochondrial DNA (mtDNA) have been shown to be a cause of many mitochondrial diseases as well as aging, it is important to understand the origin of these mutations and how replication proteins modulate this process. DNA polymerase gamma (pol gamma) is the polymerase that is responsible for replication and repair of mtDNA. Pol gamma has three main roles in mtDNA maintenance and mutagenesis. As the only known DNA polymerase in mitochondria, pol gamma is required for all replication and repair functions and is the main source of errors produced in human mtDNA. Pol gamma is also sensitive to a host of antiviral nucleoside analogs used to treat HIV-1 infections, which can cause an induced mitochondrial toxicity. Finally, the gene for pol gamma, POLG, is a genetic locus for several mitochondrial disease with over 150 genetic mutations currently identified.
C1 Natl Inst Environm Hlth Sci, Mol Genet Lab, Durham, NC 27709 USA.
RP Copeland, WC (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, Durham, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Intramural NIH HHS [ZIA ES065080-16, ZIA ES065078-17] Funding Source: Medline
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   COPELAND WC, 1992, J BIOL CHEM, V267, P21459
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FRICK LW, 1988, BIOCHEM BIOPH RES CO, V154, P124, DOI 10.1016/0006-291X(88)90659-6
   FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HART GJ, 1992, ANTIMICROB AGENTS CH, V36, P1688, DOI 10.1128/AAC.36.8.1688
   HUANG P, 1992, J BIOL CHEM, V267, P2817
   HUANG P, 1990, J BIOL CHEM, V265, P11914
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   KAGUNI LS, 1988, EUKARYOTIC DNA REPLI, V0, P0
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   NICKEL W, 1992, J BIOL CHEM, V267, P848
   PARKER WB, 1991, J BIOL CHEM, V266, P1754
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 50
TC 55
Z9 58
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0306-0225
EI 
J9 SUBCELL BIOCHEM
JI Subcell. Biochem.
PD JUN 15
PY 2010
VL 50
IS 
BP 211
EP 222
DI 10.1007/978-90-481-3471-7_11
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA BNH48
UT WOS:000274566100011
PM 20012584
DA 2024-11-01
ER

PT J
AU Balakrishnan, VS
   Rao, M
   Menon, V
   Gordon, PL
   Pilichowska, M
   Castaneda, F
   Castaneda-Sceppa, C
AF Balakrishnan, Vaidyanatha S.
   Rao, Madhumathi
   Menon, Vandana
   Gordon, Patricia L.
   Pilichowska, Monika
   Castaneda, Francisco
   Castaneda-Sceppa, Carmen
TI Resistance Training Increases Muscle Mitochondrial Biogenesis in Patients with Chronic Kidney Disease
SO CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
ID chronic renal-insufficiency; glomerular-filtration-rate; skeletal-muscle; dna deletions; exercise; hemodialysis; sarcopenia; adults; scale; diet
AB Background and objectives: Muscle wasting, a common complication in chronic kidney disease (CKD), contributes to poor outcomes. Mitochondrial biogenesis is critical for the maintenance of skeletal muscle function and structural integrity. The present study a secondary analysis from a published randomized controlled trial-examined the effect of resistance exercise training on skeletal muscle mitochondrial (mt)DNA copy number and determined its association with skeletal muscle phenotype (muscle mass and strength). Design, setting, participants, & measurements: Twenty-three patients with moderate-to-severe CKD were randomized to resistance training (n = 13) or an attention-control (n = 10) group for 12 weeks. After a run-in period of a low-protein diet that continued during the intervention, mtDNA copy number in the vastus lateralis muscle was estimated by quantitative real-time PCR at baseline and 12 weeks. Results: Participants mean age was 64 +/- 10 (SD) years and median (interquartile range, IQR) GFR 27.5 (37.0) ml/min. There were no differences between groups at baseline. Median (IQR) mtDNA copy number was 13,713 (10,618). There was a significant increase in muscle mtDNA with exercise compared with controls (1306 [13306] versus 3747 [15467], P = 0.01). The change in muscle mtDNA copy number was positively correlated with previously reported changes in types I and II muscle fiber cross-sectional area. Conclusions: In this pilot study, resistance training was highly effective in enhancing mitochondrial content in patients with moderate-to-severe CKD. This finding suggests that the mitochondrial dysfunction observed with chronic disease could potentially be restored with this exercise modality and should be investigated further. Clin J Am Sac Nephrol 5: 996-1002, 2010. doi: 10.2215/CJN.09141209
C1 [Castaneda-Sceppa, Carmen] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA.
   [Balakrishnan, Vaidyanatha S.; Rao, Madhumathi; Menon, Vandana] Tufts Med Ctr, Div Nephrol, Boston, MA USA.
   [Gordon, Patricia L.] Univ Calif San Francisco, Dept Med, VA Med Ctr, Nephrol Sect, San Francisco, CA USA.
   [Pilichowska, Monika] Tufts Med Ctr, Dept Pathol, Boston, MA USA.
   [Castaneda, Francisco] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany.
   [Castaneda-Sceppa, Carmen] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
C3 Northeastern University; Tufts Medical Center; University of California System; University of California San Francisco; Tufts Medical Center; Max Planck Society; Tufts University
RP Castaneda-Sceppa, C (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA.
EM c.sceppa@neu.edu
FU NIA [R01 AG13457]; New England Medical Center Research Fund; U.S. Department of Agriculture [58-1950-4-401]
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505
   Averous J, 2003, J NUTR, V133, P2040S, DOI 10.1093/jn/133.6.2040S
   Castaneda C, 2004, AM J KIDNEY DIS, V43, P607, DOI 10.1053/j.ajkd.2003.12.025
   Castaneda C, 2000, J NUTR HEALTH AGING, V4, P85
   Castaneda C, 2001, ANN INTERN MED, V135, P965, DOI 10.7326/0003-4819-135-11-200112040-00008
   Cheema B, 2007, AM J KIDNEY DIS, V50, P574, DOI 10.1053/j.ajkd.2007.07.005
   CHEN JL, 2010, NEPHROL DIAL TR 0125, V0, P0
   Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, PS14, DOI 10.1053/ajkd.2002.30939
   EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101
   Fahal IH, 1998, INT J ARTIF ORGANS, V21, P185, DOI 10.1177/039139889802100401
   Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827
   Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585
   FOUQUE D, 1992, BMJ-BRIT MED J, V304, P216, DOI 10.1136/bmj.304.6821.216
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Ji LL, 2001, ANN NY ACAD SCI, V928, P236
   Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034
   Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141
   KLAHR S, 1989, NEW ENGL J MED, V320, P864, DOI 10.1056/NEJM198903303201310
   Kopple JD, 2007, J AM SOC NEPHROL, V18, P2975, DOI 10.1681/ASN.2006070794
   Levey AS, 1999, J AM SOC NEPHROL, V10, P2426
   LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1159/000064728
   Majchrzak KM, 2008, NEPHROL DIAL TRANSPL, V23, P1362, DOI 10.1093/ndt/gfm773
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Melov S, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000465
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015
   Nisoli E, 2008, AM J CARDIOL, V101, P22E, DOI 10.1016/j.amjcard.2008.02.077
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   PADYKULA HA, 1955, J HISTOCHEM CYTOCHEM, V3, P161, DOI 10.1177/3.3.161
   Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031
   Rimbert Virginie, 2004, FASEB J, V18, P737
   Robertson RJ, 2003, MED SCI SPORT EXER, V35, P333, DOI 10.1249/01.MSS.0000048831.15016.2A
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Takahashi M, 1998, AM J PHYSIOL-CELL PH, V274, PC1380, DOI 10.1152/ajpcell.1998.274.5.C1380
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
NR 41
TC 80
Z9 90
U1 0
U2 11
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA
SN 1555-9041
EI 1555-905X
J9 CLIN J AM SOC NEPHRO
JI Clin. J. Am. Soc. Nephrol.
PD JUN 15
PY 2010
VL 5
IS 6
BP 996
EP 1002
DI 10.2215/CJN.09141209
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 608OY
UT WOS:000278596200007
PM 20498251
DA 2024-11-01
ER

PT J
AU Karunadharma, PP
   Nordgaard, CL
   Olsen, TW
   Ferrington, DA
AF Karunadharma, Pabalu P.
   Nordgaard, Curtis L.
   Olsen, Timothy W.
   Ferrington, Deborah A.
TI Mitochondrial DNA Damage as a Potential Mechanism for Age-Related Macular Degeneration
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID retinal-pigment epithelium; hydrogen-peroxide; oxidative stress; skeletal-muscle; progressive stages; common deletion; nuclear-dna; repair; cells; proteomics
AB PURPOSE. Increasing evidence suggests a central role for mitochondrial (mt) dysfunction in age-related macular degeneration (AMD). Previous proteomic data from the retinal pigment epithelium (RPE) revealed significant changes to mt proteins, suggesting potential functional defects and damage to mitochondrial DNA (mtDNA) with AMD progression. The present study tests the hypothesis that mtDNA damage increases with aging and AMD. METHODS. Genomic DNA was isolated from the macular region of human donor RPE graded for stages of AMD (Minnesota Grading System [MGS] 1-4). Region-specific mtDNA damage with normal aging was evaluated in 45 control subjects (ages 34-88 years, MGS 1) and AMD-associated damage in diseased subjects (n = 46), compared with that in age-matched control subjects (n = 26). Lesions per 10 kb per genome in the mtDNA and nuclear DNA were measured with long-extension polymerase chain reaction (LX PCR). The level of deleted mtDNA in each donor was measured with quantitative real-time PCR (qPCR). RESULTS. With aging, an increase in mtDNA damage was observed only in the common deletion region of the mt genome. In contrast, with AMD, mtDNA lesions increased significantly in all regions of the mt genome beyond levels found in age-matched control subjects. mtDNA accumulated more lesions than did two nuclear genes, with total damage of the mt genome estimated to be eight times higher. CONCLUSIONS. Collectively, the data indicate that mtDNA is preferentially damaged with AMD progression. These results suggest a potential link between mt dysfunction due to increased mtDNA lesions and AMD. (Invest Ophthalmol Vis Sci. 2010; 51: 5470-5479) DOI: 10.1167/iovs.10-5429
C1 [Olsen, Timothy W.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Karunadharma, Pabalu P.; Nordgaard, Curtis L.; Ferrington, Deborah A.] Univ Minnesota Twin Cities, Dept Ophthalmol, Minneapolis, MN USA.
   [Karunadharma, Pabalu P.; Ferrington, Deborah A.] Univ Minnesota Twin Cities, Grad Program Biochem Mol Biol & Biophys, Minneapolis, MN USA.
C3 Emory University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities
RP Ferrington, DA (corresponding author), Univ Minnesota, 380 Lions Res Bldg,2001 6th St SE, Minneapolis, MN 55455 USA.
EM ferri013@umn.edu
FU National Institute on Aging [AG025392]; Research to Prevent Blindness; Emory University
CR Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668
   Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, PC1200, DOI 10.1152/ajpcell.00126.2009
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655
   Brown MM, 2006, CURR OPIN OPHTHALMOL, V17, P257
   Canter JA, 2008, PHARMACOGENOMICS J, V8, P71, DOI 10.1038/sj.tpj.6500470
   Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006
   Ethen CM, 2006, INVEST OPHTH VIS SCI, V47, P2280, DOI 10.1167/iovs.05-1395
   Ethen CM, 2005, INVEST OPHTH VIS SCI, V46, P769, DOI 10.1167/iovs.04-0810
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   GRAMAJO AL, 2007, INVEST OPHTH VIS SCI, V51, P1164
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Jin GF, 2001, CURR EYE RES, V22, P165, DOI 10.1076/ceyr.22.3.165.5517
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485
   Kovalenko Olga A, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1901s62
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976
   Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352
   Olsen TW, 2004, INVEST OPHTH VIS SCI, V45, P4484, DOI 10.1167/iovs.04-0342
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   SanGiovanni JP, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005508
   Santos Janine H, 2006, METHODS MOL BIOL, V314, P183
   Santos Janine H, 2002, METHODS MOL BIOL, V197, P159, DOI 10.1385/1-59259-284-8:159
   Sawyer DE, 2001, REDOX REP, V6, P182, DOI 10.1179/135100001101536157
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015
   Wang AL, 2008, MOL VIS, V14, P644
   Xie L, 2008, INVEST OPHTH VIS SCI, V49, P4203, DOI 10.1167/iovs.07-1364
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200
NR 49
TC 194
Z9 216
U1 1
U2 14
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD NOV 15
PY 2010
VL 51
IS 11
BP 5470
EP 5479
DI 10.1167/iovs.10-5429
PG 10
WC Ophthalmology
SC Ophthalmology
GA 672BQ
UT WOS:000283558400009
PM 20505194
DA 2024-11-01
ER

PT J
AU Wang, L
   Eriksson, S
AF Wang, L.
   Eriksson, S.
TI Tissue Specific Distribution of Pyrimidine Deoxynucleoside Salvage Enzymes Shed Light on the Mechanism of Mitochondrial DNA Depletion
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article; Proceedings Paper
DE Thymidine kinase 2; rat tissue; mitochondrial; cytosolic; mitochondrial DNA depletion
ID thymidine kinase; myopathy
AB Deficiency in thymidine kinase 2 (TK2) activity due to genetic alterations caused tissue specific mitochondrial DNA (mtDNA) depletion syndrome with symptoms resembling these of AIDS patients treated with nucleoside analogues. Mechanisms behind this mitochondrial effects is still not well understood. With rat as a model we isolated mitochondrial and cytosolic fractions from major organs and studied enzymes involved in thymidine (dT) and deoxycytidine (dC) phosphorylation by using ionic exchange column chromatography. A cytosolic form of TK2 was identified in all tested tissues in addition to mitochondrial TK2. TK1 was detected in liver and spleen cytosolic extracts while dCK was found in liver, spleen and lung cytosolic extracts. Thus, the nature of dT and dC salvage enzymes in each tissue type was determined. In most tissues TK2 is the only salvage enzyme present except liver and spleen. These results may help to explain the mechanisms of mitochondrial toxicity of antiviral nucleoside analogues and mtDNA depletion caused by TK2 deficiency.
C1 [Wang, L.] BMC, SLU, Sect Vet Med Biochem, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden.
C3 Swedish University of Agricultural Sciences
RP Wang, L (corresponding author), BMC, SLU, Sect Vet Med Biochem, Dept Anat Physiol & Biochem, Box 575, SE-75123 Uppsala, Sweden.
EM Liya.Wang@afb.slu.se
CR GRAHAM JM, 1999, CURRENT PROTOCOLS CE, V0, P0
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   WANG LY, 1993, J BIOL CHEM, V268, P22847
NR 6
TC 18
Z9 19
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1525-7770
EI 
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PD JUN 15
PY 2010
VL 29
IS 4-6
BP 400
EP 403
DI 10.1080/15257771003741042
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 610EE
UT WOS:000278713200023
PM 20544526
DA 2024-11-01
ER

PT J
AU Ylikallio, E
   Page, JL
   Xu, X
   Lampinen, M
   Bepler, G
   Ide, T
   Tyynismaa, H
   Weiss, RS
   Suomalainen, A
AF Ylikallio, Emil
   Page, Jennifer L.
   Xu, Xia
   Lampinen, Milla
   Bepler, Gerold
   Ide, Tomomi
   Tyynismaa, Henna
   Weiss, Robert S.
   Suomalainen, Anu
TI Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID saccharomyces-cerevisiae; thymidine kinase; deoxynucleotide pools; resting cells; dntp pools; in-vitro; damage; mtdna; gene; overexpression
AB Ribonucleotide reductase (RNR) is the rate-limiting enzyme in deoxyribonucleoside triphosphate (dNTP) biosynthesis, with important roles in nuclear genome maintenance. RNR is also essential for maintenance of mitochondrial DNA (mtDNA) in mammals. The mechanisms regulating mtDNA copy number in mammals are only being discovered. In budding yeast, RNR overexpression resulted in increased mtDNA levels, and rescued the disease phenotypes caused by a mutant mtDNA polymerase. This raised the question of whether mtDNA copy number increase by RNR induction could be a strategy for treating diseases with mtDNA mutations. We show here that high-level overexpression of RNR subunits (Rrm1, Rrm2 and p53R2; separately or in different combinations) in mice does not result in mtDNA copy number elevation. Instead, simultaneous expression of two RNR subunits leads to imbalanced dNTP pools and progressive mtDNA depletion in the skeletal muscle, without mtDNA mutagenesis. We also show that endogenous RNR transcripts are downregulated in response to large increases of mtDNA in mice, which is indicative of nuclear-mitochondrial crosstalk with regard to mtDNA copy number. Our results establish that RNR is not limiting for mtDNA copy number in mice, and provide new evidence for the importance of balanced dNTP pools in mtDNA maintenance in postmitotic tissues.
C1 [Ylikallio, Emil; Lampinen, Milla; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Programme Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Page, Jennifer L.; Xu, Xia; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.
   [Bepler, Gerold] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA.
   [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; Cornell University; H Lee Moffitt Cancer Center & Research Institute; Kyushu University; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programme Mol Neurol, Biomedicum Helsinki, RC523B,Haartmaninkatu 8,POB 63, FIN-00290 Helsinki, Finland.
EM rsw26@cornell.edu; anu.wartiovaara@helsinki.fi
FU Academy of Finland; University of Helsinki; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Helsinki Biomedical Graduate School; Cornell University Center for Vertebrate Genomics; National Institutes of Health [T32 GM07617]
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fan HZ, 1996, P NATL ACAD SCI USA, V93, P14036, DOI 10.1073/pnas.93.24.14036
   FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1141
   Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9
   Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SCHWENKE WD, 1981, BIOCHEM J, V200, P405, DOI 10.1042/bj2000405
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 45
TC 28
Z9 36
U1 2
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD DEC 15
PY 2010
VL 38
IS 22
BP 8208
EP 8218
DI 10.1093/nar/gkq735
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 696CU
UT WOS:000285420300037
PM 20724444
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Lai-Cheong, J
   Borthwick, GM
   He, LP
   Taylor, GA
   Greaves, LC
   Taylor, RW
   Griffiths, PG
   Turnbull, DM
AF Yu-Wai-Man, Patrick
   Lai-Cheong, Joey
   Borthwick, Gillian M.
   He, Langping
   Taylor, Geoffrey A.
   Greaves, Laura C.
   Taylor, Robert W.
   Griffiths, Philip G.
   Turnbull, Douglass M.
TI Somatic Mitochondrial DNA Deletions Accumulate to High Levels in Aging Human Extraocular Muscles
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID cytochrome-c-oxidase; point mutations; wild-type; functionally dominant; individual cells; age; fibers; mtdna; disease; common
AB PURPOSE. Mitochondrial function and the presence of somatic mitochondrial DNA (mtDNA) defects were investigated in extraocular muscles (EOMs) collected from individuals covering a wide age range, to document the changes seen with normal aging. METHODS. Cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) histochemistry was performed on 46 EOM samples to determine the level of COX deficiency in serial cryostat muscle sections (mean age, 42.6 years; range, 3.0-96.0 years). Competitive three-primer and real-time PCR were performed on single-fiber lysates to detect and quantify mtDNA deletions. Whole-genome mitochondrial sequencing was also performed to evaluate the contribution of mtDNA point mutations to the overall mutational load. RESULTS. COX-negative fibers were seen in EOMs beginning in the third decade of life, and there was a significant age-related increase: <30 years, 0.05% (n = 17); 30 to 60 years, 1.94% (n = 13); and >60 years, 3.34% (n = 16, P = 0.0001). Higher levels of COX deficiency were also present in EOM than in skeletal muscle in all three age groups (P < 0.0001). Most of the COX-negative fibers harbored high levels (>70%) of mtDNA deletions (206/284, 72.54%) and the mean deletion level was 66.64% (SD 36.45%). The mutational yield from whole mitochondrial genome sequencing was relatively low (1/19, 5.3%), with only a single mtDNA point mutation identified among COX-negative fibers with low deletion levels <= 70%. CONCLUSIONS. The results show an exponential increase in COX deficiency in EOMs beginning in early adulthood, which suggests an accelerated aging process compared with other post-mitotic tissues. (Invest Ophthalmol Vis Sci. 2010; 51:3347-3353) DOI:10.1167/iovs.09-4660
C1 [Yu-Wai-Man, Patrick; Borthwick, Gillian M.; He, Langping; Taylor, Geoffrey A.; Greaves, Laura C.; Taylor, Robert W.; Griffiths, Philip G.; Turnbull, Douglass M.] Med Sch Newcastle Upon Tyne, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick; Griffiths, Philip G.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Lai-Cheong, Joey] Kings Coll London, St Johns Inst Dermatol, Div Genet & Mol Med, London WC2R 2LS, England.
C3 Newcastle University - UK; Newcastle University - UK; University of London; King's College London
RP Yu-Wai-Man, P (corresponding author), Med Sch Newcastle Upon Tyne, Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM patrick.yu-wai-man@ncl.ac.uk
FU Wellcome Trust; Medical Research Council Translational Muscle Centre; Newcastle upon Tyne Hospitals NHS Trust; UK National Commissioning Group for Rare Mitochondrial Disorders of Adults and Children; Newcastle University Centre for Brain Ageing and Vitality; MRC [G0701386, G0601943, G0800674] Funding Source: UKRI
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FUCHS AF, 1983, J NEUROPHYSIOL, V49, P28, DOI 10.1152/jn.1983.49.1.28
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   JOHNSON MA, 1996, HDB MUSCLE DIS, V0, P61
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012
   McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P1927, DOI 10.1167/iovs.02-0673
   McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Reeve Amy K, 2008, BIOTECHNOLOGY JOURNAL, V3, P750, DOI 10.1002/biot.200800066
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
NR 57
TC 39
Z9 44
U1 0
U2 3
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL 15
PY 2010
VL 51
IS 7
BP 3347
EP 3353
DI 10.1167/iovs.09-4660
PG 7
WC Ophthalmology
SC Ophthalmology
GA 614HX
UT WOS:000279047500004
PM 20164450
DA 2024-11-01
ER

PT J
AU Rinaldi, T
   Dallabona, C
   Ferrero, I
   Frontali, L
   Bolotin-Fukuhara, M
AF Rinaldi, Teresa
   Dallabona, Cristina
   Ferrero, Ileana
   Frontali, Laura
   Bolotin-Fukuhara, Monique
TI Mitochondrial diseases and the role of the yeast models
SO FEMS YEAST RESEARCH
LA English
DT Review
DE mitochondrial diseases; fusion; fission; mitochondrial transformation; mitochondrial tRNAs; mtDNA stability and maintenance
ID dynamin-related gtpase; dna-polymerase-gamma; progressive external ophthalmoplegia; differentiation-associated protein-1; adenine-nucleotide translocator; cytochrome-b mutations; dominant optic atrophy; saccharomyces-cerevisiae; succinate-dehydrogenase; membrane protein
AB Nowadays, mitochondrial diseases are recognized and studied with much attention and they cannot be considered anymore as 'rare diseases'. Yeast has been an instrumental organism to understand the genetic and molecular aspects of the many roles of mitochondria within the cells. Thanks to the general conservation of mitochondrial genes and pathways between human and yeast, it can also be used to model some diseases. In this review, we focus on the most recent topics, exemplifying those for which yeast models have been especially valuable.
C1 [Bolotin-Fukuhara, Monique] Univ Paris 11, Inst Genet & Microbiol, CNRS, F-91405 Orsay, France.
   [Rinaldi, Teresa; Frontali, Laura] Univ Roma La Sapienza, Dept Cell & Dev Biol, Inst Pasteur, Cenci Bolognetti Fdn, Rome, Italy.
   [Dallabona, Cristina; Ferrero, Ileana] Univ Parma, Dept Genet, I-43100 Parma, Italy.
C3 Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Fondazione Cenci Bolognetti; Sapienza University Rome; University of Parma
RP Bolotin-Fukuhara, M (corresponding author), Univ Paris 11, Inst Genet & Microbiol, CNRS, Batiment 400, F-91405 Orsay, France.
EM bolotin@igmors.u-psud.fr
FU Telethon [GGP07164]
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855
   Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929
   Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0
   Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Baysal BE, 2000, FEBS J, V272, P3583
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   BOLOTIN M, 1971, B I PASTEUR, V69, P215
   Bonnefoy Nathalie, 2007, METHODS MOL BIOL, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bratton M, 2003, EUR J BIOCHEM, V270, P1222, DOI 10.1046/j.1432-1033.2003.03482.x
   Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309
   Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Chen Y, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005386
   Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596
   Cheng WC, 2008, BBA-MOL CELL RES, V1783, P1272, DOI 10.1016/j.bbamcr.2008.04.012
   CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651
   Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Davidson MM, 2009, J MOL CELL CARDIOL, V46, P936, DOI 10.1016/j.yjmcc.2009.02.011
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003
   DiMauro S, 2010, J INHERIT METAB DIS, V0, P0
   Ding MG, 2008, BBA-BIOENERGETICS, V1777, P1147, DOI 10.1016/j.bbabio.2008.04.029
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Fisher N, 2005, PEST MANAG SCI, V61, P973, DOI 10.1002/ps.1066
   Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200
   Fisher N, 2004, EUR J BIOCHEM, V271, P1292, DOI 10.1111/j.1432-1033.2004.04036.x
   Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x
   Fisher N, 2008, FEMS YEAST RES, V8, P183, DOI 10.1111/j.1567-1364.2007.00328.x
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Foury F, 2004, CELL MOL LIFE SCI, V61, P2799, DOI 10.1007/s00018-004-4220-y
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   FOX TD, 1988, P NATL ACAD SCI USA, V85, P7288, DOI 10.1073/pnas.85.19.7288
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   García-Rodríguez LJ, 2009, CURR BIOL, V19, P1730, DOI 10.1016/j.cub.2009.08.041
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010
   Goffrini P, 2009, HUM MOL GENET, V18, P1860, DOI 10.1093/hmg/ddp102
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002
   JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200
   Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809
   Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2
   Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Levitas A, 2010, EUR J HUM GENET, V18, P1160, DOI 10.1038/ejhg.2010.83
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9
   Lin Tsu-Kung, 2009, CHANG GUNG MED J, V32, P589
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mayevsky A, 2009, MITOCHONDRION, V9, P165, DOI 10.1016/j.mito.2009.01.009
   MCCONNELL SJ, 1990, J CELL BIOL, V111, P967, DOI 10.1083/jcb.111.3.967
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Meunier B, 2001, BIOCHEM J, V354, P407, DOI 10.1042/0264-6021:3540407
   Mithani SK, 2007, CLIN CANCER RES, V13, P4331, DOI 10.1158/1078-0432.CCR-06-2613
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   Moraes CT, 2001, NAT GENET, V28, P200, DOI 10.1038/90020
   Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367
   Nachman MW, 1996, GENETICS, V142, P953
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001
   Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y
   Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santel A, 2001, J CELL SCI, V114, P867
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X
   Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200
   Schwimmer Christine, 2006, BIOTECHNOLOGY JOURNAL, V1, P270, DOI 10.1002/biot.200500053
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123
   Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253
   Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x
   Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353
   Tribouillard Deborah, 2006, BIOTECHNOLOGY JOURNAL, V1, P58, DOI 10.1002/biot.200500001
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   WARBURG O, 1956, SCIENCE, V124, P269
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x
   Wenz T, 2006, BIOCHEMISTRY-US, V45, P9042, DOI 10.1021/bi060280g
   Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341
   Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226
   Yan SD, 2006, J ALZHEIMERS DIS, V9, P127
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
   Zhou JW, 2010, EUKARYOT CELL, V9, P806, DOI 10.1128/EC.00349-09
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x
NR 171
TC 34
Z9 37
U1 0
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1567-1356
EI 1567-1364
J9 FEMS YEAST RES
JI FEMS Yeast Res.
PD DEC 15
PY 2010
VL 10
IS 8
BP 1006
EP 1022
DI 10.1111/j.1567-1364.2010.00685.x
PG 17
WC Biotechnology & Applied Microbiology; Microbiology; Mycology
SC Biotechnology & Applied Microbiology; Microbiology; Mycology
GA 674GR
UT WOS:000283725500006
PM 20946356
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Hampel, KG
   Nelson, I
   Jardel, C
   Mirandola, SR
   Sassen, R
   Kornblum, C
   Marcorelles, P
   Lavoué, S
   Lombès, A
   Kunz, WS
AF Zsurka, G.
   Hampel, K. G.
   Nelson, I.
   Jardel, C.
   Mirandola, S. R.
   Sassen, R.
   Kornblum, C.
   Marcorelles, P.
   Lavoue, S.
   Lombes, A.
   Kunz, W. S.
TI Severe epilepsy as the major symptom of new mutations in the mitochondrial tRNA<SUP>Phe</SUP> gene
SO NEUROLOGY
LA English
DT Article
ID dna; merrf; melas
AB Objective: To present 2 families with maternally inherited severe epilepsy as the main symptom of mitochondrial disease due to point mutations at position 616 in the mitochondrial tRNAPhe (MTTF) gene. Methods: Histologic stainings were performed on skeletal muscle slices from the 2 index patients. Oxidative phosphorylation activity was measured by oxygraphic and spectrophotometric methods. The patients' complete mitochondrial DNA (mtDNA) and the relevant mtDNA region in maternal relatives were sequenced. Results: Muscle histology showed only decreased overall COX staining, while a combined respiratory chain defect, most severely affecting complex IV, was noted in both patients' skeletal muscle. Sequencing of the mtDNA revealed in both patients a mutation at position 616 in the MT-TF gene (T > C or T > G). These mutations disrupt a base pair in the anticodon stem at a highly conserved position. They were apparently homoplasmic in both patients, and had different heteroplasmy levels in the investigated maternal relatives. Conclusions: Deleterious mutations in the mitochondrial tRNAPhe may solely manifest with epilepsy when segregating to homoplasmy. They may be overlooked in the absence of lactate accumulation and typical mosaic mitochondrial defects in muscle. Neurology (R) 2010; 74: 507-512
C1 [Kunz, W. S.] Univ Bonn, Dept Epileptol, Med Ctr, D-53105 Bonn, Germany.
   [Zsurka, G.; Hampel, K. G.; Mirandola, S. R.; Sassen, R.; Kunz, W. S.] Univ Bonn, Life & Brain Ctr, D-53105 Bonn, Germany.
   [Kornblum, C.] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.
   [Nelson, I.; Jardel, C.; Lombes, A.] INSERM, UMRS 975, Paris, France.
   [Lombes, A.] Univ Pierre & Marie Curie UPMC Paris 6, Paris, France.
   [Jardel, C.; Lombes, A.] Hop La Pitie Salpetriere, AP HP, Dept Metab Biochem, Paris, France.
   [Marcorelles, P.] Morvan Hosp, Dept Pathol, Brest, France.
   [Lavoue, S.] CHU Rennes, Intens Care Unit, Rennes, France.
C3 University of Bonn; University of Bonn; University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CHU Brest; CHU Rennes; Universite de Rennes
RP Kunz, WS (corresponding author), Univ Bonn, Dept Epileptol, Med Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
FU Deutsche Forschungsgemeinschaft [KU-911/15-1, TR3-A11, TR3-D12]; BMBF [01GZ0704, 01GM0868]; AFM (Association Francaise contre les Myopathies)
CR Dinour D, 2004, CLIN NEPHROL, V62, P149
   Dubowitz V, 1973, MUSCLE BIOPSY MODERN, V0, P0
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HIRANO M, 2008, EPILEPSY COMPREHENSI, V3, P2621
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Kunz WS, 2000, J BIOL CHEM, V275, P27741
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   TEREIRA L, 2009, AM J HUM GENET, V84, P628
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
NR 21
TC 36
Z9 40
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB 9
PY 2010
VL 74
IS 6
BP 507
EP 512
DI 10.1212/WNL.0b013e3181cef7ab
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 553PF
UT WOS:000274378600012
PM 20142618
DA 2024-11-01
ER

PT J
AU Sadikovic, B
   Wang, J
   El-Hattab, A
   Landsverk, M
   Douglas, G
   Brundage, EK
   Craigen, WJ
   Schmitt, ES
   Wong, LJC
AF Sadikovic, Bekim
   Wang, Jing
   El-Hattab, Ayman
   Landsverk, Megan
   Douglas, Ganka
   Brundage, Ellen K.
   Craigen, William J.
   Schmitt, Eric S.
   Wong, Lee-Jun C.
TI Sequence Homology at the Breakpoint and Clinical Phenotype of Mitochondrial DNA Deletion Syndromes
SO PLOS ONE
LA English
DT Article
ID human skeletal-muscle; double-strand breaks; mtdna deletions; saccharomyces-cerevisiae; lagging-strand; direct repeats; cells; myopathy; mutations; disease
AB Mitochondrial DNA (mtDNA) deletions are a common cause of mitochondrial disorders. Large mtDNA deletions can lead to a broad spectrum of clinical features with different age of onset, ranging from mild mitochondrial myopathies (MM), progressive external ophthalmoplegia (PEO), and Kearns-Sayre syndrome (KSS), to severe Pearson syndrome. The aim of this study is to investigate the molecular signatures surrounding the deletion breakpoints and their association with the clinical phenotype and age at onset. MtDNA deletions in 67 patients were characterized using array comparative genomic hybridization (aCGH) followed by PCR-sequencing of the deletion junctions. Sequence homology including both perfect and imperfect short repeats flanking the deletion regions were analyzed and correlated with clinical features and patients' age group. In all age groups, there was a significant increase in sequence homology flanking the deletion compared to mtDNA background. The youngest patient group (<6 years old) showed a diffused pattern of deletion distribution in size and locations, with a significantly lower sequence homology flanking the deletion, and the highest percentage of deletion mutant heteroplasmy. The older age groups showed rather discrete pattern of deletions with 44% of all patients over 6 years old carrying the most common 5 kb mtDNA deletion, which was found mostly in muscle specimens (22/41). Only 15% (3/20) of the young patients (<6 years old) carry the 5 kb common deletion, which is usually present in blood rather than muscle. This group of patients predominantly (16 out of 17) exhibit multisystem disorder and/or Pearson syndrome, while older patients had predominantly neuromuscular manifestations including KSS, PEO, and MM. In conclusion, sequence homology at the deletion flanking regions is a consistent feature of mtDNA deletions. Decreased levels of sequence homology and increased levels of deletion mutant heteroplasmy appear to correlate with earlier onset and more severe disease with multisystem involvement.
C1 [Sadikovic, Bekim; Wang, Jing; El-Hattab, Ayman; Landsverk, Megan; Douglas, Ganka; Brundage, Ellen K.; Craigen, William J.; Schmitt, Eric S.; Wong, Lee-Jun C.] Baylor Coll Med, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Sadikovic, B (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.
EM ljwong@bcm.edu
FU Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BD/38543/2007, PTDC/SAU-ESA/64888/2006, PIC/IC/83065/2007]; GlaxoSmithkline; Fundacao Calouste Gulbenkian; Fundação para a Ciência e a Tecnologia [PTDC/SAU-ESA/64888/2006, PIC/IC/83065/2007, SFRH/BD/38543/2007, SFRH/BD/35854/2007] Funding Source: FCT
CR Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Hammans SR, 1994, ESSAYS BIOCHEM, V28, P99
   Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418
   Hastings PJ, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000327
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379
   McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
NR 31
TC 45
Z9 48
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2010
VL 5
IS 12
BP 
EP 
DI 10.1371/journal.pone.0015687
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 698EM
UT WOS:000285575200064
PM 21187929
DA 2024-11-01
ER

PT J
AU Massie, R
   Wong, LJC
   Milone, M
AF Massie, Rami
   Wong, Lee-Jun C.
   Milone, Margherita
TI EXERCISE INTOLERANCE DUE TO CYTOCHROME <i>b</i> MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE cytochrome b; exercise intolerance; mitochondrial myopathy; mutation; ragged-red fibers
ID complex-iii deficiency; yeast mitochondrial-membrane; stop-codon mutation; nonsense mutation; missense mutation; dna mutations; gene; myopathy; patient; cardiomyopathy
AB Cytochrome b mutations are rare causes of exercise intolerance. We report an 18-year-old man with exercise intolerance since childhood, resting lactic acidosis, cytochrome c oxidase (COX)-positive ragged-red fibers, and isolated muscle complex III deficiency due to a heteroplasmic m.14849T>C mutation in cytochrome b. We review previously described patients carrying mutations in the same gene. COX-positive ragged-red fibers together with exercise intolerance and lactic acidemia provide a clue for the diagnosis of this rare mitochondrial disorder. Muscle Nerve 42: 136-140, 2010
C1 [Massie, Rami; Milone, Margherita] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Mayo Clinic; Baylor College of Medicine
RP Milone, M (corresponding author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM milone.margherita@mayo.edu
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   BOUZIDI MF, 1993, NEUROMUSCULAR DISORD, V3, P599
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   DIRAGO JP, 1993, FEBS LETT, V328, P153, DOI 10.1016/0014-5793(93)80984-3
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   LIN LFH, 1978, EUR J BIOCHEM, V87, P171, DOI 10.1111/j.1432-1033.1978.tb12364.x
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   MOUSSON B, 1995, ACTA NEUROL SCAND, V91, P488
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   SIDHU A, 1983, J BIOL CHEM, V258, P2308
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
NR 30
TC 15
Z9 15
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JUL 15
PY 2010
VL 42
IS 1
BP 136
EP 140
DI 10.1002/mus.21649
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 619US
UT WOS:000279456400019
PM 20544923
DA 2024-11-01
ER

PT J
AU Kobayashi, A
   Goto, Y
   Nagata, M
   Yamaguchi, Y
AF Kobayashi, Akimitsu
   Goto, Yu-ichi
   Nagata, Michio
   Yamaguchi, Yutaka
TI Granular Swollen Epithelial Cells: A Histologic and Diagnostic Marker for Mitochondrial Nephropathy
SO AMERICAN JOURNAL OF SURGICAL PATHOLOGY
LA English
DT Article
DE mitochondrial nephropathy; focal segmental glomerulosclerosis; mitochondrial disease
ID focal segmental glomerulosclerosis; lactic-acidosis; mutation; dna; encephalopathy; myopathy; deletion; patient; disease
AB Focal segmental glomerulosclerosis (FSGS) is a progressive kidney disease, and mitochondrial disease known to be a primary malady for secondary FSGS. Mitochondrial nephropathy with FSGS is diagnosed by genetic analysis or electron microscopy when it is suspected. As adequate morphologic features to diagnose mitochondrial nephropathy by light microscopy are lacking, this study used 10 cases v genetically proven mitochondrial disease and analyzed the kidney samples obtained by biopsy (n = 7) or autopsy (n = 3). We found granular swollen epithelial cells (GSECs) among the distal tubuli and collecting ducts in all patients, whereas such features were absent in IgA nephropathy, primary FSGS, and interstitial nephritis. Ultrastructural analysis of GSECs displayed accumulation of abnormal-shaped mitochondria in GSECs. To test whether GSECs were really associated with mitochondrial mutations, laser-captured single GSECs in I case with a position where 3,271 mutation were measured using a single-cell PCR analysis. This revealed that the mutant load of GSECs was significantly higher than normal-appearing epithelial cells within the same sample (63.4 +/- 17.8% vs. 32.5 +/- 4.6%; P < 0.0001). This is direct evidence that GSEC is a characteristic Cellular feature, indicating cells with mutant mitochondrial DNA accumulation. In addition, the incidence of GSECs did not correlate with serum creatinine levels, proteinuria, percent glomerulosclerosis, tubulointerstitial changes, or arteriolar hyalinosis, suggesting that GSECs per se may not cause tissue damage. In conclusion, GSEC is a distinct morphologic feature suggesting mitochondrial nephropathy and is a useful tool to identify secondary FSGS on the basis of mitochondrial abnormalities.
C1 [Kobayashi, Akimitsu] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, Tokyo 1058471, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Nagata, Michio] Univ Tsukuba, Dept Pathol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.
   [Yamaguchi, Yutaka] Jikei Univ, Kashiwa Hosp, Sch Med, Dept Pathol, Chiba, Japan.
C3 Jikei University; National Center for Neurology & Psychiatry - Japan; University of Tsukuba; Jikei University
RP Kobayashi, A (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058471, Japan.
EM akimitsu@kk.iij4u.or.jp
FU Ministry of Health, Labour and Welfare of Japan [18A-5]; Japan Health Sciences Foundation [KHD2207]
CR Adedoyin O, 2004, PEDIATR NEPHROL, V19, P408, DOI 10.1007/s00467-003-1396-6
   Au KM, 2007, PEDIATR NEPHROL, V22, P136, DOI 10.1007/s00467-006-0288-y
   DAgati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, J PEDIATR-US, V116, P904, DOI 10.1016/S0022-3476(05)80648-1
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Mallick N, 2003, NEPHROL DIAL TRANSPL, V18, P64, DOI 10.1093/ndt/gfg1065
   Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x
   Yamagata K, 2002, J AM SOC NEPHROL, V13, P0, DOI 10.1097/01.ASN.0000019772.17954.F8
NR 23
TC 17
Z9 19
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0147-5185
EI 1532-0979
J9 AM J SURG PATHOL
JI Am. J. Surg. Pathol.
PD FEB 15
PY 2010
VL 34
IS 2
BP 262
EP 270
DI 10.1097/PAS.0b013e3181cb4ed3
PG 9
WC Pathology; Surgery
SC Pathology; Surgery
GA 551OV
UT WOS:000274219800015
PM 20090504
DA 2024-11-01
ER

PT J
AU Wu, SB
   Ma, YS
   Wu, YT
   Chen, YC
   Wei, YH
AF Wu, Shi-Bei
   Ma, Yi-Shing
   Wu, Yu-Ting
   Chen, Yin-Chiu
   Wei, Yau-Huei
TI Mitochondrial DNA Mutation-Elicited Oxidative Stress, Oxidative Damage, and Altered Gene Expression in Cultured Cells of Patients with MERRF Syndrome
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Mitochondrial disease; MERRF; Oxidative stress; Antioxidant enzyme; Mitochondrial aconitase; Prohibitin; Lon protease; MMP-1
ID amyotrophic-lateral-sclerosis; electron-transport-chain; ragged-red fibers; alzheimers-disease brain; lon protease; complex-i; matrix metalloproteinases; proteomic identification; glutamate-dehydrogenase; pyruvate-dehydrogenase
AB Myoclonic epilepsy and ragged-red fibers (MERRF) syndrome is a rare disorder characterized by myoclonus, muscle weakness, cerebellar ataxia, heart conduction block, and dementia. It has been documented that 80-90% of the patients with MERRF syndrome are caused by the A8344G mutation in the tRNA(Lys) gene of mitochondrial DNA (mtDNA). We and other investigators have reported that the mtDNA mutation results in not only inefficient generation of adenosine triphosphate but also increased production of reactive oxygen species (ROS) in cultured cells harboring A8344G mutation of mtDNA. In addition, we found an imbalance in the gene expression of antioxidant enzymes in the skin fibroblasts of MERRF patients. The mRNA, protein, and enzyme activity levels of manganese-superoxide dismutase were increased, but those of Cu,Zn-SOD, catalase, and glutathione peroxidase did not show significant changes. Recently, we showed that the excess ROS could damage voltage-dependent anion channel, prohibitin, Lon protease, and aconitase in the MERRF cells. Moreover, there was a dramatic increase in the gene expression and activity of matrix metalloproteinase 1, which may contribute to the cytoskeleton remodeling involved in the weakness and atrophy of muscle commonly seen in MERRF patients. Taken together, we suggest that mtDNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression are involved in the pathogenesis and progression of MERRF syndrome.
C1 [Wu, Shi-Bei; Ma, Yi-Shing; Wu, Yu-Ting; Chen, Yin-Chiu; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei 252, Taiwan.
C3 National Yang Ming Chiao Tung University; Mackay Medical College
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
FU National Science Council, Executive Yuan, Taiwan [NSC96-2320-B-010-006, NSC97-2320 -B-010-013-MY3]; Nation Science Council of Taiwan
CR Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   Babu GN, 2008, NEUROCHEM INT, V52, P1284, DOI 10.1016/j.neuint.2008.01.009
   BACMAN SR, 2003, BIOCHEM J, V15, P131
   Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013
   Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2
   Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102
   Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y
   Cantu D, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007095
   Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x
   Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163
   Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704
   Conrad CC, 2001, PROTEOMICS, V1, P829, DOI 10.1002/1615-9861(200107)1:7<829::AID-PROT829>3.3.CO;2-I
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   Díez-Vives C, 2009, J NEUROCHEM, V111, P945, DOI 10.1111/j.1471-4159.2009.06374.x
   Dukes AA, 2008, J NEUROCHEM, V106, P333, DOI 10.1111/j.1471-4159.2008.05392.x
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   FAFFMICHALAK L, 1993, BRAIN RES, V618, P299, DOI 10.1016/0006-8993(93)91279-2
   Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x
   Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936
   Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381
   Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x
   Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Katayama Y, 2009, MITOCHONDRION, V9, P306, DOI 10.1016/j.mito.2009.04.002
   Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010
   Kunishige M, 2003, MUSCLE NERVE, V28, P484, DOI 10.1002/mus.10466
   Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127
   Lijnen P, 2008, AM J HYPERTENS, V21, P1129, DOI 10.1038/ajh.2008.242
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Liu CY, 2007, MITOCHONDRION, V7, P89, DOI 10.1016/j.mito.2006.11.020
   Liu CY, 2009, J FORMOS MED ASSOC, V108, P599, DOI 10.1016/S0929-6646(09)60380-6
   LIU CY, 2009, BIOCHIM BIOPHYS ACTA, V783, P1792
   LIU J, 1991, J ORTHOPAED RES, V9, P568, DOI 10.1002/jor.1100090413
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Lu CY, 2003, MOL GENET METAB, V80, P321, DOI 10.1016/j.ymgme.2003.08.005
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   MATTHEWS PM, 1994, BRAIN, V117, P435, DOI 10.1093/brain/117.3.435
   McKenna MC, 2000, NEUROCHEM INT, V37, P229, DOI 10.1016/S0197-0186(00)00042-5
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262
   Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008
   Nelson KK, 2006, J BIOL CHEM, V281, P14100, DOI 10.1074/jbc.M601820200
   Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024
   Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0
   Nikolic-Kokic A, 2006, CLIN CHEM LAB MED, V44, P589, DOI 10.1515/CCLM.2006.111
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229
   Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   OZAWA T, 1995, EXP GERONTOL, V30, P269, DOI 10.1016/0531-5565(94)00057-A
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Plecitá-Hlavatá L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015
   QUINTANA E, 2010, J INHERIT M IN PRESS, V0, P0
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   RUSTIN P, 1997, BIOCHIM BIOPHYS ACTA, V136, P185
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014
   Stanyer L, 2008, NEUROCHEM INT, V53, P95, DOI 10.1016/j.neuint.2008.06.004
   Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166
   Tabatabaie T, 1996, ARCH BIOCHEM BIOPHYS, V336, P290, DOI 10.1006/abbi.1996.0560
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Tretter L, 2000, J NEUROSCI, V20, P8972
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wani AA, 2008, FREE RADICAL RES, V42, P415, DOI 10.1080/10715760802068571
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Wei YH, 2003, ADV CLIN CHEM, V37, P83, DOI 10.1016/S0065-2423(03)37007-6
   Zeviani Massimo, 2003, CURR NEUROL NEUROSCI REP, V3, P423, DOI 10.1007/s11910-003-0026-9
NR 85
TC 64
Z9 72
U1 0
U2 11
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUN 15
PY 2010
VL 41
IS 2-3
BP 256
EP 266
DI 10.1007/s12035-010-8123-7
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 601WI
UT WOS:000278095800021
PM 20411357
DA 2024-11-01
ER

PT J
AU Wibrand, F
   Jeppesen, TD
   Frederiksen, AL
   Olsen, DB
   Duno, M
   Schwartz, M
   Vissing, J
AF Wibrand, Flemming
   Jeppesen, Tina D.
   Frederiksen, Anja L.
   Olsen, David B.
   Duno, Morten
   Schwartz, Marianne
   Vissing, John
TI LIMITED DIAGNOSTIC VALUE OF ENZYME ANALYSIS IN PATIENTS WITH MITOCHONDRIAL tRNA MUTATIONS
SO MUSCLE & NERVE
LA English
DT Article
DE mitochondrial myopathy; respiratory chain enzyme analysis; single, large-scale deletions; tRNA gene mutations; 3243A > G
ID respiratory-chain complexes; skeletal-muscle; point mutation; encephalomyopathy; deficiency; disorders; deletions; capacity; mtdna; load
AB We evaluated the diagnostic value of respiratory chain (RC) enzyme analysis of muscle in adult patients with mitochondria! myopathy (MM). RC enzyme activity was measured in muscle biopsies from 39 patients who carry either the 3243A>G mutation, other tRNA point mutations, or single, large-scale deletions of mtDNA. Findings were compared with those obtained from asymptomatic relatives with the 3243A>G mutation, myotonic dystrophy patients, and healthy subjects. Plasma lactate concentration, maximal oxygen uptake, and ragged-red fibers/cytochrome c-negative fibers in muscle were also determined. Only 10% of patients with the 3243A>G point mutation had decreased enzyme activity of one or more RC complexes, whereas this was the case for 83% of patients with other point mutations and 62% of patients with deletions. Abnormal muscle histochemistry was found in 65%, 100%, and 85% of patients, respectively, in these three groups. The results indicate that RC enzyme analysis in muscle is not a sensitive test for MM in adults. In these patients, abnormal muscle histochemistry appears to be a better predictor of MM. Muscle Nerve 41: 607-613, 2010
C1 [Wibrand, Flemming; Duno, Morten; Schwartz, Marianne] Rigshosp, Dept Clin Genet 4061, DK-2100 Copenhagen, Denmark.
   [Jeppesen, Tina D.; Olsen, David B.; Vissing, John] Univ Copenhagen, Dept Neurol, Neuromuscular Res Unit, Copenhagen, Denmark.
   [Jeppesen, Tina D.; Olsen, David B.; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark.
   [Frederiksen, Anja L.] Ribe Cty Hosp, Dept Endocrinol, Esbjerg, Denmark.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet
RP Wibrand, F (corresponding author), Rigshosp, Dept Clin Genet 4061, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM flemming.wibrand@rh.regionh.dk
FU Novo Nordisk Foundation; P.C. Petersen's Foundation; Copenhagen Muscle Research Center; Sara and Ludvig Elsass Foundation; Danish National Research Council [22-03-0474]; Fabrikant Vilhelm Pedersen og Hustrus Legat
CR ARGOV Z, 1991, ANN NEUROL, V30, P90, DOI 10.1002/ana.410300116
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Hui J, 2006, DEV MED CHILD NEUROL, V48, P132, DOI 10.1017/S0012162206000284
   ISASHIKI Y, 1989, NEURO-OPHTHALMOLOGY, V9, P115, DOI 10.3109/01658108909007466
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirino Yohei, 2005, RNA BIOL, V2, P41, DOI 10.4161/rna.2.2.1610
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   McDermott CJ, 2003, NEUROREPORT, V14, P485, DOI 10.1097/01.wnr.0000058774.36017.cf
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   ONO S, 1986, J NEUROL SCI, V74, P247, DOI 10.1016/0022-510X(86)90110-3
   Piemonte F, 2001, NEUROMUSCULAR DISORD, V11, P565, DOI 10.1016/S0960-8966(01)00214-0
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Seijo-Martínez M, 2003, J NEUROL SCI, V208, P87, DOI 10.1016/S0022-510X(02)00442-2
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
NR 30
TC 20
Z9 20
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD MAY 15
PY 2010
VL 41
IS 5
BP 607
EP 613
DI 10.1002/mus.21541
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 589ZE
UT WOS:000277191900004
PM 19941338
DA 2024-11-01
ER

PT J
AU Moore, AZ
   Biggs, ML
   Matteini, A
   O'Connor, A
   McGuire, S
   Beamer, BA
   Fallin, MD
   Fried, LP
   Walston, J
   Chakravarti, A
   Arking, DE
AF Moore, Ann Z.
   Biggs, Mary L.
   Matteini, Amy
   O'Connor, Ashley
   McGuire, Sarah
   Beamer, Brock A.
   Fallin, M. Danielle
   Fried, Linda P.
   Walston, Jeremy
   Chakravarti, Aravinda
   Arking, Dan E.
TI Polymorphisms in the Mitochondrial DNA Control Region and Frailty in Older Adults
SO PLOS ONE
LA English
DT Article
ID metabolic-rate; free-radicals; diseases; replication; phenotype; longevity; paradigm; variant; cancer; risk
AB Background: Mitochondria contribute to the dynamics of cellular metabolism, the production of reactive oxygen species, and apoptotic pathways. Consequently, mitochondrial function has been hypothesized to influence functional decline and vulnerability to disease in later life. Mitochondrial genetic variation may contribute to altered susceptibility to the frailty syndrome in older adults. Methodology/Principal Findings: To assess potential mitochondrial genetic contributions to the likelihood of frailty, mitochondrial DNA (mtDNA) variation was compared in frail and non-frail older adults. Associations of selected SNPs with a muscle strength phenotype were also explored. Participants were selected from the Cardiovascular Health Study (CHS), a population-based observational study (1989-1990, 1992-1993). At baseline, frailty was identified as the presence of three or more of five indicators (weakness, slowness, shrinking, low physical activity, and exhaustion). mtDNA variation was assessed in a pilot study, including 315 individuals selected as extremes of the frailty phenotype, using an oligonucleotide sequencing microarray based on the Revised Cambridge Reference Sequence. Three mtDNA SNPs were statistically significantly associated with frailty across all pilot participants or in sex-stratified comparisons: mt146, mt204, and mt228. In addition to pilot participants, 4,459 additional men and women with frailty classifications, and an overlapping subset of 4,453 individuals with grip strength measurements, were included in the study population genotyped at mt204 and mt228. In the study population, the mt204 C allele was associated with greater likelihood of frailty (adjusted odds ratio = 2.04, 95% CI = 1.07-3.60, p = 0.020) and lower grip strength (adjusted coefficient = 22.04, 95% CI = 23.33-20.74, p = 0.002). Conclusions: This study supports a role for mitochondrial genetic variation in the frailty syndrome and later life muscle strength, demonstrating the importance of the mitochondrial genome in complex geriatric phenotypes.
C1 [Moore, Ann Z.; Matteini, Amy; Fallin, M. Danielle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Biggs, Mary L.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA.
   [O'Connor, Ashley; McGuire, Sarah; Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.
   [Beamer, Brock A.] Univ Maryland, Sch Med, Div Gerontol, Baltimore, MD 21201 USA.
   [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
   [Walston, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Columbia University; Johns Hopkins University
RP Moore, AZ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
EM arking@jhmi.edu
FU National Institute on Aging, Claude D. Pepper Older Americans Independence Centers [P30 AG021334]; National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; National Institute of Neurological Disorders and Stroke
CR BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   Fried Linda P, 1991, ANNALS OF EPIDEMIOLOGY, V1, P263
   Fried LP, 2001, J GERONTOL A-BIOL, V56, PM146, DOI 10.1093/gerona/56.3.M146
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Liu VWS, 2003, HUM MUTAT, V22, P173, DOI 10.1002/humu.10244
   MITOMAP, 2009, MITOMAP HUM MIT GEN, V0, P0
   Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   Ruggiero C, 2006, J GERONTOL A-BIOL, V61, P466, DOI 10.1093/gerona/61.5.466
   Scheffler IE, 2008, MITOCHONDRIA, V0, P1
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 26
TC 40
Z9 45
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2010
VL 5
IS 6
BP 
EP 
DI 10.1371/journal.pone.0011069
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 608QA
UT WOS:000278599600025
PM 20548781
DA 2024-11-01
ER

PT J
AU Sahin, N
AF Sahin, Nilay
TI THE EFFECTS OF AGING ON MUSCLE STRENGTH
SO MUSCLE STRENGTH TYPES, EFFICIENCY AND DRUG EFFECTS
LA English
DT Article; Book Chapter
ID mitochondrial-dna mutations; fiber-type; sarcopenia; age; maintenance; protection; apoptosis; origins; mass
AB Aging is a process affecting all living beings. Its mechanisms are highly diverse and part of them are currently tried to be explained. Aging; is the decrease of physiological and organisation reserves of the individual, deterioration of the strength against any kind of stress in the organism and the increase of sensitivity for various pathologies. Along with the aging process, an increase in the tendency of various painful pathologies and diseases are also observed in the musculoskeletal system. Weakness observed in the muscle strength is related with numerous musculoskeletal system diseases. Diseases observed in the musculoskeletal system may affect the muscle strength or a weakness observed in the muscle strength may lead to a disease. Well then, does the physiological change process of the muscle strength developing along with aging contribute to the occurrence of diseases in old individuals? The general impacts of aging on the muscle strength are; decrease in mass, decrease in power production, decrease in the pain perception threshold. With aging sarcopenia develops in muscles. Sarcopenia is the decrease of mass, power and function in the muscles depending on the age, after 30 years of age, the muscle mass diminishes by 3 to 5% at each decade. The decrease in the muscle mass increases after 60 years of age and it reaches 30% for each decade after age 70 and above. Is sarcopenia a situation seen in everyone? Sarcopenia may develop due to reasons such as physical inactivity, reformation in motor units, decreased sex hormone levels, decreased protein synthesis, increase in catabolic cytokine synthesis, decrease in growth hormone synthesis, insufficient protein in diet and increase in fat mass. It is not clear whether reasons other than these exist. In particular further studies are needed for clarifying the information related with the potential effects of genetic factors which assume a major role in many diseases on the development of sarcopenia. Comorbid diseases and the drugs used accordingly are other factors that should be taken into account in terms of their impacts on the muscle strength. Understanding the impact of aging on the muscle strength will take an important part in diagnosing and treating the problems observed in the musculoskeletal system.
C1 Selcuk Univ, Meram Fac Med, Dept Phys Med & Rehabil, Meram Konya, Turkey.
C3 Selcuk University
RP Sahin, N (corresponding author), Selcuk Univ, Meram Fac Med, Dept Phys Med & Rehabil, Meram Konya, Turkey.
EM nilaysahin@gmail.com
CR ABYAD A, 1992, CURRENT OPINION IN RHEUMATOLOGY, V4, P153, DOI 10.1097/00002281-199204000-00004
   Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001
   Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc
   Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35
   Çakatay U, 2003, CLIN BIOCHEM, V36, P51, DOI 10.1016/S0009-9120(02)00407-1
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   Cayley P, 2008, HEART LUNG CIRC, V17, PS70, DOI 10.1016/j.hlc.2008.08.015
   Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829
   Clark GS, 1998, REHABILITATION MED P, V0, P963
   Combaret L, 2009, CURR OPIN CLIN NUTR, V12, P37, DOI 10.1097/MCO.0b013e32831b9c31
   Di Giulio C, 2009, J BIOL REG HOMEOS AG, V23, P55
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Gajdosik RL, 1999, J ORTHOP SPORT PHYS, V29, P181, DOI 10.2519/jospt.1999.29.3.181
   HAMERMAN D, 1995, ANN RHEUM DIS, V54, P82, DOI 10.1136/ard.54.2.82
   HEPPLE RT, 2006, SCI AGING KNOWLEDGE, V18, PPE3, DOI 10.1126/SAGEKE.2006.3.PE3
   Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164
   Jensen GL, 2008, JPEN-PARENTER ENTER, V32, P656, DOI 10.1177/0148607108324585
   Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141
   Keysor JJ, 2005, J AGING HEALTH, V17, P734, DOI 10.1177/0898264305280998
   Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006
   Leveille SG, 2004, CURR OPIN RHEUMATOL, V16, P114, DOI 10.1097/00002281-200403000-00007
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5
   MCCULLY KK, 1995, J GERONTOL A-BIOL, V50, P130
   Menz HB, 2006, FOOT ANKLE INT, V27, P1103, DOI 10.1177/107110070602701217
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058
   OConnell K, 2007, INT J MOL MED, V20, P145
   Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b
   Pette D, 2001, INT J SPORT NUTR EXE, V11, PS3, DOI 10.1123/ijsnem.11.s1.s3
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RESNICK NM, 1997, PRINCIPLES INTERNAL, V0, P1501
   Riley GP, 2001, RHEUMATOLOGY, V40, P229, DOI 10.1093/rheumatology/40.2.229
   Roth S M, 2000, J NUTR HEALTH AGING, V4, P143
   Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006
   Sayer AA, 2008, J NUTR HEALTH AGING, V12, P427, DOI 10.1007/BF02982703
   Semba RD, 2007, ARCH BIOCHEM BIOPHYS, V458, P141, DOI 10.1016/j.abb.2006.11.025
   Short KR, 1999, JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, V22, P95
   Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d
   Theou O, 2008, APPL PHYSIOL NUTR ME, V33, P651, DOI 10.1139/H08-058
   Thompson LV, 2009, EXP GERONTOL, V44, P106, DOI 10.1016/j.exger.2008.05.003
   Timiras PS, 2007, PHYSL BASIS AGING GE, V0, P329
   Topinková E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340
   VALKENBURG HA, 1988, GERONTOLOGY, V34, P2, DOI 10.1159/000212980
   Vecchiet L, 2002, J MUSCULOSKELET PAIN, V10, P5, DOI 10.1300/J094v10n01_02
   VOIGHT C, 2001, TECHNIQUES MUSCULOSK, V0, P679
   Waters D L, 2000, J NUTR HEALTH AGING, V4, P133
   Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032
NR 49
TC 0
Z9 0
U1 0
U2 1
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
SN 
EI 
J9 MUSCULAR SYST-ANAT F
PD JUN 15
PY 2010
VL 0
IS 
BP 107
EP 130
DI 
PG 24
WC Anatomy & Morphology; Physiology
SC Anatomy & Morphology; Physiology
GA BPS30
UT WOS:000279766000003
DA 2024-11-01
ER

PT J
AU Larsson, NG
AF Larsson, Nils-Goeran
TI Somatic Mitochondrial DNA Mutations in Mammalian Aging
SO ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79
LA English
DT Review; Book Chapter
DE mitochondria; oxidative phosphorylation; respiratory chain
ID cultured skin fibroblasts; oxygen species production; substantia-nigra neurons; mtdna mutator mice; point mutations; polymerase-gamma; skeletal-muscle; in-vivo; oxidative-phosphorylation; transcription factor
AB Mitochondrial dysfunction is heavily implicated in the multifactorial aging process. Aging humans have increased levels of somatic mtDNA mutations that tend to undergo clonal expansion to cause mosaic respiratory chain deficiency in various tissues, such as heart, brain, skeletal muscle, and gut. Genetic mouse models have shown that somatic mtDNA mutations and cell type-specific respiratory chain dysfunction can cause a variety of phenotypes associated with aging and age-related disease. There is thus strong observational and experimental evidence to implicate somatic mtDNA mutations and mosaic respiratory chain dysfunction in the mammalian aging process. The hypothesis that somatic mtDNA mutations are generated by oxidative damage has not been conclusively proven. Emerging data instead suggest that the inherent error rate of mitochondrial DNA (mtDNA) polymerase gamma (Pol gamma) may be responsible for the majority of somatic mtDNA mutations. The roles for mtDNA damage and replication errors in aging need to be further experimentally addressed.
C1 Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
C3 Max Planck Society
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
EM larsson@age.mpg.de
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Antoshechkin I, 1997, EMBO J, V16, P3198, DOI 10.1093/emboj/16.11.3198
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   BENZER S, 1958, P NATL ACAD SCI USA, V44, P112, DOI 10.1073/pnas.44.2.112
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   Birket MJ, 2009, J INVEST DERMATOL, V129, P1361, DOI 10.1038/jid.2008.373
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   Brockmann GA, 2002, TRENDS GENET, V18, P367, DOI 10.1016/S0168-9525(02)02703-8
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648
   Chan SW, 2009, METHODS MOL BIOL, V554, P183, DOI 10.1007/978-1-59745-521-3_12
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Clayton D A, 1975, INT REV EXP PATHOL, V14, P1
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ekstrand Mats, 2002, METHODS MOL BIOL, V197, P391, DOI 10.1385/1-59259-284-8:391
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   Freyer C, 2007, CELL, V131, P448, DOI 10.1016/j.cell.2007.10.027
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Hamilton ML, 2001, NUCLEIC ACIDS RES, V29, P2117, DOI 10.1093/nar/29.10.2117
   Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 1999, NAT MED, V5, P965, DOI 10.1038/12379
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V50, P360
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   MacAlpine DM, 2001, EMBO J, V20, P1807, DOI 10.1093/emboj/20.7.1807
   MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1
   Shen EL, 2001, NUCLEIC ACIDS RES, V29, P2822, DOI 10.1093/nar/29.13.2822
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   SOONG NW, 1992, NAT GENET, V2, P318
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Terzioglu Mugen, 2007, NOVARTIS FOUND SYMP, V287, P197
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010
   Wilding CS, 2006, RADIAT RES, V165, P202, DOI 10.1667/RR3494.1
   Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 152
TC 392
Z9 442
U1 0
U2 72
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4154
EI 
J9 ANNU REV BIOCHEM
JI Annu. Rev. Biochem..
PD JUN 15
PY 2010
VL 79
IS 
BP 683
EP 706
DI 10.1146/annurev-biochem-060408-093701
PG 24
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BPX29
UT WOS:000280225300024
PM 20350166
DA 2024-11-01
ER

PT J
AU Wu, SB
   Wu, YT
   Wang, CH
   Lee, WY
   Wei, YH
AF Wu, Shi-Bei
   Wu, Yu-Ting
   Wang, Chih-Hao
   Lee, Wan-Yu
   Wei, Yau-Huei
TI Mitochondrial Respiratory Function Decline in Aging and Life-Span Extension by Caloric Restriction
SO AGING AND AGE-RELATED DISORDERS
LA English
DT Article; Book Chapter
DE Aging; Mitochondrial dysfunction; Oxidative stress; mtDNA mutation; Vicious cycle; Caloric restriction; Sirt1
ID gene-expression profile; human skeletal-muscle; cytochrome-c-oxidase; foxo transcription factors; oxygen species production; free-radical production; human skin fibroblasts; oxidative damage; dna mutations; electron-transport
AB Extensive studies have established that progressive accumulation of somatic mutations in mitochondrial DNA (mtDNA) leads to a decline in mitochondrial bioenergetic function and contributes to human aging. Mitochondrial respiratory chain dysfunction not only causes inefficient ATP production but also increases mitochondrial generation of reactive oxygen species (ROS), which can induce further oxidative damage and mutation to mtDNA during the aging process. Indeed, a wide spectrum of mtDNA mutations has been found to occur in somatic tissues of elderly subjects. Besides, mitochondrial abnormalities have been associated with age-related diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). On the other hand, age-associated reduction in the efficiency of oxidative phosphorylation (OXPHOS) may cause alterations of gene expression in affected tissues for the sake of compensation or adaptation. Recent studies have revealed that the expression levels of several clusters of genes and posttranslational modifications of proteins are changed in various tissues of old animals and cultured cells from elderly subjects. In addition, the changes in age-associated gene expression profiles were tissue-specific, which suggests that different tissues are subject to different degree of oxidative stress during the aging process. Surprisingly, the majority of the age-related alterations in gene expression can be reversed by caloric restriction (CR) through the elevation of sirtuin 1 (Sirt1) expression, which promotes survival in organisms ranging from yeast to rodents and primates. The anti-aging effects of Sirt1 mediated by CR could be conferred by the activation of mitochondrial biogenesis and respiratory function. On the other hand, the mitochondrial sirtuins (Sirt3, Sirt4, and Sirt5) also play a critical role not only in the upregulation of mitochondrial function but also in the protection against oxidative stress and culminate in the extension of the life span of animals. Taking these findings together, we suggest that mitochondria' dysfunction, accumulation of mtDNA mutation, enhanced oxidative stress, and alteration of gene expression are important contributors to human aging. On the other hand, Sirt1 and mitochondrial sirtuins could be the therapeutic targets for the treatment of various age-related diseases such as mitochondrial disorders, neurodegenerative diseases, and metabolic syndrome.
C1 [Wu, Shi-Bei; Wu, Yu-Ting; Wang, Chih-Hao; Lee, Wan-Yu; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
C3 National Yang Ming Chiao Tung University
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Ashmore LJ, 2009, HUM GENET, V126, P431, DOI 10.1007/s00439-009-0673-2
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Bodyak N, 2002, NUCLEIC ACIDS RES, V30, P3788, DOI 10.1093/nar/gkf497
   Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   Bregere C, 2008, METHOD ENZYMOL, V441, P339, DOI 10.1016/S0076-6879(08)01219-6
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357
   Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2
   Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651
   Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Drew B, 2003, AM J PHYSIOL-REG I, V284, PR474, DOI 10.1152/ajpregu.00455.2002
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Feng J, 2008, J GERONTOL A-BIOL, V63, P1137, DOI 10.1093/gerona/63.11.1137
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   Gannon J, 2008, INT J MOL MED, V22, P33
   Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104
   Gelfi C, 2006, J PROTEOME RES, V5, P1344, DOI 10.1021/pr050414x
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HORTON AA, 1981, MECH AGEING DEV, V17, P253, DOI 10.1016/0047-6374(81)90062-2
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   LEE HC, 1994, FEBS LETT, V354, P79, DOI 10.1016/0014-5793(94)01063-3
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Li M, 2007, J BIOCHEM MOL BIOL, V40, P72
   Lin G, 2009, CELL MOL LIFE SCI, V66, P919, DOI 10.1007/s00018-009-8696-3
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Mambo E, 2003, P NATL ACAD SCI USA, V100, P1838, DOI 10.1073/pnas.0437910100
   Manfredi G, 2000, BRAIN PATHOL, V10, P462
   Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Meissner C, 2006, EXP GERONTOL, V41, P518, DOI 10.1016/j.exger.2006.03.010
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miyazawa M, 2009, J RADIAT RES, V50, P73, DOI 10.1269/jrr.08097
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Rebrin I, 2007, BIOCHEMISTRY-US, V46, P10130, DOI 10.1021/bi7001482
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Schroeder P, 2008, J INVEST DERMATOL, V128, P2297, DOI 10.1038/jid.2008.57
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shimokawa I, 2008, MOL CELLS, V26, P427
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   Solvioli Stefano, 2008, BIOTECHNOLOGY JOURNAL, V3, P740, DOI 10.1002/biot.200800046
   Sorarù G, 2007, NEUROPATH APPL NEURO, V33, P204, DOI 10.1111/j.1365-2990.2006.00791.x
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, PE38, DOI 10.1152/ajpendo.00387.2001
   Stöckl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wei YH, 2003, ADV CLIN CHEM, V37, P83, DOI 10.1016/S0065-2423(03)37007-6
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   WEI YH, 1981, BIOCHEM BIOPH RES CO, V99, P1411, DOI 10.1016/0006-291X(81)90776-2
   Weindruch R, 2001, J NUTR, V131, P918S, DOI 10.1093/jn/131.3.918S
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 153
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 2197-7224
EI 
J9 OXID STRESS APPL BAS
JI Oxid. Stress Appl. Basic Res. Clin. Pract.
PD JUN 15
PY 2010
VL 0
IS 
BP 129
EP 148
DI 10.1007/978-1-60761-602-3_7
PG 20
WC Medicine, General & Internal
SC General & Internal Medicine
GA BQX53
UT WOS:000282063600007
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Bailey, CM
   Spell, D
   Stillwagon, M
   Anderson, KS
   Copeland, WC
AF Stumpf, Jeffrey D.
   Bailey, Christopher M.
   Spell, Diana
   Stillwagon, Matthew
   Anderson, Karen S.
   Copeland, William C.
TI <i>mip1</i> containing mutations associated with mitochondrial disease causes mutagenesis and depletion of mtDNA in <i>Saccharomyces cerevisiae</i>
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID dna-polymerase-gamma; progressive external ophthalmoplegia; type-1 reverse-transcriptase; polg mutations; point mutations; defects; deletions; gene; resistance; subunit
AB DNA polymerase gamma (pol gamma) is responsible for replication and repair of mitochondrial DNA (mtDNA). Over 150 mutations in POLG (which encodes pol gamma) have been discovered in patients with mitochondrial disorders including Alpers, progressive external ophthalmoplegia and ataxia-neuropathy syndrome. However, the severity and dominance of many POLG disease-associated mutations are unclear, because they have been reported in sporadic cases. To understand the consequences of pol gamma disease-associated mutations in vivo, we identified dominant and recessive changes in mtDNA mutagenesis, depletion and mitochondrial dysfunction caused by 31 mutations in the conserved regions of the gene, MIP1, which encodes the Saccharomyces cerevisiae ortholog of human pol gamma. Twenty mip1 mutant enzymes were shown to disrupt mtDNA replication and may be sufficient to cause disease. Previously uncharacterized sporadic mutations, Q308H, R807C, G1076V, R1096H and S1104C, caused decreased polymerase activity leading to mtDNA depletion and mitochondrial dysfunction. We present evidence showing a limited role of point mutagenesis by these POLG mutations in mitochondrial dysfunction and disease progression. Instead, most mitochondrial defective mip1 mutants displayed reduced or depleted mtDNA. We also determined that the severity of the phenotype of the mip1 mutant strain correlates with the age of onset of disease associated with the human ortholog. Finally, we demonstrated that increasing nucleotide pools by overexpression of ribonucleotide reductase (RNR1) suppressed mtDNA replication defects caused by several dominant mip1 mutations, and the orthologous human mutations revealed severe nucleotide binding defects.
C1 [Stumpf, Jeffrey D.; Spell, Diana; Stillwagon, Matthew; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Bailey, Christopher M.; Anderson, Karen S.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Yale University
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Room E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU National Institute of Environmental Health Sciences National Institutes of Health (NIH) [ES 065078]; NIH [GM49551]; National Institutes of Health
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Burgers PM, 2001, J BIOL CHEM, V28, P28
   Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Doublié S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Merz S, 2009, GENOME BIOL, V10, P0, DOI 10.1186/gb-2009-10-9-r95
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901
   Shcherbakova Polina V, 2003, SCI AGING KNOWLEDGE ENVIRON, V2003, PRE3, DOI 10.1126/sageke.2003.8.re3
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yang Y, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000264
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 58
TC 36
Z9 42
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUN 1
PY 2010
VL 19
IS 11
BP 2123
EP 2133
DI 10.1093/hmg/ddq089
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 593IX
UT WOS:000277448500004
PM 20185557
DA 2024-11-01
ER

PT J
AU Bergmann, AK
   Campagna, DR
   McLoughlin, EM
   Agarwal, S
   Fleming, MD
   Bottomley, SS
   Neufeld, EJ
AF Bergmann, Anke K.
   Campagna, Dean R.
   McLoughlin, Erin M.
   Agarwal, Suneet
   Fleming, Mark D.
   Bottomley, Sylvia S.
   Neufeld, Ellis J.
TI Systematic Molecular Genetic Analysis of Congenital Sideroblastic Anemia: Evidence for Genetic Heterogeneity and Identification of Novel Mutations
SO PEDIATRIC BLOOD & CANCER
LA English
DT Article
DE iron; microcytic anemia; ringed sideroblasts; sideroblastic anemia
ID mitochondrial myopathy; megaloblastic-anemia; missense mutation; ataxia; abc7; transporter; disorder; repeat
AB Background. Sideroblastic anemias are heterogeneous congenital and acquired bone marrow disorders characterized by pathologic iron deposits in mitochondria of erythroid precursors. Among the congenital sideroblastic anemias (CSAs), the most common form is X-linked sideroblastic anemia, due to Mutations in 5-aminolevulinate synthase (ALAS2). A novel autosomal recessive CSA, caused by mutations in the erythroid specific mitochondrial transporter SLC25A38, was recently defined. Other known etiologies include mutations in genes encoding the thiamine transporter SLC19A2, the RNA-modifying enzyme pSeLldouridine synthase 1 (PUS1), a mitochondrial ATP-binding cassette transporter (ABCB7), glutaredoxin 5 (GLRX5), as well as mitochondrial DNA deletions. Despite these known diverse causes, in a Substantial portion of CSA cases a presumed genetic defect remains unknown. Procedure. In the context of the recent discovery of SLC25A38 as a major novel cause, we systematically analyzed a large cohort of previously unreported CSA patients. Sixty CSA probands (28 females, 32 males) were examined for ALAS2, SLC25A38, PUS1, GLRX5, and ABCB7 mutations. SLC19A2 and mitochondrial DNA were only analyzed if characteristic syndromic features were apparent. Results. Twelve probands had biallelic mutations in SLC25A38. Seven ALAS2 mutations were detected in eight sporadic CSA cases, two being novel. We also identified a novel homozygous null PUSI mutation and novel mitochondrial DNA deletions in two patients with Pearson syndrome. No mutations were encountered in GLRX5, ABCB7, or SLC19A2. Conclusions. The remaining undefined probands (43%) can be grouped according to gender, family, and clinical characteristics, suggesting novel X-linked and autosomal recessive forms of CSA. Pediatr Blood Cancer 2010;54:273-278. (C) 2009 Wiley-Liss, Inc.
C1 [Campagna, Dean R.; Fleming, Mark D.] Harvard Univ, Dept Pathol, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA.
   [Bergmann, Anke K.; McLoughlin, Erin M.; Agarwal, Suneet; Neufeld, Ellis J.] Harvard Univ, Div Hematol Oncol, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA.
   [Agarwal, Suneet; Neufeld, Ellis J.] Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Bottomley, Sylvia S.] Univ Oklahoma, Coll Med, Hematol Oncol Sect, Oklahoma City, OK 73190 USA.
C3 Harvard University; Harvard Medical School; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center
RP Fleming, MD (corresponding author), Harvard Univ, Dept Pathol, Childrens Hosp Boston, Sch Med, 300 Longwood Ave,Enders 1116-1, Boston, MA 02115 USA.
EM mark.fleming@childrens.harvard.edu
FU NIH [R01 DK080011, K08 HL089150, K24 HL004184]; The U.S. Department of Veterans, Affairs, University of Oklahoma Health Sciences Center Provost's Fund; The Oklahoma Center for Advancement of Science and Technology
CR ABBOUD MR, 1985, J PEDIATR-US, V107, P537, DOI 10.1016/S0022-3476(85)80011-1
   ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bekri S, 2000, BLOOD, V96, P3256
   Bekri S, 2003, BLOOD, V102, P698, DOI 10.1182/blood-2002-06-1623
   BERGMANN AK, 2009, J PEDIAT, V0, P0
   Bottomley SS, 2008, WINTROBES CLINICAL HEMATOLOGY, V12th, P835
   Bottomley Sylvia S, 2006, CURR HEMATOL REP, V5, P41
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   COOLEY TB, 1945, AM J MED SCI, V209, P561
   DIERLAMM J, 1995, BRIT J HAEMATOL, V91, P885, DOI 10.1111/j.1365-2141.1995.tb05405.x
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fleming MD, 2002, SEMIN HEMATOL, V39, P270, DOI 10.1053/shem.2002.35637
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x
   May A, 2005, BLOOD, V106, P0
   Neufeld EJ, 2001, BLOOD CELL MOL DIS, V27, P135, DOI 10.1006/bcmd.2000.0356
   PAGON RA, 1985, J MED GENET, V22, P267, DOI 10.1136/jmg.22.4.267
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PEGORARO E, 1994, AM J HUM GENET, V54, P989
   Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768
   Ricketts CJ, 2006, ACTA PAEDIATR, V95, P99, DOI 10.1080/08035250500323715
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1989, LANCET, V1, P902
   ROTIG A, 1995, MUSCLE NERVE, V0, PS159
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427
   Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 34
TC 102
Z9 116
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD FEB 15
PY 2010
VL 54
IS 2
BP 273
EP 278
DI 10.1002/pbc.22244
PG 6
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA 538TK
UT WOS:000273206700019
PM 19731322
DA 2024-11-01
ER

PT J
AU Mezghani, N
   Mkaouar-Rebai, E
   Mnif, M
   Charfi, N
   Rekik, N
   Youssef, S
   Abid, M
   Fakhfakh, F
AF Mezghani, Najla
   Mkaouar-Rebai, Emna
   Mnif, Mouna
   Charfi, Nadia
   Rekik, Nabila
   Youssef, Saoussan
   Abid, Mohamed
   Fakhfakh, Faiza
TI The heteroplasmic m.14709T&gt;C mutation in the tRNA<SUP>Glu</SUP> gene in two Tunisian families with mitochondrial diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes mellitus; Mitochondrial mutations; m.14709T > C; m.3243A > G; Heteroplasmy
ID chinese han population; a3243g mutation; trna(leu(uur)) mutation; t14709c mutation; dna extraction; onset myopathy; point mutation; hearing-loss; mellitus; prevalence
AB Diabetes mellitus (DM) is a heterogeneous disorder characterized by the presence of chronic hyperglycemia. Genetic factors play an important role in the development of this disorder, and several studies reported mutations in nuclear genes implicated in the insulin function. Besides, DM can be maternally transmitted in some families, possibly due to the maternal mitochondrial inheritance. In fact, mitochondrial genes may be plausible causative agents for diabetes, since mitochondrial oxidative phosphorylation plays an important role in glucose-stimulated insulin secretion from beta cells. Materials and Methods: In this report, we screened two Tunisian families with mitochondrial diabetes for the m.3243A>G and the m.14709T>C mutations, respectively, in the tRNA(Leu(UUR)) and the tRNA(Glu) genes. Results: The polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and the sequence-specific primers by polymerase chain reaction (SSP-PCR) analysis in the leucocytes and the buccal mucosa in the members of the two families showed the absence of the m.3243A>G mutation and the presence of the heteroplasmic m.14709T>C mutation in the tRNA(Glu) gene in the two tested tissues. Conclusions: We conclude that the tn.14709T>C mutation in the tRNA(Glu) gene could be a cause of mitochondrial diabetes in Tunisian affected families. In addition, the heteroplasmic loads correlated with the severity and the onset of mitochondrial diabetes in one family but not in the other, suggesting the presence of environmental factors or nuclear modifier genes. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Mezghani, Najla; Mkaouar-Rebai, Emna; Youssef, Saoussan; Fakhfakh, Faiza] Fac Med Sfax, Human Mol Genet Lab, Sfax 3029, Tunisia.
   [Mnif, Mouna; Charfi, Nadia; Rekik, Nabila; Abid, Mohamed] CHU Habib Bourguiba Sfax, Serv Endocrinol, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba; Hopital Hedi Chaker
RP Fakhfakh, F (corresponding author), Fac Med Sfax, Human Mol Genet Lab, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com; faiza.fakhfakh@gnet.tn
FU Tunisian Ministry of Higher Education, Scientific Research and Technology
CR Akbari M, 2004, SCAND J CLIN LAB INV, V64, P86, DOI 10.1080/00365510410004209
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Au WS, 2008, J MOL ENDOCRINOL, V41, P229, DOI 10.1677/JME-08-0080
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Cao W, 2003, CANCER DETECT PREV, V27, P397, DOI 10.1016/S0361-090X(03)00103-X
   Chen Gang, 2008, YICHUAN, V30, P1279, DOI 10.3724/SP.J.1005.2008.01279
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Crispim Daisy, 2006, ARQ BRAS ENDOCRINOL METAB, V50, P862, DOI 10.1590/S0004-27302006000500006
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Kong Weijia, 2002, ZHONGHUA ER BI YAN HOU KE ZA ZHI, V37, P338
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   Lee HC, 1997, J CLIN ENDOCR METAB, V82, P372, DOI 10.1210/jc.82.2.372
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Li MZ, 2008, CHINESE MED J-PEKING, V121, P682, DOI 10.1097/00029330-200804020-00004
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   Liu LM, 2010, DIABETES CARE, V33, P144, DOI 10.2337/dc09-1258
   Liu SM, 2007, DIABETES RES CLIN PR, V76, P425, DOI 10.1016/j.diabres.2006.09.032
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   Ng MCY, 2000, CLIN ENDOCRINOL, V52, P557, DOI 10.1046/j.1365-2265.2000.00989.x
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Pandey AK, 2009, FEBS J, V276, P4181, DOI 10.1111/j.1742-4658.2009.07091.x
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Ren Yan, 2003, ZHONGHUA YI XUE YI CHUAN XUE ZA ZHI, V20, P181
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Tang Dong-ling, 2005, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V22, P636
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
NR 41
TC 26
Z9 26
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL-AUG 15
PY 2010
VL 24
IS 4
BP 270
EP 277
DI 10.1016/j.jdiacomp.2009.11.002
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 613JB
UT WOS:000278974100009
PM 20045353
DA 2024-11-01
ER

PT J
AU Crugnola, V
   Lamperti, C
   Lucchini, V
   Ronchi, D
   Peverelli, L
   Prelle, A
   Sciacco, M
   Bordoni, A
   Fassone, E
   Fortunato, F
   Corti, S
   Silani, V
   Bresolin, N
   Di Mauro, S
   Comi, GP
   Moggio, M
AF Crugnola, Veronica
   Lamperti, Costanza
   Lucchini, Valeria
   Ronchi, Dario
   Peverelli, Lorenzo
   Prelle, Alessandro
   Sciacco, Monica
   Bordoni, Andreina
   Fassone, Elisa
   Fortunato, Francesco
   Corti, Stefania
   Silani, Vincenzo
   Bresolin, Nereo
   Di Mauro, Salvatore
   Comi, Giacomo Pietro
   Moggio, Maurizio
TI Mitochondrial Respiratory Chain Dysfunction in Muscle From Patients With Amyotrophic Lateral Sclerosis
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID motor-neuron disease; superoxide-dismutase gene; spinal muscular-atrophy; skeletal-muscle; oxidative stress; als patients; mutations; protein; dna; ultrastructure
AB Background: Amyotrophic lateral sclerosis (ALS) is a major cause of neurological disability and its pathogenesis remains elusive despite a multitude of studies. Although defects of the mitochondrial respiratory chain have been described in several ALS patients, their pathogenic significance is unclear. Objective: To review systematically the muscle biopsy specimens from patients with typical sporadic ALS to search for possible mitochondrial oxidative impairment. Design: Retrospective histochemical, biochemical, and molecular studies of muscle specimens. Setting: Tertiary care university. Subjects: Fifty patients with typical sporadic ALS (mean age, 55 years). Main Outcome Measure: Number of patients showing a clear muscle mitochondrial dysfunction assessed through histochemical and biochemical muscle analysis. Results: Histochemical data showed cytochrome c oxidase (COX)-negative fibers in 46% patients. Based on COX histochemical activity, patients fell into 4 groups: 27 had normal COX activity; and 8 had mild (2-4 COX-negative fibers of 100 fibers), 8 had moderate (5-10 COX-negative fibers of 100), and 7 had severe (>10 COX-negative fibers of 100) COX deficiency. Spectrophotometric measurement of respiratory chain activities showed that 3 patients with severe histochemical COX deficiency also showed combined enzyme defects. In 1 patient, COX deficiency worsened in a second biopsy taken 9 months after the first. Among the patients with severe COX deficiency, one had a new mutation in the SOD1 gene, another a mutation in the TARDBP gene, and a third patient with biochemically confirmed COX deficiency had multiple mitochondrial DNA deletions detectable by Southern blot analysis. Conclusions: Our data confirm that the histochemical finding of COX-negative fibers is common in skeletal muscle from patients with sporadic ALS. We did not find a correlation between severity of the oxidative defect and age of the patients or duration of the disease. However, the only patient who underwent a second muscle biopsy did show a correlation between severity of symptoms and worsening of the respiratory chain defect. In 7 patients, the oxidative defect was severe enough to support the hypothesis that mitochondrial dysfunction must play a role in the pathogenesis of the disease.
C1 [Crugnola, Veronica; Lamperti, Costanza; Lucchini, Valeria; Ronchi, Dario; Peverelli, Lorenzo; Prelle, Alessandro; Sciacco, Monica; Fassone, Elisa; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo Pietro; Moggio, Maurizio] Univ Milan, Dept Neurol Sci, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Dino Ferrari Ctr,Sci Inst Res & Treatment, I-20122 Milan, Italy.
   [Silani, Vincenzo] Univ Milan, Dept Neurol & Lab Neurosci, Dino Ferrari Ctr, IRCCS Ist Auxologico Italiano, I-20122 Milan, Italy.
   [Di Mauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; Columbia University
RP Moggio, M (corresponding author), Univ Milan, Dept Neurol Sci, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Dino Ferrari Ctr,Sci Inst Res & Treatment, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM maurizio.moggio@unimi.it
FU Associazione Amici del Centro Dino Ferrari; Italian Ministry of University and Research [2006069034]; EuroBioBank [QLTR-2001-02769]; Fondazione Telethon Funding Source: Custom
CR AFIFI AK, 1966, NEUROLOGY, V16, P475, DOI 10.1212/WNL.16.5.475
   Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700
   Andersen PM, 2001, AMYOTROPH LATERAL SC, V2, P0
   Appel SH, 2006, EXP NEUROL, V198, P1, DOI 10.1016/j.expneurol.2005.12.025
   ATSUMI T, 1981, ACTA NEUROPATHOL, V55, P193, DOI 10.1007/BF00691318
   Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X
   Borthwick Gillian M, 2006, ANN NEUROL, V59, P570, DOI 10.1002/ana.20758
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0
   Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Corcia P, 2002, ANN NEUROL, V51, P243, DOI 10.1002/ana.10104
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Corti S, 2009, J NEUROL SCI, V276, P170, DOI 10.1016/j.jns.2008.09.030
   Dubowitz V, 1985, MUSCLE BIOPSY PRACTI, V2nd, P0
   Dupuis L, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005390
   Echaniz-Laguna A, 2006, EXP NEUROL, V198, P25, DOI 10.1016/j.expneurol.2005.07.020
   Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   Finsterer J, 2003, NEUROLOGIST, V9, P45, DOI 10.1097/01.nrl.0000038589.58012.a8
   Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344
   Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742
   Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166
   Hirano M, 2008, ARCH NEUROL-CHICAGO, V65, P403, DOI 10.1001/archneurol.2007.65
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112
   Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090
   Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542
   Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287
   Przedborski S, 2004, NEUROLOGIST, V10, P1, DOI 10.1097/01.nrl.0000106920.84668.37
   Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123
   Rizzardini M, 2005, J NEUROL SCI, V232, P95, DOI 10.1016/j.jns.2005.02.004
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sasaki S, 1996, NEUROSCI LETT, V204, P53, DOI 10.1016/0304-3940(96)12314-4
   Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210
   Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Xu ZS, 2004, J BIOENERG BIOMEMBR, V36, P395, DOI 10.1023/B:JOBB.0000041774.12654.e1
   Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160
NR 51
TC 114
Z9 131
U1 0
U2 22
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUL 15
PY 2010
VL 67
IS 7
BP 849
EP 854
DI 
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 624EC
UT WOS:000279798100011
PM 20625092
DA 2024-11-01
ER

PT J
AU Suomalainen, A
   Isohanni, P
AF Suomalainen, Anu
   Isohanni, Pirjo
TI Mitochondrial DNA depletion syndromes - Many genes, common mechanisms
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE Mitochondrial DNA; Mitochondrial DNA depletion syndrome; Encephalopathy; Hepatoencephalopathy; Leigh syndrome; Alpers syndrome
ID progressive external ophthalmoplegia; onset spinocerebellar ataxia; neurogastrointestinal encephalomyopathy mngie; recessive twinkle mutations; polymerase-gamma mutations; succinyl-coa synthetases; mtdna depletion; thymidine kinase; deoxyguanosine kinase; polg1 mutations
AB Mitochondrial DNA depletion syndrome has become an important cause of inherited metabolic disorders, especially in children, but also in adults. The manifestations vary from tissue-specific mtDNA depletion to wide-spread multisystemic disorders. Nine genes are known to underlie this group of disorders, and many disease genes are still unidentified. However, the disease mechanisms seem to be intimately associated with mtDNA replication and nucleotide pool regulation. We review here the current knowledge on the clinical and molecular genetic features of mitochondrial DNA depletion syndrome. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Suomalainen, Anu; Isohanni, Pirjo] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Div Child Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, R C523B,POB 63, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU Juselius Foundation; Aatos and Jane Erkko Foundation; Academy of Finland; Helsinki University; Helsinki University Central Hospital
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Delarue A, 2000, PEDIATR TRANSPLANT, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DEVRIES MC, 2008, J INHERIT METAB DIS, V0, P0
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   ELHATTAB AW, 2009, MOL GENET METAB, V0, P0
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Eriksson S, 2008, NUCLEOS NUCLEOT NUCL, V27, P800, DOI 10.1080/15257770802146197
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kayihan N, 2000, PEDIATR TRANSPLANT, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2008, J INHERIT METAB DIS, V0, P0
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Poulton Joanna, 2009, NEUROMUSCUL DISORD, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 88
TC 152
Z9 175
U1 3
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL 15
PY 2010
VL 20
IS 7
BP 429
EP 437
DI 10.1016/j.nmd.2010.03.017
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 630PH
UT WOS:000280285000001
PM 20444604
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Griffiths, PG
   Gorman, GS
   Lourenco, CM
   Wright, AF
   Auer-Grumbach, M
   Toscano, A
   Musumeci, O
   Valentino, ML
   Caporali, L
   Lamperti, C
   Tallaksen, CM
   Duffey, P
   Miller, J
   Whittaker, RG
   Baker, MR
   Jackson, MJ
   Clarke, MP
   Dhillon, B
   Czermin, B
   Stewart, JD
   Hudson, G
   Reynier, P
   Bonneau, D
   Marques, W
   Lenaers, G
   McFarland, R
   Taylor, RW
   Turnbull, DM
   Votruba, M
   Zeviani, M
   Carelli, V
   Bindoff, LA
   Horvath, R
   Amati-Bonneau, P
   Chinnery, PF
AF Yu-Wai-Man, P.
   Griffiths, P. G.
   Gorman, G. S.
   Lourenco, C. M.
   Wright, A. F.
   Auer-Grumbach, M.
   Toscano, A.
   Musumeci, O.
   Valentino, M. L.
   Caporali, L.
   Lamperti, C.
   Tallaksen, C. M.
   Duffey, P.
   Miller, J.
   Whittaker, R. G.
   Baker, M. R.
   Jackson, M. J.
   Clarke, M. P.
   Dhillon, B.
   Czermin, B.
   Stewart, J. D.
   Hudson, G.
   Reynier, P.
   Bonneau, D.
   Marques, W., Jr.
   Lenaers, G.
   McFarland, R.
   Taylor, R. W.
   Turnbull, D. M.
   Votruba, M.
   Zeviani, M.
   Carelli, V.
   Bindoff, L. A.
   Horvath, R.
   Amati-Bonneau, P.
   Chinnery, P. F.
TI Multi-system neurological disease is common in patients with <i>OPA1</i> mutations
SO BRAIN
LA English
DT Article
DE deletions; dominant optic atrophy; hereditary spastic paraplegia; mitochondrial DNA; multiple sclerosis; OPA1
ID dominant optic atrophy; progressive external ophthalmoplegia; mitochondrial-dna deletions; sensorineural hearing-loss; multiple-sclerosis; clinical-features; counting fingers; hand motion; neuropathy; mtdna
AB Additional neurological features have recently been described in seven families transmitting pathogenic mutations in OPA1, the most common cause of autosomal dominant optic atrophy. However, the frequency of these syndromal 'dominant optic atrophy plus' variants and the extent of neurological involvement have not been established. In this large multi-centre study of 104 patients from 45 independent families, including 60 new cases, we show that extra-ocular neurological complications are common in OPA1 disease, and affect up to 20% of all mutational carriers. Bilateral sensorineural deafness beginning in late childhood and early adulthood was a prominent manifestation, followed by a combination of ataxia, myopathy, peripheral neuropathy and progressive external ophthalmoplegia from the third decade of life onwards. We also identified novel clinical presentations with spastic paraparesis mimicking hereditary spastic paraplegia, and a multiple sclerosis-like illness. In contrast to initial reports, multi-system neurological disease was associated with all mutational subtypes, although there was an increased risk with missense mutations [odds ratio = 3.06, 95% confidence interval = 1.44-6.49; P = 0.0027], and mutations located within the guanosine triphosphate-ase region (odds ratio = 2.29, 95% confidence interval = 1.08-4.82; P = 0.0271). Histochemical and molecular characterization of skeletal muscle biopsies revealed the presence of cytochrome c oxidase-deficient fibres and multiple mitochondrial DNA deletions in the majority of patients harbouring OPA1 mutations, even in those with isolated optic nerve involvement. However, the cytochrome c oxidase-deficient load was over four times higher in the dominant optic atrophy + group compared to the pure optic neuropathy group, implicating a causal role for these secondary mitochondrial DNA defects in disease pathophysiology. Individuals with dominant optic atrophy plus phenotypes also had significantly worse visual outcomes, and careful surveillance is therefore mandatory to optimize the detection and management of neurological disability in a group of patients who already have significant visual impairment.
C1 [Yu-Wai-Man, P.; Griffiths, P. G.; Gorman, G. S.; Whittaker, R. G.; Stewart, J. D.; Hudson, G.; McFarland, R.; Taylor, R. W.; Turnbull, D. M.; Horvath, R.; Chinnery, P. F.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, P.; Griffiths, P. G.; Clarke, M. P.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Lourenco, C. M.; Marques, W., Jr.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurosci, BR-05508 Sao Paulo, Brazil.
   [Wright, A. F.] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.
   [Auer-Grumbach, M.] Med Univ Graz, Inst Human Genet, Graz, Austria.
   [Auer-Grumbach, M.] Med Univ Graz, Univ Clin Internal Med, Div Endocrinol & Nucl Med, Graz, Austria.
   [Toscano, A.; Musumeci, O.] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy.
   [Valentino, M. L.; Caporali, L.; Carelli, V.] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy.
   [Lamperti, C.; Zeviani, M.] Natl Neurol Inst, Study Childrens Mitochondrial Disorders, Pierfranco & Luisa Mariani Ctr, Unit Mol Neurogenet, Milan, Italy.
   [Tallaksen, C. M.] Oslo Univ Hosp, Ulleval Dept Neurol, Oslo, Norway.
   [Duffey, P.] York Hosp, Dept Neurol, York, N Yorkshire, England.
   [Miller, J.; Baker, M. R.; Jackson, M. J.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Baker, M. R.] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Dhillon, B.] Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland.
   [Czermin, B.] Med Genet Ctr MGZ, Munich, Germany.
   [Reynier, P.; Bonneau, D.; Amati-Bonneau, P.] CHU Angers, Dept Biochim & Genet, Angers, France.
   [Reynier, P.; Bonneau, D.; Amati-Bonneau, P.] INSERM, U694, Angers, France.
   [Lenaers, G.] Univ Montpellier I & II, Inst Neurosci Montpellier, INSERM, U583, Montpellier, France.
   [Votruba, M.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.
   [Votruba, M.] Univ Wales Hosp, Cardiff Eye Unit, Cardiff CF4 4XW, S Glam, Wales.
   [Bindoff, L. A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Bindoff, L. A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Horvath, R.] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany.
   [Chinnery, P. F.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Universidade de Sao Paulo; University of Edinburgh; Medical University of Graz; Medical University of Graz; University of Messina; University of Bologna; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Oslo; Newcastle University - UK; Newcastle University - UK; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Cardiff University; Cardiff University; University of Bergen; University of Bergen; Haukeland University Hospital; University of Munich; Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
FU Parkinson's Disease Society (UK); Medical Research Council Translational Muscle Centre; UK NIHR Biomedical Research Centre in Ageing and Age related disease; Deutsche Forschungsgemeinschaft [HO2505/2-1]; Academy of Medical Sciences; Wellcome Trust; UK National Commissioning Group for Rare Mitochondrial Disorders of Adults and Children; Helse Vest (RHF); Norwegian Research Council; NIHR Biomedical research Centre for Ageing and Age-related disease; Telethon-Italy [GGP06233]; MRC [G0701386, G0800674, MC_U127584475, G0700949] Funding Source: UKRI
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2005, CLIN GENET, V67, P102, DOI 10.1111/j.1399-0004.2004.00358.x
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bigal ME, 2006, NEUROLOGY, V67, P246, DOI 10.1212/01.wnl.0000225186.76323.69
   Bland M, 1995, INTRO MED STAT, V2nd, P0
   Brais B, 2009, CURR NEUROL NEUROSCI, V9, P76, DOI 10.1007/s11910-009-0012-y
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Carelli V, 2008, NEUROLOGY, V70, P1075, DOI 10.1212/01.wnl.0000307668.75233.35
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chen SQ, 2007, AM J OPHTHALMOL, V143, P186, DOI 10.1016/j.ajo.2006.06.049
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2006, MITOCHONDRIAL MED, V0, P161
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Cornille K, 2008, ANN NEUROL, V63, P667, DOI 10.1002/ana.21376
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Davies V, 2006, EXP EYE RES, V83, P1003, DOI 10.1016/j.exer.2005.11.021
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Ferré M, 2009, HUM MUTAT, V30, PE692, DOI 10.1002/humu.21025
   Fox CM, 2004, J NEUROL NEUROSUR PS, V75, P56
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   HOYT CS, 1980, OPHTHALMOLOGY, V87, P245
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   JOHNSON MA, 1996, HDB MUSCLE DIS, V0, P61
   Ke Tie, 2006, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V23, P481
   Khanim F, 2001, HUM MUTAT, V17, P357, DOI 10.1002/humu.1110.abs
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0
   Li CM, 2005, AM J MED GENET A, V138A, P208, DOI 10.1002/ajmg.a.30794
   Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9
   Liguori M, 2008, J NEUROL, V255, P127, DOI 10.1007/s00415-008-0571-x
   Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   McDermott CJ, 2003, NEUROREPORT, V14, P485, DOI 10.1097/01.wnr.0000058774.36017.cf
   MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   *NHS QUAL OUTC FRA, 2008, DIS PREV, V0, P0
   *OFF NAT STAT, 2008, POP HOUS, V0, P0
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 70
TC 325
Z9 343
U1 1
U2 26
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAR 15
PY 2010
VL 133
IS 
BP 771
EP 786
DI 10.1093/brain/awq007
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 575DI
UT WOS:000276046000013
PM 20157015
DA 2024-11-01
ER

PT J
AU Malfatti, E
   Cardaioli, E
   Battisti, C
   Da Pozzo, P
   Malandrini, A
   Rufa, A
   Rocchi, R
   Federico, A
AF Malfatti, Edoardo
   Cardaioli, Elena
   Battisti, Carla
   Da Pozzo, Paola
   Malandrini, Alessandro
   Rufa, Alessandra
   Rocchi, Raffaele
   Federico, Antonio
TI A novel point mutation in the mitochondrial tRNA<SUP>(TrP)</SUP> gene produces late-onset encephalomyopathy, plus additional features
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial diseases; mtDNA; Transfer RNA(TrP)
ID transfer-rna; trna(trp) gene; mtdna mutation; encephalopathy; deficiency; myopathy; database; genome
AB Background: Mitochondrial diseases due to mitochondrial tRNA genes mutations are usually multisystem disorders with infantile or adult onset. Objective: To identify the molecular defect underlying a mitochondrial encephalomyopathy. Methods/Patients: Case report of a 51 year-old woman presenting with late-onset myoclonic epilepsy plus additional features. Proband's mother presented hypothyroidism and diabetes. Results: Muscle biopsy showed mitochondrial changes. Respiratory chain activities were reduced. The novel G5538A mutation was identified in different tissues DNAs from the proband and from her mother. Conclusion: We were able to identify a novel mtDNA tRNA((TrP)) gene pathogenic mutation. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Malfatti, Edoardo; Cardaioli, Elena; Battisti, Carla; Da Pozzo, Paola; Malandrini, Alessandro; Rufa, Alessandra; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Rocchi, Raffaele] Univ Siena, Dept Neurosci, Neurol Sect, I-53100 Siena, Italy.
C3 University of Siena; University of Siena
RP Federico, A (corresponding author), Univ Siena, Dept Neurol Neurosurg & Behav Sci, Viale Mario Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
FU Regione Toscana; University of Siena
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOFFNER JM, 2001, METABOLIC MOL BASES, V2, P2367
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 16
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2010
VL 297
IS 1-2
BP 105
EP 108
DI 10.1016/j.jns.2010.06.009
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 663QY
UT WOS:000282904000023
PM 20708751
DA 2024-11-01
ER

PT J
AU Falk, MJ
   Sondheimer, N
AF Falk, Marni J.
   Sondheimer, Neal
TI Mitochondrial genetic diseases
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE diagnosis; mtDNA; nDNA; respiratory chain; therapy
ID c-oxidase deficiency; leigh-syndrome; disorders; dna; myopathy; mutations; diagnosis; defects; patient; muscle
AB Purpose of review Mitochondrial diseases are individually uncommon, but collectively pose a significant burden on human health. Primary mitochondrial disease is caused by defects in the mitochondrial DNA-encoded genes or in nuclear genes whose products are imported into the mitochondrion. Great strides have been made in determining the cause of mitochondrial disorders, but the clinical ability to diagnose these conditions lags behind because of phenotypic overlap between distinct genetic entities and the complexity and invasiveness of standard diagnostic testing. In this review, we evaluate new findings in mitochondrial genetics, recent developments in mitochondrial disease diagnostic testing, and emerging ideas for mitochondrial disease therapies. Recent findings Clinical cohort studies have revealed important themes in patient care relative to manifestations of mitochondrial disease. Significant strides have also been made toward creating embryos free from the risk of maternally inherited mitochondrial DNA-based disease. Several new genetic causes of both nuclear and mitochondrial DNA-based diseases have been identified in the past year. In addition, novel insights have emerged from basic studies of mitochondrial biology that hold promise for the development of targeted mitochondrial disease therapies. Summary Research on mitochondrial biology and disease continues to improve the clinical capacity to diagnose the heterogeneous group of mitochondrial diseases that afflict the pediatric population. This research also provides a framework for future approaches to devise effective mitochondrial disease therapies.
C1 [Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.
   [Sondheimer, Neal] Childrens Hosp Philadelphia, Dept Pediat, Div Metab Dis, Philadelphia, PA 19104 USA.
   Univ Penn, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania
RP Falk, MJ (corresponding author), ARC 1002C,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM falkm@email.chop.edu
FU National Institutes of Health [K08-DK073545-05, K08-HD058022]
CR Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   Almousa R, 2009, OPHTHAL PLAST RECONS, V25, P366, DOI 10.1097/IOP.0b013e3181b2fd06
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Bredenoord AL, 2010, CLIN GENET, V77, P10, DOI 10.1111/j.1399-0004.2009.01312.x
   Bredenoord A, 2009, EUR J HUM GENET, V17, P1550, DOI 10.1038/ejhg.2009.88
   Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Diogo L, 2010, PEDIATR NEUROL, V42, P196, DOI 10.1016/j.pediatrneurol.2009.09.010
   Distelmaier F, 2009, J MOL MED, V87, P515, DOI 10.1007/s00109-009-0452-5
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Janssen RJRJ, 2009, HUM MOL GENET, V18, P3365, DOI 10.1093/hmg/ddp276
   Jonckheere AI, 2010, CLIN CHEM, V56, P424, DOI 10.1373/clinchem.2009.131441
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Zhang R, 2010, FOOD CHEM TOXICOL, V48, P922, DOI 10.1016/j.fct.2010.01.001
NR 32
TC 31
Z9 36
U1 0
U2 22
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-8703
EI 
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD DEC 15
PY 2010
VL 22
IS 6
BP 711
EP 716
DI 10.1097/MOP.0b013e3283402e21
PG 6
WC Pediatrics
SC Pediatrics
GA 679EL
UT WOS:000284143600005
PM 21045694
DA 2024-11-01
ER

PT J
AU Michot, C
   Hubert, L
   Brivet, M
   De Meirleir, L
   Valayannopoulos, V
   Müller-Felber, W
   Venkateswaran, R
   Ogier, H
   Desguerre, I
   Altuzarra, C
   Thompson, E
   Smitka, M
   Huebner, A
   Husson, M
   Horvath, R
   Chinnery, P
   Vaz, FM
   Munnich, A
   Elpeleg, O
   Delahodde, A
   de Keyzer, Y
   de Lonlay, P
AF Michot, Caroline
   Hubert, Laurence
   Brivet, Michele
   De Meirleir, Linda
   Valayannopoulos, Vassili
   Mueller-Felber, Wolfgang
   Venkateswaran, Ramesh
   Ogier, Helene
   Desguerre, Isabelle
   Altuzarra, Cecilia
   Thompson, Elizabeth
   Smitka, Martin
   Huebner, Angela
   Husson, Marie
   Horvath, Rita
   Chinnery, Patrick
   Vaz, Frederic M.
   Munnich, Arnold
   Elpeleg, Orly
   Delahodde, Agnes
   de Keyzer, Yves
   de Lonlay, Pascale
TI <i>LPIN1</i> Gene Mutations: A Major Cause of Severe Rhabdomyolysis in Early Childhood
SO HUMAN MUTATION
LA English
DT Article
DE Rhabdomyolysis; LPIN1; intragenic deletion; founder effect
ID adipose-tissue; barth-syndrome; dual roles; lipin-1; expression; myoglobinuria; biosynthesis; deficiency; dystrophy; disease
AB Autosomal recessive LPIN1 mutations have been recently described as a novel cause of rhabdomyolysis in a few families. The purpose of the study was to evaluate the prevalence of LPIN1 mutations in patients exhibiting severe episodes of rhabdomyolysis in infancy. After exclusion of primary fatty acid oxidation disorders, LPIN1 coding sequence was determined in genomic DNA and cDNA. Among the 29 patients studied, 17 (59%) carried recessive nonsense or frameshift mutations, or a large scale intragenic deletion. In these 17 patients, episodes of rhabdomyolysis occurred at a mean age of 21 months. Secondary defect of mitochondrial fatty oxidation or respiratory chain was found in skeletal muscle of two patients. The intragenic deletion, c. 2295-866_2410-30del, was identified in 8/17 patients (47%), all Caucasians, and occurred on the background of a common haplotype, suggesting a founder effect. This deleted human LPIN1 form was unable to complement Delta pah1 yeast for growth on glycerol, in contrast to normal LPIN1. Since more than 50% of our series harboured LPIN1 mutations, LPIN1 should be regarded as a major cause of severe myoglobinuria in early childhood. The high frequency of the intragenic LPIN1 deletion should provide a valuable criterion for fast diagnosis, prior to muscle biopsy. (C) 2010 Wiley-Liss, Inc.
C1 [Michot, Caroline; Hubert, Laurence; Valayannopoulos, Vassili; Desguerre, Isabelle; Munnich, Arnold; de Keyzer, Yves; de Lonlay, Pascale] Hop Necker Enfants Malad, Reference Ctr Metab Dis, F-75015 Paris, France.
   [Michot, Caroline; Hubert, Laurence; Valayannopoulos, Vassili; Desguerre, Isabelle; Munnich, Arnold; de Keyzer, Yves; de Lonlay, Pascale] Paris Descartes Univ, INSERM, U781, F-75015 Paris, France.
   [Brivet, Michele] Kremlin Bicetre Hosp, Dpt Biochem, Le Kremlin Bicetre, France.
   [De Meirleir, Linda] UZ Brussel, Brussels, Belgium.
   [Mueller-Felber, Wolfgang] Univ Munich, Dpt Pediat, Munich, Germany.
   [Venkateswaran, Ramesh] Newcastle Gen Hosp, Dpt Pediat, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
   [Ogier, Helene] Hop Robert Debre, Ref Ctr Metab Dis, F-75019 Paris, France.
   [Altuzarra, Cecilia] Besancon CHU, Dpt Pediat, Besancon, France.
   [Thompson, Elizabeth] Womens & Childrens Hosp, SA Clin Genet, Adelaide, SA, Australia.
   [Smitka, Martin; Huebner, Angela] Tech Univ Dresden, Childrens Hosp, Dpt Neuropaediat, Dresden, Germany.
   [Husson, Marie] Bordeaux CHU, Dpt Pediat, Bordeaux, France.
   [Horvath, Rita] Univ Munich, Friedrich Baur Inst, Munich, Germany.
   [Horvath, Rita; Chinnery, Patrick] Newcastle Univ, Inst Hlth & Aging, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Dpt Clin Chem, NL-1105 AZ Amsterdam, Netherlands.
   [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Dpt Genet & Metab Dis, Jerusalem, Israel.
   [Delahodde, Agnes] Univ Paris 11, CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; University of Munich; Newcastle General Hospital; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Universite de Franche-Comte; CHU Besancon; Women's & Children's Hospital; Technische Universitat Dresden; CHU Bordeaux; University of Munich; Newcastle University - UK; University of Amsterdam; Academic Medical Center Amsterdam; Hebrew University of Jerusalem; Hadassah University Medical Center; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay
RP de Lonlay, P (corresponding author), Hop Necker Enfants Malad, Reference Ctr Metab Dis, 149 Rue Sevres, F-75015 Paris, France.
EM pascale.delonlay@nck.aphp.fr
FU AFM [13864, 13988]; Fondation de l'Avenir [09071]; Fondation pour la Recherche Medicale; Prinses Beatrix Fonds [WAR05-0126]; Barth syndrome foundation; MRC [G0601943] Funding Source: UKRI
CR Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, PC33, DOI 10.1152/ajpcell.00243.2006
   de Lonlay-Debeney P, 1999, NEUROPEDIATRICS, V30, P42, DOI 10.1055/s-2007-973456
   Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535
   Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200
   DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P253, DOI 10.1016/0960-8966(95)90011-X
   Ellis KJ, 2000, ANN NY ACAD SCI, V904, P374
   Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6
   Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607
   Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200
   Higashida K, 2008, BIOCHEM BIOPH RES CO, V374, P587, DOI 10.1016/j.bbrc.2008.07.079
   Isackson PJ, 2006, MOL GENET METAB, V89, P323, DOI 10.1016/j.ymgme.2006.08.004
   KISHIMOTO C, 1994, CIRCULATION, V89, P2836, DOI 10.1161/01.CIR.89.6.2836
   Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096
   Lu B, 2008, AM J PHYSIOL-ENDOC M, V295, PE1502, DOI 10.1152/ajpendo.90323.2008
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Ohkuma A, 2009, MUSCLE NERVE, V39, P333, DOI 10.1002/mus.21167
   Péterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685
   Phan J, 2005, DRUG NEWS PERSPECT, V18, P5, DOI 10.1358/dnp.2005.18.1.877165
   Reue K, 2000, J LIPID RES, V41, P1067
   Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200
   Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Tein I, 1999, SEMIN PERINATOL, V23, P125, DOI 10.1016/S0146-0005(99)80046-9
   TONIN P, 1990, ANN NEUROL, V27, P181, DOI 10.1002/ana.410270214
   Tsuchiya Y, 2009, BIOCHEM BIOPH RES CO, V382, P348, DOI 10.1016/j.bbrc.2009.03.021
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002
NR 31
TC 97
Z9 108
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD JUL 15
PY 2010
VL 31
IS 7
BP E1564
EP E1573
DI 10.1002/humu.21282
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 626QQ
UT WOS:000279982300004
PM 20583302
DA 2024-11-01
ER

PT J
AU Alston, CL
   Bender, A
   Hargreaves, IP
   Mundy, H
   Deshpande, C
   Klopstock, T
   McFarland, R
   Horvath, R
   Taylor, RW
AF Alston, Charlotte L.
   Bender, Andreas
   Hargreaves, Iain P.
   Mundy, Helen
   Deshpande, Charulata
   Klopstock, Thomas
   McFarland, Robert
   Horvath, Rita
   Taylor, Robert W.
TI The pathogenic m.3243A&gt;T mitochondrial DNA mutation is associated with a variable neurological phenotype
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA; m.3243; CPEO; Pathogenicity; Single fibres
ID human-disease; mtdna; diagnosis; cells
AB The m.3243A>G point mutation in the mitochondrial tRNA(Leu(UUR)) (MTTL1) gene is a common cause of mitochondrial DNA disease and is associated with a variety of clinical presentations. A different mutation occurring at the same site - an m.3243A>T transversion - is less prevalent, but has previously been observed in two patients with encephalopathy and lactic acidosis. We report the investigations of a further two patients with the m.3243A>T mutation who presented with either a chronic progressive external ophthalmoplegia (CPEO) phenotype or sensorineural hearing loss, with single fibre mutation studies confirming segregation of the m.3243A>T mutation with COX deficiency. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Alston, Charlotte L.; McFarland, Robert; Horvath, Rita; Taylor, Robert W.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Bender, Andreas; Klopstock, Thomas] Univ Munich, Dept Neurol, Klinikum Grosshadern, D-81377 Munich, Germany.
   [Hargreaves, Iain P.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Mundy, Helen] Guys & St Thomas NHS Fdn Trust, Ctr Inherited Metab Dis, London, England.
   [Deshpande, Charulata] Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London, England.
   [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, Klinikum Innenstadt, D-80336 Munich, Germany.
C3 Newcastle University - UK; University of Munich; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Munich
RP Taylor, RW (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Wellcome Trust; UK National Commissioning Group for Rare Mitochondrial Disorders of Adults and Children Service; German ministry of education and research (BMBF), Bonn, Germany [01GM0862]; MRC [G0800674] Funding Source: UKRI
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 22
TC 5
Z9 9
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN 15
PY 2010
VL 20
IS 6
BP 403
EP 406
DI 10.1016/j.nmd.2010.04.003
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 614ZS
UT WOS:000279099100006
PM 20471262
DA 2024-11-01
ER

PT J
AU Milone, M
   Massie, R
AF Milone, Margherita
   Massie, Rami
TI Polymerase Gamma 1 Mutations <i>Clinical Correlations</i>
SO NEUROLOGIST
LA English
DT Review
DE ataxia; Alpers; mitochondrial disease; PEO; POLG
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; alpers-huttenlocher-syndrome; sensory ataxic neuropathy; magnetic-resonance spectroscopy; onset spinocerebellar ataxia; dominant optic atrophy; polg1 mutations; neuronal degeneration; phenotypic spectrum
AB Background: Mitochondrial disorders result from primary defects in the mitochondrial DNA (mtDNA) or from defects in nuclear genes which cause disease by affecting the mtDNA. POLG1 is a nuclear gene which encodes for the catalytic subunit of the mtDNA polymerase gamma, essential for mtDNA replication. Less than a decade ago, POLG1 mutations were discovered in patients with progressive external ophthalmoplegia. Since then, it has emerged that POLG1 mutations can result in a spectrum of clinical manifestations, resulting in autosomal recessive or dominant mitochondrial diseases. Review Summary: Here we summarize the common clinical phenotypes associated with POLG1 mutations. Alpers syndrome, progressive external ophthalmoplegia with or without limb myopathy, ataxia-neuropathy syndrome, and epilepsy are frequent clinical manifestations of the POLG1-related disease. Childhood progressive encephalopathy, Parkinsonism, stroke-like events, and isolated exercise intolerance can occur in association with POLG1 mutations. Muscle biopsy can show signs of mitochondrial dysfunction by histologic and biochemical studies or it can be unrevealing. mtDNA analysis of affected tissues can reveal depletion, multiple deletions or point mutations, but it can be occasionally noninformative by routine analysis. Conclusions: POLG1 mutations result in extremely heterogenous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes. The lack of signs of mitochondrial dysfunction in the muscle biopsy does not exclude a POLG1-related disease. Analysis of mtDNA of clinically affected tissues is often informative, but not always. Molecular analysis of POLG1 is essential when POLG1-related disease is suspected. Sodium valproate should be avoided because of the risk of liver failure.
C1 [Milone, Margherita; Massie, Rami] Mayo Clin, Dept Neurol, Rochester, MN 55902 USA.
C3 Mayo Clinic
RP Milone, M (corresponding author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55902 USA.
EM milone.margherita@mayo.edu
CR Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Chan SSL, 2009, MITOCHONDRION, V9, P340, DOI 10.1016/j.mito.2009.05.002
   CHAN SS, 2008, BIOCHIM BIOPHYS ACTA, V1787, P312
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   de Laveaucoupet J, 2005, PRENATAL DIAG, V25, P307, DOI 10.1002/pd.1128
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Flemming K, 2002, AM J NEURORADIOL, V23, P1421
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Johansen KK, 2008, MOVEMENT DISORD, V23, P1624, DOI 10.1002/mds.22178
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114
   Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 77
TC 72
Z9 74
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1074-7931
EI 
J9 NEUROLOGIST
JI Neurologist
PD MAR 15
PY 2010
VL 16
IS 2
BP 84
EP 91
DI 10.1097/NRL.0b013e3181c78a89
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 567ZU
UT WOS:000275490500003
PM 20220442
DA 2024-11-01
ER

PT J
AU Addo, MG
   Cossard, R
   Pichard, D
   Obiri-Danso, K
   Rötig, A
   Delahodde, A
AF Addo, Matthew Glover
   Cossard, Raynald
   Pichard, Damien
   Obiri-Danso, Kwasi
   Roetig, Agnes
   Delahodde, Agnes
TI <i>Caenorhabditis elegans</i>, a pluricellular model organism to screen new genes involved in mitochondrial genome maintenance
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mitochondria; mtDNA maintenance; Nematode/Caenorhabditis elegans
ID progressive external ophthalmoplegia; membrane-protein; dna depletion; atp synthase; mutations; inner; expression; bromide; rnai; dynamics
AB The inheritance of functional mitochondria depends on faithful replication and transmission of mitochondrial DNA (mtDNA). A large and heterogeneous group of human disorders is associated with mitochondrial genome quantitative and qualitative anomalies. Several nuclear genes have been shown to account for these severe OXPHOS disorders. However, in several cases, the disease-causing mutations still remain unknown. Caenorhabditis elegans has been largely used for studying various biological functions because this multicellular organism has short life cycle and is easy to grow in the laboratory. Mitochondrial functions are relatively well conserved between human and C. elegans, and heteroplasmy exists in this organism as in human. C elegans therefore represents a useful tool for studying mtDNA maintenance. Suppression by RNA interference of genes involved in mtDNA replication such as polg-1, encoding the mitochondrial DNA polymerase, results in reduced mtDNA copy number but in a normal phenotype of the F1 worms. By combining RNAi of genes involved in mtDNA maintenance and EtBr exposure, we were able to reveal a strong and specific phenotype (developmental larval arrest) associated to a severe decrease of mtDNA copy number. Moreover, we tested and validated the screen efficiency for human orthologous genes encoding mitochondrial nucleoid proteins. This allowed us to identify several genes that seem to be closely related to mtDNA maintenance in C elegans. This work reports a first step in the further development of a large-scale screening in C. elegans that should allow to identify new genes of mtDNA maintenance whose human orthologs will obviously constitute new candidate genes for patients with quantitative or qualitative mtDNA anomalies. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Addo, Matthew Glover; Cossard, Raynald; Pichard, Damien; Delahodde, Agnes] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.
   [Addo, Matthew Glover; Obiri-Danso, Kwasi] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana.
   [Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
C3 Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Kwame Nkrumah University Science & Technology; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP
RP Delahodde, A (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.
EM agnes.delahodde@igmors.u-psud.fr
FU ANR GENOPAT; French government
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Belzacq AS, 2001, ONCOGENE, V20, P7579, DOI 10.1038/sj.onc.1204953
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Farina F, 2008, DEV DYNAM, V237, P1668, DOI 10.1002/dvdy.21578
   Fernandez AG, 2005, GENOME RES, V15, P250, DOI 10.1101/gr.3194805
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Giraud S, 1998, J MOL BIOL, V281, P409, DOI 10.1006/jmbi.1998.1955
   Gönczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526
   Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300
   HAYASHI J, 1990, BIOCHEM BIOPH RES CO, V167, P216, DOI 10.1016/0006-291X(90)91753-F
   Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327
   Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01
   Hoffmann M, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007644
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   King M P, 1996, METHODS ENZYMOL, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OKIMOTO R, 1992, GENETICS, V130, P471
   Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Praitis V, 2001, GENETICS, V157, P1217
   RICHARDSJP, 1973, J MOL BIOL, V78, P703, DOI 10.1016/0022-2836(73)90290-8
   RICHARDSJP, 1973, J MOL BIOL, V78, P715, DOI 10.1016/0022-2836(73)90291-X
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Shoubridge EA, 1998, CURR OPIN NEUROL, V11, P491, DOI 10.1097/00019052-199810000-00012
   Sönnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sugimoto T, 2008, EXP CELL RES, V314, P103, DOI 10.1016/j.yexcr.2007.08.015
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI 10.1139/O02-135
   Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814
   Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052
   Zeng XM, 2007, GENETICS, V175, P55, DOI 10.1534/genetics.106.065821
NR 61
TC 22
Z9 34
U1 2
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD SEP 15
PY 2010
VL 1802
IS 9
BP 765
EP 773
DI 10.1016/j.bbadis.2010.05.007
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 638VN
UT WOS:000280925700009
PM 20580819
DA 2024-11-01
ER

PT J
AU Komulainen, T
   Hinttala, R
   Kärppä, M
   Pajunen, L
   Finnilä, S
   Tuominen, H
   Rantala, H
   Hassinen, I
   Majamaa, K
   Uusimaa, J
AF Komulainen, Tuomas
   Hinttala, Reetta
   Karppa, Mikko
   Pajunen, Leila
   Finnila, Saara
   Tuominen, Hannu
   Rantala, Heikki
   Hassinen, Ilmo
   Majamaa, Kari
   Uusimaa, Johanna
TI <i>POLG1</i> p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype
SO BMC NEUROLOGY
LA English
DT Article
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; w748s mutation; alpers-syndrome; spacer-region; gamma; ataxia; spectrum; a467t
AB Background: The c.2447G>A (p.R722H) mutation in the gene POLG1 of the catalytic subunit of human mitochondrial polymerase gamma has been previously found in a few occasions but its pathogenicity has remained uncertain. We set out to ascertain its contribution to neuromuscular disease. Methods: Probands from two families with probable mitochondrial disease were examined clinically, muscle and buccal epithelial DNA were analyzed for mtDNA deletions, and the POLG1, POLG2, ANT1 and Twinkle genes were sequenced. Results: An adult proband presented with progressive external ophthalmoplegia, sensorineural hearing impairment, diabetes mellitus, dysphagia, a limb myopathy and dementia. Brain MRI showed central and cortical atrophy, and F-18-deoxyglucose PET revealed reduced glucose uptake. Histochemical analysis of muscle disclosed ragged red fibers and cytochrome c oxidase-negative fibers. Electron microscopy showed subsarcolemmal aggregates of morphologically normal mitochondria. Multiple mtDNA deletions were found in the muscle, and sequencing of the POLG1 gene revealed a homozygous c.2447G>A (p.R722H) mutation. His two siblings were also homozygous with respect to the p.R722H mutation and presented with dementia and sensorineural hearing impairment. In another family the p.R722H mutation was found as compound heterozygosity with the common p.W748S mutation in two siblings with mental retardation, ptosis, epilepsy and psychiatric symptoms. The estimated carrier frequency of the p.R722H mutation was 1:135 in the Finnish population. No mutations in POLG2, ANT1 and Twinkle genes were found. Analysis of the POLG1 sequence by homology modeling supported the notion that the p.R722H mutation is pathogenic. Conclusions: The recessive c.2447G>A (p.R722H) mutation in the linker region of the POLG1 gene is pathogenic for multiple mtDNA deletions in muscle and is associated with a late-onset neurological phenotype as a homozygous state. The onset of the disease can be earlier in compound heterozygotes.
C1 [Hinttala, Reetta; Karppa, Mikko; Finnila, Saara; Majamaa, Kari] Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland.
   [Komulainen, Tuomas; Rantala, Heikki; Uusimaa, Johanna] Univ Oulu, Dept Pediat, FIN-90014 Oulu, Finland.
   [Pajunen, Leila] Univ Oulu, Oulu Univ Hosp, Dept Clin Genet, FIN-90014 Oulu, Finland.
   [Tuominen, Hannu] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland.
   [Hassinen, Ilmo] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland.
   [Komulainen, Tuomas; Hinttala, Reetta; Karppa, Mikko; Finnila, Saara; Majamaa, Kari; Uusimaa, Johanna] Univ Oulu, Oulu Univ Hosp, Clin Res Ctr, FIN-90014 Oulu, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu
RP Majamaa, K (corresponding author), Univ Oulu, Dept Neurol, Box 5000, FIN-90014 Oulu, Finland.
EM kari.majamaa@oulu.fi
FU Research Council for Health at the Academy of Finland; Sigrid Juselius Foundation; Finnish Medical Foundation; Arvo and Lea Ylppo Foundation; Finnish Foundation for Pediatric Research; Alma and K.A. Snellman Foundation
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987
   Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Cole C, 2008, NUCLEIC ACIDS RES, V36, PW197, DOI 10.1093/nar/gkn238
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HOPKINS SE, 2009, J CHILD NEUROL, V0, P0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
NR 37
TC 17
Z9 17
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD MAY 3
PY 2010
VL 10
IS 
BP 
EP 
DI 10.1186/1471-2377-10-29
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA 603SF
UT WOS:000278227700001
PM 20438629
DA 2024-11-01
ER

PT J
AU Nakamura, M
   Yabe, I
   Sudo, A
   Hosoki, K
   Yaguchi, H
   Saitoh, S
   Sasaki, H
AF Nakamura, M.
   Yabe, I.
   Sudo, A.
   Hosoki, K.
   Yaguchi, H.
   Saitoh, S.
   Sasaki, H.
TI MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID hereditary optic neuropathy; ragged-red fibers; stroke-like episodes; dna mutation; lactic-acidosis; mtdna mutation; myoclonic epilepsy; clinical-features; family; myopathy
AB Background Myoclonic epilepsy with ragged-red fibres (MERU) and mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) are established phenotypes of mitochondrial encephalomyopathy. The m.8356T>C transition in the mitochondrial tRNA(LYs) gene is a pathogenic mutations of MERRF. The m.3243A>G transition in the mitochondrial tRNALeu gene is detected in most MELAS patients. Although previous analyses of double mutations in mitochondrial DNA (mtDNA) were useful for discussing their nature, many unsolved questions remain. Objective To describe the clinical and genetic features of a family with the above mtDNA double-point mutations and discuss the role of double mtDNA mutations in diverse clinical features in the family. Patients and methods The proband was a 23-year-old woman with MERRF harbouring m.8356T>C and m.3243A>G transitions in mitochondrial tRNA genes. We assessed clinical aspects of her and those other three relatives and performed mutation analyses on their mtDNA. Results Phenotypes of the four patients were MERRF, MERRF/MELAS overlap syndrome and asymptomatic carrier. We hypothesise that the course of the phenotype of this family begins with MERRF and is followed by MELAS. This double mutation was heteroplasmic in blood of all four patients but with different rates in each patient, while m.8356T>C appeared homoplasmic and m.3243A>G was heteroplasmic in muscle of the two examined cases. No other mutations were detected in the total mtDNA sequence in this family. Conclusions This is the first reported case of a double-point mutation in mtDNA, both of which were heteroplasmic and pathogenic for the established phenotypes.
C1 [Nakamura, M.; Yabe, I.; Yaguchi, H.; Sasaki, H.] Hokkaido Univ, Dept Neurol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Sudo, A.; Hosoki, K.; Saitoh, S.] Hokkaido Univ, Dept Pediat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.
C3 Hokkaido University; Hokkaido University
RP Yabe, I (corresponding author), Hokkaido Univ, Dept Neurol, Grad Sch Med, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.
EM yabe@med.hokudai.ac.jp
FU Ministry of Education, Science, Sports and Culture, Japan; Uehara Foundation
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Dai DC, 2008, BIOCHEM BIOPH RES CO, V377, P1152, DOI 10.1016/j.bbrc.2008.10.132
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   FOLGERO T, 1995, EUR NEUROL, V35, P168, DOI 10.1159/000117115
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE S, V3, P107
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Tonska K, 2008, MITOCHONDRION, V8, P383, DOI 10.1016/j.mito.2008.08.002
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Weber K, 1997, AM J HUM GENET, V60, P373
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128
NR 29
TC 16
Z9 22
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD OCT 15
PY 2010
VL 47
IS 10
BP 659
EP 664
DI 10.1136/jmg.2009.072058
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 671TI
UT WOS:000283533500002
PM 20610441
DA 2024-11-01
ER

PT J
AU Giordano, C
   Pichiorri, F
   Blakely, EL
   Perli, E
   Orlandi, M
   Gallo, P
   Taylor, RW
   Inghilleri, M
   d'Amati, G
AF Giordano, Carla
   Pichiorri, Floriana
   Blakely, Emma L.
   Perli, Elena
   Orlandi, Maurizia
   Gallo, Pietro
   Taylor, Robert W.
   Inghilleri, Maurizio
   d'Amati, Giulia
TI Isolated Distal Myopathy of the Upper Limbs Associated With Mitochondrial DNA Depletion and Polymerase γ Mutations
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID polg mutations; deletions
AB Objective: To describe an unusual clinical phenotype in an adult harboring 2 compound heterozygous polymerase gamma (POLG) mutations. Design: Case report. Setting: University-based outpatient neurology clinic and pathology and genetics laboratory. Patient: A 27-year-old man presenting with isolated distal myopathy of the upper extremities in the absence of sensory disturbances. Results: Histochemical analysis of a muscle biopsy specimen showed numerous cytochrome c oxidase deficient fibers. Molecular analysis revealed marked depletion of muscle mitochondrial DNA in the absence of multiple mitochondrial DNA deletions. Sequence analysis of the POLG gene revealed heterozygous sequence variants in compound c.1156C>T (p.R386C) and c.2794C>T (p.H932Y) segregating with clinical disease in the family. The p.R386C change appears to be a novel mutation. Conclusion: Our case broadens the phenotypic spectrum of disorders associated with POLG mutations and highlights the complex relationship between genotype and phenotype in POLG-related disease.
C1 [Giordano, Carla; Perli, Elena; Orlandi, Maurizia; Gallo, Pietro; d'Amati, Giulia] Sapienza Univ, Dipartimento Med Sperimentale, Rome, Italy.
   [Pichiorri, Floriana; Inghilleri, Maurizio] Sapienza Univ, UOC Neurol B, Rome, Italy.
   [Inghilleri, Maurizio] Sapienza Univ, IRCCS, S Raffaele Inst, Rome, Italy.
   [Blakely, Emma L.; Taylor, Robert W.] Univ Newcastle, Inst Ageing & Hlth, Adults & Children Serv, Natl Commissioning Grp Rare Mitochondrial Disorde, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Newcastle University - UK
RP d'Amati, G (corresponding author), Sapienza Univ, Policlin Umberto 1, Sect Pathol, Dept Expt Pathol, Viale Regina Elena 324, I-00161 Rome, Italy.
EM giulia.damati@uniroma1.it
FU Telethon [GGP06233A]; Associazione Serena Talarico per i giovani nel mondo; UK National Commissioning Group Rare Mitochondrial Disorders of Adults and Children Service
CR Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mussini C, 2005, AIDS, V19, P1627, DOI 10.1097/01.aids.0000186019.47297.0d
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
NR 10
TC 16
Z9 17
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD SEP 15
PY 2010
VL 67
IS 9
BP 1144
EP 1146
DI 
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA 653OW
UT WOS:000282102800017
PM 20837862
DA 2024-11-01
ER

PT J
AU Jarrett, SG
   Lewin, AS
   Boulton, ME
AF Jarrett, Stuart G.
   Lewin, Alfred S.
   Boulton, Michael E.
TI The Importance of Mitochondria in Age-Related and Inherited Eye Disorders
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Mitochondria; Ocular function; Reactive oxygen species
ID retinal-pigment epithelium; dna-polymerase-gamma; hereditary optic neuropathy; base excision-repair; oxidative stress; superoxide-dismutase; hydrogen-peroxide; nuclear-dna; macular degeneration; progressive stages
AB Mitochondria are critical for ocular function as they represent the major source of a cell's supply of energy and play an important role in cell differentiation and survival. Mitochondrial dysfunction can occur as a result of inherited mitochondrial mutations (e.g. Leber's hereditary optic neuropathy and chronic progressive external ophthalmoplegia) or stochastic oxidative damage which leads to cumulative mitochondrial damage and is an important factor in age-related disorders (e.g. age-related macular degeneration, cataract and diabetic retinopathy). Mitochondrial DNA (mtDNA) instability is an important factor in mitochondrial impairment culminating in age-related changes and pathology, and in all regions of the eye mtDNA damage is increased as a consequence of aging and age-related disease. It is now apparent that the mitochondrial genome is a weak link in the defenses of ocular cells since it is susceptible to oxidative damage and it lacks some of the systems that protect the nuclear genome, such as nucleotide excision repair. Accumulation of mitochondrial mutations leads to cellular dysfunction and increased susceptibility to adverse events which contribute to the pathogenesis of numerous sporadic and chronic disorders in the eye. Copyright (C) 2010 S. Karger AG, Basel
C1 [Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Coll Med, Gainesville, FL 32610 USA.
   [Jarrett, Stuart G.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY USA.
   [Lewin, Alfred S.] Univ Florida, Dept Mol Genet, Gainesville, FL 32610 USA.
C3 State University System of Florida; University of Florida; University of Kentucky; State University System of Florida; University of Florida
RP Boulton, ME (corresponding author), Univ Florida, Dept Anat & Cell Biol, Coll Med, POB 100235, Gainesville, FL 32610 USA.
EM meboulton@ufl.edu
FU NIH [EY019688]
CR Abner CW, 2004, DNA REPAIR, V3, P1141, DOI 10.1016/j.dnarep.2004.03.009
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   Besch D, 2000, OPHTHALMOLOGE, V97, P27, DOI 10.1007/PL00007105
   Bohr VA, 2007, NEUROSCIENCE, V145, P1183, DOI 10.1016/j.neuroscience.2007.03.015
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bosch-Morell F, 2002, FREE RADICAL BIO MED, V33, P669, DOI 10.1016/S0891-5849(02)00954-1
   Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018
   Burkhalter MD, 2009, DNA REPAIR, V8, P1258, DOI 10.1016/j.dnarep.2009.07.009
   Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813
   Carelli V, 2001, OPHTHALMOLOGY, V108, P1172, DOI 10.1016/S0161-6420(01)00618-2
   Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0
   Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   CHEN EP, 1992, CURR EYE RES, V11, P825, DOI 10.3109/02713689209033480
   Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ESTABROOK RW, 1962, BIOCHIM BIOPHYS ACTA, V60, P249, DOI 10.1016/0006-3002(62)90400-6
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   GERSCHMAN R, 1954, P SOC EXP BIOL MED, V86, P27
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200
   Godley BF, 2008, INVEST OPHTHALMOL VI, V49, P0
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   GREEN K, 1995, OPHTHALMIC RES, V27, P143, DOI 10.1159/000267860
   Grishko VI, 2005, J BIOL CHEM, V280, P8901, DOI 10.1074/jbc.M413022200
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gusdon AM, 2008, J BIOL CHEM, V283, P10690, DOI 10.1074/jbc.M708801200
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harrison JF, 2005, NUCLEIC ACIDS RES, V33, P4660, DOI 10.1093/nar/gki759
   Hightower KR, 1999, PHOTOCHEM PHOTOBIOL, V69, P595, DOI 10.1111/j.1751-1097.1999.tb03333.x
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   HOWELL N, 1993, AM J HUM GENET, V53, P959
   Huang L, 2006, FREE RADICAL BIO MED, V41, P926, DOI 10.1016/j.freeradbiomed.2006.05.023
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jarrett SG, 2005, FREE RADICAL BIO MED, V38, P1382, DOI 10.1016/j.freeradbiomed.2005.02.003
   Jarrett SG, 2007, OPHTHALMIC RES, V39, P213, DOI 10.1159/000104683
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Johns D R, 1995, SEMIN OPHTHALMOL, V10, P295, DOI 10.3109/08820539509063800
   Jones M, 2004, AM J OPHTHALMOL, V138, P1051, DOI 10.1016/j.ajo.2004.06.026
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432
   Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104
   Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280
   KERRISON JB, 1995, OPHTHALMOLOGY, V102, P1509
   Khurana RN, 2008, INVEST OPHTH VIS SCI, V49, P3299, DOI 10.1167/iovs.07-1607
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f
   Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850
   Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276
   Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581
   Kowluru RA, 2003, INVEST OPHTH VIS SCI, V44, P5327, DOI 10.1167/iovs.03-0353
   Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818
   Kowluru RA, 2007, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2007/43603
   Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012
   Kowluru RA, 2010, BRAIN RES BULL, V81, P297, DOI 10.1016/j.brainresbull.2009.05.006
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Liang FQ, 2005, EXP EYE RES, V80, P113, DOI 10.1016/j.exer.2004.08.017
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Liang LP, 2004, J NEUROCHEM, V90, P1076, DOI 10.1111/j.1471-4159.2004.02567.x
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Liu ZR, 2008, MOL VIS, V14, P1995
   Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Mathews CE, 2005, DIABETOLOGIA, V48, P261, DOI 10.1007/s00125-004-1644-8
   MCCORD JM, 1969, J BIOL CHEM, V244, P6056
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Min D B, 2002, COMPR REV FOOD SCI FOOD SAF, V1, P58, DOI 10.1111/j.1541-4337.2002.tb00007.x
   Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451
   Monsalve M, 2007, FRONT BIOSCI-LANDMRK, V12, P1131, DOI 10.2741/2132
   Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871
   Nishikawa T, 2007, DIABETES RES CLIN PR, V77, PS41, DOI 10.1016/j.diabres.2007.01.031
   Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976
   Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352
   OCONNOR GR, 1983, AM J OPHTHALMOL, V96, P577, DOI 10.1016/S0002-9394(14)73415-4
   Ohia SE, 2005, MUTAT RES-FUND MOL M, V579, P22, DOI 10.1016/j.mrfmmm.2005.03.025
   Osborne NN, 2006, BRIT J OPHTHALMOL, V90, P237, DOI 10.1136/bjo.2005.082230
   Panahi MSS, 2006, ARCH MED RES, V37, P1028, DOI 10.1016/j.arcmed.2006.04.009
   Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5
   Puomila A, 2002, J NEUROL SCI, V205, P41, DOI 10.1016/S0022-510X(02)00276-9
   Rajendram R, 2007, BRIT J OPHTHALMOL, V91, P531, DOI 10.1136/bjo.2006.101576
   Reddan JR, 1999, EXP EYE RES, V68, P117, DOI 10.1006/exer.1998.0606
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SanGiovanni JP, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005508
   Santos DL, 2003, MOL CELL BIOCHEM, V246, P163, DOI 10.1023/A:1023475022025
   Santosa S, 2005, CAN MED ASSOC J, V173, P861, DOI 10.1503/cmaj.1031425
   Saraswathy S, 2009, INVEST OPHTH VIS SCI, V50, P5559, DOI 10.1167/iovs.08-2842
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073
   SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stitt AW, 2005, PHARMACOL REP, V57, P156
   Stuart JA, 2005, NUCLEIC ACIDS RES, V33, P3722, DOI 10.1093/nar/gki683
   Tatton W, 2001, SURV OPHTHALMOL, V45, P0
   Tatton WG, 2001, SURV OPHTHALMOL, V45, PS277, DOI 10.1016/S0039-6257(01)00207-7
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010
   TOMKINSON AE, 1990, NUCLEIC ACIDS RES, V18, P929, DOI 10.1093/nar/18.4.929
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Uchigata Y, 2002, DIABETES CARE, V25, P2106, DOI 10.2337/diacare.25.11.2106
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wang AL, 2008, MOL VIS, V14, P644
   Whiteside CL, 2005, CURR HYPERTENS REP, V7, P148, DOI 10.1007/s11906-005-0090-4
   Williams DL, 2008, VET CLIN N AM-SMALL, V38, P179, DOI 10.1016/j.cvsm.2007.10.006
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yao K, 2009, AM J CHINESE MED, V37, P785, DOI 10.1142/S0192415X09007247
   Yorek MA, 2003, FREE RADICAL RES, V37, P471, DOI 10.1080/1071576031000083161
NR 147
TC 83
Z9 94
U1 0
U2 20
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
EI 1423-0259
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PD JUN 15
PY 2010
VL 44
IS 3
BP 179
EP 190
DI 10.1159/000316480
PG 12
WC Ophthalmology
SC Ophthalmology
GA 652AN
UT WOS:000281972300006
PM 20829642
DA 2024-11-01
ER

PT J
AU Yarham, JW
   Elson, JL
   Blakely, EL
   McFarland, R
   Taylor, RW
AF Yarham, John W.
   Elson, Joanna L.
   Blakely, Emma L.
   McFarland, Robert
   Taylor, Robert W.
TI Mitochondrial tRNA mutations and disease
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Review
AB Mitochondrial (mt-) tRNA (MTT) gene mutations are an important cause of human morbidity and are associated with a wide range of pathology, from isolated organ-specific diseases such as myopathy or hearing loss, through to multisystem disorders with encephalopathy, gastrointestinal dysmotility, and life-threatening cardiomyopathy. Our understanding of how MTT mutations cause disease remains poor and progress has been hampered by the complex interaction of genotype with phenotype that can result in patients who harbor the same mutation exhibiting starkly contrasting phenotypes, whereas other (genetically heterogeneous) patients manifest clinically identical syndromes. A further complexity is the highly polymorphic nature of mitochondrial DNA (mtDNA), which must temper any reflex assumptions of pathogenicity for novel MTT substitutions. Nevertheless significant progress is being made and we shall review the methods employed to identify and characterize MTT mutations as pathogenic. Also important is our understanding of the molecular processes involved and we shall discuss the data available on two of the most studied MTT mutations (m.8344A>G and m.3243A>G) as well as other potential pathogenic mechanisms. Knowledge of factors influencing the inheritance of MTT mutations, and therefore the likelihood of disease transmission, is of particular importance to female patients. At present, the factors determining transmission remain elusive, but we shall examine several possible mechanisms and discuss the evidence for each. Finally, a number of different yeast and mouse models are currently used to investigate mitochondrial disease and we will assess the importance of and difficulties associated with each model as well as the future of possible therapies for patients with mitochondrial disease. (C) 2010 John Wiley & Sons, Ltd. WIREs RNA 2010 1 304-324
C1 [Yarham, John W.; Elson, Joanna L.; Blakely, Emma L.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Medical Research Council (UK); Research Council UK RCUK; HEFCE/DoH; Medical Research Council Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; Wellcome Trust [074454/Z/04/Z]; Newcastle upon Tyne Hospitals NHS Foundation Trust; UK National Commissioning Group; MRC [G0800674, G108/539, G90/63] Funding Source: UKRI
CR Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BARRELL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3164, DOI 10.1073/pnas.77.6.3164
   BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   CANN RL, 1982, SCIENCE, V217, P303, DOI 10.1126/science.217.4557.303
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cao LQ, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000756
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Chen J, 2008, MITOCHONDRION, V8, P285, DOI 10.1016/j.mito.2008.05.002
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 1998, J INHERIT METAB DIS, V21, P321, DOI 10.1023/A:1005357221101
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0
   DAurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   FOX TD, 1991, METHOD ENZYMOL, V194, P149
   Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Hyslop SJ, 1997, BIOCHEM MOL BIOL INT, V42, P567
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jin LJ, 2007, BIOCHEM BIOPH RES CO, V361, P133, DOI 10.1016/j.bbrc.2007.06.171
   Kamenski P, 2010, MITOCHONDRION, V10, P284, DOI 10.1016/j.mito.2010.01.002
   Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200
   KING MP, 1993, J BIOL CHEM, V268, P10228
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   KOGA Y, 1993, NUCLEIC ACIDS RES, V21, P657, DOI 10.1093/nar/21.3.657
   Kogelnik AM, 1997, NUCLEIC ACIDS RES, V25, P196, DOI 10.1093/nar/25.1.196
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kornblum C, 2008, BIOSCIENCE REP, V28, P89, DOI 10.1042/BSR20080004
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MANAM S, 1987, J BIOL CHEM, V262, P10272
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martin Nancy C, 1995, P127, V0, P0
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x
   Meinnel Thierry, 1995, P251, V0, P0
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MUKERJI SK, 1972, J BIOL CHEM, V247, P481
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5
   Ohtsuki T, 2002, NAT STRUCT BIOL, V9, P669, DOI 10.1038/nsb826
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rohou H, 2001, YEAST, V18, P219, DOI 10.1002/1097-0061(200102)18:3<219::AID-YEA651>3.0.CO;2-C
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515
   Sissler M, 2005, AMINOACYL TRNA SYNTH, V0, P0
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200
   Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   YAMANE T, 1977, P NATL ACAD SCI USA, V74, P2246, DOI 10.1073/pnas.74.6.2246
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2002, MITOCHONDRION, V2, P129, DOI 10.1016/S1567-7249(02)00033-8
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
NR 147
TC 140
Z9 151
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD SEP-OCT 15
PY 2010
VL 1
IS 2
BP 304
EP 324
DI 10.1002/wrna.27
PG 21
WC Cell Biology
SC Cell Biology
GA V22HV
UT WOS:000208267200009
PM 21935892
DA 2024-11-01
ER

PT J
AU Kurt, B
   Jaeken, J
   Van Hove, J
   Lagae, L
   Löfgren, A
   Everman, DB
   Jayakar, P
   Naini, A
   Wierenga, KJ
   Van Goethem, G
   Copeland, WC
   DiMauro, S
AF Kurt, Bulent
   Jaeken, Jaak
   Van Hove, Johan
   Lagae, Lieven
   Lofgren, Ann
   Everman, David B.
   Jayakar, Parul
   Naini, Ali
   Wierenga, Klaas J.
   Van Goethem, Gert
   Copeland, William C.
   DiMauro, Salvatore
TI A Novel <i>POLG</i> Gene Mutation in 4 Children With Alpers-like Hepatocerebral Syndromes
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID progressive external ophthalmoplegia; mitochondrial-dna polymerase; gamma; disease; depletion; defects; a467t
AB Objective: To describe a novel POLG missense mutation (c.3218C>T; p.P1073L) that, in association with 2 previously described mutations, caused an Alpers-like hepatocerebral syndrome in 4 children. Design: Genotype-phenotype correlation. Setting: Tertiary care universities. Patients: Four children, 2 related and 2 unrelated, with the novel p.P1073L mutation (all patients) and either the p.A467T (2 patients), p.G848S (1 patient), or p.W748S (1 patient) mutation presented with psychomotor delay, encephalopathy, and liver failure. Interventions: Detailed clinical and laboratory examinations including brain magnetic resonance imaging, muscle biopsy, measurement of mitochondrial DNA, and sequencing of the POLG gene. Main Outcome Measures: Definition of clinical variability. Results: All 4 patients had psychomotor delay, seizures, and liver disease. Three patients had severe gastrointestinal dysmotility, which may be associated with the new p.P1073L mutation. Conclusions: The heterozygous presence of the novel p.P1073L mutation in trans with another recessive POLG mutation causes a hepatocerebral disorder identical or very similar to Alpers syndrome. This adds to the already striking clinical heterogeneity of POLG mutations. In the Belgian patients, the familial occurrence without consanguinity is related to the high frequency of the recessive p.A467T and p.W748S mutations in northwestern Europe and reveals a pitfall for diagnosis and genetic counseling.
C1 [Kurt, Bulent; Naini, Ali; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Jaeken, Jaak] Univ Hosp Gasthuisberg, Ctr Metab Dis, B-3000 Louvain, Belgium.
   [Lagae, Lieven] Univ Hosp Gasthuisberg, Div Pediat Neurol, B-3000 Louvain, Belgium.
   [Van Hove, Johan] Childrens Hosp, Div Clin Genet & Metab, Denver, CO 80218 USA.
   [Lofgren, Ann] Univ Antwerp, VIB, Dept Mol Genet, B-2020 Antwerp, Belgium.
   [Everman, David B.] Greenwood Genet Ctr, Greenwood, SC 29646 USA.
   [Jayakar, Parul; Wierenga, Klaas J.] Miami Childrens Hosp, Div Genet & Metab, Miami, FL USA.
   [Wierenga, Klaas J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Genet Sect, Oklahoma City, OK 73190 USA.
   [Van Goethem, Gert] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium.
   [Van Goethem, Gert] Univ Antwerp Hosp, Neuromuscular Reference Ctr, Antwerp, Belgium.
   [Copeland, William C.] NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
C3 Columbia University; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Children's Hospital Colorado; University of Antwerp; Flanders Institute for Biotechnology (VIB); Greenwood Genetic Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Antwerp; University of Antwerp; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP DiMauro, S (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St,4th Floor,Box 31, New York, NY 10032 USA.
EM sd12@columbia.edu
FU National Institutes of Health [HD 32062]; Marriott Mitochondrial Disorder Clinical Research Fund
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   COPELAND WC, 1993, J BIOL CHEM, V268, P11028
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gillis LA, 2003, GASTROENTEROL CLIN N, V32, P789, DOI 10.1016/S0889-8553(03)00052-9
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 19
TC 23
Z9 24
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
EI 
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD FEB 15
PY 2010
VL 67
IS 2
BP 239
EP 244
DI 
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 553NR
UT WOS:000274374600016
PM 20142534
DA 2024-11-01
ER

PT J
AU Hopkins, SE
   Somoza, A
   Gilbert, DL
AF Hopkins, Sarah E.
   Somoza, Arthur
   Gilbert, Donald L.
TI Rare Autosomal Dominant POLG1 Mutation in a Family With Metabolic Strokes, Posterior Column Spinal Degeneration, and Multi-Endocrine Disease
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial disease; DNA polymerase gamma; basal ganglia; autoimmune polyglandular syndrome type II
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; syndrome type-ii; gene; children; type-1; ataxia
AB DNA POLG is the only mitochondrial DNA polymerase and is encoded by nuclear DNA. Depending on the location and inheritance, mutations in POLG1, the catalytic subunit, can cause symptoms including severe infantile epilepsy, metabolic strokes, chronic ataxia, neuropathy, and ophthalmoplegia. We reviewed medical records and conducted extensive interviews with the family of identical twin probands with a mutation in the linker region of DNA polymerase gamma 1 (POLG1) (G517V) and discuss postmortem findings from their grandmother. Both twins developed type I diabetes, adrenal insufficiency, hypothyroidism, and psychiatric problems in addition to neurological difficulties including bilateral basal ganglia infarcts, headaches, and seizures. The maternal grandmother, now deceased, had psychosis and balance problems, and postmortem findings include lacunar infarcts in the basal ganglia (caudate nucleus, putamen, and globus pallidus) and posterior spinal column degeneration. We discuss novel aspects of their presentation and implications for practice.
C1 [Hopkins, Sarah E.; Gilbert, Donald L.] Univ Cincinnati, Div Neurol, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA.
   [Hopkins, Sarah E.; Gilbert, Donald L.] Univ Cincinnati, Div Pathol, Cincinnati, OH 45229 USA.
   [Somoza, Arthur] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45229 USA.
C3 Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati
RP Gilbert, DL (corresponding author), Univ Cincinnati, Div Neurol, Cincinnati Childrens Hosp, Med Ctr, ML 11007,3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM d.gilbert@cchmc.org
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Berger JR, 2008, NEUROLOGY, V70, P2248, DOI 10.1212/01.wnl.0000313837.45525.b6
   Burusnukul P, 2009, J CHILD NEUROL, V24, P482, DOI 10.1177/0883073808324539
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Falorni A, 2002, ENDOCRIN METAB CLIN, V31, P369, DOI 10.1016/S0889-8529(01)00010-X
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Ho J, 2006, PEDIATR DIABETES, V7, P116, DOI 10.1111/j.1399-543X.2006.00151.x
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kon A, 1997, J INVEST DERMATOL, V108, P224, DOI 10.1111/1523-1747.ep12335324
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7
   Robles DT, 2002, ENDOCRIN METAB CLIN, V31, P353, DOI 10.1016/S0889-8529(01)00015-9
   Rosenbloom AL, 2007, J PEDIATR ENDOCR MET, V20, P5
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Vatta M, 2002, MOL GENET METAB, V75, P317, DOI 10.1016/S1096-7192(02)00006-9
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 22
TC 33
Z9 34
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD JUN 15
PY 2010
VL 25
IS 6
BP 752
EP 756
DI 10.1177/0883073809343313
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 600QC
UT WOS:000278001000016
PM 19815814
DA 2024-11-01
ER

PT J
AU Santa, KM
AF Santa, Kristin M.
TI Treatment Options for Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Syndrome
SO PHARMACOTHERAPY
LA English
DT Review
DE mitochondrial myopathy; encephalopathy; lactic acidosis; stroke-like episodes; MELAS syndrome; mitochondria; coenzyme Q(10); L-arginine
ID point mutation; management; patient; encephalomyopathy; dna; dichloroacetate; nicotinamide; prevalence; deficiency; neuropathy
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a rare neurodegenerative disease caused by the decreased ability of cells to produce sufficient energy in the form of adenosine 5'-tripliosphate. Although it is one of the most common maternally inherited mitochondrial disorders, its exact incidence is unknown. Caused most frequently by an A-to-G point mutation at the 3243 position in the mitochondrial DNA, MELAS syndrome has a broad range of clinical manifestations and a highly variable course. The classic neurologic characteristics include encephalopathy, seizures, and stroke-like episodes. In addition to its neurologic manifestations, MELAS syndrome exhibits multisystem effects including cardiac conduction defects, diabetes mellitus, short stature, myopathy, and gastrointestinal disturbances. Unfortunately, no consensus guidelines outlining standard drug regimens exist for this syndrome. Many of the accepted therapies used in treating MELAS syndrome have been identified through a small number of clinical trials or isolated case reports. Currently, the drugs most often used include antioxidants and various vitamins aimed at minimizing the demands on the mitochondria and supporting and maximizing their function. Some of the most frequently prescribed agents include coenzyme Q(10), L-arginine, B vitamins, and levocarnitine. Although articles describing MELAS syndrome are available, few specifically target education for clinical pharmacists. This article will provide pharmacists with a practical resource to enhance their understanding of MELAS syndrome in order to provide safe and effective pharmaceutical care.
C1 Froedtert Hosp, Dept Pharm, Milwaukee, WI 53226 USA.
RP Santa, KM (corresponding author), Froedtert Hosp, Dept Pharm, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.
EM ksanta@fmlh.edu
CR Bandyopadhyay S K, 2005, J ASSOC PHYSICIANS INDIA, V53, P973
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   BRAUNWALD E, 2001, DIS CAUSED GENETIC D, V0, P404
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery P F, 2003, NEUROMUSCUL DISORD, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   Clay AS, 2001, CHEST, V120, P634, DOI 10.1378/chest.120.2.634
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer J, 1998, CAN J ANAESTH, V45, P781, DOI 10.1007/BF03012149
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Gvozdjakova Anna, 2008, P1, V0, P0, DOI DOI 10.1007/978-1-4020-6714-3_1
   Hilton G, 1995, J NEUROSCI NURS, V27, P278
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HOWARD RS, 1995, QJM-INT J MED, V88, P197
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Karvonen SL, 1999, BRIT J DERMATOL, V140, P634
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kurogouchi F, 1998, AM J NEPHROL, V18, P551, DOI 10.1159/000013406
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Napolitano A, 2000, NEUROL SCI, V21, PS981, DOI 10.1007/s100720070015
   Neargarder SA, 2007, COGN BEHAV NEUROL, V20, P83, DOI 10.1097/WNN.0b013e3180335faf
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   RANTIKOVA LA, 1978, BIOKHIMIYA, V43, P1989
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rossi FH, 2002, NEUROLOGIST, V8, P313, DOI 10.1097/00127893-200209000-00004
   Salpeter S, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD002967.pub2
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Shinmei Y, 2007, J NEURO-OPHTHALMOL, V27, P22, DOI 10.1097/WNO.0b013e3180334cb0
   SPROULE DM, 2008, J INHERIT METAB DIS, V64, P625
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   STACPOOLE PW, 1990, FUND APPL TOXICOL, V14, P327, DOI 10.1016/0272-0590(90)90212-3
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013
   Tan TMM, 2009, CLIN ENDOCRINOL, V70, P340, DOI 10.1111/j.1365-2265.2008.03341.x
   Tanaka J, 1997, BRAIN DEV-JPN, V19, P262, DOI 10.1016/S0387-7604(97)00573-1
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tarnopolsky Mark A, 2007, V46, V0, P183
   Taylor RW, 2000, NEUROL SCI, V21, PS909, DOI 10.1007/s100720070002
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   Thomas JE, 2007, EUR NEUROL, V57, P232, DOI 10.1159/000101287
   VOROBJEV IA, 1983, FEBS LETT, V163, P311, DOI 10.1016/0014-5793(83)80842-4
NR 62
TC 39
Z9 45
U1 2
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0277-0008
EI 1875-9114
J9 PHARMACOTHERAPY
JI Pharmacotherapy
PD NOV 15
PY 2010
VL 30
IS 11
BP 1179
EP 1196
DI 10.1592/phco.30.11.1179
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 676GK
UT WOS:000283898800009
PM 20973690
DA 2024-11-01
ER

PT J
AU Fang, P
   Wu, CS
   Zhou, MH
   Xu, RS
   Liu, XH
   Wei, CX
AF Fang, Pu
   Wu, Chengsi
   Zhou, Meihong
   Xu, Renshi
   Liu, Xianhua
   Wei, Caixia
TI Myopathological features in MELAS syndrome without significant changes in muscle biopsy pathology
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome; muscle biopsy; neuroimaging; pathology
ID stroke-like-episodes; a3243g mutation; mitochondrial; diseases; load; mri
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) are common types of mitochondrial encephalomyopathy. The involved muscular pathology is characterized by typical changes of mitochondrial abnormalities. Gene screening has been the gold diagnostic standard for MELAS diagnosis. This study presents three primary MELAS patients, with an age of onset from 13 to 18 years, including one patient with seizure, and two with headache and vomiting. All patients had a family history of disease, with maternal inheritance. Cerebral magnetic resonance imaging revealed abnormally high signals in T2-weighted images: temporal lobe in three cases, occipital lobe in two cases, and parietal lobe in one case. Migrating stroke-like lesions were confirmed in one patient. Muscle biopsy revealed several strongly succinate dehydrogenase-reactive vessels scattered in muscle sections of three patients, but ragged-red fibers and cytochrome c oxidase-negative/dense (COX-/+) fibers were not observed. Mitochondrial DNA A3243G mutation was identified in all three cases. MELAS syndrome has obvious clinical heterogeneity, and muscle weakness was not prominent in some of the cases. Muscle pathological changes did not accompany ragged-red fibers or COX-/+ fibers, but succinate dehydrogenase-reactive vessels are important for MELAS diagnosis.
C1 [Fang, Pu; Wu, Chengsi; Zhou, Meihong; Xu, Renshi; Liu, Xianhua; Wei, Caixia] Nanchang Univ, Dept Neurol, Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
C3 Nanchang University
RP Fang, P (corresponding author), Nanchang Univ, Dept Neurol, Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
EM fangpu1972@163.com
CR Abu-Amero Khaled K, 2009, J MED CASE REP, V3, P77, DOI 10.1186/1752-1947-3-77
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   Edmond Jane C, 2009, INT OPHTHALMOL CLIN, V49, P27, DOI 10.1097/IIO.0b013e3181a8de58
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer J, 2009, INT J CARDIOL, V137, P60, DOI 10.1016/j.ijcard.2008.04.089
   Geldof K, 2007, JBR-BTR, V90, P288
   Hong DJ, 2010, MUSCLE NERVE, V41, P92, DOI 10.1002/mus.21439
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Stoquart-ElSankari S, 2008, J NEUROL, V255, P1593, DOI 10.1007/s00415-008-0968-6
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Zhang ZQ, 2010, NEUROL RES, V32, P403, DOI 10.1179/016164110X12670144526345
NR 21
TC 0
Z9 0
U1 0
U2 4
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
EI 
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD NOV 15
PY 2010
VL 5
IS 21
BP 1673
EP 1677
DI 10.3969/j.issn.1673-5374.2010.21.013
PG 5
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 701EC
UT WOS:000285796100013
DA 2024-11-01
ER

PT J
AU Connolly, BS
   Feigenbaum, ASJ
   Robinson, BH
   Dipchand, AI
   Simon, DK
   Tarnopolsky, MA
AF Connolly, Barbara S.
   Feigenbaum, Annette S. J.
   Robinson, Brian H.
   Dipchand, Anne I.
   Simon, David K.
   Tarnopolsky, Mark A.
TI MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE MELAS syndrome; Leucine transfer RNA; Mitochondrial myopathy; Ragged red fibres
ID spectrum disorders; lactic-acidosis; point mutation; transfer rnaleu(uur); episodes melas; myopathy; encephalopathy; dysfunction; abnormality; genome
AB The A to G transition mutation at position 3260 of the mitochondrial genome is usually associated with cardiomyopathy and myopathy. One Japanese kindred reported the phenotype of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS syndrome) in association with the A3260G mtDNA mutation. We describe the first Caucasian cases of MELAS syndrome associated with the A3260G mutation. Furthermore, this mutation was associated with exercise-induced rhabdomyolysis, hearing loss, seizures, cardiomyopathy, and autism in the large kindred. We conclude that the A3260G mtDNA mutation is associated with wide phenotypic heterogeneity with MELAS and other "classical" mitochondrial phenotypes being manifestations. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Connolly, Barbara S.; Tarnopolsky, Mark A.] Hamilton Hlth Sci, Dept Med, Hamilton, ON, Canada.
   [Feigenbaum, Annette S. J.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Feigenbaum, Annette S. J.; Robinson, Brian H.; Dipchand, Anne I.] Univ Toronto, Toronto, ON, Canada.
   [Robinson, Brian H.] Hosp Sick Children, Program Genet & Genome Biol, SickKids Res Inst, Toronto, ON M5G 1X8, Canada.
   [Robinson, Brian H.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada.
   [Robinson, Brian H.] Hosp Sick Children, Dept Biochem, Toronto, ON M5G 1X8, Canada.
   [Dipchand, Anne I.] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada.
   [Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
   [Simon, David K.] Harvard Univ, Sch Med, Boston, MA USA.
   [Tarnopolsky, Mark A.] Hamilton Hlth Sci, Dept Pediat Neuromuscular & Neurometab Disorders, Hamilton, ON, Canada.
C3 McMaster University; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Med Ctr, Dept Pediat & Med, Rm 2H26,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Carnpos Y, 2003, NEUROMUSCULAR DISORD, V13, P416, DOI 10.1016/S0960-8966(03)00039-7
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Lombard J, 1998, MED HYPOTHESES, V50, P497, DOI 10.1016/S0306-9877(98)90270-5
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Safdar A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010778
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   SWEENEY MG, 1993, Q J MED, V86, P435
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Tsao CY, 2007, J CHILD NEUROL, V22, P1121, DOI 10.1177/0883073807306266
   Weissman JR, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003815
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 26
TC 24
Z9 26
U1 1
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 12
PY 2010
VL 402
IS 2
BP 443
EP 447
DI 10.1016/j.bbrc.2010.10.060
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 688PA
UT WOS:000284862300050
PM 20965148
DA 2024-11-01
ER

PT J
AU Hervé, D
   Touraine, P
   Verloes, A
   Miskinyte, S
   Krivosic, V
   Logeart, D
   Alili, N
   Laredo, JD
   Gaudric, A
   Houdart, E
   Metzger, JP
   Tournier-Lasserve, E
   Woimant, F
AF Herve, D.
   Touraine, P.
   Verloes, A.
   Miskinyte, S.
   Krivosic, V.
   Logeart, D.
   Alili, N.
   Laredo, J. D.
   Gaudric, A.
   Houdart, E.
   Metzger, J. P.
   Tournier-Lasserve, E.
   Woimant, F.
TI A hereditary moyamoya syndrome with multisystemic manifestations
SO NEUROLOGY
LA English
DT Article
ID familial dilated cardiomyopathy; disease; hypogonadism; secondary; relatives; cataract; linkage; locus
AB Objective: We report a detailed description of a family affected by a hereditary multisystem disorder associated with moyamoya syndrome. Methods: In this family case report, we evaluated 9 members of the same family originating from Algeria. Investigations included neuroimaging, cardiologic and ophthalmologic evaluation, hormonal testing, hemoglobin electrophoresis, chromosomal karyotyping, muscle biopsy for morphology, immunohistochemistry and enzyme assays, mtDNA mutation screening, and haplotype analysis of 2 loci previously linked to moyamoya, on chromosomes 10 (ACTA2) and 17. Results: Five males related through a maternal lineage were affected, suggesting an X-linked inheritance. Four of them had symptomatic moyamoya syndrome with an onset of acute neurologic manifestations between 4 and 32 years. Hypergonadotropic hypogonadism, azoospermia, short stature of postnatal onset (-2 to -4 SD in adulthood), premature graying of hair, and dysmorphism were present in all patients. The other features of the disease included early cataract in 4, dilated cardiomyopathy in 3, and partial growth hormone deficiency in 2 members. Muscle biopsy data did not reveal signs of a mitochondrial disorder. All conditions known to be associated with moyamoya syndrome such as Down syndrome, neurofibromatosis, and sickle cell disease were excluded. We also excluded linkage to the 2 loci previously reported to be involved in autosomal dominant syndromic and nonsyndromic moyamoya. Carrier females had normal phenotype and clinical history. Conclusions: These data strongly suggest that this family is affected by a hereditary moyamoya multisystem disorder with X-linked recessive pattern of inheritance. Neurology (R) 2010;75:259-264
C1 [Herve, D.; Alili, N.; Woimant, F.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neurol, Paris, France.
   [Krivosic, V.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Ophtalmol, Paris, France.
   [Logeart, D.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Cardiol, Paris, France.
   [Houdart, E.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neuroradiol, Paris, France.
   [Tournier-Lasserve, E.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Genet Lab, Paris, France.
   [Touraine, P.] Grp Hosp Pitie Salpetriere, Dept Endocrinol & Med Reprod, AP HP, F-75634 Paris, France.
   [Metzger, J. P.] Grp Hosp Pitie Salpetriere, Serv Cardiol, AP HP, F-75634 Paris, France.
   [Verloes, A.] Hop Robert Debre, AP HP, UF Genet Clin, F-75019 Paris, France.
   [Miskinyte, S.; Tournier-Lasserve, E.] Univ Paris 07, INSERM, UMR S 740, F-75221 Paris 05, France.
   [Laredo, J. D.] Univ Paris Diderot, Serv Radiol Osteoarticulaire, Grp Hosp Lariboisiere Fernand Widal, AP HP, Paris, France.
   [Gaudric, A.] Univ Paris Diderot, Serv Ophtalmol, Grp Hosp Lariboisiere Fernand Widal, AP HP, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP
RP Hervé, D (corresponding author), Hop Lariboisiere, Serv Neurol, Ctr Reference Malad Vasc Rares Cerveau & Oeil CER, 2 Rue Ambroise Pare, F-75010 Paris, France.
EM dominique.herve@lrb.ap-hop-paris.fr
FU Novartis; Alcon; Boston Scientific; MicroVention Inc.; Servier; Leducq [ANR-07-MRAR-002]; Programme Hospitalier de Recherche Clinique [AOM 06 037]; INSERM
CR *CCNE, 1998, 58 CCNE NAT ETH ADV, V0, P0
   Coccia M, 2009, HUM MOL GENET, V18, P2643, DOI 10.1093/hmg/ddp206
   Francis PJ, 2002, J MED GENET, V39, P105, DOI 10.1136/jmg.39.2.105
   Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007
   Gursoy A, 2006, AM J MED GENET A, V140A, P895, DOI 10.1002/ajmg.a.31161
   Hankinson TC, 2008, J NEUROSURG-PEDIATR, V1, P211, DOI 10.3171/PED/2008/1/3/211
   HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054
   Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243
   Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307
   Jea A, 2005, PEDIATRICS, V116, PE694, DOI 10.1542/peds.2005-0568
   Kalina Maria, 2004, HORMONES (ATHENS), V3, P204
   Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714
   Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0
   Lin TJ, 2005, J CLIN NEUROSCI, V12, P472, DOI 10.1016/j.jocn.2004.05.022
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   MACKENZIE CA, 1990, ARCH DIS CHILD, V65, P232, DOI 10.1136/adc.65.2.232
   Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009
   Matsumura Y, 2006, HEART, V92, P405, DOI 10.1136/hrt.2005.065474
   Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9
   Rosser TL, 2005, NEUROLOGY, V64, P553, DOI 10.1212/01.WNL.0000150544.00016.69
   Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6
   Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622
   STEWART PM, 1988, LANCET, V1, P1208
   Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930
NR 24
TC 36
Z9 36
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
EI 
J9 NEUROLOGY
JI Neurology
PD JUL 20
PY 2010
VL 75
IS 3
BP 259
EP 264
DI 10.1212/WNL.0b013e3181e8ee3f
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 628ES
UT WOS:000280097900013
PM 20644152
DA 2024-11-01
ER

PT J
AU Tucker, EJ
   Compton, AG
   Thorburn, DR
AF Tucker, Elena J.
   Compton, Alison G.
   Thorburn, David R.
TI Recent Advances in the Genetics of Mitochondrial Encephalopathies
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Mitochondrial disease; Encephalopathy; High-throughput sequencing; Next-generation sequencing; Oxidative phosphorylation; Electron transport chain
ID cytochrome-c-oxidase; oxidative-phosphorylation disorders; respiratory-chain deficiency; dna mutations; 1555a-greater-than-g mutation; succinate-dehydrogenase; atp synthase; disease; prevalence; diagnosis
AB Mitochondrial encephalopathy, the most common neurometabolic disorder, may be caused by mutations in approximately 100 different genes and may present with various symptoms, such as seizures, ataxia, myopathy, cognitive impairment, blindness, and stroke. Fewer than 50% of patients with mitochondrial encephalopathy receive a molecular diagnosis, primarily because of the large degree of clinical and genetic heterogeneity among patients and the limited knowledge of the genes involved in mitochondrial function. Here we review the most recent discoveries of genes associated with mitochondrial disease with variable neuropathology. All these genes have been identified via homozygosity mapping or linkage analysis; however, advances in sequencing technology indicate that the future of genetic diagnosis and disease gene discovery likely lies in high-throughput sequencing.
C1 [Tucker, Elena J.; Compton, Alison G.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Compton, Alison G.; Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic, Australia.
   [Tucker, Elena J.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne
RP Tucker, EJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, 10th Floor,Flemington Rd, Parkville, Vic 3052, Australia.
EM e.tucker3@pgrad.unimelb.edu.au; alison.compton@mcri.edu.au; david.thorburn@mcri.edu.au
FU National Health and Medical Research Council (NHMRC); Muscular Dystrophy Association
CR Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   GERARDS M, 2009, J MED GENET 0618, V0, P0
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Houstek J, 2009, BBA-BIOENERGETICS, V1787, P529, DOI 10.1016/j.bbabio.2008.11.013
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Nelson DL, 2009, NAT GENET, V41, P510, DOI 10.1038/ng0509-510
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V251, P883, DOI 10.1006/bbrc.1998.9553
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 39
TC 38
Z9 45
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1528-4042
EI 
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD JUL 15
PY 2010
VL 10
IS 4
BP 277
EP 285
DI 10.1007/s11910-010-0112-8
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 602AZ
UT WOS:000278111800004
PM 20446063
DA 2024-11-01
ER

PT J
AU Ylikallio, E
   Tyynismaa, H
   Tsutsui, H
   Ide, T
   Suomalainen, A
AF Ylikallio, Emil
   Tyynismaa, Henna
   Tsutsui, Hiroyuki
   Ide, Tomomi
   Suomalainen, Anu
TI High mitochondrial DNA copy number has detrimental effects in mice
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID transcription factor-a; progressive external ophthalmoplegia; substantia-nigra neurons; multiple mtdna deletions; double-strand breaks; helicase twinkle; replication; mutations; polymerase; nucleoids
AB Mitochondrial DNA (mtDNA) is an essential multicopy genome, compacted into protein-DNA clusters called nucleoids. Maintaining an adequate mtDNA copy number is crucial for cellular viability. Loss of mtDNA results in severe human syndromes, whereas increased mtDNA copy number has been suggested to improve survival from myocardial infarction in mice and to be a promising therapeutic strategy for mitochondrial disease. The mechanisms that regulate mtDNA amount and organization are, however, not fully understood. Of the proteins required for mtDNA existence, only the mitochondrial helicase Twinkle and mitochondrial transcription factor A (TFAM) have been shown to increase mtDNA copy number in vivo, when expressed in physiological levels. Here we studied how Twinkle and TFAM affect mtDNA synthesis and nucleoid structure in mice. Using in vivo BrdU labeling, we show that Twinkle specifically regulates de novo mtDNA synthesis. Remarkably, high mtDNA copy number in mice is accompanied by nucleoid enlargement, which in turn correlates with defective transcription, age-related accumulation of mtDNA deletions and respiratory chain (RC) deficiency. Simultaneous overexpression of Twinkle and TFAM in bitransgenic mice has an additive effect on mtDNA copy number, increasing it up to 6-fold in skeletal muscle. Bitransgenic mice also exhibit further enlargement of nucleoids and aggravation of the RC defect. In conclusion, we show that Twinkle acts as a regulator of mtDNA replication initiation, and provide evidence that high mtDNA copy number and alteration of nucleoid architecture may be detrimental to mitochondrial function.
C1 [Ylikallio, Emil; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Ide, Tomomi] Kyushu Univ, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00014, Finland.
C3 University of Helsinki; Hokkaido University; Kyushu University; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Room c523B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU Academy of Finland; University of Helsinki; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Helsinki Biomedical Graduate School
CR Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004
   Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
NR 40
TC 104
Z9 112
U1 4
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUL 1
PY 2010
VL 19
IS 13
BP 2695
EP 2705
DI 10.1093/hmg/ddq163
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 622OX
UT WOS:000279674200014
PM 20413656
DA 2024-11-01
ER

PT J
AU Pilch, J
   Asman, M
   Jamroz, E
   Kajor, M
   Kotrys-Puchalska, E
   Goss, M
   Krzak, M
   Witecka, J
   Gminski, J
   Sieron, AL
AF Pilch, Jacek
   Asman, Marek
   Jamroz, Ewa
   Kajor, Maciej
   Kotrys-Puchalska, Elibieta
   Goss, Malgorzata
   Krzak, Maria
   Witecka, Joanna
   Gminski, Jan
   Sieron, Aleksander L.
TI Surveyor Nuclease Detection of Mutations and Polymorphisms of mtDNA in Children
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID mitochondrial-dna polymorphisms; respiratory-chain disorders; rapid identification; heteroplasmic mutations; exercise intolerance; lactic-acidosis; genome; childhood; diagnosis; disease
AB Mitochondrial encephalomyopathies are complex disorders with wide range of clinical manifestations. Particularly time-consuming is the identification of mutations in mitochondria! DNA. A group of 20 children with clinical manifestations of mitochondrial encephalomyopathies was selected for molecular studies. The aims were (a) to identify mutations in mtDNA isolated from muscle and (b) to verify detected mutations in DNA isolated from blood, in order to assess the utility of a Surveyor nuclease assay kit for patient screening. The most common changes found were polymorphisms, including a few missense mutations altering the amino acid sequence of mitochondrial proteins. In two boys with MELAS (i.e., mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), a mutation A --> G3243 was detected in the tRNALeu gene of mtDNA isolated from muscle and blood. In one boy, the carrier status of his mother was confirmed, based on molecular analysis of DNA isolated from blood. A method using Surveyor nuclease allows systematic screening for small mutations in mtDNA, using as its source blood of the patients and asymptomatic carriers. The method still requires confirmation studying a larger group. In some patients, the use of this method should precede and might limit indications for traumatic muscle and skin biopsy. (C) 2010 by Elsevier Inc. All rights reserved.
C1 [Pilch, Jacek; Jamroz, Ewa] Med Univ Silesia, Dept Child Neurol, PL-40752 Katowice, Poland.
   [Kajor, Maciej] Med Univ Silesia, Dept Anatomopathol, PL-40752 Katowice, Poland.
   [Kotrys-Puchalska, Elibieta; Goss, Malgorzata; Gminski, Jan] Med Univ Silesia, Dept Biochem, PL-40752 Katowice, Poland.
   [Krzak, Maria; Witecka, Joanna; Sieron, Aleksander L.] Med Univ Silesia, Dept Gen & Mol Biol & Genet, PL-40752 Katowice, Poland.
   [Asman, Marek] Med Univ Silesia, Dept Parasitol, Sosnowiec, Poland.
C3 Medical University Silesia; Medical University Silesia; Medical University Silesia; Medical University Silesia; Medical University Silesia
RP Pilch, J (corresponding author), Med Univ Silesia, Dept Child Neurol, Ul Medykow 16, PL-40752 Katowice, Poland.
EM japilch@poczta.onet.pl
FU Ministry of Science and Higher Education [2PO5E 087 26]; European Union [WKP1/1.4/3/2/2005/103/223/565/2007/U];  [NN-1-014/06]
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bannwarth S, 2008, MITOCHONDRION, V8, P136, DOI 10.1016/j.mito.2007.10.008
   Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177
   Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318
   Cesaroni E, 2009, PEDIATR NEUROL, V41, P131, DOI 10.1016/j.pediatrneurol.2009.02.018
   Chinnery PF, 2006, PRACT. NEUROL, V6, P90, DOI 10.1136/JNNP.2006.090050
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Gropman A L, 2001, CURR NEUROL NEUROSCI REP, V1, P185
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   KARCZMAREWICZ E, 1994, PEDIATR POL, V5, P311
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Moslemi AR, 2007, MITOCHONDRION, V7, P241, DOI 10.1016/j.mito.2007.02.002
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597
   Patterson K, 2004, PEDIATR DEVEL PATHOL, V7, P629, DOI 10.1007/s10024-004-5051-4
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2004, INTERN MED J, V34, P3, DOI 10.1111/j.1444-0903.2004.00537.x
   Tsao CY, 2000, J CHILD NEUROL, V15, P445, DOI 10.1177/088307380001500704
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Yang B, 2000, BIOCHEMISTRY-US, V39, P3533, DOI 10.1021/bi992376z
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 49
TC 5
Z9 6
U1 0
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD NOV 15
PY 2010
VL 43
IS 5
BP 325
EP 330
DI 10.1016/j.pediatrneurol.2010.05.023
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 672FB
UT WOS:000283567300004
PM 20933175
DA 2024-11-01
ER

PT J
AU DiMauro, S
   Garone, C
AF DiMauro, Salvatore
   Garone, Caterina
TI HISTORICAL PERSPECTIVE ON MITOCHONDRIAL MEDICINE
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE mitochondria; mitochondrial DNA; maternal inheritance; intergenomic signaling
ID cytochrome-c-oxidase; dominant optic atrophy; progressive external ophthalmoplegia; ragged-red fibers; complex-i; skeletal-muscle; lactic-acidosis; gene-mutations; intramitochondrial fibers; severe hypermetabolism
AB In this review, we trace the origins and follow the development of mitochondrial medicine from the premolecular era (1962-1988) based on clinical clues, muscle morphology, and biochemistry into the molecular era that started in 1988 and is still advancing at a brisk pace. We have tried to stress conceptual advances, such as endosymbiosis, uniparental inheritance, intergenomic signaling and its defects, and mitochondria! dynamics. We hope that this historical review also provides an update on mitochondrial medicine, although we fully realize that the speed of progress in this area makes any such endeavor akin to writing on water. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:106-113.
C1 [DiMauro, Salvatore] Columbia Univ, Med Ctr, New York, NY USA.
   [Garone, Caterina] Univ Bologna, S Orsola Malpighi Hosp, Unit Child Neuropsychiat, Bologna, Italy.
C3 Columbia University; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna
RP DiMauro, S (corresponding author), 4-424B Coll Phys & Surg,630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
FU National Institute of Health [HD 32062]; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF)
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   BLASS J P, 1970, JOURNAL OF CLINICAL INVESTIGATION, V49, P423, DOI 10.1172/JCI106251
   Blázques A, 2009, NEUROMUSCULAR DISORD, V19, P143, DOI 10.1016/j.nmd.2008.11.016
   Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Carelli V, 2006, MITOCHONDRIAL MEDICINE, V0, P105
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   ENGEL AG, 1973, SCIENCE, V179, P899, DOI 10.1126/science.179.4076.899
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582
   Fernandes MPP, 2006, ANAESTHESIA, V61, P73, DOI 10.1111/j.1365-2044.2005.04490.x
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200
   GONATAS NK, 1965, EXCERPTA MED INT C S, V100, P606
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   HAYDAR NA, 1971, ANN INTERN MED, V74, P548, DOI 10.7326/0003-4819-74-4-548
   HERS HG, 1965, GASTROENTEROLOGY, V48, P625
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hoefs SJG, 2010, MOL GENET METAB, V100, P251, DOI 10.1016/j.ymgme.2010.03.015
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   KARPATI G, 1975, NEUROLOGY, V25, P16, DOI 10.1212/WNL.25.1.16
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   LEDLEY FD, 1990, P NATL ACAD SCI USA, V87, P3147, DOI 10.1073/pnas.87.8.3147
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Rowland LP, 1994, MITOCHONDRIAL DISORDERS IN NEUROLOGY, V0, P116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHATZ G, 1964, BIOCHEM BIOPH RES CO, V15, P127, DOI 10.1016/0006-291X(64)90311-0
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sedlák E, 2006, BIOCHEMISTRY-US, V45, P746, DOI 10.1021/bi050870z
   Servidei Serenella, 2004, NEUROMUSCUL DISORD, V14, P107
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   SHAPIRA Y, 1977, ISRAEL J MED SCI, V13, P161
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   SPIRO AJ, 1970, ARCH NEUROL-CHICAGO, V23, P103, DOI 10.1001/archneur.1970.00480260009002
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   TAKAKUBO F, 1995, AM J HUM GENET, V57, P772
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 139
TC 18
Z9 22
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PD JUN 15
PY 2010
VL 16
IS 2
BP 106
EP 113
DI 10.1002/ddrr.102
PG 8
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100002
PM 20818724
DA 2024-11-01
ER

PT J
AU Lederer, SR
   Klopstock, T
   Schiffl, H
AF Lederer, Stephan R.
   Klopstock, Thomas
   Schiffl, Helmut
TI MELAS: a mitochondrial disorder in an adult patient with a renal transplant
SO WIENER KLINISCHE WOCHENSCHRIFT
LA English
DT Article
DE Mitochondrial disorders; stroke-like episodes; multisystemic disorders; kidney transplantation; kidney failure
ID stroke-like-episodes; lactic-acidosis; encephalopathy; management; myopathy; disease; dna
AB Mitochondrial diseases are a heterogeneous group of syndromes caused by genetic defects in mitochondrial DNA (mtDNA) or nuclear-encoded mitochondrial genes [1]. They present with a wide range of clinical phenotypes. Myopathy may be the sole or main sign, or merely an incidental finding occurring in the late course of a multisystemic illness. Although mitochondrial disorders are increasingly being recognized, confirming a specific diagnosis remains a great challenge due to the clinical heterogeneity of the diseases. Several well-defined clinical syndromes associated with specific mutations have been described. Thus, suspicion of mitochondrial diseases among patients with multiple, seemingly unrelated neuromuscular and multisystem disorders should be confirmed by the finding of deleterious mutations in genes involving mitochondrial biogenesis and function. This case report describes a 58-year-old patient with a 40-year course of a multisystemic illness representing the diagnostic challenges of mitochondrial disease.
C1 [Lederer, Stephan R.; Schiffl, Helmut] Klinikum Univ Munchen, KfH Nierenzentrum Munchen, W & Nephrol Zentrum, Munich, Germany.
   [Klopstock, Thomas] Klinikum Univ Munchen, Friedrich Baur Inst, Neurol Klin & Poliklin, Munich, Germany.
C3 University of Munich; University of Munich
RP Lederer, SR (corresponding author), KfH Nierenzentrum, Elsenheimerstr 63, D-80687 Munich, Germany.
EM Stephan.lederer@kfh-dialyse.de
CR Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
NR 7
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0043-5325
EI 
J9 WIEN KLIN WOCHENSCHR
JI Wien. Klin. Wochen.
PD JUN 15
PY 2010
VL 122
IS 11-12
BP 363
EP 365
DI 10.1007/s00508-010-1388-z
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA 621HY
UT WOS:000279568000009
PM 20552288
DA 2024-11-01
ER

PT J
AU Perry, JJP
   Shin, DS
   Tainer, JA
AF Perry, J. Jefferson P.
   Shin, David S.
   Tainer, John A.
TI Amyotrophic Lateral Sclerosis
SO DISEASES OF DNA REPAIR
LA English
DT Article; Book Chapter
ID motor-neuron disease; cu,zn superoxide-dismutase; frontotemporal lobar degeneration; transgenic mouse model; gulf-war veterans; cerebrospinal-fluid; mitochondrial-dna; fus/tls-chop; recombinant human; cycad hypothesis
AB Amyotrophic lateral sclerosis (ALS) is a common neurological disorder that results in loss of motor neurons, leading to a rapidly progressive form of muscle paralysis that is fatal. There is no available cure and current therapies only provide minimal benefit at best. The disease is predominantly sporadic and until very recently only the Cu,Zn superoxide dismutase (Cu,ZnSOD), which is involved in a small number of sporadic cases and a larger component of familial ones, have been analyzed in any detail. Here we describe the clinical aspects of ALS and highlight the genetics and molecular mechanisms behind the disease. We discuss the current understanding and controversies of how mutations in Cu,ZnSOD may cause the disease. We also focus on the recent discovery that mutations in either TDP-43 or FUS/TLS, which are both involved in DNA/RNA synthesis, are likely the cause behind many cases of ALS that are not linked to Cu,ZnSOD.
C1 [Perry, J. Jefferson P.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
C3 Scripps Research Institute
RP Perry, JJP (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM jjperry@scripps.edu
FU NCI NIH HHS [P01 CA092584] Funding Source: Medline; NIGMS NIH HHS [R01 GM039345] Funding Source: Medline
CR Abhinav K, 2007, NEUROEPIDEMIOLOGY, V29, P44, DOI 10.1159/000108917
   Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093
   Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105
   Beghi E, 2007, NEUROLOGY, V68, P141, DOI 10.1212/01.wnl.0000250339.14392.bb
   BENHAMIDA M, 1990, BRAIN, V113, P347
   Bongioanni P, 2004, COCHRANE DATABASE SYST REV, V0, PPCD004302, DOI 10.1002/14651858.CD004302.pub2
   Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851
   Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727
   Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512
   Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769
   Charcot, 1869, ARCH PHYSL NORM PATH, V2, P354
   Chiò A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463
   DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1
   Distad BJ, 2008, PHYS MED REH CLIN N, V19, P633, DOI 10.1016/j.pmr.2008.04.005
   DISTAD BJ, 2008, PHYS MED REH CLIN N, V19, P0
   Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1
   Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008
   Fang F, 2006, NEUROEPIDEMIOLOGY, V27, P217, DOI 10.1159/000096956
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Ferri KF, 2001, BIOESSAYS, V23, P111, DOI 10.1002/1521-1878(200102)23:2<111::AID-BIES1016>3.0.CO;2-Y
   Forbes RB, 2004, AGE AGEING, V33, P131, DOI 10.1093/ageing/afh013
   Gaudette M, 2000, AMYOTROPH LATERAL SC, V1, P83, DOI 10.1080/14660820050515377
   GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408
   GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0
   GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0
   Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344
   Guégan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610
   HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3
   HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707
   HAYASHI H, 1989, J NEUROL SCI, V93, P19, DOI 10.1016/0022-510X(89)90158-5
   HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425
   HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001
   Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648
   IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995
   Ince PG, 2005, NEUROPATH APPL NEURO, V31, P345, DOI 10.1111/j.1365-2990.2005.00686.x
   Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y
   JOHNSTON RB, 1978, J EXP MED, V148, P115
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Kong JM, 1998, J NEUROSCI, V18, P3241
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185
   Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758
   Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006
   Law Warren J, 2006, BRIEFINGS IN FUNCTIONAL GENOMICS & PROTEOMICS, V5, P8, DOI 10.1093/bfgp/ell015
   LEIGH PN, 1989, BRAIN, V112, P521, DOI 10.1093/brain/112.2.521
   Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335
   LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778
   Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828
   Mantovani V, 2007, CLIN CHEM, V53, P531, DOI 10.1373/clinchem.2006.074807
   Meininger V, 2004, AMYOTROPH LATERAL SC, V5, P107, DOI 10.1080/14660820410019602
   Miller RG, 2007, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001447.pub2
   Mills KI, 2000, BRIT J HAEMATOL, V108, P316
   Miranda ML, 2008, NEUROTOXICOLOGY, V29, P964, DOI 10.1016/j.neuro.2008.05.005
   MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315
   NORRIS F, 1993, J NEUROL SCI, V118, P48, DOI 10.1016/0022-510X(93)90245-T
   Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197
   PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109
   Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897
   Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763
   Pérez-Losada J, 2000, ONCOGENE, V19, P6015, DOI 10.1038/sj.onc.1204018
   Pérez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572
   Piao YS, 2003, BRAIN PATHOL, V13, P10
   RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0
   ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106
   Rutherford NJ, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000193
   SASAKI S, 1992, ACTA NEUROPATHOL, V84, P211, DOI 10.1007/BF00311398
   SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026
   Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031
   Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419
   Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Steele JC, 2008, NEUROLOGY, V70, P1984, DOI 10.1212/01.wnl.0000312571.81091.26
   Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007
   TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7
   Talbot K, 2006, HUM MOL GENET, V15, PR182, DOI 10.1093/hmg/ddl202
   Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311
   Tohgi H, 1999, ANN NEUROL, V46, P129, DOI 10.1002/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y
   Tohgi H, 1999, NEUROSCI LETT, V260, P204, DOI 10.1016/S0304-3940(98)00986-0
   Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504
   Turner MR, 2003, J NEUROL NEUROSUR PS, V74, P995, DOI 10.1136/jnnp.74.7.995
   Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   VELTEMA AN, 1990, J NEUROL SCI, V97, P93, DOI 10.1016/0022-510X(90)90101-R
   Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x
   Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x
   Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992
   Wanker EE, 2000, MOL MED TODAY, V6, P387, DOI 10.1016/S1357-4310(00)01761-5
   Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179
   WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   Worms PA, 2001, J NEUROL SCI, V191, P3, DOI 10.1016/S0022-510X(01)00630-X
   Yang XZ, 1995, JPN J CLIN ONCOL, V25, P234
   Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018
NR 107
TC 24
Z9 24
U1 0
U2 12
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PD JUN 15
PY 2010
VL 685
IS 
BP 9
EP 20
DI 
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BOZ50
UT WOS:000278107500002
PM 20687491
DA 2024-11-01
ER

PT J
AU Holt, IJ
AF Holt, Ian J.
TI Zen and the art of mitochondrial DNA maintenance
SO TRENDS IN GENETICS
LA English
DT Review
ID substantia-nigra neurons; tumor-suppressor p53; transcription factor; thymidine kinase; mtdna depletion; point mutation; deletions; mutant; myopathy; cells
AB Because mitochondrial genes encode proteins essential for aerobic ATP production, mitochondrial DNA defects can cause an energy crisis. These defects fall into two broad categories: primary mutations in mitochondrial DNA and mutations in nuclear genes, whose protein products are involved in mitochondrial DNA maintenance. Evidence is accumulating that both types of defects can cause mitochondrial DNA loss. Hence, regulatory factors, which determine whether mitochondrial DNA molecules are maintained or lost, potentially play a more important role in these disorders than hitherto recognised. Candidates include reactive oxygen species (ROS) and the tumour suppressor p53. The cell might not always be the best judge of when to dispense with the services of mitochondrial DNA, and so interventions that favour its retention could potentially limit the adverse effects of pathological mitochondrial DNAs.
C1 MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
RP Holt, IJ (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.
EM holt@mrc-mbu.cam.ac.uk
FU MRC [MC_U105663140] Funding Source: UKRI; Medical Research Council [MC_U105663140] Funding Source: Medline
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Durham SE, 2006, NEUROLOGY, V67, P502, DOI 10.1212/01.wnl.0000227961.55640.2f
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Iacovino M, 2009, HUM MOL GENET, V18, P65, DOI 10.1093/hmg/ddn313
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Poulton Joanna, 2009, NEUROMUSCUL DISORD, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Turner CJ, 2005, GENETICS, V170, P1879, DOI 10.1534/genetics.105.043653
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vergani L, 2007, BRAIN, V130, P2715, DOI 10.1093/brain/awm151
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750
   Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Yoshida Y, 2003, CANCER RES, V63, P3729
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 64
TC 24
Z9 28
U1 0
U2 11
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
EI 
J9 TRENDS GENET
JI Trends Genet.
PD MAR 15
PY 2010
VL 26
IS 3
BP 103
EP 109
DI 10.1016/j.tig.2009.12.011
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA 565ES
UT WOS:000275272600004
PM 20117854
DA 2024-11-01
ER

PT J
AU Weiss, MD
   Saneto, RP
AF Weiss, Michael D.
   Saneto, Russell P.
TI SENSORY ATAXIC NEUROPATHY WITH DYSARTHRIA AND OPHTHALMOPARESIS (SANDO) IN LATE LIFE DUE TO COMPOUND HETEROZYGOUS <i>POLG</i> MUTATIONS
SO MUSCLE & NERVE
LA English
DT Article
DE dysarthria; polymerase gamma; mitochondrial myopathy; progressive external ophthalmoplegia; sensory ataxic neuropathy
ID progressive external ophthalmoplegia; polymerase-gamma; mitochondrial-dna; deletions; gene; disorders; spectrum; twinkle; disease; ant1
AB Missense mutations in the gene for polymerase gamma 1 (POLG1) cause a number of phenotypically heterogeneous mitochondrial diseases, most commonly progressive external ophthalmoplegia, and are characterized by the accumulation of multiple, large-scale deletions of mitochondrial DNA. The triad of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO) has been demonstrated in a small subset of patients with POLG1 mutations. We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/p.P587L/p.G848S). To our knowledge, none of these mutations have been demonstrated previously in SANDO. This patient's late presentation illustrates that a mitochondrial disorder should be considered regardless of age if the clinical symptoms warrant. Muscle Nerve 41: 882-885,2010
C1 [Weiss, Michael D.] Univ Washington, Med Ctr, Dept Neurol, Seattle, WA 98195 USA.
   [Saneto, Russell P.] Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA USA.
C3 University of Washington; University of Washington Seattle; Seattle Children's Hospital
RP Weiss, MD (corresponding author), Univ Washington, Med Ctr, Dept Neurol, Box 356115,1959 NE Pacific St, Seattle, WA 98195 USA.
EM mdweiss@u.washington.edu
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Farrugia ME, 2005, CLIN NEUROPHYSIOL, V116, P2550, DOI 10.1016/j.clinph.2005.07.018
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rivner MH, 2001, MUSCLE NERVE, V24, P1134, DOI 10.1002/mus.1124
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 21
TC 20
Z9 23
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 
J9 MUSCLE NERVE
JI Muscle Nerve
PD JUN 15
PY 2010
VL 41
IS 6
BP 882
EP 885
DI 10.1002/mus.21636
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 604NI
UT WOS:000278285300022
PM 20513108
DA 2024-11-01
ER

PT J
AU Yokoyama, T
   Hasegawa, K
   Obama, R
   Ishihara, T
   Yagishita, S
AF Yokoyama, Teruo
   Hasegawa, Kazuko
   Obama, Runko
   Ishihara, Tadayuki
   Yagishita, Saburou
TI MELAS with diffuse degeneration of the cerebral white matter: Report of an autopsy case
SO NEUROPATHOLOGY
LA English
DT Article
DE A3243G transition; cerebral white matter; MELAS; metabolic abnormality; mitochondrial angiopathy
ID stroke-like episodes; lactic-acidosis; mitochondrial encephalomyopathy; point mutation; myopathy; encephalopathy; brain; dna; features
AB Up to now diffuse white matter demyelination of the cerebrum has been reported in only a few cases of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). Here we document an autopsy case with this rare neuropathology. Most MELAS cases are diagnosed antemortem by A3243G transition of mitochondrial DNA. While cerebral damage including necrotic foci in the cerebral cortex are common findings in MELAS, prominent white matter involvement best characterizes this MELAS case. There were numerous necrotic foci, varying in size and chronological stage, in the cerebral white matter. In the areas of the white matter without necrotic foci, there was diffuse fibrillary gliosis with the loss of axons and oligodendrocytes. The gliosis was dominant in the deep white matter, sparing the U-fiber. The cerebral cortex showed diffuse cortical atrophy with few scattered necrotic foci. Distribution of the cerebral lesions does not coincide with the territory of blood supply. The vascular wall presented only slight to mild hyalinosis. We assumed a common pathogenesis to the cortical lesions and the white matter change. The pathogenesis of the present diffuse cerebral lesions may not be just secondary to circulatory disturbance but partly due to metabolic abnormality.
C1 [Hasegawa, Kazuko] Natl Sagamihara Hosp, Dept Neurol, Sagamihara, Kanagawa 2288522, Japan.
   [Yokoyama, Teruo; Obama, Runko; Ishihara, Tadayuki] Hakone Natl Hosp, Dept Neurol, Kanagawa, Japan.
   [Yagishita, Saburou] Kanagawa Rehabil Ctr, Div Pathol, Kanagawa, Japan.
RP Yokoyama, T (corresponding author), Natl Sagamihara Hosp, Dept Neurol, Sacradai 18-1, Sagamihara, Kanagawa 2288522, Japan.
EM teruoyokoyamamd@yahoo.co.jp
CR BOGOUSSLAVSKY J, 1982, J NEUROL SCI, V55, P351, DOI 10.1016/0022-510X(82)90132-0
   FUJII T, 1990, PEDIATR NEUROL, V6, P253, DOI 10.1016/0887-8994(90)90116-I
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kawasaki Y, 1990, NO TO SHINKEI, V42, P533
   KISHI M, 1988, J NEUROL SCI, V86, P31, DOI 10.1016/0022-510X(88)90005-6
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   MUKOYAMA M, 1986, J NEUROL, V233, P228, DOI 10.1007/BF00314025
   NICOLL JAR, 1993, CLIN NEUROPATHOL, V12, P38
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P978
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Terauchi A, 1996, BRAIN DEV-JPN, V18, P224, DOI 10.1016/0387-7604(96)00015-0
   Tsuchiya K, 1999, ACTA NEUROPATHOL, V97, P520, DOI 10.1007/s004010051023
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
NR 18
TC 14
Z9 14
U1 0
U2 3
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0919-6544
EI 
J9 NEUROPATHOLOGY
JI Neuropathology
PD FEB 15
PY 2010
VL 30
IS 1
BP 56
EP 60
DI 10.1111/j.1440-1789.2009.01026.x
PG 5
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 545XX
UT WOS:000273771400008
PM 19496942
DA 2024-11-01
ER

PT J
AU Alston, CL
   Morak, M
   Reid, C
   Hargreaves, IP
   Pope, SAS
   Land, JM
   Heales, SJ
   Horvath, R
   Mundy, H
   Taylor, RW
AF Alston, Charlotte L.
   Morak, Monika
   Reid, Christopher
   Hargreaves, Iain P.
   Pope, Simon A. S.
   Land, John M.
   Heales, Simon J.
   Horvath, Rita
   Mundy, Helen
   Taylor, Robert W.
TI A novel mitochondrial <i>MTND5</i> frameshift mutation causing isolated complex I deficiency, renal failure and myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA; Complex I; Frameshift mutation; Myopathy; Heteroplasmy
ID leigh-syndrome; g13513a mutation; dna mutations; nd3 gene; disease; melas; encephalopathy; sequence
AB Isolated complex I deficiency is the most commonly reported enzyme defect in paediatric mitochondrial disorders, and may arise due to mutations in nuclear-encoded structural or assembly genes, or the mitochondrial genome. We present the clinical, biochemical and molecular genetic data in a young girl whose clinical picture is dominated by chronic renal failure, myopathy and persistent lactic acidosis. An isolated complex I deficiency in muscle was identified due to a novel mutation (m.12425delA) in the MTND5 gene. This single nucleotide deletion is heteroplasmic and detectable in several tissues from the proband but not her mother, suggesting a de novo Mutation event. The description of the first frameshift mutation in a mitochondrial complex I gene affirms mitochondrial DNA mutations as an important cause of isolated complex I deficiency in children and the importance of whole mitochondrial genome sequencing in the diagnostic work-up to elucidate the underlying molecular genetic abnormality and provide important genetic advice. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Horvath, Rita; Taylor, Robert W.] Newcastle Univ, NCG Rare Mitochondrial Disorders Adults, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Horvath, Rita; Taylor, Robert W.] Newcastle Univ, Childrens Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Morak, Monika] Univ Munich, Univ Hosp, Munich, Germany.
   [Morak, Monika] Ctr Med Genet, MGZ, Munich, Germany.
   [Reid, Christopher] Evelina Childrens Hosp, Dept Paediat Nephrol, Guys & St Thomas NHS Fdn Trust, London, England.
   [Hargreaves, Iain P.; Pope, Simon A. S.; Land, John M.; Heales, Simon J.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Heales, Simon J.] Great Ormond St Hosp Sick Children, London, England.
   [Mundy, Helen] Guys St Thomas NHS Fdn Trust, Ctr Inherited Metab Dis, London, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Munich; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Deutsche Forschungsgemeinschaft [HO2505/2-1]; Academy of Medical Sciences [BH090164]; RVI/NGH; Newcastle upon Tyne Hospitals NHS Charity [RES0211/7262]; Wellcome Trust; UK National Commissioning Group
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
NR 23
TC 28
Z9 33
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB 15
PY 2010
VL 20
IS 2
BP 131
EP 135
DI 10.1016/j.nmd.2009.10.010
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 563RP
UT WOS:000275151400009
PM 20018511
DA 2024-11-01
ER

PT J
AU Jokinen, R
   Marttinen, P
   Sandell, HK
   Manninen, T
   Teerenhovi, H
   Wai, T
   Teoli, D
   Loredo-Osti, JC
   Shoubridge, EA
   Battersby, BJ
AF Jokinen, Riikka
   Marttinen, Paula
   Sandell, Helen Katarin
   Manninen, Tuula
   Teerenhovi, Heli
   Wai, Timothy
   Teoli, Daniella
   Loredo-Osti, J. C.
   Shoubridge, Eric A.
   Battersby, Brendan J.
TI <i>Gimap3</i> Regulates Tissue-Specific Mitochondrial DNA Segregation
SO PLOS GENETICS
LA English
DT Article
ID skeletal-muscle; mtdna mutation; heteroplasmic mice; rapid segregation; peptide export; selection; replication; survival; disease; genm
AB Mitochondrial DNA (mtDNA) sequence variants segregate in mutation and tissue-specific manners, but the mechanisms remain unknown. The segregation pattern of pathogenic mtDNA mutations is a major determinant of the onset and severity of disease. Using a heteroplasmic mouse model, we demonstrate that Gimap3, an outer mitochondrial membrane GTPase, is a critical regulator of this process in leukocytes. Gimap3 is important for T cell development and survival, suggesting that leukocyte survival may be a key factor in the genetic regulation of mtDNA sequence variants and in modulating human mitochondrial diseases.
C1 [Jokinen, Riikka; Marttinen, Paula; Sandell, Helen Katarin; Manninen, Tuula; Teerenhovi, Heli; Battersby, Brendan J.] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
   [Jokinen, Riikka; Marttinen, Paula; Sandell, Helen Katarin; Manninen, Tuula; Teerenhovi, Heli; Battersby, Brendan J.] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Helsinki, Finland.
   [Wai, Timothy; Teoli, Daniella; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
   [Wai, Timothy; Teoli, Daniella; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada.
   [Loredo-Osti, J. C.] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.
C3 University of Helsinki; University of Helsinki; McGill University; McGill University; Memorial University Newfoundland
RP Jokinen, R (corresponding author), Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
EM brendan.battersby@helsinki.fi
FU Canadian Institutes of Health Research; NSERC; Academy of Finland; University of Helsinki; Biocentrum Helsinki; UMDF-USA; Helsinki Biomedical Graduate School
CR Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dahéron L, 2001, NUCLEIC ACIDS RES, V29, P1308, DOI 10.1093/nar/29.6.1308
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   KAWAKAMI Y, 1994, ANN NEUROL, V35, P370, DOI 10.1002/ana.410350322
   Krücken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F
   MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103
   Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002
   Perego M, 1997, P NATL ACAD SCI USA, V94, P8612, DOI 10.1073/pnas.94.16.8612
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555
   SHAWAR SM, 1991, J EXP MED, V174, P941, DOI 10.1084/jem.174.4.941
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
   Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957
NR 35
TC 50
Z9 53
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
EI 
J9 PLOS GENET
JI PLoS Genet.
PD OCT 15
PY 2010
VL 6
IS 10
BP 
EP 
DI 10.1371/journal.pgen.1001161
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 673GP
UT WOS:000283647800032
PM 20976251
DA 2024-11-01
ER

PT J
AU Sanaker, PS
   Toompuu, M
   Hogan, VE
   He, LP
   Tzoulis, C
   Chrzanowska-Lightowlers, ZMA
   Taylor, RW
   Bindoff, LA
AF Sanaker, Petter S.
   Toompuu, Marina
   Hogan, Vanessa E.
   He, Langping
   Tzoulis, Charalampos
   Chrzanowska-Lightowlers, Zofia M. A.
   Taylor, Robert W.
   Bindoff, Laurence A.
TI Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Metabolic myopathy; Exercise intolerance; ISCU; Mitochondrial respiratory chain; Splice affecting mutation; RNA processing
ID sulfur cluster biogenesis; exercise intolerance; mitochondrial-dna; mutation; deficiency; complexes; gene; cells
AB Hereditary myopathy with lactic acidosis, or myopathy with exercise intolerance. Swedish type (OMIM #255125) is caused by mutations in the iron-sulfur cluster scaffold (ISCU) gene. The g.7044G>C ISCU mutation induces a splicing error in the pre-mRNA that strengthens a weak intronic splice site leading to inclusion of a new exon and subsequent loss of mRNA and protein. While ISCU is widely expressed, homozygosity for this particular intronic mutation gives rise to a pure myopathy. In order to investigate tissue specificity and disease mechanism, we studied muscle, myoblasts, fibroblasts and blood cells from the first non-Swedish case of this disease. Consistent with the recognised role of ISCU, we found abnormal activities of respiratory chain complexes containing iron-sulfur clusters in patient muscle. We confirmed that, in the presence of the g.7044G>C mutation, splicing produces both abnormally and normally spliced mRNA in all tissues. The ratio of these products varies dramatically between tissues, being most abnormal in mature skeletal muscle that also has the lowest relative starting levels of ISCU mRNA compared with other tissues. Myoblasts and fibroblasts have more of the normally spliced variant as well as higher starting levels of ISCU mRNA. Up-regulation of mtDNA copy number was found in skeletal muscle and myoblasts, but not fibroblasts, and is thought to represent a compensatory response. Tissue specificity in this disorder appears therefore to be dependent on the mRNA starting level, the amount of remaining normally spliced RNA, and the degree to which compensatory mechanisms can respond. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Sanaker, Petter S.; Toompuu, Marina; Tzoulis, Charalampos; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway.
   [Sanaker, Petter S.; Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Hogan, Vanessa E.; He, Langping; Chrzanowska-Lightowlers, Zofia M. A.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 University of Bergen; University of Bergen; Haukeland University Hospital; Newcastle University - UK
RP Bindoff, LA (corresponding author), Univ Bergen, Haukeland Univ Hosp, Dept Clin Med, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
FU Norwegian Research Council; Heise Vest RHF; Wellcome Trust [074454/Z/04/Z]
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bradley JL, 2004, NEUROCHEM RES, V29, P561, DOI 10.1023/B:NERE.0000014826.00881.c3
   Bruno C, 2008, CURR OPIN NEUROL, V21, P601, DOI 10.1097/WCO.0b013e32830dd5a6
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   Hicks D, 2009, BRAIN, V132, P147, DOI 10.1093/brain/awn289
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361
   Linderholm H, 1992, LAKARTIDNINGEN, V89, P1283
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Stehling O, 2009, METHOD ENZYMOL, V456, P209, DOI 10.1016/S0076-6879(08)04412-1
   Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352
NR 23
TC 29
Z9 35
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 15
PY 2010
VL 1802
IS 6
BP 539
EP 544
DI 10.1016/j.bbadis.2010.02.010
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 605AZ
UT WOS:000278321000005
PM 20206689
DA 2024-11-01
ER

PT J
AU Wanrooij, S
   Falkenberg, M
AF Wanrooij, Sjoerd
   Falkenberg, Maria
TI The human mitochondrial replication fork in health and disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE mtDNA; DNA replication; Mitochondria; POLRMT; Twinkle; Mitochondrial disease
ID dna-polymerase-gamma; progressive external ophthalmoplegia; onset spinocerebellar ataxia; transcription factor-a; double-strand breaks; mouse l-cells; structure-function defects; multiple mtdna deletions; twinkle linker region; ribosomal-rna genes
AB Mitochondria are organelles whose main function is to generate power by oxidative phosphorylation. Some of the essential genes required for this energy production are encoded by the mitochondrial genome, a small circular double stranded DNA molecule. Human mtDNA is replicated by a specialized machinery distinct from the nuclear replisome. Defects in the mitochondrial replication machinery can lead to loss of genetic information by deletion and/or depletion of the mtDNA, which subsequently may cause disturbed oxidative phosphorylation and neuromuscular symptoms in patients. We discuss here the different components of the mitochondrial replication machinery and their role in disease. We also review the mode of mammalian mtDNA replication. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wanrooij, Sjoerd; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Falkenberg, Maria] Max Planck Inst Biol Alters, D-50931 Cologne, Germany.
C3 University of Gothenburg; Max Planck Society
RP Wanrooij, S (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM sjoerd.wanrooij@medkem.gu.se
FU Swedish Research Council
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   AHOLAERKKILA S, 2010, HUM MOL GENET, V0, P0
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARNBERG A, 1971, BIOCHIM BIOPHYS ACTA, V246, P353, DOI 10.1016/0005-2787(71)90147-X
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003
   BARAT M, 1985, EXP CELL RES, V157, P207, DOI 10.1016/0014-4827(85)90163-6
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181
   Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bohlega S, 2009, NEUROMUSCULAR DISORD, V19, P845, DOI 10.1016/j.nmd.2009.10.002
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X
   Brewer LR, 2003, BIOPHYS J, V85, P2519, DOI 10.1016/S0006-3495(03)74674-8
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710
   Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHANG DD, 1985, EMBO J, V4, P1559, DOI 10.1002/j.1460-2075.1985.tb03817.x
   CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451
   Clayton DA, 2000, EXP CELL RES, V255, P4, DOI 10.1006/excr.1999.4763
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144
   CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   ERIKSSON S, 1984, J BIOL CHEM, V259, P1695
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Friddle RW, 2004, BIOPHYS J, V86, P1632, DOI 10.1016/S0006-3495(04)74231-9
   FUCHS E, 1971, FEBS LETT, V19, P159, DOI 10.1016/0014-5793(71)80503-3
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   GENUARIO R, 1993, CELL MOL BIOL RES, V39, P625
   GILLUM AM, 1978, P NATL ACAD SCI USA, V75, P677, DOI 10.1073/pnas.75.2.677
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391
   GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KELLY JL, 1986, J BIOL CHEM, V261, P348
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   LANDES T, 2010, SEMIN CELL DEV BIOL, V0, P0
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Li K, 1997, J BIOL CHEM, V272, P8686, DOI 10.1074/jbc.272.13.8686
   Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   MASUKATA H, 1990, CELL, V62, P331, DOI 10.1016/0092-8674(90)90370-T
   Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430
   MIGNOTTE B, 1988, EUR J BIOCHEM, V174, P479, DOI 10.1111/j.1432-1033.1988.tb14123.x
   Mikhailov VS, 1996, J BIOL CHEM, V271, P30774, DOI 10.1074/jbc.271.48.30774
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001
   Seligmann H, 2008, J MOL BIOL, V379, P188, DOI 10.1016/j.jmb.2008.03.066
   Seligmann H, 2006, J THEOR BIOL, V241, P321, DOI 10.1016/j.jtbi.2005.11.035
   Seligmann H, 2010, BIOSYSTEMS, V99, P85, DOI 10.1016/j.biosystems.2009.09.003
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   STONINGTOG, 1971, P NATL ACAD SCI USA, V68, P6, DOI 10.1073/pnas.68.1.6
   STUMPF JD, 2010, HUM MOL GENET, V0, P0
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   TERSCHEGGET J, 1971, BIOCHIM BIOPHYS ACTA, V254, P1
   THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   TIRANTI V, 1991, NUCLEIC ACIDS RES, V19, P4291, DOI 10.1093/nar/19.15.4291
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   TSURUMI T, 1990, J VIROL, V64, P450, DOI 10.1128/JVI.64.1.450-452.1990
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200
   Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200
   White DJ, 2009, MOL BIOL EVOL, V26, P1435, DOI 10.1093/molbev/msp073
   WONG TW, 1986, CELL, V45, P817, DOI 10.1016/0092-8674(86)90556-8
   WONG TW, 1985, J BIOL CHEM, V260, P1530
   WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 193
TC 87
Z9 102
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD AUG 15
PY 2010
VL 1797
IS 8
BP 1378
EP 1388
DI 10.1016/j.bbabio.2010.04.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 625IM
UT WOS:000279888700004
PM 20417176
DA 2024-11-01
ER

PT J
AU Eerola, J
   Luoma, PT
   Peuralinna, T
   Scholz, S
   Paisan-Ruiz, C
   Suomalainen, A
   Singleton, AB
   Tienari, PJ
AF Eerola, Johanna
   Luoma, Petri T.
   Peuralinna, Terhi
   Scholz, Sonja
   Paisan-Ruiz, Coro
   Suomalainen, Anu
   Singleton, Andrew B.
   Tienari, Pentti J.
TI POLG1 polyglutamine tract variants associated with Parkinson's disease
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Polymerase gamma; Trinucleotide repeat; Polyglutamine; Parkinson's disease; Genetic susceptibility; POLG1
ID dna-polymerase-gamma; substantia-nigra neurons; mitochondrial complex-i; cag repeat; glucocerebrosidase mutations; male-infertility; alpha-synuclein; lrrk2 g2019s; gene polg; pathogenesis
AB A possible role of allelic variation of the mitochondrial DNA polymerase gamma (POLG I) gene in Parkinson's disease (PD) has been suggested. First, POLG I missense mutations have been found in patients with familial parkinsonism and mitochondrial myopathy. Second, increased frequency of rare alleles of the POLG1 CAG-repeat (poly-Q) has been found in Finnish idiopathic apparently sporadic PD patients, but conflicting reports exist. The POLG1 poly-Q exhibits one major allele with 10 repeats (10Q, frequency >= 80%) and several less common alleles such as 11Q (frequency 6-9%), 6Q-9Q and 12Q-14Q (frequencies <4%). It is not known, whether the poly-Q variation modulates POLG1 function. Here we sequenced the poly-Q in 641 North American Caucasian PD patients and 292 controls. Caucasian literature controls were also used. Normal allele was defined either as 10/11Q or as 10Q according to the previous literature. The frequency of the non-10/11Q alleles in cases was not significantly different from the controls. Variant alleles defined as non-10Q were significantly increased in the PD patients compared to the North American controls (17.6% vs. 12.3%, p=0.004) as well as compared to the larger set of 897 controls (17.6% vs. 13.2%, p=0.0007). These results suggest that POLG1 poly-Q alleles other than the conserved 10Q allele may increase susceptibility to PD. This finding may be attributable to a beneficial function of the 10Q repeat protein or linkage disequilibrium between the 10Q allele and another variation within or close to POLG1. Other large case-control studies and analyses on functional differences of POLG1 poly-Q variants are warranted. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Eerola, Johanna; Luoma, Petri T.; Suomalainen, Anu; Tienari, Pentti J.] Univ Helsinki, Biomedicum, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Eerola, Johanna; Luoma, Petri T.; Peuralinna, Terhi; Suomalainen, Anu; Tienari, Pentti J.] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
   [Scholz, Sonja; Singleton, Andrew B.] NIH, Neurogenet Lab, Bethesda, MD 20892 USA.
   [Paisan-Ruiz, Coro] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Paisan-Ruiz, Coro] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
C3 University of Helsinki; University of Helsinki; Helsinki University Central Hospital; National Institutes of Health (NIH) - USA; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Tienari, PJ (corresponding author), Univ Helsinki, Biomedicum, Res Program Mol Neurol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM pentti.tienari@hus.fi
FU Helsinki University Central Hospital; Finnish Cultural Foundation; Oskar Oflund Foundation; Finnish Parkinson Foundation; Sigrid Juselius Foundation; Academy of Finland; National Institute on Aging; National Institutes of Health; Department of Health and Human Services [1 Z01 AG000957-05]
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847
   Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   HAVULINNA AS, 2000, MOVEMENT DISORD, V23, P1024
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Jensen MB, 2008, ANN ONCOL, V19, P1910, DOI 10.1093/annonc/mdn407
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LANGSTON JW, 1984, BRAIN RES, V292, P390
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004
   Malyarchuk BA, 2005, HUM BIOL, V77, P355, DOI 10.1353/hub.2005.0050
   Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438
   Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044
   Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509
   Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Sveinbjörnsdóttir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tobin JE, 2008, NEUROLOGY, V71, P28, DOI 10.1212/01.wnl.0000304051.01650.23
   Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004
NR 36
TC 39
Z9 42
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUN 14
PY 2010
VL 477
IS 1
BP 1
EP 5
DI 10.1016/j.neulet.2010.04.021
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 614HG
UT WOS:000279045600001
PM 20399836
DA 2024-11-01
ER

PT J
AU Longley, MJ
   Humble, MM
   Sharief, FS
   Copeland, WC
AF Longley, Matthew J.
   Humble, Margaret M.
   Sharief, Farida S.
   Copeland, William C.
TI Disease Variants of the Human Mitochondrial DNA Helicase Encoded by <i>C10orf2</i> Differentially Alter Protein Stability, Nucleotide Hydrolysis, and Helicase Activity
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID progressive external ophthalmoplegia; single-stranded-dna; onset spinocerebellar ataxia; recessive twinkle mutations; structure-function defects; primase-helicase; gene mutation; mtdna maintenance; bacteriophage t7; linker region
AB Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia. To understand the biochemical consequences of C10orf2 mutations, we overproduced wild type and 20 mutant forms of human mtDNA helicase in Escherichia coli and developed novel schemes to purify the recombinant enzymes to near homogeneity. A combination of molecular crowding, non-ionic detergents, Mg2+ ions, and elevated ionic strength was required to combat insolubility and intrinsic instability of certain mutant variants. Asystematic biochemical assessment of the enzymes included analysis of DNA binding affinity, DNA helicase activity, the kinetics of nucleotide hydrolysis, and estimates of thermal stability. In contrast to other studies, we found that all 20 mutant variants retain helicase function under optimized in vitro conditions despite partial reductions in DNA binding affinity, nucleotide hydrolysis, or thermal stability for some mutants. Such partial defects are consistent with the delayed presentation of mitochondrial diseases associated with mutation of C10orf2.
C1 [Longley, Matthew J.; Humble, Margaret M.; Sharief, Farida S.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU National Institutes of Health through the NIEHS [ES 065078]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744
   Heyduk T, 1996, METHOD ENZYMOL, V274, P492
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105
   Leipe DD, 2000, GENOME RES, V10, P5
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   MATSON SW, 1985, J BIOL CHEM, V260, P2281
   MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   VAN GOETHEM G, 2003, HUM MUTAT, V22, P175
   VAN HOVE JLK, 2009, AM J MED GENET A A, V149, P861
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 62
TC 41
Z9 49
U1 1
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 24
PY 2010
VL 285
IS 39
BP 29690
EP 29702
DI 10.1074/jbc.M110.151795
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 652EK
UT WOS:000281984300004
PM 20659899
DA 2024-11-01
ER

PT J
AU Szczepanowska, K
   Foury, F
AF Szczepanowska, Karolina
   Foury, Francoise
TI A cluster of pathogenic mutations in the 3'-5' exonuclease domain of DNA polymerase gamma defines a novel module coupling DNA synthesis and degradation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; virion rna-polymerase; beta-hairpin loop; mitochondrial-dna; saccharomyces-cerevisiae; crystal-structure; yeast mitochondria; polg1 mutations; depletion; disease
AB Mutations in DNA polymerase gamma (pol g), the unique replicase inside mitochondria, cause a broad and complex spectrum of diseases in human. We have used Mip1, the yeast pol g, as a model enzyme to characterize six pathogenic pol g mutations. Four mutations clustered in a highly conserved 3'-5' exonuclease module are localized in the DNA-binding channel in close vicinity to the polymerase domain. They result in an increased frequency of point mutations and high instability of the mitochondrial DNA (mtDNA) in yeast cells, and unexpectedly for mutator mutations in the exonuclease domain, they favour exonucleolysis versus polymerization. This trait is associated with highly decreased DNA-binding affinity and poorly processive DNA synthesis. Our data show for the first time that a 3'-5' exonuclease module of pol g plays a crucial role in the coordination of the polymerase and exonuclease functions and they strongly suggest that in patients the disease is not caused by defective proofreading but results from poor mtDNA replication generated by a severe imbalance between DNA synthesis and degradation.
C1 [Szczepanowska, Karolina; Foury, Francoise] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain, Belgium.
C3 Universite Catholique Louvain
RP Foury, F (corresponding author), Catholic Univ Louvain, Inst Life Sci, Croix du Sud 4-15, B-1348 Louvain, Belgium.
EM francoise.foury@uclouvain.be
FU Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium); Belgian National Fund for Scientific Research; Association Francaise contre les Myopathies; Interuniversity Attraction Poles Program-Belgian Science Policy
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Foury F, 2004, CELL MOL LIFE SCI, V61, P2799, DOI 10.1007/s00018-004-4220-y
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010
   Goodman MF, 1998, GENETICS, V148, P1475
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaiser C, 1994, METHODS YEAST GENETI, V0, P0
   Kim SW, 2008, INT J BIOL MACROMOL, V42, P356, DOI 10.1016/j.ijbiomac.2008.01.010
   KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497
   Kuroita T, 2005, J MOL BIOL, V351, P291, DOI 10.1016/j.jmb.2005.06.015
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   PEREZAMAIZ P, 2006, NUCLEIC ACIDS RES, V34, P107
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Subuddhi U, 2008, BIOCHEMISTRY-US, V47, P6130, DOI 10.1021/bi800211f
   Tatsuta T, 2009, J BIOCHEM, V146, P455, DOI 10.1093/jb/mvp122
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Truniger V, 1996, EMBO J, V15, P3430, DOI 10.1002/j.1460-2075.1996.tb00709.x
   Trzemecka A, 2009, J MOL BIOL, V389, P797, DOI 10.1016/j.jmb.2009.04.055
   Tuske S, 2000, J BIOL CHEM, V275, P23759, DOI 10.1074/jbc.M001804200
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 54
TC 37
Z9 40
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD SEP 15
PY 2010
VL 19
IS 18
BP 3516
EP 3529
DI 10.1093/hmg/ddq267
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 644AU
UT WOS:000281343600003
PM 20601675
DA 2024-11-01
ER

PT J
AU Sanaker, PS
   Nakkestad, HL
   Downham, E
   Bindoff, LA
AF Sanaker, P. S.
   Nakkestad, H. L.
   Downham, E.
   Bindoff, L. A.
TI A novel mutation in the mitochondrial tRNA for tryptophan causing a late-onset mitochondrial encephalomyopathy
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE mitochondrial diseases; mitochondrial genome; metabolic brain diseases
ID c-oxidase deficiency; trna(trp) gene; point mutation; leigh-syndrome; dna mutation; disease; encephalopathy; insertion; database
AB Background - Mitochondrial DNA (mtDNA) mutations are increasingly being recognized as causes of late-onset disease. We report a patient with a late-onset mitochondrial encephalomyopathy caused by a novel G > C transition in mtDNA at position 5556 in the gene encoding the tRNA for tryptophan (MTTW). Aims - To investigate the cause of disease and assess the pathogenicity of this new mutation. Methods - Clinical, histopathological and gene sequencing studies. Quantification of the mutation was performed in different tissues from the patient and two relatives and in single muscle fibres. Results - The mutation was heteroplasmic, segregated in biochemically affected muscle fibres and was absent in blood. The level of mutation in skeletal muscle was higher than in brain, although the brain was clinically the most affected tissue. Discussion - The 5556G > C mutation appears sporadic. It was not found in any of the family members tested, although some of them manifested disorders that can be associated with mtDNA disease. In addition to reporting the eighth mutation in MTTW, our case illustrates the challenges posed when assigning pathogenicity to mtDNA mutations.
C1 [Sanaker, P. S.; Bindoff, L. A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Sanaker, P. S.; Nakkestad, H. L.; Downham, E.; Bindoff, L. A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
FU Norwegian Research Council (PSS); Helse Vest RHF and University of Bergen
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Martínez-Fernández E, 2001, STROKE, V32, P2507, DOI 10.1161/hs1101.098328
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
NR 20
TC 7
Z9 7
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD FEB 15
PY 2010
VL 121
IS 2
BP 109
EP 113
DI 10.1111/j.1600-0404.2009.01243.x
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA 541EC
UT WOS:000273395700006
PM 19744136
DA 2024-11-01
ER

PT J
AU Cohen, BH
   Naviaux, RK
AF Cohen, Bruce H.
   Naviaux, Robert K.
TI The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders
SO METHODS
LA English
DT Review
DE Mitochondrial disease diagnosis; Mitochondrial DNA depletion syndrome; Alpers-Huttenlocher syndrome; Ataxia-neuropathy spectrum disorders; Progressive external ophthalmoplegia; Childhood myocerebrohepatopathy spectrum; Myoclonic epilepsy myopathy sensory ataxia; POLG
ID progressive neuronal degeneration; diffuse cerebral degeneration; poliodystrophy alpers-disease; respiratory-chain deficiency; citric-acid cycle; polymerase-gamma; infantile poliodystrophy; external ophthalmoplegia; ataxic neuropathy; mutations
AB Disorders of oxidative phosphorylation and mitochondrial function can be caused from mutations involving both mitochondrial DNA (mtDNA) or mitochondrial-targeted nuclear DNA genes. Progressive depletion of mtDNA is one mechanism of mitochondrial dysfunction leading to human disease, which is the end result of loss of the sufficient mtDNA-encoded proteins for normal electron transport chain function. Mitochondrial DNA depletion is caused by germline deletions and duplications of segments within the mtDNA as well as germline mutations in the nuclear genes responsible for mtDNA duplication (the polymerase apparatus including POLG, POLG2 and PEO1) and mtDNA maintenance (those genes that regulate the deoxynucleotide triphosphate pools and other functions including TP1, TK2, DGUOK, SUCLA1, SUCLA2, ANT1, RRM2B and MPV17). This review will focus on the most common disorders that result from mutations with POLG, with some discussion of the other nuclear-encoded genes involved in mtDNA maintenance. Mutations in POLG can cause a wide range of disease, which vary in both age of onset and severity. These disorders comprise a continuous spectrum of overlapping symptoms and signs; and range from a rapidly fatal infantile cerebrohepatic disease to a progressive external ophthalmoplegia (PEO) that may not present until the sixth decade of life. Many of the disorders seem to have a more unique and restrictive clinical presentation, at least to date. Since the first disorders linked to mtDNA depletion were described in 2001, the nomenclature, methods of diagnosis, clinical evaluation and treatment of these disorders have been better defined. However, this remains a rapidly evolving field, with additional proteins and genes are being discovered as DNA testing becomes part of the standard of care in everyday medical practice. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Cohen, Bruce H.] Cleveland Clin, Neurol Inst, Brain Tumor & Neurooncol Ctr, Pediat Neurol Ctr, Cleveland, OH USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
C3 Cleveland Clinic Foundation; University of California System; University of California San Diego
RP Cohen, BH (corresponding author), Cleveland Clin, Neurol Inst, Brain Tumor & Neurooncol Ctr, Pediat Neurol Ctr, Desk S-63,9500 Euclid Ave, Cleveland, OH USA.
EM brucehcohen@gmail.com
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   Bohan TP, 2001, NEUROLOGY, V56, P1405, DOI 10.1212/WNL.56.10.1405
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Chan SSL, 2009, METHODS MOL BIOL, V554, P59, DOI 10.1007/978-1-59745-521-3_4
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Cohen BH, 2010, GENEREVIEWS GENETEST, V0, P0
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   GABREELS FJM, 1984, ACTA NEUROL SCAND, V70, P145
   Gallagher RC, 2009, ANN NEUROL, V65, P550, DOI 10.1002/ana.21568
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   JAKOB A, 1930, DTSCH Z NERVENHEILK, V116, P240
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mochel F, 2005, J CLIN ENDOCR METAB, V90, P3780, DOI 10.1210/jc.2005-0009
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   PRICK MJJ, 1982, NEUROPEDIATRICS, V13, P108, DOI 10.1055/s-2008-1059608
   PRICK MJJ, 1981, ARCH NEUROL-CHICAGO, V38, P767, DOI 10.1001/archneur.1981.00510120067011
   RICCI E, 1992, BRAIN PATHOL, V2, P141, DOI 10.1111/j.1750-3639.1992.tb00682.x
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SANDBANK U, 1972, J NEUROL NEUROSUR PS, V35, P749, DOI 10.1136/jnnp.35.6.749
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   Smith JK, 1996, CLIN IMAG, V20, P235, DOI 10.1016/0899-7071(95)00039-9
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
NR 68
TC 74
Z9 81
U1 0
U2 24
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG 15
PY 2010
VL 51
IS 4
BP 364
EP 373
DI 10.1016/j.ymeth.2010.05.008
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 640KK
UT WOS:000281049900002
PM 20558295
DA 2024-11-01
ER

PT J
AU Blackwood, JK
   Whittaker, RG
   Blakely, EL
   Alston, CL
   Turnbull, DM
   Taylor, RW
AF Blackwood, John K.
   Whittaker, Roger G.
   Blakely, Emma L.
   Alston, Charlotte L.
   Turnbull, Douglass M.
   Taylor, Robert W.
TI The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial DNA (mtDNA); Heteroplasmy; MELAS; Urothelial cells; mtDNA rearrangements; Non-invasive diagnosis
ID ragged-red fibers; real-time pcr; gene mutation; mtdna mutation; tissue distribution; myoclonus epilepsy; individual cells; point mutation; pure myopathy; human-disease
AB Patients with mitochondrial DNA disease are amongst the most challenging to diagnose and manage given the striking phenotypic and genetic heterogeneity, which characterise these conditions. Recently, we and others have demonstrated the m.3243A>G mutation, one of the most common mitochondrial DNA pathogenic mutations, is present at clinically relevant levels in urinary epithelium, thus providing a practical, non-invasive test for diagnosis and mutation screening. In this study we further evaluate the use of these cells in detecting the m.3243A>G mutation, other mtDNA tRNA gene point mutations including the m.8344A>G mutation and single large-scale mtDNA deletions. We observe a robust relationship between m.3243A>G levels in urothelial cells and clinically affected tissues that does not change with time. Conversely, single large-scale mtDNA deletions can be detected in urothelial cells, with higher levels present in younger patients with more severe disease, but generally mtDNA deletion levels are not representative of those seen in a clinically affected tissue. Our results have implications for the diagnosis, management and counselling of families with mtDNA disease. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Blackwood, John K.; Whittaker, Roger G.; Blakely, Emma L.; Alston, Charlotte L.; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU SPARKS; Wellcome Trust; UK National Commissioning Group for Rare Mitochondrial Disorders of Adults and Children Service
CR Al-Dosary M, 2009, NEUROMUSCULAR DISORD, V19, P841, DOI 10.1016/j.nmd.2009.10.001
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   GOT YI, 1990, NATURE, V348, P651
   Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   TANNO Y, 1993, NEUROLOGY, V43, P1198, DOI 10.1212/WNL.43.6.1198
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   tHart LM, 1996, HUM MUTAT, V7, P193
   Weber K, 1997, AM J HUM GENET, V60, P373
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
NR 35
TC 21
Z9 21
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 19
PY 2010
VL 393
IS 4
BP 740
EP 745
DI 10.1016/j.bbrc.2010.02.072
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 575GB
UT WOS:000276053800033
PM 20171163
DA 2024-11-01
ER

PT J
AU Leshinsky-Silver, E
   Lev, D
   Malinger, G
   Shapira, D
   Cohen, S
   Lerman-Sagie, T
   Saada, A
AF Leshinsky-Silver, Esther
   Lev, Dorit
   Malinger, Gustavo
   Shapira, Daniel
   Cohen, Sarit
   Lerman-Sagie, Tally
   Saada, Ann
TI Leigh disease presenting in utero due to a novel missense mutation in the mitochondrial DNA-ND3
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondria; Respiratory chain; Leigh syndrome; mtDNA; ND3
ID respiratory-chain deficiency; dna g13513a mutation; complex-i; nd3 gene; trna(trp) gene; encephalopathy; childhood; insertion; children
AB Leigh syndrome can be caused by defects in both nuclear and mitochondrial genes involved in energy metabolism. Recently, an increasing number of mutations in mitochondrial DNA encoding regions, especially in NADH dehydrogenase (respiratory chain complex I) subunits, have been reported as causative of early onset Leigh syndrome. We describe a patient whose fetal brain ultrasound demonstrated periventricular pseudocyst suggestive of a possible mitochondrial disorder who presented postnatally with Leigh syndrome. A muscle biopsy demonstrated a partial decrease in complex I and pyruvate dehydrogenase (PDH-E1 alpha) activity. Sequencing of the PDH-E1 alpha gene did not reveal any mutation. Sequencing of the mtDNA revealed a novel heteroplasmic G10254A (D66N) mutation in the ND3 gene. This change results in a substitution of aspartic acid to asparagine in a highly conserved domain of the ND3 subunit. The mutation could not be detected in the mother's blood or urine sediment. Blue native gel electrophoresis of muscle mitochondria revealed a normal size, albeit a decreased level of complex I. The G10254A substitution in the mtDNA-ND3 gene is another cause of maternally inherited Leigh syndrome. This case demonstrates that periventricular pseudocysts may be the initial in utero presentation in patients with mitochondrial disorders. We emphasize the importance of screening the mtDNA in pediatric patients as the first step in molecular diagnosis of Leigh syndrome. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Leshinsky-Silver, Esther; Cohen, Sarit] Wolfson Med Ctr, Mol Genet Lab, Holon, Israel.
   [Leshinsky-Silver, Esther; Cohen, Sarit] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Leshinsky-Silver, Esther; Lev, Dorit; Lerman-Sagie, Tally] Wolfson Med Ctr, Mitochondrial Dis Ctr, Holon, Israel.
   [Lev, Dorit] Wolfson Med Ctr, Inst Med Genet, Holon, Israel.
   [Lev, Dorit; Malinger, Gustavo; Lerman-Sagie, Tally] Wolfson Med Ctr, Dept Obstet & Gynecol, Prenatal Diag Unit, Fetal Neurol Clin, Holon, Israel.
   [Shapira, Daniel; Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, Holon, Israel.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, Jerusalem, Israel.
C3 Tel Aviv University; Hebrew University of Jerusalem; Hadassah University Medical Center
RP Leshinsky-Silver, E (corresponding author), Wolfson Med Ctr, Mol Genet Lab, Holon, Israel.
EM leshinsky@wolfson.health.gov.il
CR Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   BACH MR, 2009, FETAL DIAGN THER, V25, P177
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P447, DOI 10.1046/j.1469-0705.2002.00840.x
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Papa S, 2008, BBA-BIOENERGETICS, V1777, P719, DOI 10.1016/j.bbabio.2008.04.005
   Prasad AN, 2009, CLIN PERINATOL, V36, P621, DOI 10.1016/j.clp.2009.06.004
   Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5
   Remacle C, 2008, MOL GENET GENOMICS, V280, P93, DOI 10.1007/s00438-008-0350-5
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
NR 40
TC 20
Z9 22
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD MAY 15
PY 2010
VL 100
IS 1
BP 65
EP 70
DI 10.1016/j.ymgme.2010.02.002
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 587IO
UT WOS:000276984700012
PM 20202874
DA 2024-11-01
ER

PT J
AU Zhang, SL
   Li, FY
   Bass, HN
   Pursley, A
   Schmitt, ES
   Brown, BL
   Brundage, EK
   Mardach, R
   Wong, LJ
AF Zhang, Shulin
   Li, Fang-yuan
   Bass, Harold N.
   Pursley, Amber
   Schmitt, Eric S.
   Brown, Blaire L.
   Brundage, Ellen K.
   Mardach, Rebecca
   Wong, Lee-Jun
TI Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear <i>TK2</i> gene and mtDNA depletion
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE TK2 deletion; Array CGH; mtDNA depletion
ID mitochondrial-dna depletion; comparative genomic hybridization; thymidine kinase; myopathy; replication; diagnosis
AB Thymidine kinase 2 (TK2), encoded by the TK2 gene on chromosome 16q22, is one of the deoxyribonucleoside kinases responsible for the maintenance of mitochondrial deoxyribonucleotide pools. Defects in TK2 mainly cause a myopathic form of the mitochondrial DNA depletion syndrome (MDDS). Currently, only point mutations and small insertions and deletions have been reported in TK2 gene; gross rearrangements of TK2 gene and possible hepatic involvement in patients with TK2 mutations have not been described. We report a non-consanguineous Jordanian family with three deceased siblings due to mtDNA depletion. Sequence analysis of the father detected a heterozygous c.761T > A (p.1254N) mutation in his TK2 gene; however, point mutations in the mother were not detected. Subsequent gene dosage analysis using oligonucleotide array CGH identified an intragenic approximately 5.8-kb deletion encompassing the 5'UTR to intron 2 of her TK2 gene. Sequence analysis confirmed that the deletion spans c.1-495 to c.283-2899 of the TK2 gene (nucleotide 65,136,256-65,142,086 of chromosome 16). Analysis of liver and muscle specimens from one of the deceased infants in this family revealed compound heterozygosity for the paternal point mutation and maternal intragenic deletion. In addition, a significant reduction of the mtDNA content in liver and muscle was detected (10% and 20% of age- and tissue-matched controls, respectively). Prenatal diagnosis was performed in the third pregnancy. The fetus was found to carry both the point mutation and the deletion. This child died 6 months after birth due to myopathy. A serum specimen demonstrated elevated liver transaminases in two of the infants from whom results were available. This report expands the mutation spectrum associated with TK2 deficiency. While the myopathic form of MDDS appears to be the main phenotype of TK2 mutations, liver dysfunction may also be a part of the mitochondrial depletion syndrome caused by TK2 gene defects. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Zhang, Shulin; Li, Fang-yuan; Pursley, Amber; Schmitt, Eric S.; Brundage, Ellen K.; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Med Genet Lab, Houston, TX 77030 USA.
   [Bass, Harold N.; Brown, Blaire L.; Mardach, Rebecca] Kaiser Permanente Med Program, Dept Genet, Los Angeles, CA USA.
   [Bass, Harold N.; Brown, Blaire L.; Mardach, Rebecca] Kaiser Permanente Med Program, Dept Genet, Bakersfield, CA USA.
   [Bass, Harold N.; Brown, Blaire L.; Mardach, Rebecca] Kaiser Permanente Med Program, Dept Genet, Panorama City, CA USA.
C3 Baylor College of Medicine; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Mitochondrial Diagnost Lab, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Beaudet AL, 2008, ANNU REV MED, V59, P113, DOI 10.1146/annurev.med.59.012907.101800
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   DIMAURO S, 1991, REV NEUROL, V147, P443
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lu XY, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000327
   Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
NR 22
TC 14
Z9 14
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JAN 15
PY 2010
VL 99
IS 1
BP 53
EP 57
DI 10.1016/j.ymgme.2009.09.003
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 545SV
UT WOS:000273758000008
PM 19815440
DA 2024-11-01
ER

PT J
AU Saneto, RP
   Singh, KK
AF Saneto, Russell P.
   Singh, Keshav K.
TI Illness-induced exacerbation of Leigh syndrome in a patient with the <i>MTATP6</i> mutation, m. 9185 T&gt;C
SO MITOCHONDRION
LA English
DT Article
DE Leigh syndrome; Brainstem; Magnetic resonance imaging; Complex V
ID mitochondrial-dna; disease; children; cardiomyopathy; heteroplasmy; deficiency; mtdna; acid
AB The most common mitochondrial DNA (mtDNA) mutations giving rise to Leigh syndrome reside in the MTATP6 gene. We report a rare mutation, m. 9185 T>C that gives rise to a progressive, but episodic pattern of neurological impairment with partial recovery. Disease progression corresponded to febrile viral illness and nuclear magnetic resonance imaging (MRI) changes. The patient displayed nearly 100% homoplasmy, while his asymptomatic mother was 30%. Phenotypically, exacerbations of muscle weakness with endurance intolerance, dysarthric speech, ataxia, and eyelid ptosis accompanied febrile viral illness. This case demonstrates an episodic pattern of febrile illness-induced disease exacerbation with corresponding MRI changes. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Saneto, Russell P.] Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA.
   [Saneto, Russell P.] Univ Washington, Seattle, WA 98105 USA.
   [Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14623 USA.
C3 Seattle Children's Hospital; University of Washington; University of Washington Seattle; Roswell Park Comprehensive Cancer Center
RP Saneto, RP (corresponding author), Seattle Childrens Hosp, Div Pediat Neurol, 4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
FU Mitochondrial Disease Research Guild at Seattle Children's Hospital; NIH [R01 CA121904]
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 20
TC 13
Z9 18
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 
J9 MITOCHONDRION
JI Mitochondrion
PD AUG 15
PY 2010
VL 10
IS 5
BP 567
EP 572
DI 10.1016/j.mito.2010.05.006
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 640LA
UT WOS:000281051500021
PM 20546952
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Neckelmann, G
   Mork, SJ
   Engelsen, BE
   Viscomi, C
   Moen, G
   Ersland, L
   Zeviani, M
   Bindoff, LA
AF Tzoulis, Charalampos
   Neckelmann, Gesche
   Mork, Sverre J.
   Engelsen, Bernt E.
   Viscomi, Carlo
   Moen, Gunnar
   Ersland, Lars
   Zeviani, Massimo
   Bindoff, Laurence A.
TI Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes
SO BRAIN
LA English
DT Article
DE polymerase gamma; magnetic resonance imaging; pathology; diffusion; Alpers' syndrome
ID cortical laminar necrosis; autosomal recessive ataxia; polg mutations; purkinje-cells; brain; mri; lesions; neuropathology; disorders; injury
AB Mutations in the catalytic subunit of the mitochondrial DNA-polymerase gamma cause a wide spectrum of clinical disease ranging from infantile hepato-encephalopathy to juvenile/adult-onset spinocerebellar ataxia and late onset progressive external ophthalmoplegia. Several of these syndromes are associated with an encephalopathy that characteristically shows episodes of rapid neurological deterioration and the development of acute cerebral lesions. The purpose of this study was to investigate the nature, distribution and natural evolution of central nervous system lesions in polymerase gamma associated encephalopathy focusing particularly on lesions identified by magnetic resonance imaging. We compared radiological, electrophysiological and pathological findings where available to study potential mechanisms underlying the episodes of exacerbation and acute cerebral lesions. We studied a total of 112 magnetic resonance tomographies and 11 computed tomographies in 32 patients with polymerase gamma-encephalopathy, including multiple serial examinations performed during both the chronic and acute phases of the disease and, in several cases, magnetic resonance spectroscopy and serial diffusion weighted studies. Data from imaging, electroencephalography and post-mortem examination were compared in order to study the underlying disease process. Our findings show that magnetic resonance imaging in polymerase gamma-related encephalopathies has high sensitivity and can identify patterns that are specific for individual syndromes. One form of chronic polymerase gamma-encephalopathy, that is associated with the c.1399G > A and c.2243G > C mutations, is characterized by progressive cerebral and cerebellar atrophy and focal lesions of the thalamus, deep cerebellar structures and medulla oblongata. Acute encephalopathies, both infantile and later onset, show similar pictures with cortical stroke-like lesions occurring during episodes of exacerbation. These lesions can occur both with and without electroencephalographic evidence of concurrent epileptic activity, and have diffusion, spectroscopic and histological profiles strongly suggestive of neuronal energy failure. We suggest therefore that both infantile and later onset polymerase gamma related encephalopathies are part of a continuum.
C1 [Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway.
   [Neckelmann, Gesche; Moen, Gunnar] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway.
   [Mork, Sverre J.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Viscomi, Carlo; Zeviani, Massimo] Natl Neurol Inst C Besta, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, I-20133 Milan, Italy.
   [Ersland, Lars] Haukeland Hosp, Dept Clin Engn, N-5021 Bergen, Norway.
   [Ersland, Lars] Haukeland Hosp, Dept Surg Sci, N-5021 Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
FU Helse Vest; Norwegian Research council; Pierfranco and Luisa Mariani Foundation; Telethon-Italy Foundation [GGP07019]; Italian Ministry of Health [RF-INN-2007-634163]
CR Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Böttcher J, 2005, STROKE, V36, PE20, DOI 10.1161/01.STR.0000155733.65215.c2
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fujioka M, 1997, STROKE, V28, P584, DOI 10.1161/01.STR.28.3.584
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Johansen KK, 2008, MOVEMENT DISORD, V23, P1624, DOI 10.1002/mds.22178
   Kondo A, 2007, BRAIN DEV-JPN, V29, P174, DOI 10.1016/j.braindev.2006.08.002
   Lo CP, 2007, AM J ROENTGENOL, V189, PW205, DOI 10.2214/AJR.07.2425
   Mena H, 2004, ACTA NEUROPATHOL, V108, P524, DOI 10.1007/s00401-004-0918-z
   NAKKI R, 1995, J NEUROSCI, V15, P2097, DOI 10.1523/JNEUROSCI.15-03-02097.1995
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   OHearn E, 1997, J NEUROSCI, V17, P8828
   Rachinger J, 2002, AM J NEURORADIOL, V23, P1398
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Riudavets MA, 2005, AM J FOREN MED PATH, V26, P189, DOI 10.1097/01.pag.0000160680.08769.541
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331
   Siskas N, 2003, NEURORADIOLOGY, V45, P283, DOI 10.1007/s00234-002-0887-7
   Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454
   TAKAHASHI S, 1993, RADIOLOGY, V189, P449, DOI 10.1148/radiology.189.2.8210374
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Uemura K, 2001, FORENSIC SCI INT, V116, P213, DOI 10.1016/S0379-0738(00)00375-3
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   YOKOTA T, 1989, J NEUROL, V236, P115, DOI 10.1007/BF00314408
   Yoneda Y, 2005, DIABETIC MED, V22, P1098, DOI 10.1111/j.1464-5491.2005.01568.x
NR 36
TC 54
Z9 54
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY 15
PY 2010
VL 133
IS 
BP 1428
EP 1437
DI 10.1093/brain/awq067
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 590KV
UT WOS:000277225700021
PM 20400524
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Kunz, WS
AF Zsurka, Gabor
   Kunz, Wolfram S.
TI Mitochondrial dysfunction in neurological disorders with epileptic phenotypes
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE Epilepsy; Mitochondrial DNA mutations; POLG; Mitochondria
ID stroke-like episodes; temporal-lobe epilepsy; progressive external ophthalmoplegia; hippocampal slice cultures; n-acetyl aspartate; lactic-acidosis; point mutation; oxidative-phosphorylation; missense mutation; dna mutations
AB A broad variety of mutations of the mitochondrial DNA or nuclear genes that lead to the impairment of mitochondrial respiratory chain or mitochondrial ATP synthesis have been associated with epileptic phenotypes. Additionally, evidence for an impaired mitochondrial function in seizure focus of patients with temporal lobe epilepsy and Ammon's horn sclerosis, as well as, animal models of temporal lobe epilepsy has been accumulated. This implies a direct pathogenic role of mitochondrial dysfunction in the process of epileptogenesis and seizure generation in certain forms of epilepsy.
C1 [Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, Div Neurochem, D-53105 Bonn, Germany.
C3 University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Dept Epileptol, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
FU Deutsche Forschungsgemeinschaft [TR3-A11, TR3-D12]; BMBF [mitoNET 01GM0868]; Stiftung fur Medizinische Wissenschaft (Frankfurt am Main)
CR Baron M, 2007, BIOCHEM SOC T, V35, P1228, DOI 10.1042/BST0351228
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Bindokas VP, 1998, J NEUROSCI, V18, P4570
   Blümcke I, 1999, J COMP NEUROL, V414, P437, DOI 10.1002/(SICI)1096-9861(19991129)414:4<437::AID-CNE2>3.0.CO;2-3
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   Campos Y, 2000, NEUROMUSCULAR DISORD, V10, P493, DOI 10.1016/S0960-8966(00)00107-3
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Cock H, 1999, EPILEPSIA, V40, P33, DOI 10.1111/j.1528-1157.1999.tb00897.x
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Frantseva MV, 2000, EUR J NEUROSCI, V12, P1431, DOI 10.1046/j.1460-9568.2000.00016.x
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Gulyás AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kann O, 2005, BRAIN, V128, P2396, DOI 10.1093/brain/awh568
   Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752
   Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Kudin AP, 2002, EUR J NEUROSCI, V15, P1105, DOI 10.1046/j.1460-9568.2002.01947.x
   Kunz WS, 2000, ANN NEUROL, V48, P766, DOI 10.1002/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M
   Kunz WS, 1999, BRAIN RES, V826, P236, DOI 10.1016/S0006-8993(99)01279-2
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3
   Malinska D, 2010, BBA-BIOENERGETICS, V1797, P1163, DOI 10.1016/j.bbabio.2010.03.001
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Manfredi G, 1996, HUM MUTAT, V7, P158
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   OBrien TJ, 1997, EPILEPSIA, V38, P74, DOI 10.1111/j.1528-1157.1997.tb01080.x
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Schuchmann S, 2002, NEUROBIOL DIS, V11, P96, DOI 10.1006/nbdi.2002.0533
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Vielhaber S, 2003, EUR J NEUROSCI, V18, P2292, DOI 10.1046/j.1460-9568.2003.02954.x
   Vielhaber S, 2003, EPILEPSIA, V44, P193, DOI 10.1046/j.1528-1157.2003.38102.x
   Vielhaber S, 2008, EPILEPSIA, V49, P40, DOI 10.1111/j.1528-1167.2007.01280.x
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 70
TC 23
Z9 25
U1 0
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD DEC 15
PY 2010
VL 42
IS 6
BP 443
EP 448
DI 10.1007/s10863-010-9314-7
PG 6
WC Biophysics; Cell Biology
SC Biophysics; Cell Biology
GA 700OJ
UT WOS:000285753300002
PM 21069442
DA 2024-11-01
ER

PT J
AU Echaniz-Laguna, A
   Chanson, JB
   Wilhelm, JM
   Sellal, F
   Mayençon, M
   Mohr, M
   Tranchant, C
   de Camaret, BM
AF Echaniz-Laguna, Andoni
   Chanson, Jean-Baptiste
   Wilhelm, Jean-Marie
   Sellal, Francois
   Mayencon, Martine
   Mohr, Michel
   Tranchant, Christine
   de Camaret, Benedicte Mousson
TI A novel variation in the Twinkle linker region causing late-onset dementia
SO NEUROGENETICS
LA English
DT Article
DE Dementia; Chronic progressive external ophthalmoplegia; Mitochondrial disease; Twinkle; PEO1; Myopathy
ID progressive external ophthalmoplegia; mitochondrial-dna deletions; helicase twinkle; mutations; disease
AB Variations in the mitochondrial helicase Twinkle (PEO1) gene are usually associated with autosomal dominant chronic progressive external ophthalmoplegia (PEO). We describe five patients from two unrelated Alsatian families with the new R374W variation in the Twinkle linker region who progressively developed an autosomal dominant multisystem disorder with PEO, hearing loss, myopathy, dysphagia, dysphonia, sensory neuropathy, and late-onset dementia resembling Alzheimer's disease. These observations demonstrate that Twinkle variations in the linker domain alter cerebral function and further implicate disrupted mitochondrial DNA integrity in the pathogenesis of dementia.
C1 [Echaniz-Laguna, Andoni; Chanson, Jean-Baptiste; Tranchant, Christine] Hop Civil, Dept Neurol, F-67091 Strasbourg, France.
   [Wilhelm, Jean-Marie] Ctr Hosp Reg, Serv Med Interne, F-68130 Altkirch, France.
   [Sellal, Francois] Ctr Hosp Reg, Serv Neurol, F-68000 Colmar, France.
   [Mayencon, Martine; de Camaret, Benedicte Mousson] CHU Lyon, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, F-69677 Bron, France.
   [Mohr, Michel] Hop Hautepierre, Dept Anatomopathol, F-67091 Strasbourg, France.
C3 CHU Strasbourg; Centre Hospitalier Annecy Genevois; Centre Hospitalier Annecy Genevois; CHU Lyon; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg
RP Echaniz-Laguna, A (corresponding author), Hop Civil, Dept Neurol, BP 426, F-67091 Strasbourg, France.
EM Echaniz-Laguna@medecine.u-strasbg.fr
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Ferlin T, 1997, MOL CELL BIOCHEM, V174, P221, DOI 10.1023/A:1006860508606
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
NR 15
TC 15
Z9 18
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1364-6745
EI 
J9 NEUROGENETICS
JI Neurogenetics
PD FEB 15
PY 2010
VL 11
IS 1
BP 21
EP 25
DI 10.1007/s10048-009-0202-4
PG 5
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA 544UQ
UT WOS:000273685200003
PM 19513767
DA 2024-11-01
ER

PT J
AU Parsons, T
   Weimer, L
   Engelstad, K
   Linker, A
   Battista, V
   Wei, Y
   Hirano, M
   DiMauro, S
   De Vivo, DC
   Kaufmann, P
AF Parsons, Timothy
   Weimer, Louis
   Engelstad, Kristin
   Linker, Alex
   Battista, Vanessa
   Wei, Ying
   Hirano, Michio
   DiMauro, Salvatore
   De Vivo, Darryl C.
   Kaufmann, Petra
TI Autonomic Symptoms in Carriers of the m.3243A&gt;G Mitochondrial DNA Mutation
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID quality-of-life; a3243g mutation; melas; features; 3243a-greater-than-g; encephalomyopathy; impairment
AB Background: The m.3243A>G mutation can cause multisystem medical problems and can affect the autonomic nervous system. Objective: To study the frequency and spectrum of autonomic symptoms associated with the m.3243A>G mitochondrial DNA point mutation. Design, Setting, and Patients: We studied a cohort of 88 matrilineal relatives from 40 families, including 35 fully symptomatic patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS), 53 carrier relatives, and 16 controls using a questionnaire based on existing standard instruments for the evaluation of autonomic dysfunction. We compared the questionnaire with an expert evaluation. We compared data among the 3 groups using the Mantel-Haenszel chi(2) test to determine the statistical significance of differences between groups. Results: Mutation carriers frequently had symptoms of autonomic dysfunction, specifically gastrointestinal and orthostatic intolerance. Conclusions: Carriers of the m.3243A>G mutation have frequent autonomic symptoms. The m.3243A>G mutation should be considered as an etiological factor in patients with autonomic dysfunction and a medical or family history suggestive of mitochondrial disease. Because some autonomic symptoms are treatable, early detection and proactive management may mitigate the burden of morbidity.
C1 [Parsons, Timothy; Weimer, Louis; Engelstad, Kristin; Battista, Vanessa; Hirano, Michio; DiMauro, Salvatore; De Vivo, Darryl C.; Kaufmann, Petra] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Wei, Ying] Columbia Univ, Med Ctr, Dept Biostat, New York, NY 10032 USA.
   [De Vivo, Darryl C.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA.
   [Linker, Alex] Columbia Univ, Med Ctr, Coll Phys & Surg, New York, NY 10032 USA.
C3 Columbia University; Columbia University; Columbia University; Columbia University
RP Kaufmann, P (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 710 168th St, New York, NY 10032 USA.
EM pk88@columbia.edu
FU National Institute of Child Health and Human Development [PO1-HD32062]; National Center for Research Resources [1 UL1 RR024156]; Irving Research Scholar Award; Marriott Mitochondrial Disorder Clinical Research Fund; Colleen Giblin Foundation
CR Benrud-Larson LM, 2002, MAYO CLIN PROC, V77, P531, DOI 10.4065/77.6.531
   BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Di Leo R, 2007, J NEUROL, V254, P1498, DOI 10.1007/s00415-007-0536-5
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   MANTEL N, 1959, JNCI-J NATL CANCER I, V22, P719
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523
   van den Berg MP, 2001, EUR HEART J, V22, P247, DOI 10.1053/euhj.2001.2180
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
NR 16
TC 20
Z9 26
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
EI 
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD AUG 15
PY 2010
VL 67
IS 8
BP 976
EP 979
DI 
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 637HU
UT WOS:000280809000010
PM 20697048
DA 2024-11-01
ER

PT J
AU Passarino, G
   Rose, G
   Bellizzi, D
AF Passarino, Giuseppe
   Rose, Giuseppina
   Bellizzi, Dina
TI Mitochondrial function, mitochondrial DNA and ageing: a reappraisal
SO BIOGERONTOLOGY
LA English
DT Article
DE Mitochondrion; mtDNA; Programmed death; Human ageing; Age related diseases; Longevity; Epigenetic modifications; Cybrids
ID hereditary optic neuropathy; skeletal-muscle; gene-expression; uncoupling proteins; replication origin; oxidative stress; point mutations; control region; cytochrome-c; y-chromosome
AB The impressive performance of the research in biology of mitochondrion has greatly improved our knowledge on the functions of this organelle and highlighted the influence its functioning has on numerous human phenotypes. In particular, many studies have focused on the involvement of mitochondrion function (and dysfunction) in human ageing. To date, the literature in this specific field of mitochondrial biology is so vast that it is often difficult to properly put new data and new findings in the right context. The present paper aims to review the findings of the last few years in order to outline a general framework to understand how mitochondria can affect ageing and how ageing affects mitochondria.
C1 [Passarino, Giuseppe; Rose, Giuseppina; Bellizzi, Dina] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy.
C3 University of Calabria
RP Passarino, G (corresponding author), Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy.
EM g.passarino@unical.it
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556
   BANDINELLI S, 2010, ACTA BIOMED S, V811, P15
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barrett TG, 2000, J MED GENET, V37, P463, DOI 10.1136/jmg.37.6.463
   Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x
   Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Bertoni-Freddari C, 2007, ANN NY ACAD SCI, V1097, P51, DOI 10.1196/annals.1379.019
   BERTONIFREDDARI C, 1993, BRAIN RES, V628, P193, DOI 10.1016/0006-8993(93)90955-M
   Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877
   Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004
   Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424
   da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   DAS DK, 1989, BIOCHEM BIOPH RES CO, V165, P1004, DOI 10.1016/0006-291X(89)92702-2
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Dietrich MO, 2010, PFLUG ARCH EUR J PHY, V459, P269, DOI 10.1007/s00424-009-0729-0
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, PR519, DOI 10.1152/ajpregu.00458.2001
   Drouet M, 1999, EXP GERONTOL, V34, P843, DOI 10.1016/S0531-5565(99)00058-3
   Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Ferrucci L, 2008, MECH AGEING DEV, V129, P677, DOI 10.1016/j.mad.2008.09.007
   Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Franceschi C, 2005, MECH AGEING DEV, V126, P351, DOI 10.1016/j.mad.2004.08.028
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Fried LP, 2001, J GERONTOL A-BIOL, V56, PM146, DOI 10.1093/gerona/56.3.M146
   Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x
   Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harper ME, 2002, JOURNAL OF ANIMAL SCIENCE, V80, PE90, DOI 10.2527/ANIMALSCI2002.80E-SUPPL_
   Hepple RT, 2009, EXERC SPORT SCI REV, V37, P23, DOI 10.1097/JES.0b013e3181877dc5
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Jia JJ, 2009, OBES REV, V10, P519, DOI 10.1111/j.1467-789X.2009.00569.x
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, PH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LEE CT, 1974, NATURE, V251, P240, DOI 10.1038/251240a0
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006
   LESTIENNE P, 1994, BIOMED PHARMACOTHER, V48, P199, DOI 10.1016/0753-3322(94)90134-1
   Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5
   Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575
   Malik S, 2002, HUM GENET, V110, P402, DOI 10.1007/s00439-002-0717-3
   Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Möpert K, 2009, EXP CELL RES, V315, P2165, DOI 10.1016/j.yexcr.2009.04.016
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Morgan HD, 2005, HUM MOL GENET, V14, PR47, DOI 10.1093/hmg/ddi114
   Naviaux RK, 2008, CANCER BIOL THER, V7, P1191, DOI 10.4161/cbt.7.8.6741
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Nübel T, 2006, HORM RES, V65, P300, DOI 10.1159/000092847
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702
   Perls T, 2002, J AM GERIATR SOC, V50, P359, DOI 10.1046/j.1532-5415.2002.49283.x
   Phelouzat MA, 1997, MECH AGEING DEV, V96, P35, DOI 10.1016/S0047-6374(97)01883-6
   POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811
   Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1
   Richards M, 1996, AM J HUM GENET, V59, P185
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Rönn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8
   Rose G, 2002, INT J BIOCHEM CELL B, V34, P1449, DOI 10.1016/S1357-2725(02)00042-0
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Rose G, 2007, BMC GENOMICS, V8, P0, DOI 10.1186/1471-2164-8-293
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Salopuro T, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-94
   Santoro A, 2006, BBA-BIOENERGETICS, V1757, P1388, DOI 10.1016/j.bbabio.2006.05.040
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Simková H, 1998, PLANT CELL REP, V17, P220, DOI 10.1007/s002990050382
   Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Solvioli Stefano, 2008, BIOTECHNOLOGY JOURNAL, V3, P740, DOI 10.1002/biot.200800046
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Suissa S, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000474
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Tanaka M, 2000, MECH AGEING DEV, V116, P65, DOI 10.1016/S0047-6374(00)00149-4
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Terzioglu Mugen, 2007, NOVARTIS FOUND SYMP, V287, P197
   Torroni A, 1996, GENETICS, V144, P1835
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407
   VANYUSHIN BF, 1977, BIOCHIM BIOPHYS ACTA, V475, P323, DOI 10.1016/0005-2787(77)90023-5
   VILKKI J, 1989, HUM GENET, V82, P208, DOI 10.1007/BF00291155
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wallace Douglas C, 2002, METHODS MOL BIOL, V197, P3, DOI 10.1385/1-59259-284-8:003
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391
   Wang SC, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002698
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 142
TC 19
Z9 20
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD OCT 15
PY 2010
VL 11
IS 5
BP 575
EP 588
DI 10.1007/s10522-010-9294-3
PG 14
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 644KU
UT WOS:000281376900006
PM 20602257
DA 2024-11-01
ER

PT J
AU Brinckmann, A
   Weiss, C
   Wilbert, F
   von Moers, A
   Zwirner, A
   Stoltenburg-Didinger, G
   Wilichowski, E
   Schuelke, M
AF Brinckmann, Anja
   Weiss, Claudia
   Wilbert, Friederike
   von Moers, Arpad
   Zwirner, Angelika
   Stoltenburg-Didinger, Gisela
   Wilichowski, Ekkehard
   Schuelke, Markus
TI Regionalized Pathology Correlates with Augmentation of mtDNA Copy Numbers in a Patient with Myoclonic Epilepsy with Ragged-Red Fibers (MERRF-Syndrome)
SO PLOS ONE
LA English
DT Article
ID mitochondrial-dna mutation; anterior cingulate cortex; tissue distribution; clinical phenotype; transfer rna(lys); oxidative stress; rnalys mutation; human-cells; disease; segregation
AB Human patients with myoclonic epilepsy with ragged-red fibers (MERRF) suffer from regionalized pathology caused by a mutation in the mitochondrial DNA (m.8344A -> G). In MERRF-syndrome brain and skeletal muscles are predominantly affected, despite mtDNA being present in any tissue. In the past such tissue-specificity could not be explained by varying mtDNA mutation loads. In search for a region-specific pathology in human individuals we determined the mtDNA/nDNA ratios along with the mutation loads in 43 different post mortem tissue samples of a 16-year-old female MERRF patient and in four previously healthy victims of motor vehicle accidents. In brain and muscle we further determined the quantity of mitochondrial proteins (COX subunits II and IV), transcription factors (NRF1 and TFAM), and VDAC1 (Porin) as a marker for the mitochondrial mass. In the patient the mutation loads varied merely between 89-100%. However, mtDNA copy numbers were increased 3-7 fold in predominantly affected brain areas (e.g. hippocampus, cortex and putamen) and in skeletal muscle. Similar increases were absent in unaffected tissues (e.g. heart, lung, kidney, liver, and gastrointestinal organs). Such mtDNA copy number increase was not paralleled by an augmentation of mitochondrial mass in some investigated tissues, predominantly in the most affected tissue regions of the brain. We thus conclude that "futile'' stimulation of mtDNA replication per se or a secondary failure to increase the mitochondrial mass may contribute to the regionalized pathology seen in MERRF-syndrome.
C1 [Brinckmann, Anja; Weiss, Claudia; Wilbert, Friederike; Zwirner, Angelika; Schuelke, Markus] Charite, Dept Neuropediat, Berlin, Germany.
   [von Moers, Arpad] DRK Kliniken Westend, Berlin, Germany.
   [Stoltenburg-Didinger, Gisela] Charite, Dept Neuropathol, Berlin, Germany.
   [Wilichowski, Ekkehard] Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany.
   [Wilbert, Friederike; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, Berlin, Germany.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Brinckmann, A (corresponding author), Charite, Dept Neuropediat, Berlin, Germany.
EM markus.schuelke@charite.de
FU Deutsche Forschungsgemeinschaft [SFB 665 TP C4]; NeuroCure Cluster of Excellence at the Charite, Berlin [Exc 257]; German ministry of education and research (BMBF, Bonn, Germany)
CR ABERCROMBIE M, 1946, ANAT RECORD, V94, P239, DOI 10.1002/ar.1090940210
   Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516
   Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104
   Battersby BJ, 2007, NAT GENET, V39, P571, DOI 10.1038/ng0507-571
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brinckmann A, 2007, J MOL MED-JMM, V85, P163, DOI 10.1007/s00109-006-0112-y
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gittins R, 2004, BRAIN RES, V1013, P212, DOI 10.1016/j.brainres.2004.03.064
   Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   LERTRIT P, 1992, HUM GENET, V90, P251
   LOMBES A, 1992, NEUROMUSCULAR DISORD, V2, P323, DOI 10.1016/S0960-8966(06)80003-9
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   TANNO Y, 1993, NEUROLOGY, V43, P1198, DOI 10.1212/WNL.43.6.1198
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
NR 30
TC 22
Z9 24
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2010
VL 5
IS 10
BP 
EP 
DI 10.1371/journal.pone.0013513
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 667TI
UT WOS:000283216400018
PM 20976001
DA 2024-11-01
ER

PT J
AU McFarland, R
   Taylor, RW
   Turnbull, DM
AF McFarland, Robert
   Taylor, Robert W.
   Turnbull, Douglass M.
TI A neurological perspective on mitochondrial disease
SO LANCET NEUROLOGY
LA English
DT Review
ID cytochrome-c-oxidase; complex-iii deficiency; dominant optic atrophy; dna-polymerase-gamma; respiratory-chain; coenzyme-q10 deficiency; monitor progression; assembly factor; i deficiency; hot-spot
AB Disruption of the most fundamental cellular energy process, the mitochondrial respiratory chain, results in a diverse and variable group of multisystem disorders known collectively as mitochondrial disease. The frequent involvement of the brain, nerves, and muscles, often in the same patient, places neurologists at the forefront of the interesting and challenging process of diagnosing and caring for these patients. Mitochondrial diseases are among the most frequently inherited neurological disorders, and can be caused by mutations in mitochondrial or nuclear DNA. Substantial progress has been made over the past decade in understanding the genetic basis of these disorders, with important implications for the general neurologist in terms of the diagnosis, investigation, and multidisciplinary management of these patients.
C1 [McFarland, Robert; Taylor, Robert W.; Turnbull, Douglass M.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
FU Department of Health and the Higher Education Funding Council for England; Wellcome Trust; Medical Research Council; Muscular Dystrophy Campaign; Marriott Foundation; Knott Trust; MRC [G0700718, G108/539, G0601943, G0800674] Funding Source: UKRI
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Aniello MS, 2008, MOVEMENT DISORD, V23, P114, DOI 10.1002/mds.21760
   Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   BOUGERON T, 1995, NAT GENET, V11, P144
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Delarue A, 2000, PEDIATR TRANSPLANT, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Gioltzoglou T, 2005, J NEUROL NEUROSUR PS, V76, P1594, DOI 10.1136/jnnp.2004.057661
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   IHARA Y, 1989, J NEUROL SCI, V90, P263, DOI 10.1016/0022-510X(89)90112-3
   Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   Kayihan N, 2000, PEDIATR TRANSPLANT, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   LUNKES A, 1995, AM J HUM GENET, V57, P968
   Mahad D, 2008, NEUROPATH APPL NEURO, V34, P577, DOI 10.1111/j.1365-2990.2008.00987.x
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARGULIS L, 1976, EXP PARASITOL, V39, P277, DOI 10.1016/0014-4894(76)90127-2
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Milea D, 2010, ACTA OPHTHALMOL, V88, P342, DOI 10.1111/j.1755-3768.2008.01469.x
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Ramos-Arroyo MA, 2009, CLIN GENET, V75, P585, DOI 10.1111/j.1399-0004.2009.01160.x
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli F M, 2001, AM HEART J, V141, PE1, DOI 10.1067/mhj.2001.112088
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Welzing L, 2009, EUR J PEDIATR, V168, P757, DOI 10.1007/s00431-008-0831-x
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Yuan N, 2009, J PERINATOL, V29, P166, DOI 10.1038/jp.2008.178
   Zhang Y, 2007, FEBS LETT, V581, P2168, DOI 10.1016/j.febslet.2007.01.095
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 130
TC 221
Z9 243
U1 0
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD AUG 15
PY 2010
VL 9
IS 8
BP 829
EP 840
DI 10.1016/S1474-4422(10)70116-2
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA 635LS
UT WOS:000280657800014
PM 20650404
DA 2024-11-01
ER

PT J
AU Pohjoismäki, JLO
   Goffart, S
   Taylor, RW
   Turnbull, DM
   Suomalainen, A
   Jacobs, HT
   Karhunen, PJ
AF Pohjoismaki, Jaakko L. O.
   Goffart, Steffi
   Taylor, Robert W.
   Turnbull, Douglas M.
   Suomalainen, Anu
   Jacobs, Howard T.
   Karhunen, Pekka J.
TI Developmental and Pathological Changes in the Human Cardiac Muscle Mitochondrial DNA Organization, Replication and Copy Number
SO PLOS ONE
LA English
DT Article
ID progressive external ophthalmoplegia; multiple mtdna deletions; transcription factor-a; autosomal-dominant; helicase twinkle; mutations; heart; expression; skeletal; failure
AB Adult human heart mitochondrial DNA (mtDNA) has recently been shown to have a complex organization with abundant dimeric molecules, branched structures and four-way junctions. In order to understand the physiological significance of the heart-specific mtDNA maintenance mode and to find conditions that modify human heart mtDNA structure and replication, we analyzed healthy human heart of various ages as well as several different heart diseases, including ischemic heart disease, dilated as well as hypertrophic cardiomyopathies, and several mitochondrial disorders. By using one-and two-dimensional agarose gel electrophoresis, various enzymatic treatments and quantitative PCR we found that in human newborns heart mtDNA has a simple organization, lacking junctional forms and dimers. The adult-type branched forms are acquired in the early childhood, correlating with an increase in mtDNA copy number. Mitochondrial disorders involving either mutations in the mtDNA polymerase gamma (PolG alpha) or mtDNA helicase Twinkle, while having no obvious cardiac manifestation, show distinct mtDNA maintenance phenotypes, which are not seen in various types of diseased heart or in mitochondrial disorders caused by point mutations or large-scale deletions of mtDNA. The findings suggest a link between cardiac muscle development, mtDNA copy number, replication mode and topological organization. Additionally, we show that Twinkle might have a direct role in the maintenance of four-way junctions in human heart mtDNA.
C1 [Pohjoismaki, Jaakko L. O.; Karhunen, Pekka J.] Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.
   [Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.
   [Taylor, Robert W.; Turnbull, Douglas M.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Helsinki, Finland.
C3 Tampere University; Tampere University; Newcastle University - UK; University of Helsinki
RP Pohjoismäki, JLO (corresponding author), Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.
EM Jaakko.Pohjoismaki@uta.fi
FU EU; Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; UK National Comissioning Group
CR Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BOGENHAGEN D, 1981, J MOL BIOL, V148, P77, DOI 10.1016/0022-2836(81)90236-9
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942
   Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Leipe DD, 2000, GENOME RES, V10, P5
   Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x
   Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010
   Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SWALWELL H, 2008, EUR J HUM GENET, V18, P63
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
NR 36
TC 41
Z9 43
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2010
VL 5
IS 5
BP 
EP 
DI 10.1371/journal.pone.0010426
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 590PW
UT WOS:000277240300006
PM 20454654
DA 2024-11-01
ER

PT J
AU Ronchi, D
   Virgilio, R
   Bordoni, A
   Fassone, E
   Sciacco, M
   Ciscato, P
   Moggio, M
   Govoni, A
   Corti, S
   Bresolin, N
   Comi, GP
AF Ronchi, Dario
   Virgilio, Roberta
   Bordoni, Andreina
   Fassone, Elisa
   Sciacco, Monica
   Ciscato, Patrizia
   Moggio, Maurizio
   Govoni, Alessandra
   Corti, Stefania
   Bresolin, Nereo
   Comi, Giacomo P.
TI The m.12316G&gt;A mutation in the mitochondrial tRNA<SUP>Leu(CUN)</SUP> gene is associated with mitochondrial myopathy and respiratory impairment
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE mtDNA; tRNA(Leu(CUN)); Late-onset myopathy
ID progressive external ophthalmoplegia; mtdna point mutation; skeletal-muscle; sporadic patient; dna; encephalomyopathy; termination; disorders; disease; melas
AB Mitochondrial disorders are often associated with mutations in mitochondria! tRNA. Independent observation of the same molecular defect in unrelated subjects is a generally required proof of pathogenicity. A sporadic case of chronic external ophthalmoplegia (cPEO) with ragged red fibres (RRFs) has been previously related to an m.12316G>A substitution in tRNA(Leu(CUN)). Sequencing muscle-derived mtDNA, we found the m.12316G>A substitution in an adult woman with mitochondrial myopathy and respiratory impairment. Her muscle biopsy presented several cytochrome c oxidase-negative (COX) fibres, and RRFs as signs of mitochondrial proliferation. Restriction-fragment length polymorphism (RFLP) analysis of the mutation in isolated muscle fibres showed a threshold of at least 60% of mutated mtDNA to determine a COX deficiency phenotype. This second report of the m.12316G>A mutation in a sporadic patient consolidates its pathogenic nature and provides further elements for genetic counselling. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Ronchi, Dario; Virgilio, Roberta; Bordoni, Andreina; Fassone, Elisa; Sciacco, Monica; Ciscato, Patrizia; Moggio, Maurizio; Govoni, Alessandra; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Dept Neurol Sci, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Corti, Stefania; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy.
   [Bresolin, Nereo] IRCCS Eugenio Medea, Parini, Lecco, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Eugenio Medea
RP Comi, GP (corresponding author), Univ Milan, Dept Neurol Sci, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Dino Ferrari Ctr, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM giacomo.comi@unimi.it
FU Associazione Amici del Centro Dino Ferrari; MIUR (Ministry of Education University and Research) Italian Ministry [PRIN 2007]; Telethon [GTB07001E]; Eurobiobank [QLTR-2001-02769]
CR Abu-Amero EK, 2006, J CHILD NEUROL, V21, P971, DOI 10.2310/7010.2006.00208
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Filosto M, 2008, NEUROMUSCULAR DISORD, V18, P204, DOI 10.1016/j.nmd.2007.12.005
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   Moraes C T, 1996, METHODS ENZYMOL, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   van Eijsden RGE, 2008, J MED GENET, V45, P525, DOI 10.1136/jmg.2008.057497
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 23
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAY 15
PY 2010
VL 292
IS 1-2
BP 107
EP 110
DI 10.1016/j.jns.2010.01.026
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 584WJ
UT WOS:000276784100022
PM 20163808
DA 2024-11-01
ER

PT J
AU Felk, S
   Ohrt, S
   Kussmaul, L
   Storch, A
   Gillardon, F
AF Felk, Sandra
   Ohrt, Susanne
   Kussmaul, Lothar
   Storch, Alexander
   Gillardon, Frank
TI Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS; Mitochondria; Proteome; 2D DIGE; Lon protease; Actin cytoskeleton
ID lon protease; lactic-acidosis; encephalopathy; stress; myopathy; proteolysis; proteomics; aconitase; subgroup; episodes
AB Point mutations in the mitochondrial genome are associated with a variety of metabolic disorders. The myopathy, encephalopathy, lactic acidosis, stroke-like episodes syndrome (MELAS), is most frequently associated with an A to G transition at position 3243 of the mitochondrial tRNA(Leu(UUR)) gene, and is characterized by biochemical and structural alterations of mitochondria. In the present study, we analyzed proteomic changes in an immortalized B-cell line harbouring the MELAS A3243G mutation by two-dimensional difference gel electrophoresis and immunoblot analysis. Although the cell line contained only 10% mutated mitochondrial genomes, we detected significant alterations in numerous proteins associated with the actin cytoskeleton and in nuclear-encoded subunits of mitochondrial respiratory chain complexes. Notably, mitochondria! Lon protease and Hsp60 were deregulated in MELAS cells, indicating an effect on the mitochondrial protein quality control system. By immunofluorescence microscopy, we detected mitochondrial Lon protease accumulation and changes in actin-binding proteins preferentially in MELAS cells containing numerous mitochondria with mutated genomes. Enzymatic assays revealed that Lon protease activity is increased in MELAS cell lysates. Although Lon protease has been shown to degrade misfolded proteins and to stabilize respiratory chain complexes within mitochondria, our MELAS cell line exhibited a higher sensitivity to mitochondria! stress. These findings provide novel insights into the cellular response to dysfunctional mitochondria containing mutated genomes. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, D-88397 Biberach, Germany.
   [Ohrt, Susanne; Storch, Alexander] Tech Univ Dresden, Dept Neurol, D-8027 Dresden, Germany.
C3 Boehringer Ingelheim; Technische Universitat Dresden
RP Gillardon, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Birkendorfer Str 65, D-88397 Biberach, Germany.
EM Frank.Gillardon@boehringer-ingelheim.com
FU Medical Faculty Carl Gustav Carus at the Dresden University of Technology; Roland Ernst Foundation [AZ 21-0563]
CR Bakker A, 2000, PEDIATR RES, V48, P143, DOI 10.1203/00006450-200008000-00005
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200
   Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200
   Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07
   Danzeisen R, 2006, J PHARMACOL EXP THER, V316, P189, DOI 10.1124/jpet.105.092312
   Deocaris C, 2008, BIOGERONTOLOGY, V9, P391, DOI 10.1007/s10522-008-9174-2
   Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043
   FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MAURIZI MR, 1987, J BIOL CHEM, V262, P2696
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776
   Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Stanyer L, 2008, NEUROCHEM INT, V53, P95, DOI 10.1016/j.neuint.2008.06.004
   Swatton JE, 2004, MOL PSYCHIATR, V9, P128, DOI 10.1038/sj.mp.4001475
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   Tonge R, 2001, PROTEOMICS, V1, P377
   van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584
   Vasilyeva OV, 2002, FEBS LETT, V526, P66, DOI 10.1016/S0014-5793(02)03117-4
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WAXMAN L, 1985, J BIOL CHEM, V260, P2022
NR 42
TC 10
Z9 12
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2010
VL 295
IS 1-2
BP 46
EP 52
DI 10.1016/j.jns.2010.05.013
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 628LA
UT WOS:000280120000010
PM 20570288
DA 2024-11-01
ER

PT J
AU Birch-Machin, MA
   Swalwell, H
AF Birch-Machin, Mark A.
   Swalwell, Helen
TI How mitochondria record the effects of UV exposure and oxidative stress using human skin as a model tissue
SO MUTAGENESIS
LA English
DT Review
ID mtdna control-region; ultraviolet-radiation exposure; substantia-nigra neurons; dna deletions; common deletion; degenerative diseases; hacat keratinocytes; cellular senescence; hydrogen-peroxide; skeletal-muscle
AB The accumulation of mitochondrial DNA (mtDNA) mutations has been proposed as an underlying cause of the ageing process and mutations have been associated with cancer in many tissues, including human skin. This involvement is linked to the key roles of mitochondrial function and mtDNA in oxidative stress production and as a mediator of apoptosis. We and others have pioneered the use of mtDNA damage as a highly sensitive biomarker of ultraviolet exposure in human skin and have also shown that the accumulation of an ageing-dependent mtDNA mutation is accelerated by exposure to sunlight, which is known to induce oxidative stress in skin. This is important as ultraviolet radiation (UVR)-induced gene mutations play a key role in the development of skin cancer and ageing in human skin. Novel applications of mtDNA as a biomarker of UVR-induced oxidative stress will also be highlighted in this review.
C1 [Birch-Machin, Mark A.; Swalwell, Helen] Newcastle Univ, Sch Med, Inst Cellular Med, Dept Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Dept Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM m.a.birch-machin@ncl.ac.uk
FU Cancer Research UK [C1474/A10235]
CR Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101
   Aitken GR, 2007, CLIN EXP DERMATOL, V32, P722, DOI 10.1111/j.1365-2230.2007.02474.x
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x
   Birch-Machin MA, 2000, CLIN EXP DERMATOL, V25, P141, DOI 10.1046/j.1365-2230.2000.00605.x
   Birch-Machin MA, 2005, BRIT J CANCER, V93, P271, DOI 10.1038/sj.bjc.6602711
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   Birket MJ, 2009, J INVEST DERMATOL, V129, P1361, DOI 10.1038/jid.2008.373
   Boukamp Petra, 2005, J DTSCH DERMATOL GES, V3, P493, DOI 10.1111/j.1610-0387.2005.05037.x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253
   Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506
   CARON F, 1979, P NATL ACAD SCI USA, V76, P4265, DOI 10.1073/pnas.76.9.4265
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Deichmann M, 2004, INT J ONCOL, V24, P137
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Diffey B, 2004, PHYS MED BIOL, V49, PR1, DOI 10.1088/0031-9155/49/1/R01
   Diffey BL, 2005, BRIT J DERMATOL, V153, P378, DOI 10.1111/j.1365-2133.2005.06729.x
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, PS128, DOI 10.1002/mnfr.200700195
   Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gniadecki R, 2000, J CELL BIOCHEM, V80, P216
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Haldar S, 2007, EUR J CLIN NUTR, V61, P1011, DOI 10.1038/sj.ejcn.1602615
   Harbottle A, 2004, J INVEST DERMATOL, V122, P1518, DOI 10.1111/j.0022-202X.2004.22608.x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HENDERSON JR, 2009, FREE RADICAL RES, V0, P1
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1
   Ikehata H, 2004, MUTAT RES-FUND MOL M, V556, P11, DOI 10.1016/j.mrfmmm.2004.06.038
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Jang JH, 2001, MUTAT RES-GEN TOX EN, V496, P181, DOI 10.1016/S1383-5718(01)00233-9
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14
   LU J, 2005, J MOL DIAGN, V7, P258
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   NASS MMK, 1969, J MOL BIOL, V42, P529, DOI 10.1016/0022-2836(69)90241-1
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   Parr Ryan L, 2006, HUMAN GENOMICS, V2, P252
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Petersen AB, 2000, J PHOTOCH PHOTOBIO B, V59, P123, DOI 10.1016/S1011-1344(00)00149-4
   Poetsch M, 2004, DIAGN MOL PATHOL, V13, P26, DOI 10.1097/00019606-200403000-00005
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   RIZWAN M, 2008, BRIT J DERMATOL, V158, P900
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009
   Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0
   Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   VANTUYLE GC, 1979, J BIOL CHEM, V254, P6044
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
NR 94
TC 109
Z9 122
U1 2
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD MAR 15
PY 2010
VL 25
IS 2
BP 101
EP 107
DI 10.1093/mutage/gep061
PG 7
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA 561OA
UT WOS:000274986100001
PM 19955330
DA 2024-11-01
ER

PT J
AU Cevoli, S
   Pallotti, F
   La Morgia, C
   Valentino, ML
   Pierangeli, G
   Cortelli, P
   Baruzzi, A
   Montagna, P
   Carelli, V
AF Cevoli, Sabina
   Pallotti, Francesco
   La Morgia, Chiara
   Valentino, Maria L.
   Pierangeli, Giulia
   Cortelli, Pietro
   Baruzzi, Agostino
   Montagna, Pasquale
   Carelli, Valerio
TI High frequency of migraine-only patients negative for the 3243 A&gt;G tRNA<SUP>Leu</SUP> mtDNA mutation in two MELAS families
SO CEPHALALGIA
LA English
DT Article
DE MELAS; CPEO; migraine; oxidative phosphorylation; genetic; stroke-like
ID magnetic-resonance-spectroscopy; mitochondrial-dna; energy-metabolism; point mutation; stroke; brain; headache; neurons; a3243g; aura
AB Migraine is associated with stroke-like episodes in mitochondrial encephalomyopathy, lactic acidosis, stroke-like syndrome (MELAS). Moreover, abnormalities of oxidative phosphorylation are also reported in migraine. We studied two maternal lineages with MELAS and chronic progressive external ophthalmoplegia (CPEO) affected probands carrying the 3243 A>G tRNA(Leu) (MELAS) mutation, remarkable for a high frequency of subjects suffering only migraine. Thus, migraine could be a monosymptomatic expression of the MELAS mutation. We assessed the 3243 A>G tRNA(Leu) mutational load in skeletal muscle and other somatic tissues from the migraine-only subjects, as well as lactic acid levels after exercise. All migraine-only subjects did not carry the MELAS mutation. Muscle biopsy showed mild mitochondrial abnormalities in the non-mutant, migraine-only subjects and, occasionally, abnormal lactic acid. Clear features of mitochondrial myopathy and pathological lactic acid characterised the subjects carrying the MELAS mutation. Our study demonstrates that migraine-only subjects lacked the MELAS mutation, but still had a possible mtDNA-associated genetic predisposition, being maternally related and having some evidence of impaired mitochondrial oxidative phosphorylation.
C1 [Carelli, Valerio] Univ Bologna, Neurogenet Lab, Dept Neurol Sci, I-40123 Bologna, Italy.
   [Pallotti, Francesco] Univ Insubria, Dept Expt & Clin Biomed Sci, Varese, Italy.
C3 University of Bologna; University of Insubria
RP Carelli, V (corresponding author), Univ Bologna, Neurogenet Lab, Dept Neurol Sci, Via Ugo Foscolo 7, I-40123 Bologna, Italy.
EM valerio.carelli@unibo.it
FU Bologna University [RFO-ex]
CR BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   BRESOLIN N, 1991, J NEUROL SCI, V104, P182, DOI 10.1016/0022-510X(91)90308-T
   Buzzi MG, 2000, NEUROLOGY, V54, P1005, DOI 10.1212/WNL.54.4.1005
   CORTELLI P, 1995, LANCET, V345, P1120, DOI 10.1016/S0140-6736(95)90853-6
   Cupini LM, 2003, NEUROLOGY, V60, P717, DOI 10.1212/01.WNL.0000048662.77572.FB
   Di Gennaro G, 2000, HEADACHE, V40, P568, DOI 10.1046/j.1526-4610.2000.00088.x
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Finnila Saara, 2001, MUTATION RESEARCH, V458, P31, DOI 10.1016/S1383-5726(01)00012-7
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GRONSETH GS, 1995, NEUROLOGY, V45, P1263, DOI 10.1212/WNL.45.7.1263
   Haan J, 1999, CEPHALALGIA, V19, P20, DOI 10.1046/j.1468-2982.1999.1901020.x
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   MONTAGNA P, 1995, J NEUROL NEUROSUR PS, V58, P640, DOI 10.1136/jnnp.58.5.640
   MONTAGNA P, 1994, NEUROLOGY, V44, P666, DOI 10.1212/WNL.44.4.666
   Montagna P, 2000, CEPHALALGIA, V20, P3, DOI 10.1046/j.1468-2982.2000.00003.x
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Montagna Pasquale, 2008, EXPERT REV NEUROTHER, V8, P1321, DOI 10.1586/14737175.8.9.1321
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rhode AM, 2007, CEPHALALGIA, V27, P1255, DOI 10.1111/j.1468-2982.2007.01453.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   SHIMOMURA T, 1994, LANCET, V344, P625, DOI 10.1016/S0140-6736(94)92015-X
   Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Watanabe H, 1996, NEUROLOGY, V47, P1093
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Zaki E A, 2009, CEPHALALGIA, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x
NR 40
TC 10
Z9 11
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0333-1024
EI 1468-2982
J9 CEPHALALGIA
JI Cephalalgia
PD AUG 15
PY 2010
VL 30
IS 8
BP 919
EP 927
DI 10.1177/0333102409354654
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 691BB
UT WOS:000285054200005
PM 20656703
DA 2024-11-01
ER

PT J
AU Wojewoda, M
   Duszynski, J
   Szczepanowska, J
AF Wojewoda, Marta
   Duszynski, Jerzy
   Szczepanowska, Joanna
TI Antioxidant defence systems and generation of reactive oxygen species in osteosarcoma cells with defective mitochondria: Effect of selenium
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
DE Mitochondria; NARP; Selenium; ROS; Antioxidant enzyme
ID oxidative stress; narp mutation; human-disease; atp synthase; mtdna; reductase; gene; dna; hydroethidine; thioredoxin
AB Mitochondrial diseases originate from mutations in mitochondrial or nuclear genes encoding for mitochondrial proteome. Neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome is associated with the T8993G transversion in ATP6 gene which results in substitution at the very conservative site in the subunit 6 of mitochondrial ATP synthase. Defects in the mitochondrial respiratory chain and the ATPase are considered to be accompanied by changes in the generation of reactive oxygen species (ROS). This study aimed to elucidate effects of selenium on ROS and antioxidant system of NARP cybrid cells with 98% of T8993G mutation load. We found that selenium decreased ROS generation and increased the level and activity of antioxidant enzymes such as glutathione peroxidase (GPx) and thioredoxin reductase (TrxR). Therefore, we propose selenium to be a promising therapeutic agent not only in the case of NARP syndrome but also other diseases associated with mitochondrial dysfunctions and oxidative stress. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wojewoda, Marta; Duszynski, Jerzy; Szczepanowska, Joanna] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland.
C3 Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences
RP Duszynski, J (corresponding author), M Nencki Inst Expt Biol, Dept Biochem, Pasteura 3, PL-02093 Warsaw, Poland.
EM j.duszynski@nencki.gov.pl; j.szczepanowska@nencki.gov.pl
CR Arnér ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009
   Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029
   Dassa EP, 2008, BIOCHEM BIOPH RES CO, V368, P620, DOI 10.1016/j.bbrc.2008.01.125
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199
   Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006
   Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010
   Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929
   King M P, 1996, METHODS ENZYMOL, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007
   Lee JW, 2006, EXP EYE RES, V82, P816, DOI 10.1016/j.exer.2005.10.003
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Máximo V, 2009, VIRCHOWS ARCH, V454, P481, DOI 10.1007/s00428-009-0766-2
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018
   ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Szczepanowska J, 2004, FEBS LETT, V578, P316, DOI 10.1016/j.febslet.2004.11.022
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026
   Yang JL, 2008, DNA REPAIR, V7, P1110, DOI 10.1016/j.dnarep.2008.03.012
   Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031
NR 34
TC 23
Z9 26
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUN-JUL 15
PY 2010
VL 1797
IS 6-7
BP 890
EP 896
DI 10.1016/j.bbabio.2010.01.035
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 622KV
UT WOS:000279663200034
PM 20138159
DA 2024-11-01
ER

PT J
AU Kayani, AC
   Close, GL
   Dillmann, WH
   Mestril, R
   Jackson, MJ
   McArdle, A
AF Kayani, Anna C.
   Close, Graeme L.
   Dillmann, Wolfgang H.
   Mestril, Ruben
   Jackson, Malcolm J.
   McArdle, Anne
TI Overexpression of HSP10 in skeletal muscle of transgenic mice prevents the age-related fall in maximum tetanic force generation and muscle cross-sectional area
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
LA English
DT Article
DE aging; heat shock protein; Cpn10; Hspe1; atrophy
ID mitochondrial-dna mutations; oxidative stress; lengthening contractions; cytoskeletal disruption; deletion mutations; escherichia-coli; cardiac-muscle; induced injury; protein; hsp60
AB Kayani AC, Close GL, Dillmann WH, Mestril R, Jackson MJ, McArdle A. Overexpression of HSP10 in skeletal muscle of transgenic mice prevents the age-related fall in maximum tetanic force generation and muscle cross-sectional area. Am J Physiol Regul Integr Comp Physiol 299: R268-R276, 2010. First published April 21, 2010; doi: 10.1152/ajpregu.00334.2009.-Skeletal muscle atrophy and weakness are major contributors to frailty and impact significantly on quality of life of older people. Muscle aging is characterized by a loss of maximum tetanic force (P-o) generation, primarily due to muscle atrophy, to which mitochondrial dysfunction is hypothesized to contribute. We hypothesized that lifelong overexpression of the mitochondrial heat shock protein (HSP) HSP10 in muscle of mice would protect against development of these deficits. Po generation by extensor digitorum longus muscles of adult and old wild-type and HSP10-overexpressing mice was determined in situ. Muscles were subjected to damaging lengthening contractions, and force generation was remeasured at 3 h or 28 days to examine susceptibility to, and recovery from, damage, respectively. Muscles of old wild-type mice had a 23% deficit in P-o generation and a 10% deficit in muscle cross-sectional area compared with muscles of adult wild-type mice. Overexpression of HSP10 prevented this age-related fall in Po generation and reduction in cross-sectional area observed in muscles of old wild-type mice. Additionally, overexpression of HSP10 protected against contraction-induced damage independent of age but did not improve recovery if damage occurred. Preservation of muscle force generation and CSA by HSP10 overexpression was associated with protection against the age-related accumulation of protein carbonyls. Data demonstrate that development of age-related muscle weakness may not be inevitable and show, for the first time, that lifelong overexpression of an HSP prevents the age-related loss of Po generation. These findings support the hypothesis that mitochondrial dysfunction is involved in the development of age-related muscle deficits.
C1 [Kayani, Anna C.; Close, Graeme L.; Jackson, Malcolm J.; McArdle, Anne] Univ Liverpool, Pathophysiol Res Unit, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England.
   [Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.
   [Mestril, Ruben] Loyola Univ, Dept Physiol, Chicago, IL 60611 USA.
C3 University of Liverpool; University of California System; University of California San Diego; Loyola University Chicago
RP McArdle, A (corresponding author), Univ Liverpool, Pathophysiol Res Unit, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England.
EM mdcr02@liv.ac.uk
FU Research into Aging; Biotechnology and Biological Sciences Research Council; BBSRC [BB/D014379/1] Funding Source: UKRI; MRC [G0700919, G0400911] Funding Source: UKRI
CR ARMSTRONG RB, 1983, J APPL PHYSIOL, V54, P80, DOI 10.1152/jappl.1983.54.1.80
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROOKS SV, 1990, AM J PHYSIOL, V258, PC436, DOI 10.1152/ajpcell.1990.258.3.C436
   BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279
   Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cappello F, 2003, CANCER LETT, V196, P35, DOI 10.1016/S0304-3835(03)00212-X
   Cappello F, 2003, EUR J HISTOCHEM, V47, P105
   Czarnecka AM, 2006, CELL STRESS CHAPERON, V11, P287, DOI 10.1379/CSC-200.1
   Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   FAULKNER JA, 1995, J GERONTOL A-BIOL, V50, P124
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P927, DOI 10.1093/gerona/glp066
   GETHING MJ, 1997, MOL CHAPERONES PROTE, V0, P0
   GOFF SA, 1984, P NATL ACAD SCI-BIOL, V81, P6647, DOI 10.1073/pnas.81.21.6647
   Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402
   KANDROR O, 1994, J BIOL CHEM, V269, P23575
   Kayani AC, 2008, AM J PHYSIOL-REG I, V294, PR568, DOI 10.1152/ajpregu.00575.2007
   Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X
   Kirkwood TBL, 2002, J INHERIT METAB DIS, V25, P189, DOI 10.1023/A:1015625811569
   Koh TJ, 2004, AM J PHYSIOL-CELL PH, V286, PC713, DOI 10.1152/ajpcell.00341.2003
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   Lieber RL, 1996, J APPL PHYSIOL, V80, P278, DOI 10.1152/jappl.1996.80.1.278
   Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787
   Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, PD12, DOI 10.2741/Liu
   Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520
   MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   McArdle A, 2002, AGEING RES REV, V1, P79, DOI 10.1016/S0047-6374(01)00368-2
   McArdle A, 2004, FASEB J, V18, P0, DOI 10.1096/fj.03-0395fje
   MCCULLY KK, 1986, J APPL PHYSIOL, V61, P293, DOI 10.1152/jappl.1986.61.1.293
   Morton JP, 2006, J APPL PHYSIOL, V101, P176, DOI 10.1152/japplphysiol.00046.2006
   NEWHAM DJ, 1983, J NEUROL SCI, V61, P109, DOI 10.1016/0022-510X(83)90058-8
   Shan YX, 2003, J BIOL CHEM, V278, P45492, DOI 10.1074/jbc.M304498200
   Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vasilaki A, 2007, PROTEOM CLIN APPL, V1, P362, DOI 10.1002/prca.200600702
   ZERBA E, 1990, AM J PHYSIOL, V258, PC429, DOI 10.1152/ajpcell.1990.258.3.C429
NR 43
TC 31
Z9 33
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD JUL 15
PY 2010
VL 299
IS 1
BP R268
EP R276
DI 10.1152/ajpregu.00334.2009
PG 9
WC Physiology
SC Physiology
GA 616FR
UT WOS:000279194900028
PM 20410481
DA 2024-11-01
ER

PT J
AU Bakker, JA
   Schlesser, P
   Smeets, HJM
   Francois, B
   Bierau, J
AF Bakker, Jaap A.
   Schlesser, Patrick
   Smeets, Hubert J. M.
   Francois, Baudouin
   Bierau, Jorgen
TI Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
AB Deficiency of the cytosolic enzyme thymidine phosphorylase (TP) causes a multisystem disorder called mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome. Clinical symptoms are gastrointestinal dysfunction, muscle involvement and neurological deterioration. TP deficiency is biochemically characterised by accumulation of thymidine and deoxyuridine in body fluids and compromised mitochondrial deoxyribose nucleic acid (mtDNA) integrity (depletion and multiple deletions). In this report we describe a patient with the clinical and biochemical features related to the end stage of the disease. Home parenteral nutrition had started to improve the clinical condition and preparations were initiated for stem cell transplantation (SCT) as a last resort treatment. Unfortunately, the patient died during the induction phase of SCT. This report shows that TP deficiency is a severe clinical condition with a broad spectrum of affected tissues. TP deficiency can be easily determined by the measurement of pyrimidine metabolites in body fluids and TP activity in peripheral blood leucocytes. Early detection and treatment may prevent the progress of the clinical symptoms and, therefore, should be considered for inclusion in newborn screening programmes.
C1 [Bakker, Jaap A.; Bierau, Jorgen] Maastricht Univ, Med Ctr, Dept Clin Genet, Lab Biochem Genet, NL-6229 HX Maastricht, Netherlands.
   [Schlesser, Patrick; Francois, Baudouin] CHC Clin Esperance, Dept Paediat, Montegnee Liege, Belgium.
   [Smeets, Hubert J. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, Clin Genom Unit, NL-6229 HX Maastricht, Netherlands.
C3 Maastricht University; Maastricht University
RP Bakker, JA (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Genet, Lab Biochem Genet, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.
EM jaap.bakker@gen.unimaas.nl
CR Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Fairbanks LD, 2002, J INHERIT METAB DIS, V25, P603, DOI 10.1023/A:1022007827133
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   la Marca G, 2006, J MASS SPECTROM, V41, P586, DOI 10.1002/jms.1013
   Laforce R, 2009, CLIN NEUROL NEUROSUR, V111, P691, DOI 10.1016/j.clineuro.2009.05.005
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002
   Teitelbaum JE, 2002, J PEDIATR GASTR NUTR, V35, P377, DOI 10.1097/00005176-200209000-00029
   Temmink OH, 2007, INT J BIOCHEM CELL B, V39, P565, DOI 10.1016/j.biocel.2006.10.009
   van Kuilenburg ABP, 2005, J CHROMATOGR B, V820, P271, DOI 10.1016/j.jchromb.2005.04.009
   VanKuilenburg ABP, 1997, J INHERIT METAB DIS, V20, P331, DOI 10.1023/A:1005305323052
NR 19
TC 6
Z9 6
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD DEC 15
PY 2010
VL 33
IS 
BP S139
EP S143
DI 10.1007/s10545-010-9049-y
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA V33ME
UT WOS:000209022100021
PM 20151198
DA 2024-11-01
ER

PT J
AU Scuderi, C
   Borgione, E
   Castello, F
   Lo Giudice, M
   Fichera, M
   Elia, M
   Amato, C
   Savio, M
   Di Blasi, FD
   Vitello, GA
   Romano, S
   DiMauro, S
   Musumeci, SA
AF Scuderi, Carmela
   Borgione, Eugenia
   Castello, Filippa
   Lo Giudice, Mariangela
   Fichera, Marco
   Elia, Maurizio
   Amato, Carmelo
   Savio, Maria
   Di Blasi, Francesco Domenico
   Vitello, Girolamo Aurelio
   Romano, Salvatore
   DiMauro, Salvatore
   Musumeci, Sebastiano Antonino
TI Coexistence of mitochondrial and nuclear DNA mutations in a woman with mitochondrial encephalomyopathy and double cortex
SO MITOCHONDRION
LA English
DT Article
DE DCX; m.3243A > G; Mitochondrial disorders; Mental retardation
ID subcortical band heterotopia; lactic-acidosis; neuronal migration; episodes melas; encephalopathy; brain; gene; deficiency; dcx; disturbances
AB We describe a 16-year-old girl with mental retardation, myoclonic epilepsy, ataxia, mitochondrial myopathy, sensorineural hearing loss, lactic acidosis, and MRI evidence of diffuse subcortical laminar heterotopia and agyria/pachygyria. Restriction fragment length polymorphism (RFLP) and DNA sequence analyses revealed two pathogenic mutations: a heteroplasmic m.3243A > G in muscle and blood, and a new heterozygous insertion at nt697 in the doublecortin gene (DCX), resulting in a frameshift after amino acid residue 232, with a premature stop codon at amino acid residue 244. This is yet another example of genetic "double trouble" resulting in a complex phenotype. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Scuderi, Carmela; Borgione, Eugenia; Castello, Filippa; Lo Giudice, Mariangela] IRCCS Oasi Maria SS, Unita Operat Malattie Neuromuscolari, I-94018 Troina, EN, Italy.
   [Fichera, Marco] IRCCS Oasi Maria SS, Lab Diagnosi Genet, Troina, Italy.
   [Amato, Carmelo] IRCCS Oasi Maria SS, Unita Operat Neuroradiol, Troina, Italy.
   [Savio, Maria; Di Blasi, Francesco Domenico] IRCCS Oasi Maria SS, Unita Operat Psicol, Troina, Italy.
   [Vitello, Girolamo Aurelio; Romano, Salvatore; Musumeci, Sebastiano Antonino] IRCCS Oasi Maria SS, Unita Operat Neurol Ritardo Mentale, Troina, Italy.
   [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
C3 IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; Columbia University
RP Scuderi, C (corresponding author), IRCCS Oasi Maria SS, Unita Operat Malattie Neuromuscolari, V Conte Ruggero 73, I-94018 Troina, EN, Italy.
EM cscuderi@oasi.en.it
CR BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409
   Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127
   Cai Y, 2009, EXP NEUROL, V216, P342, DOI 10.1016/j.expneurol.2008.12.008
   Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071
   Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Damian MS, 1996, AM J MED GENET, V62, P398, DOI 10.1002/(SICI)1096-8628(19960424)62:4<398::AID-AJMG13>3.0.CO;2-J
   des Portes V, 1998, CELL, V92, P51
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5
   Gressens P, 2000, PEDIATR RES, V48, P725, DOI 10.1203/00006450-200012000-00004
   Griffiths R, 1984, THE ABILITIES OF YOUNG CHILDREN: A COMPREHENSIVE SYSTEM OF MENTAL MEASUREMENT FOR THE FIRST EIGHT YEARS OF LIFE (REVISED EDITION), V0, P0
   Keng WT, 2003, DEV MED CHILD NEUROL, V45, P704
   Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909
   Leger PL, 2008, NEUROGENETICS, V9, P277, DOI 10.1007/s10048-008-0141-5
   Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nissenkorn A, 2001, NEUROLOGY, V56, P1265, DOI 10.1212/WNL.56.10.1265
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Poolos NP, 2002, NEUROLOGY, V58, P1559, DOI 10.1212/WNL.58.10.1559
   Roid GH, 1997, LEITER INT PERFORMAN, V0, P0
   ROSEN CD, 1996, BRAIN RES, V15, P71
   Ross ME, 1997, HUM MOL GENET, V6, P555, DOI 10.1093/hmg/6.4.555
   Rusanen H, 2002, CELL MOTIL CYTOSKEL, V53, P231, DOI 10.1002/cm.10066
   Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   Wagner OI, 2003, J NEUROSCI, V23, P9046
   Wechsler D, 1997, WECHSLER ADULT INTELLIGENCE SCALE - FOURTH EDITION (WAIS-IV), V0, P0
NR 34
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD AUG 15
PY 2010
VL 10
IS 5
BP 548
EP 554
DI 10.1016/j.mito.2010.04.004
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 640LA
UT WOS:000281051500018
PM 20433951
DA 2024-11-01
ER

PT J
AU Cardaioli, E
   Da Pozzo, P
   Malfatti, E
   Battisti, C
   Gallus, GN
   Gaudiano, C
   Macucci, M
   Malandrini, A
   Margollicci, M
   Rubegni, A
   Dotti, MT
   Federico, A
AF Cardaioli, Elena
   Da Pozzo, Paola
   Malfatti, Edoardo
   Battisti, Carla
   Gallus, Gian Nicola
   Gaudiano, Carmen
   Macucci, Marco
   Malandrini, Alessandro
   Margollicci, Maria
   Rubegni, Anna
   Dotti, Maria Teresa
   Federico, Antonio
TI A second MNGIE patient without typical mitochondrial skeletal muscle involvement
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Thymidine phosphorylase gene; MNGIE syndrome; mtDNA; Muscle biopsy
ID neurogastrointestinal encephalomyopathy mngie; thymidine phosphorylase; mutations; siblings; disorder
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disease caused by mutations in the gene encoding thymidine phosphorylase (TYMP). Clinically, MNGIE is characterized by gastrointestinal dysmotility, cachexia, ptosis, ophthalmoparesis, peripheral neuropathy and leukoencephalopathy. Most MNGIE patients have signs of mitochondrial dysfunction in skeletal muscle at morphological and enzyme level, as well as mitochondrial DNA depletion, multiple deletions and point mutations. A case without mitochondrial skeletal muscle involvement and with a TYMP splice-acceptor site mutation (c. 215-1 G > C) has been reported. Here, we describe an Italian patient with the same mutation and without mitochondrial skeletal muscle involvement, suggesting a possible genotype-phenotype correlation.
C1 [Cardaioli, Elena; Da Pozzo, Paola; Malfatti, Edoardo; Battisti, Carla; Gallus, Gian Nicola; Gaudiano, Carmen; Malandrini, Alessandro; Rubegni, Anna; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Macucci, Marco] S Giuseppe Hosp, Neurol Unit, Florence, Italy.
   [Margollicci, Maria] Univ Siena, Paediat Sect, Dept Paediat Obstet & Reprod Med, I-53100 Siena, Italy.
C3 University of Siena; University of Siena
RP Federico, A (corresponding author), Univ Siena, Dept Neurol Neurosurg & Behav Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
FU University of Siena
CR Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Debouverie M, 1997, REV NEUROL, V153, P547
   Hamano H, 1997, RINSHO SHINKEIGAKU, V37, P917
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Nishino I, 2000, ANN NEUROL, V47, P792
   Schuepbach WMM, 2007, J NEUROL, V254, P146, DOI 10.1007/s00415-006-0255-3
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   van Adel Brian A, 2009, J CLIN NEUROMUSCUL DIS, V10, P97, DOI 10.1097/CND.0b013e3181903126
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
NR 12
TC 15
Z9 16
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1590-1874
EI 
J9 NEUROL SCI
JI Neurol. Sci.
PD AUG 15
PY 2010
VL 31
IS 4
BP 491
EP 494
DI 10.1007/s10072-010-0225-5
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 624RK
UT WOS:000279837500012
PM 20232099
DA 2024-11-01
ER

PT J
AU Swiderska, N
   Appleton, R
   Morris, A
   Isherwood, D
   Selby, A
AF Swiderska, Nina
   Appleton, Richard
   Morris, Andrew
   Isherwood, David
   Selby, Andrew
TI A Novel Presentation of Inappropriate Antidiuretic Hormone Secretion in Leigh Syndrome With the Myoclonic Epilepsy and Ragged Red Fibers, Mitochondrial DNA 8344A&gt;G Mutation
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Leigh syndrome; mitochondrial cytopathy; mitochondrial DNA; myoclonic epilepsy with ragged red fibers; inappropriate antidiuretic hormone secretion
ID clinical-features; a8344g mutation; merrf mutation; disease
AB A 17-month-old infant presented with a 2-week history of lethargy, anorexia, and an abnormal respiratory pattern on a previous 4-month history of hypotonia and gross motor delay, suggesting a clinical phenotype of Leigh syndrome. The patient experienced no epileptic seizures. Biochemical investigations were normal other than showing evidence of inappropriate secretion of antidiuretic hormone, and cerebral magnetic resonance imaging (MRI) showed symmetrical lesions in the cervical cord and lower brain stem. Initial screening investigations for a mitochondrial cytopathy were negative. Muscle histochemistry demonstrated reduced staining of cytochrome c oxidase but no ragged red fibers. Blood and muscle-derived DNA demonstrated a high level (92% and 82%, respectively) of the m.8344A>G mutation seen in patients with the mitochondrial cytopathy, "myoclonic epilepsy with ragged red fibers on muscle biopsy." This infant's early presentation including inappropriate antidiuretic secretion due to presumed renal salt loss and rapid course appears to be unique to this mutation.
C1 [Swiderska, Nina] Alder Hey Childrens NHS Fdn Trust, Roald Dahl EEG Dept, Paediat Neurosci Fdn, Liverpool L12 2AP, Merseyside, England.
   [Morris, Andrew] Royal Manchester Childrens Hosp, Willink Metab Unit, Manchester M27 1HA, Lancs, England.
   [Isherwood, David] Alder Hey Childrens NHS Fdn Trust, Dept Biochem, Liverpool L12 2AP, Merseyside, England.
   [Selby, Andrew] Alder Hey Childrens NHS Fdn Trust, Intens Care Unit, Liverpool L12 2AP, Merseyside, England.
C3 Alder Hey Children's NHS Foundation Trust; Royal Manchester Children's Hospital; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust
RP Swiderska, N (corresponding author), Alder Hey Childrens NHS Fdn Trust, Roald Dahl EEG Dept, Paediat Neurosci Fdn, Eaton Rd, Liverpool L12 2AP, Merseyside, England.
EM ninaswiderska@hotmail.com
CR Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Kubota H, 2005, J CHILD NEUROL, V20, P116, DOI 10.1177/08830738050200020601
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Santorelli FM, 1998, ANN NEUROL, V44, P962, DOI 10.1002/ana.410440616
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Southgate HJ, 2000, ANN CLIN BIOCHEM, V37, P805, DOI 10.1258/0004563001900002
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Yasaki E, 2001, NEUROPEDIATRICS, V32, P299
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
NR 12
TC 6
Z9 7
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 
J9 J CHILD NEUROL
JI J. Child Neurol.
PD JUN 15
PY 2010
VL 25
IS 6
BP 782
EP 785
DI 10.1177/0883073809347594
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 600QC
UT WOS:000278001000023
PM 20332385
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Chamkha, I
   Kammoun, T
   Chabchoub, I
   Aloulou, H
   Fendri, N
   Hachicha, M
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Chamkha, Imen
   Kammoun, Thouraya
   Chabchoub, Imen
   Aloulou, Hajer
   Fendri, Nourhene
   Hachicha, Mongia
   Fakhfakh, Faiza
TI A case of Kearns-Sayre syndrome with two novel deletions (9.768 and 7.253 kb) of the mtDNA associated with the common deletion in blood leukocytes, buccal mucosa and hair follicles
SO MITOCHONDRION
LA English
DT Article
DE Kearns-Sayre syndrome; mtDNA deletion; Mitochondrial DNA; Heteroplasmy; Long-range PCR; Common deletion
ID mitochondrial-dna deletions; hereditary optic neuropathy; progressive external ophthalmoplegia; mutations; heart; disease; patient; genome
AB Kearns-Sayre syndrome is a mitochondrial disorder characterized by the emergence before the age of 20 years of progressive external ophthalmoplegia, pigmentary retinopathy, with other heterogeneous clinical manifestations. Generally, mitochondria! DNA deletions were associated with KSS but the size and position of these deletions differ among patients. This study reported a Tunisian patient with typical features of KSS. Long-range PCR amplification of the mtDNA in different tissues from this patient showed multiple mitochondrial deletions: two novel 9.768 and 7.253 kb deletions spanning respectively nucleotides 6124-15,893 and 8572-15,826 associated with the common 4.977 kb deletion. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Mkaouar-Rebai, Emna; Chamkha, Imen; Fendri, Nourhene; Fakhfakh, Faiza] Fac Med Sfax, Human Mol Genet Lab, Sfax 3029, Tunisia.
   [Kammoun, Thouraya; Chabchoub, Imen; Aloulou, Hajer; Hachicha, Mongia] CHU Habib Bourguiba Sfax, Serv Pediat, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Hopital Habib Bourguiba
RP Mkaouar-Rebai, E (corresponding author), Fac Med Sfax, Human Mol Genet Lab, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com
FU Tunisian Ministry of Higher Education, Scientific Research and Technology
CR Abu-Amero KK, 2008, MOL VIS, V14, P29
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BLOK RB, 1995, HUM GENET, V95, P75
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   BROWN MD, 1994, AM J HUM GENET, V55, P410
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Fromenty B, 1997, AM J MED GENET, V71, P443, DOI 10.1002/(SICI)1096-8628(19970905)71:4<443::AID-AJMG14>3.0.CO;2-G
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KIYOMOTO BH, 1997, J NEUROL SCI, V25, P160
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   MIYABAYASHI S, 1991, J INHERIT METAB DIS, V14, P805, DOI 10.1007/BF01799954
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MULLERHOCKER J, 1992, HUM PATHOL, V23, P1431, DOI 10.1016/0046-8177(92)90065-B
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   OOSTRA RJ, 1995, AM J HUM GENET, V57, P954
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Toth T, 1998, CLIN GENET, V53, P210
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 38
TC 13
Z9 16
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 
J9 MITOCHONDRION
JI Mitochondrion
PD AUG 15
PY 2010
VL 10
IS 5
BP 449
EP 455
DI 10.1016/j.mito.2010.04.003
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 640LA
UT WOS:000281051500006
PM 20388556
DA 2024-11-01
ER

PT J
AU Wong, LJC
   Scaglia, F
   Graham, BH
   Craigen, WJ
AF Wong, Lee-Jun C.
   Scaglia, Fernando
   Graham, Brett H.
   Craigen, William J.
TI Current molecular diagnostic algorithm for mitochondrial disorders
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Mitochondrial disorder; mtDNA mutation; mtDNA depletion; mtDNA deletion
ID respiratory-chain disorders; coenzyme q(10) deficiency; c-oxidase deficiency; dna depletion; complex-i; oxidative-phosphorylation; clinical spectrum; sucla2 mutations; lactic-acidosis; mtdna mutation
AB Mitochondrial respiratory chain disorders (RCD) are a group of genetically and clinically heterogeneous diseases, clue in part to the biochemical complexity of mitochondrial respiration and the fact that two genomes, one mitochondrial and one nuclear, encode the components of the respiratory chain. Because of the large number of genes involved, attempts to classify mitochondrial RCD incorporate clinical, biochemical, and histological criteria, in addition to DNA-based molecular diagnostic testing. While molecular testing is widely viewed as definitive, confirmation of the diagnosis by molecular methods often remains a challenge because of the large number of genes, the two genome complexity and the varying proportions of pathogenic mitochondrial DNA (mtDNA) molecules in a patient, a concept termed heteroplasmy. The selection of genes to be analyzed depends on the family history and clinical, biochemical, histopathological, and imaging results, as well as the availability of different tissues for analysis. Screening of common point mutations and large deletions in mtDNA is typically the first step. In cases where tissue-specific, recognizable clinical syndromes or characteristic RC complex deficiencies and histochemical abnormalities are observed, direct sequencing of the specific causative nuclear gene(s) can be performed on white blood cell DNA. Measurement of mtDNA content in affected tissues such as muscle and liver allows screening for mtDNA depletion syndromes. The ever-expanding list of known disease-causing genes will undoubtedly improve diagnostic accuracy and genetic counseling. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Wong, Lee-Jun C.; Scaglia, Fernando; Graham, Brett H.; Craigen, William J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chretien D, 2003, J INHERIT METAB DIS, V26, P189, DOI 10.1023/A:1024437201166
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hui J, 2006, DEV MED CHILD NEUROL, V48, P132, DOI 10.1017/S0012162206000284
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Jaksch M, 2001, J MED GENET, V38, P665, DOI 10.1136/jmg.38.10.665
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PoggiTravert F, 1996, J INHERIT METAB DIS, V19, P478, DOI 10.1007/BF01799109
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Wong LJC, 2004, MUSCLE NERVE, V30, P118, DOI 10.1002/mus.20045
   Wong LJC, 2003, J MED GENET, V40, P0
NR 48
TC 50
Z9 54
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUN 15
PY 2010
VL 100
IS 2
BP 111
EP 117
DI 10.1016/j.ymgme.2010.02.024
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 601SP
UT WOS:000278084600002
PM 20359921
DA 2024-11-01
ER

PT J
AU Hassani, A
   Horvath, R
   Chinnery, PF
AF Hassani, Adam
   Horvath, Rita
   Chinnery, Patrick F.
TI Mitochondrial myopathies: developments in treatment
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Article
DE coenzyme Q10; exercise training; mitochondrial myopathies; peroxisome proliferator-activated receptor/peroxisome proliferator-activated receptor-gamma coactivator-1 alpha pathway; treatment
ID c-oxidase deficiency; respiratory-chain; l-arginine; ketogenic diet; coenzyme q(10); exercise; muscle; mtdna; activation; depletion
AB Purpose of review Treatment options for mitochondrial myopathies remain limited despite rapid advances in the understanding of the molecular basis of these conditions. Existing therapies continue to be evaluated and novel treatment strategies are starting to appear on the horizon. Recent findings Exercise training continues to show promise as a method of improving exercise tolerance and enhancing oxidative capacity. Coenzyme Q10 deficiency appears to be a relatively common finding in mitochondrial disorders and is likely to benefit from exogenous supplementation. Large-scale randomized clinical trials to evaluate these treatment options are now underway and this represents one of the most important developments in recent years. Activation of the peroxisome proliferator-activated receptor/peroxisome proliferator-activated receptor-gamma coactivator-1 alpha pathway has been shown to induce mitochondrial biogenesis leading to a delayed onset of myopathy and prolonged lifespan in mouse models. A ketogenic diet has also been found to induce mitochondrial biogenesis in mice with mitochondrial myopathy. Summary Therapeutic trials of exercise training and coenzyme Q10 supplementation should continue to be offered to patients with mitochondrial myopathies pending the results of evaluation in randomized clinical trials. Further investigation of peroxisome proliferator-activated receptor/peroxisome proliferator-activated receptor-g coactivator-1a pathway activation, ketogenic diets and other new strategies is required.
C1 [Hassani, Adam; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Human Genet, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Human Genet, Mitochondrial Res Grp, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
FU Medical Research Council (UK); UK Parkinson's Disease Society; Association Francaise contre les Myopathies; UK NIHR Biomedical Research Centre for Ageing and Age-related disease; RVI/NGH; Newcastle upon Tyne Hospitals NHS Charity [RES0211/7262]; Academy of Medical Sciences, UK [BH090164]; MRC [G0601943] Funding Source: UKRI
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   *COL U, 2009, NCT00887562 NLM COL, V0, P0
   Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   HALTER J, 2010, BONE MARROW TRA 0503, V0, P0
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirata K, 2008, BRAIN DEV-JPN, V30, P238, DOI 10.1016/j.braindev.2007.08.007
   Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Janssen RJRJ, 2009, HUM MOL GENET, V18, P3365, DOI 10.1093/hmg/ddp276
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Moutaouakil F, 2009, REV NEUROL-FRANCE, V165, P482, DOI 10.1016/j.neurol.2008.08.006
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   *NIAMS, 2009, NCT00457314 NLM, V0, P0
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   SCHREUDER LT, 2010, INHERIT METAB D 0505, V0, P0
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   *U FL, 2009, NCT00432744 NLM U FL, V0, P0
   Voet NBM, 2010, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003907.pub3
   Wang YL, 2002, J BIOL CHEM, V277, P31781, DOI 10.1074/jbc.M204279200
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 62
TC 29
Z9 30
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT 15
PY 2010
VL 23
IS 5
BP 459
EP 465
DI 10.1097/WCO.0b013e32833d1096
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 647LR
UT WOS:000281620500003
PM 20651591
DA 2024-11-01
ER

PT J
AU McHugh, JC
   Lonergan, R
   Howley, R
   O'Rourke, K
   Taylor, RW
   Farrell, M
   Hutchinson, M
   Connolly, S
AF McHugh, John C.
   Lonergan, Roisin
   Howley, Rachel
   O'Rourke, Killian
   Taylor, Robert W.
   Farrell, Michael
   Hutchinson, Michael
   Connolly, Sean
TI SENSORY ATAXIC NEUROPATHY DYSARTHRIA AND OPHTHALMOPARESIS (SANDO) IN A SIBLING PAIR WITH A HOMOZYGOUS p.A467T <i>POLG</i> MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE dysarthria; mitochondrial disease; ophthalmoparesis; polymerase gamma; SANDO; sensory ataxic neuropathy
ID mitochondrial-dna deletions; external ophthalmoplegia; antibody; spectrum; dominant; twinkle; a467t; ant1
AB Two siblings who developed fifth-decade-onset, concurrent progressive sensory ataxia, dysarthria, and ophthalmoparesis were found to be homozygous for the p.A467T mutation of the polymerase gamma (POLG) gene. The clinical course in both subjects was progression to severe disability. The enlarging spectrum of sensory ataxic neuropathies associated with mitochondrial DNA (mtDNA) instability and POLG mutations should be recognized and considered in the differential diagnosis of this unusual presentation. Muscle Nerve 41: 265-269, 2010
C1 [McHugh, John C.; Lonergan, Roisin; O'Rourke, Killian; Hutchinson, Michael; Connolly, Sean] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
   [McHugh, John C.; Lonergan, Roisin; O'Rourke, Killian; Hutchinson, Michael; Connolly, Sean] St Vincents Univ Hosp, Dept Clin Neurophysiol, Dublin 4, Ireland.
   [Howley, Rachel; Farrell, Michael] Beaumont Hosp, Neuropathol Lab, Dublin 9, Ireland.
   [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; Newcastle University - UK
RP McHugh, JC (corresponding author), St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
EM drjohnmchugh@ireland.com
FU Wellcome Trust [074454] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Camdessanché JP, 2002, BRAIN, V125, P166, DOI 10.1093/brain/awf006
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Isoardo G, 2004, ACTA NEUROL SCAND, V109, P188, DOI 10.1034/j.1600-0404.2003.00203.x
   Kuntzer T, 2004, MUSCLE NERVE, V30, P255, DOI 10.1002/mus.20100
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Notturno F, 2008, MUSCLE NERVE, V37, P265, DOI 10.1002/mus.20875
   SCHAUMBURG H, 1983, NEW ENGL J MED, V309, P445, DOI 10.1056/NEJM198308253090801
   Taylor RW, 2000, METH MOLEC MED, V38, P245, DOI 10.1385/1-59259-070-5:245
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 24
TC 12
Z9 16
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD FEB 15
PY 2010
VL 41
IS 2
BP 265
EP 269
DI 10.1002/mus.21494
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 550LZ
UT WOS:000274130700019
PM 19813183
DA 2024-11-01
ER

PT J
AU Lesko, N
   Naess, K
   Wibom, R
   Solaroli, N
   Nennesmo, I
   von Döbeln, U
   Karlsson, A
   Larsson, NG
AF Lesko, Nicole
   Naess, Karin
   Wibom, Rolf
   Solaroli, Nicola
   Nennesmo, Inger
   von Doebeln, Ulrika
   Karlsson, Anna
   Larsson, Nils-Goeran
TI Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA; mtDNA depletion; Thymidine kinase-2 mutations
ID mitochondrial-dna depletion
AB Deficiency of thymidine kinase-2 (TK2) has been described in children with early onset fatal skeletal myopathy. TK2 is a mitochondrial deoxyribonucleoside kinase required for the phosphorylation of deoxycytidine and deoxythymidine and hence is vital for the maintenance of a balanced mitochondrial dNTP pool in post-mitotic tissues. We describe a patient with two novel TK2 mutations, which caused disease onset shortly after birth and death at the age of three months. One mutation (219insCG) generated an early stop codon, thus preventing the synthesis of a functional protein. The second mutation (R130W) resulted in an amino acid substitution, which caused a severe reduction (< 3%) of TK2 enzyme activity. These two novel TK2 mutations cause an extremely severe phenotype with overwhelming central nervous system symptoms not commonly seen in patients with TK2-deficiency. We conclude that the severe clinical presentation in this patient was due to a virtual lack of mitochondrial TK2 activity. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Lesko, Nicole; Naess, Karin; Wibom, Rolf; Solaroli, Nicola; Nennesmo, Inger; von Doebeln, Ulrika; Karlsson, Anna; Larsson, Nils-Goeran] Karolinska Inst, Div Metab Dis, Dept Lab Med, S-14186 Stockholm, Sweden.
   [Naess, Karin] Karolinska Inst, Dept Clin Sci, S-14186 Stockholm, Sweden.
   [Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
C3 Karolinska Institutet; Karolinska Institutet; Max Planck Society
RP Lesko, N (corresponding author), Karolinska Inst, Div Metab Dis, Dept Lab Med, S-14186 Stockholm, Sweden.
EM Nicole.Lesko@karolinska.se
FU Swedish Research Council; Swedish Heart and Lung Foundation; Stockholm County Council
CR Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
NR 8
TC 31
Z9 37
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAR 15
PY 2010
VL 20
IS 3
BP 198
EP 203
DI 10.1016/j.nmd.2009.11.013
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 584NK
UT WOS:000276759100008
PM 20083405
DA 2024-11-01
ER

PT J
AU Echaniz-Laguna, A
   Chassagne, M
   de Sèze, J
   Mohr, M
   Clerc-Renaud, P
   Tranchant, C
   de Camaret, BM
AF Echaniz-Laguna, Andoni
   Chassagne, Maite
   de Seze, Jerome
   Mohr, Michel
   Clerc-Renaud, Pascale
   Tranchant, Christine
   de Camaret, Benedicte Mousson
TI <i>POLG1</i> Variations Presenting as Multiple Sclerosis
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID mutations
AB Objective: To describe 2 unrelated patients with novel variations in the POLG1 gene and features undistinguishable from multiple sclerosis, ie, optic neuritis, brain white matter hyperintense areas, and unmatched cerebrospinal fluid oligoclonal bands. Design: Case report. Setting: University hospital. Patients: Both patients subsequently developed bilateral ophthalmoplegia, ptosis, myopathy, cardiomyopathy, ataxia, dysphagia, and hearing and cognitive impairment. Main Outcome Measures: Detailed clinical and laboratory examinations including brain magnetic reso-nance imaging, morphological analysis of a muscle biopsy, characterization of mitochondrial DNA integrity, sequencing of the POLG1 gene, and screening of control subjects for POLG1 sequence variants. Results: Ragged red fibers and multiple deletions of mitochondrial DNA were detected in the skeletal muscle. Four compound heterozygous variations, including 3 previously unreported, were identified in POLG1. Conclusion: Clinicians should be aware of the existence of POLG1-related multiple sclerosis like illness, as it has important implications for management, treatment, and genetic counseling.
C1 [Echaniz-Laguna, Andoni; de Seze, Jerome; Tranchant, Christine] Hop Civil, Dept Neurol, F-67091 Strasbourg, France.
   [Echaniz-Laguna, Andoni] INSERM, Fac Med, U692, Strasbourg, France.
   [Chassagne, Maite; Clerc-Renaud, Pascale; de Camaret, Benedicte Mousson] CHU Lyon, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, Bron, France.
   [Mohr, Michel] Hop Hautepierre, Dept Anatomopathol, Strasbourg, France.
C3 CHU Strasbourg; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg
RP Echaniz-Laguna, A (corresponding author), Hop Civil, Dept Neurol, BP 426, F-67091 Strasbourg, France.
EM andoni.echaniz-laguna@chru-strasbourg.fr
CR Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
NR 7
TC 28
Z9 28
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
EI 
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD SEP 15
PY 2010
VL 67
IS 9
BP 1140
EP 1143
DI 
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 653OW
UT WOS:000282102800016
PM 20837861
DA 2024-11-01
ER

PT J
AU Li, YF
   Li, HZ
   Hu, PQ
   Deng, J
   Banoei, MM
   Sharma, LK
   Bai, YD
AF Li, Youfen
   Li, Hong-Zhi
   Hu, Peiqing
   Deng, Janice
   Banoei, Mohammad Mehdi
   Sharma, Lokendra Kumar
   Bai, Yidong
TI Generation and bioenergetic analysis of cybrids containing mitochondrial DNA from mouse skeletal muscle during aging
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID deletion mutations; nadh dehydrogenase; human-cells; mtdna; fibers; abnormality; restriction; sarcopenia; rat; complementation
AB Mitochondrial respiratory chain defects have been associated with various diseases and normal aging, particularly in tissues with high energy demands including skeletal muscle. Muscle-specific mitochondrial DNA (mtDNA) mutations have also been reported to accumulate with aging. Our understanding of the molecular processes mediating altered mitochondrial gene expression to dysfunction associated with mtDNA mutations in muscle would be greatly enhanced by our ability to transfer muscle mtDNA to established cell lines. Here, we report the successful generation of mouse cybrids carrying skeletal muscle mtDNA. Using this novel approach, we performed bioenergetic analysis of cells bearing mtDNA derived from young and old mouse skeletal muscles. A significant decrease in oxidative phosphorylation coupling and regulation capacity has been observed with cybrids carrying mtDNA from skeletal muscle of old mice. Our results also revealed decrease growth capacity and cell viability associated with the mtDNA derived from muscle of old mice. These findings indicate that a decline in mitochondrial function associated with compromised mtDNA quality during aging leads to a decrease in both the capacity and regulation of oxidative phosphorylation.
C1 [Li, Youfen; Li, Hong-Zhi; Hu, Peiqing; Deng, Janice; Banoei, Mohammad Mehdi; Sharma, Lokendra Kumar; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Li, Youfen] Xi An Jiao Tong Univ, Sch Life Sci, Xian 710049, Peoples R China.
   [Li, Hong-Zhi] Wenzhou Med Coll, Sch Life Sci, Wenzhou 325035, Peoples R China.
C3 University of Texas System; University of Texas Health Science Center at San Antonio; Xi'an Jiaotong University; Wenzhou Medical University
RP Bai, YD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
EM baiy@uthscsa.edu
FU National Institute of Aging/National Institutions of Health [R01 AG025223, R03AG024640]
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X
   Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026
   Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848
   Bai YD, 2005, ANN NY ACAD SCI, V1042, P25, DOI 10.1196/annals.1338.003
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Inoue K, 1997, J BIOL CHEM, V272, P15510, DOI 10.1074/jbc.272.24.15510
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, PF1751, DOI 10.1152/ajprenal.00307.2006
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Miquel J, 1992, EXS, V62, P47
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MORGANHUGHES JA, 1994, CURR OPIN NEUROL, V7, P457, DOI 10.1097/00019052-199410000-00014
   NAVARRO A, 2001, FRONT BIOSCI, V6, P26
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483
NR 40
TC 7
Z9 8
U1 1
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 15
PY 2010
VL 38
IS 6
BP 1913
EP 1921
DI 10.1093/nar/gkp1162
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 578PB
UT WOS:000276304600023
PM 20022917
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Murri, L
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Murri, Luigi
   Siciliano, Gabriele
TI MITOCHONDRIAL DNA-RELATED RESPIRATORY CHAIN DISORDERS: FROM DIAGNOSTIC TO TREATMENT APPROACHES
SO MITOCHONDRIA: STRUCTURE, FUNCTIONS AND DYSFUNCTIONS
LA English
DT Article; Book Chapter
ID skeletal-muscle; external ophthalmoplegia; glutathione deficiency; creatine monohydrate; forearm exercise; double-blind; lipoic acid; mtdna; mutation; disease
AB Mitochondrial diseases (MD) are disorders caused by impairment of the mitochondrial respiratory chain, or electron transport chain (ETC). The genetic error can affect mitochondrial (mtDNA) or nuclear DNA (nDNA). Clinical phenotypes are polymorphic and range from pure myopathies to multisystemic disorders. The estimated prevalence of MD is 1-2 in 10000, which makes them among the commonest inherited neuromuscular disorders. At present, the diagnosis of MD requires a complex approach, including clinical and family data, measurement of serum lactate, exercise testing, electromyography, muscle histology and enzymology, and genetic analysis. Ragged red fibers, ragged blue fibers and cytochrome c oxidase (COX)-negative fibers are pathological hallmarks. However, reliable biomarkers for these disorders are still needed. Because mtDNA genes encode subunits of the mitochondrial ETC, oxidative base modifications to mtDNA can lead to bioenergetic dysfunctions, thus generating a vicious cycle of mitochondrial dysfunction, increased oxidative stress, and cellular death. The treatment of MD is still inadequate. Therapies that have been attempted include ETC cofactors, other metabolites secondarily decreased in MD, antioxidants and agents acting on lactic acidosis. However, their role in the treatment of the majority of MD remains unclear. This chapter reviews the diagnostic and therapeutic approaches to mtDNA-related disorders.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Murri, Luigi; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Dept Neurosci, I-56126 Pisa, Italy.
C3 University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Neurosci, Via Roma 67, I-56126 Pisa, Italy.
EM mmancuso@inwind.it
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Bardia A, 2008, MAYO CLIN PROC, V83, P23, DOI 10.4065/83.1.23
   Barshop BA, 2004, MITOCHONDRION, V4, P521, DOI 10.1016/j.mito.2004.07.010
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Bonakdar RA, 2005, AM FAM PHYSICIAN, V72, P1065
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Burke DG, 2003, INT J SPORT NUTR EXE, V13, P294, DOI 10.1123/ijsnem.13.3.294
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Capaldi RA, 2004, MITOCHONDRION, V4, P417, DOI 10.1016/j.mito.2004.07.006
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Guy J, 2008, MOL VIS, V14, P2443
   Hanisch F, 2006, J NEUROL, V253, P735, DOI 10.1007/s00415-006-0101-7
   Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jeppesen TD, 2003, J NEUROL, V250, P293, DOI 10.1007/s00415-003-0993-4
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, PC658, DOI 10.1152/ajpcell.00224.2006
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Kyriacou K, 2006, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V38, P201
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lehnhardt FG, 2008, ARCH NEUROL-CHICAGO, V65, P407, DOI 10.1001/archneur.65.3.407
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Liet JM, 2003, J PEDIATR-US, V142, P62, DOI 10.1067/mpd.2003.mpd0333
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   LINDROOS MM, 2009, CEREBRAL OXYGEN GLUC, V0, P0
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   LU J, 2009, MITOCHONDRION, V0, P0
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Meulemans A, 2007, ACTA NEUROL BELG, V107, P78
   Mizuno K, 2008, NUTRITION, V24, P293, DOI 10.1016/j.nut.2007.12.007
   Morava E, 2006, BIOL NEONATE, V90, P207, DOI 10.1159/000093590
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645
   Narla VV, 2008, CLIN NUCL MED, V33, P531, DOI 10.1097/RLU.0b013e31817dec3c
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Omar A, 2007, NEUROLOGY, V68, P1159, DOI 10.1212/01.wnl.0000258659.21421.b0
   Paddon-Jones D, 2004, J NUTR, V134, P2888S, DOI 10.1093/jn/134.10.2888S
   Pillen S, 2006, NEUROPEDIATRICS, V37, P142, DOI 10.1055/s-2006-924512
   Rizza T, 2009, BIOCHEM BIOPH RES CO, V383, P58, DOI 10.1016/j.bbrc.2009.03.121
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon Eric A, 2002, METHODS MOL BIOL, V197, P55, DOI 10.1385/1-59259-284-8:055
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tarnopolsky M, 2003, MUSCLE NERVE, V27, P359, DOI 10.1002/mus.10330
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Xie J, 2005, PROTEOMICS, V5, P2981, DOI 10.1002/pmic.200401191
   Yano S, 2003, J INHERIT METAB DIS, V26, P481, DOI 10.1023/A:1025125427868
   Yuri T, 2008, MED MOL MORPHOL, V41, P233, DOI 10.1007/s00795-008-0420-0
NR 96
TC 0
Z9 0
U1 0
U2 1
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
SN 
EI 
J9 CELL BIO RES PROG
PD JUN 15
PY 2010
VL 0
IS 
BP 659
EP 682
DI 
PG 24
WC Cell Biology
SC Cell Biology
GA BTG89
UT WOS:000286916800015
DA 2024-11-01
ER

PT J
AU Limongelli, G
   Tome-Esteban, M
   Dejthevaporn, C
   Rahman, S
   Hanna, MG
   Elliott, PM
AF Limongelli, Giuseppe
   Tome-Esteban, Maite
   Dejthevaporn, Charungthai
   Rahman, Shamima
   Hanna, Michael G.
   Elliott, Perry M.
TI Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease
SO EUROPEAN JOURNAL OF HEART FAILURE
LA English
DT Article
DE Mitochondrial respiratory chain disease; Cardiomyopathy; Outcome
ID mutations; children; dna; cardiomyopathy; criteria; gene
AB The prevalence and natural history of cardiovascular disease in adult patients with respiratory chain disease (RCD) is poorly characterized. We sought to determine the frequency and natural history of cardiac disease in patients with primary RCD. Thirty-two patients (37.8 +/- 12.6 years) with a definite diagnosis of RCD underwent clinical examination, electrocardiography (ECG), 24 h Holter ECG, and cardiopulmonary exercise testing. Patients were classified into six different phenotypes: mitochondrial myopathy (MM; n = 8), chronic progressive ophthalmoplegia (CPEO; n = 2), chronic progressive ophthalmoplegia with myopathy (CPEO + MM; n = 12), Kearns-Sayre syndrome (KSS; n = 2), mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS; n = 7), neuropathy, ataxia, and retinitis pigmentosa (NARP; n = 1). Twenty-two patients (69%) had a mitochondrial DNA mutation. Twenty-six patients (81%) had evidence for cardiac involvement: ECG abnormalities (69%) and cardiomyopathy (hypertrophic 19%; restrictive 3%; left ventricular non-compaction 3%). During follow-up (4.1 +/- 2.8 years), two patients with CPEO + MM developed hypertrophic cardiomyopathy and one patient with NARP developed peripartum dilated cardiomyopathy. Four patients (KSS = 2; MM = 1; MELAS = 1) developed arrhythmias or syncope requiring device therapy or invasive procedures. One patient with MM and cardiomyopathy had an orthotopic heart transplant. One patient with CPEO + MM died from respiratory failure. Freedom from all cardiovascular events at 5 years was 67% (95% CI 47.4-86.6). All patients with RCD should undergo careful and repeated clinical assessment to diagnose and manage cardiovascular involvement. However, life-threatening cardiovascular complications rarely occur, and the prognosis is generally favourable.
C1 [Limongelli, Giuseppe; Tome-Esteban, Maite; Elliott, Perry M.] UCL, Heart Hosp, London W1G 8PH, England.
   [Dejthevaporn, Charungthai; Rahman, Shamima; Hanna, Michael G.] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, London W1G 8PH, England.
   [Dejthevaporn, Charungthai; Rahman, Shamima; Hanna, Michael G.] UCL, Natl Hosp Neurol & Neurosurg, London W1G 8PH, England.
C3 University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Elliott, PM (corresponding author), UCL, Heart Hosp, 16-18 Westmoreland St, London W1G 8PH, England.
EM perry.elliott@ucl.ac.uk
FU MRC [G0601943, G0800674] Funding Source: UKRI; Medical Research Council [G0800674, G0601943] Funding Source: Medline
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1978, AM J CARDIOL, V41, P130
   Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011
   Elliott PM, 1999, HEART, V81, P441, DOI 10.1136/hrt.81.4.441
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Gimeno JR, 2009, EUR HEART J, V30, P2599, DOI 10.1093/eurheartj/ehp327
   Hanna MG, 1999, CELL MOL LIFE SCI, V55, P691, DOI 10.1007/s000180050327
   HANSEN JE, 1984, AM REV RESPIR DIS, V129, PS49, DOI 10.1164/arrd.1984.129.2P2.S49
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   INO H, 1991, LANCET, V337, P234, DOI 10.1016/0140-6736(91)92196-9
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
NR 27
TC 105
Z9 108
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1388-9842
EI 1879-0844
J9 EUR J HEART FAIL
JI Eur. J. Heart Fail.
PD FEB 15
PY 2010
VL 12
IS 2
BP 114
EP 121
DI 10.1093/eurjhf/hfp186
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 547EN
UT WOS:000273868800004
PM 20083621
DA 2024-11-01
ER

PT J
AU Fraser, JA
   Biousse, V
   Newman, NJ
AF Fraser, J. Alexander
   Biousse, Valerie
   Newman, Nancy J.
TI The Neuro-ophthalmology of Mitochondrial Disease
SO SURVEY OF OPHTHALMOLOGY
LA English
DT Review
DE chronic progressive external ophthalmoplegia; dominant optic atrophy; Kearns-Sayre syndrome; Leber hereditary optic neuropathy; MELAS; mitochondria; NARP; neuro-ophthalmology; pigmentary retinopathy
ID hereditary optic neuropathy; progressive external ophthalmoplegia; kearns-sayre-syndrome; stroke-like episodes; respiratory-chain dysfunction; macular pattern dystrophy; french-canadian family; marrow pancreas syndrome; placebo-controlled trial; wolfram didmoad syndrome
AB Mitochondrial diseases frequently manifest neuro-ophthalmologic symptoms and signs. Because of the predilection of mitochondrial disorders to involve the optic nerves, extraocular muscles, retina, and even the retrochiasmal visual pathways, the ophthalmologist is often the first physician to be consulted. Disorders caused by mitochondrial dysfunction can result from abnormalities in either the mitochondrial DNA or in nuclear genes which encode mitochondrial proteins. Inheritance of these mutations will follow patterns specific to their somatic or mitochondrial genetics. Genotype phenotype correlations are inconstant, and considerable overlap may occur among these syndromes. The diagnostic approach to the patient with suspected mitochondrial disease entails a detailed personal and family history, careful ophthalmic, neurologic, and systemic examination, directed investigations, and attention to potentially life-threatening sequelae. Although curative treatments for mitochondrial disorders are currently lacking, exciting research advances are being made, particularly in the area of gene therapy. Leber hereditary optic neuropathy, with its window of opportunity for timely intervention and its accessibility to directed therapy, offers a unique model to study future therapeutic interventions. Most patients and their relatives benefit from informed genetic counseling. (Surv Ophthalmol 55:299-334, 2010. (C) 2010 Elsevier Inc. All rights reserved.)
C1 [Fraser, J. Alexander; Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol Surg, Atlanta, GA USA.
C3 Emory University; Emory University; Emory University
RP Newman, NJ (corresponding author), Emory Eye Ctr, Neuroophthalmol Unit, 1365-B Clifton Rd NE, Atlanta, GA 30322 USA.
EM ophtnjn@emory.edu
FU Research to Prevent Blindness, Inc., New York, NY; National Institutes of Health, Bethesda, MD [P30-EY06360]; Research to Prevent Blindness Lew R. Wasserman Merit Award
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Adjadj E, 2008, KLIN MONATSBL AUGENH, V225, P462, DOI 10.1055/s-2008-1027257
   Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P1667, DOI 10.1167/iovs.03-1093
   Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226
   Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581
   Bernardini Francesco P, 2002, ORBIT, V21, P195, DOI 10.1076/orbi.21.3.195.7171
   Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8
   Bette S, 2007, HISTOCHEM CELL BIOL, V128, P421, DOI 10.1007/s00418-007-0321-7
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Biousse V, 1997, NEUROLOGY, V49, P1136, DOI 10.1212/WNL.49.4.1136
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Bremner FD, 2001, INVEST OPHTH VIS SCI, V42, P675
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chalmers RM, 1997, J NEUROL NEUROSUR PS, V62, P385, DOI 10.1136/jnnp.62.4.385
   Chalmers RM, 1996, J NEUROL NEUROSUR PS, V60, P195, DOI 10.1136/jnnp.60.2.195
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258
   Daut PM, 2000, AM J OPHTHALMOL, V130, P519, DOI 10.1016/S0002-9394(00)00558-4
   Davies VJ, 2008, BRAIN, V131, P368, DOI 10.1093/brain/awm333
   De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Domenech Enric, 2006, PEDIATR ENDOCRINOL REV, V3, P249
   ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Ferré M, 2009, HUM MUTAT, V30, PE692, DOI 10.1002/humu.21025
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Givre SJ, 2000, J NEURO-OPHTHALMOL, V20, P229, DOI 10.1097/00041327-200020040-00002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Guy J, 2009, INVEST OPHTH VIS SCI, V50, P4205, DOI 10.1167/iovs.08-3214
   Han J, 2006, GENET MED, V8, P217, DOI 10.1097/01.gim.0000214299.61930.c0
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOFFMAN PN, 2005, WALSH HOYTS CLIN NEU, V0, P1085
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 1998, VISION RES, V38, P1495, DOI 10.1016/S0042-6989(97)00444-6
   HOWELL N, 1991, AM J HUM GENET, V48, P935
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huoponen K, 2002, ACTA OPHTHALMOL SCAN, V80, P38, DOI 10.1034/j.1600-0420.2002.800108.x
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Ito Y, 2007, INVEST OPHTH VIS SCI, V48, P4079, DOI 10.1167/iovs.07-0024
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jacobson DM, 1998, AM J OPHTHALMOL, V126, P291, DOI 10.1016/S0002-9394(98)00152-4
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jin GF, 2001, CURR EYE RES, V23, P11, DOI 10.1076/ceyr.23.1.11.5423
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   Ju WK, 2005, J COMP NEUROL, V488, P1, DOI 10.1002/cne.20586
   Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   KERRISON JB, 2001, AM J OPHTHALMOL, V0, P803
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   KJER P, 1959, ACTA OPHTHALMOL S, V54, P1
   KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Laird PW, 2006, AM J OPHTHALMOL, V142, P186, DOI 10.1016/j.ajo.2006.02.051
   Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777
   LANG CJG, 1995, EUR J NEUROL, V2, P171, DOI 10.1111/j.1468-1331.1995.tb00112.x
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Lin DDM, 2003, AM J NEURORADIOL, V24, P33
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luzhansky JZ, 2001, AIDS, V15, P1588, DOI 10.1097/00002030-200108170-00022
   LYLE WM, 1990, REFERENCE EYE CARE P, V0, P0
   Macedo-Souza LI, 2005, ANN NEUROL, V57, P730, DOI 10.1002/ana.20478
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Macmillan C, 2000, AM J HUM GENET, V66, P332, DOI 10.1086/302716
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   MARGULIS L, 1976, EXP PARASITOL, V39, P277, DOI 10.1016/0014-4894(76)90127-2
   Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC
   Mashima Y, 1998, CURR EYE RES, V17, P403, DOI 10.1080/02713689808951221
   Mashima Y, 2003, GRAEF ARCH CLIN EXP, V241, P75, DOI 10.1007/s00417-002-0598-0
   MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   MCKECHNIE NM, 1985, BRIT J OPHTHALMOL, V69, P63, DOI 10.1136/bjo.69.1.63
   MEIRE FM, 1995, OPHTHALMIC GENET, V16, P119, DOI 10.3109/13816819509059971
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   MILEA D, 2009, ACTA OPHTHALMOL, V0, P0
   Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200
   Miyama S, 2000, NEUROPEDIATRICS, V31, P214, DOI 10.1055/s-2000-7462
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORIKAWA Y, 1993, VIRCHOWS ARCH A, V423, P227, DOI 10.1007/BF01614775
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nakamura M, 2006, OPHTHALMOLOGY, V113, P483, DOI 10.1016/j.ophtha.2005.10.054
   Newman NJ, 2005, WALSH HOYTS CLIN NEU, V0, P465
   Newman NJ, 2006, AM J OPHTHALMOL, V141, P1061, DOI 10.1016/j.ajo.2005.12.045
   Newman NJ, 2009, BRAIN, V132, P2306, DOI 10.1093/brain/awp195
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P407, DOI 10.1016/j.ajo.2005.03.058
   NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8
   Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504
   Nishino I, 2000, ANN NEUROL, V47, P792
   Ohkoshi N, 1998, J MED, V29, P13
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pesch UEA, 2004, INVEST OPHTH VIS SCI, V45, P4217, DOI 10.1167/iovs.03-1261
   Phillipson R, 1997, IMPACT, V1, P115
   Pott JWR, 2006, GRAEF ARCH CLIN EXP, V244, P1357, DOI 10.1007/s00417-006-0269-7
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Ramos CDF, 2009, INVEST OPHTH VIS SCI, V50, P1666, DOI 10.1167/iovs.08-2695
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Riordan-Eva P, 2000, CURR OPIN OPHTHALMOL, V11, P408, DOI 10.1097/00055735-200012000-00005
   RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun Alfredo A, 2006, TRANS AM OPHTHALMOL SOC, V104, P51
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   SHAEFER AM, 2004, BIOCHIM BIOPHYS ACTA, V1659, P115
   Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shimizu S, 2003, AM J OPHTHALMOL, V135, P256, DOI 10.1016/S0002-9394(02)01929-3
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Soejima K, 2006, ANN PLAS SURG, V56, P439, DOI 10.1097/01.sap.0000202885.98998.0a
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Stachowiak O, 1998, J BIOL CHEM, V273, P16694, DOI 10.1074/jbc.273.27.16694
   Stelmack JA, 2008, ARCH OPHTHALMOL-CHIC, V126, P608, DOI 10.1001/archopht.126.5.608
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Takei D, 2006, FEBS LETT, V580, P5635, DOI 10.1016/j.febslet.2006.09.007
   Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Thiselton DL, 2001, HUM GENET, V109, P498, DOI 10.1007/s004390100600
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577
   Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verny C, 2005, REV NEUROL-FRANCE, V161, P451, DOI 10.1016/S0035-3787(05)85075-1
   Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48
   Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351
   Wallace DC, 2000, AM HEART J, V139, PS70, DOI 10.1067/mhj.2000.103934
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Welzing L, 2009, EUR J PEDIATR, V168, P757, DOI 10.1007/s00431-008-0831-x
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wolfram DJ, 1938, P MAYO CLIN, V13, P715
   Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
   ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619
NR 263
TC 177
Z9 193
U1 0
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6257
EI 1879-3304
J9 SURV OPHTHALMOL
JI Surv. Ophthalmol.
PD JUL-AUG 15
PY 2010
VL 55
IS 4
BP 299
EP 334
DI 10.1016/j.survophthal.2009.10.002
PG 36
WC Ophthalmology
SC Ophthalmology
GA 623TU
UT WOS:000279768300001
PM 20471050
DA 2024-11-01
ER

PT J
AU Segrè, AV
   Groop, L
   Mootha, VK
   Daly, MJ
   Altshuler, D
AF Segre, Ayellet V.
   Groop, Leif
   Mootha, Vamsi K.
   Daly, Mark J.
   Altshuler, David
TI Common Inherited Variation in Mitochondrial Genes Is Not Enriched for Associations with Type 2 Diabetes or Related Glycemic Traits
SO PLOS GENETICS
LA English
DT Article
ID genome-wide association; oxidative-phosphorylation; insulin-resistance; pathway analysis; candidate genes; loci; glucose; susceptibility; homeostasis; dysfunction
AB Mitochondrial dysfunction has been observed in skeletal muscle of people with diabetes and insulin-resistant individuals. Furthermore, inherited mutations in mitochondrial DNA can cause a rare form of diabetes. However, it is unclear whether mitochondrial dysfunction is a primary cause of the common form of diabetes. To date, common genetic variants robustly associated with type 2 diabetes (T2D) are not known to affect mitochondrial function. One possibility is that multiple mitochondrial genes contain modest genetic effects that collectively influence T2D risk. To test this hypothesis we developed a method named Meta-Analysis Gene-set Enrichment of variaNT Associations (MAGENTA; http://www.broadinstitute.org/mpg/magenta). MAGENTA, in analogy to Gene Set Enrichment Analysis, tests whether sets of functionally related genes are enriched for associations with a polygenic disease or trait. MAGENTA was specifically designed to exploit the statistical power of large genome-wide association (GWA) study meta-analyses whose individual genotypes are not available. This is achieved by combining variant association p-values into gene scores and then correcting for confounders, such as gene size, variant number, and linkage disequilibrium properties. Using simulations, we determined the range of parameters for which MAGENTA can detect associations likely missed by single-marker analysis. We verified MAGENTA's performance on empirical data by identifying known relevant pathways in lipid and lipoprotein GWA meta-analyses. We then tested our mitochondrial hypothesis by applying MAGENTA to three gene sets: nuclear regulators of mitochondrial genes, oxidative phosphorylation genes, and,1,000 nuclear-encoded mitochondrial genes. The analysis was performed using the most recent T2D GWA meta-analysis of 47,117 people and meta-analyses of seven diabetes-related glycemic traits (up to 46,186 non-diabetic individuals). This well-powered analysis found no significant enrichment of associations to T2D or any of the glycemic traits in any of the gene sets tested. These results suggest that common variants affecting nuclear-encoded mitochondrial genes have at most a small genetic contribution to T2D susceptibility.
C1 [Segre, Ayellet V.; Mootha, Vamsi K.; Daly, Mark J.; Altshuler, David] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.
   [Segre, Ayellet V.; Mootha, Vamsi K.; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Endocrinol Res Unit, S-21401 Malmo, Sweden.
   [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.
   [Mootha, Vamsi K.; Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA.
   [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Dept Genet, Boston, MA USA.
C3 Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School
RP Segrè, AV (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.
EM asegre@broadinstitute.org; altshuler@molbio.mgh.harvard.edu
FU American Diabetes Association [7-08-MN-OK]; Swedish Research Council; Wallenberg Foundation; Sigrid Juselius Foundation; American Diabetes Association/Smith Family Foundation
CR Andrulionytè L, 2004, DIABETOLOGIA, V47, P2176, DOI 10.1007/s00125-004-1577-2
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120
   Chai HS, 2009, BMC BIOINFORMATICS, V10, P0, DOI 10.1186/1471-2105-10-102
   Chasman DI, 2008, GENET EPIDEMIOL, V32, P658, DOI 10.1002/gepi.20334
   Cho YM, 2007, DIABETES RES CLIN PR, V77, PS172, DOI 10.1016/j.diabres.2007.01.052
   Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002
   Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520
   Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395
   Eleftherohorinou H, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008068
   Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Giguère V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017
   Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500
   Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z
   Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090
   Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   KOVES TR, 2010, CELL METABOLISM, V0, P0
   Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196
   Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115
   Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMOA031314
   PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/BIOINFORMATICS/19.1.149
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Reiling E, 2009, EUR J HUM GENET, V17, P1056, DOI 10.1038/ejhg.2009.4
   Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438
   Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521
   SCHIFF M, 2009, J INHERIT METAB DIS, V0, P0
   Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382
   Sokal, 1995, BIOMETRY PRINCIPLES, V0, P0
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
   Veyrieras JB, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000214
   VOIGHT BF, 2010, NATURE GENE IN PRESS, V0, P0
   WAN J, 2009, BIOCH BIOPHYS RES CO, V0, P0
   Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374
   Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026
   Yu JJ, 2009, ANN NY ACAD SCI, V1173, PE10, DOI 10.1111/j.1749-6632.2009.04952.x
   Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
NR 57
TC 363
Z9 387
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD AUG 15
PY 2010
VL 6
IS 8
BP 
EP 
DI 10.1371/journal.pgen.1001058
PG 19
WC Genetics & Heredity
SC Genetics & Heredity
GA 644NG
UT WOS:000281383800014
PM 20714348
DA 2024-11-01
ER

PT J
AU Walter, MC
   Czermin, B
   Muller-Ziermann, S
   Bulst, S
   Stewart, JD
   Hudson, G
   Schneiderat, P
   Abicht, A
   Holinski-Feder, E
   Lochmüller, H
   Chinnery, PF
   Klopstock, T
   Horvath, R
AF Walter, Maggie C.
   Czermin, Birgit
   Muller-Ziermann, Solvig
   Bulst, Stefanie
   Stewart, Joanna D.
   Hudson, Gavin
   Schneiderat, Peter
   Abicht, Angela
   Holinski-Feder, Elke
   Lochmueller, Hanns
   Chinnery, Patrick F.
   Klopstock, Thomas
   Horvath, Rita
TI Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Ptosis; Mitochondrial myopathy; mtDNA deletions; Polymerase gamma 2 (POLG2)
ID progressive external ophthalmoplegia; mitochondrial-dna polymerase; mutations
AB Polymerase gamma 1 (POLG) mutations are a frequent cause of both autosomal dominant and recessive complex neurological phenotypes. In contrast, only a single pathogenic mutation in one patient was reported in POLG2 so far. Here we describe a 62-year-old woman, carrying a novel heterozygous sequence variant in the POLG2 gene. She developed bilateral ptosis at 30 years of age, followed by exercise intolerance, muscle weakness and mild CK increase in her late forties. Muscle histology and respiratory chain activities were normal. Southern blot and long range PCR detected multiple mtDNA deletions, but no depletion in muscle DNA. Sequencing of POLG, PEO1, ANT1, OPA1 and RRM2B showed normal results. A novel heteroallelic 24 bp insertion (c.1207_1208ins24) was detected in POLG2. This 24 bp insertion into exon 7 causes missplicing and loss of exon 7 in myoblast cDNA. We did not detect POLG2 mutations in 62 patients with multiple mtDNA deletions in muscle DNA, suggesting that POLG2 mutations may represent a rare cause of autosomal dominant PEO.
C1 [Stewart, Joanna D.; Hudson, Gavin; Chinnery, Patrick F.; Horvath, Rita] Newcastle Univ, Inst Hlth & Aging, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Walter, Maggie C.; Bulst, Stefanie; Schneiderat, Peter; Abicht, Angela; Klopstock, Thomas; Horvath, Rita] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany.
   [Czermin, Birgit; Muller-Ziermann, Solvig; Abicht, Angela; Holinski-Feder, Elke; Horvath, Rita] Ctr Med Genet, Munich, Germany.
   [Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; University of Munich; Newcastle University - UK
RP Horvath, R (corresponding author), Newcastle Univ, Inst Hlth & Aging, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM Rita.Horvath@ncl.ac.uk
FU Deutsche Forschungsgemeinschaft [HO 2505/2-1]; Academy of Medical Sciences [BH090164]; RVI/NGH; Newcastle upon Tyne Hospitals NHS Charity [RES0211/7262]; German ministry of education and research (BMBF, Bonn, Germany); EC [036825]; MRC Centre for Neuromuscular Disease; MRC [G0601943] Funding Source: UKRI
CR Carrodeguas JA, 2000, NUCLEIC ACIDS RES, V28, P1237, DOI 10.1093/nar/28.5.1237
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Fuhrmann N, 2009, J MED GENET, V46, P136, DOI 10.1136/jmg.2008.062570
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
NR 11
TC 35
Z9 36
U1 0
U2 38
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 
J9 J NEUROL
JI J. Neurol.
PD SEP 15
PY 2010
VL 257
IS 9
BP 1517
EP 1523
DI 10.1007/s00415-010-5565-9
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA 642VW
UT WOS:000281250100014
PM 20405137
DA 2024-11-01
ER

PT J
AU Cao, YY
   Ma, YN
   Zhang, Y
   Li, YJE
   Fang, F
   Wang, ST
   Bu, DF
   Xu, YF
   Pei, P
   Li, L
   Xiao, Y
   Wu, HR
   Yang, YL
   Zou, LP
   Qi, Y
AF Cao, Yanyan
   Ma, Yinan
   Zhang, Ying
   Li, Yujie
   Fang, Fang
   Wang, Songtao
   Bu, Dingfang
   Xu, Yufeng
   Pei, Pei
   Li, Lin
   Xiao, Yang
   Wu, Hairong
   Yang, Yanling
   Zou, Liping
   Qi, Yu
TI Detection of eight frequently encountered point mutations in mitochondria in Chinese patients suggestive of mitochondrial encephalomyopathies
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial encephalomyopathy; Mitochondrial DNA; Mutation; MELAS
ID respiratory-chain disorders; diagnostic-criteria; a3243g mutation; prevalence; children; dna; disease; adults; melas; epidemiology
AB To evaluate eight frequently encountered mitochondrial DNA (mtDNA) point mutations (A3243G, T8993G/C, A8344G, A1555G, G11778A, G3460A and T14484C) in Chinese, we recruited 1559 sporadic patients suspected of mitochondrial diseases and 206 family members. In suspected patients, 158 cases were detected with one of these eight mtDNA mutations (10.1%). A3243G was the most common mtDNA mutation both in suspected patients (9.4%) and in the relatives (34.2%). In addition, the ratios of A3243G (mutant/wild-type) and A8344G were significantly correlated with the patients' age of examination. Moreover, in 76 unrelated probands, the ratio of A3243G was correlated well with their seizures and myopathies. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Cao, Yanyan; Ma, Yinan; Zhang, Ying; Li, Yujie; Wang, Songtao; Bu, Dingfang; Xu, Yufeng; Pei, Pei; Li, Lin; Xiao, Yang; Wu, Hairong; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China.
   [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China.
   [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
   [Zou, Liping] Gen Hosp Chinese Peoples Liberat Army, Dept Pediat, Beijing 100853, Peoples R China.
C3 Peking University; Capital Medical University; Peking University
RP Qi, Y (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 Xishiku St, Beijing 100034, Peoples R China.
EM qiyu0724@yahoo.com
FU National Natural Science Foundation of China [30700912]
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Diogo L, 2009, PEDIATR NEUROL, V40, P351, DOI 10.1016/j.pediatrneurol.2008.11.012
   Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Niu Shu-lan, 2003, ZHONGGUO YI XUE KE XUE YUAN XUE BAO, V25, P153
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   [王朝霞 Wang Zhaoxia], 2003, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V36, P28
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
   Zhang Ying, 2005, ZHONGGUO YI XUE KE XUE YUAN XUE BAO, V27, P77
NR 22
TC 6
Z9 11
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUN 15
PY 2010
VL 10
IS 4
BP 330
EP 334
DI 10.1016/j.mito.2010.01.008
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 604FL
UT WOS:000278262600004
PM 20123042
DA 2024-11-01
ER

PT J
AU Reiner, JE
   Kishore, RB
   Levin, BC
   Albanetti, T
   Boire, N
   Knipe, A
   Helmerson, K
   Deckman, KH
AF Reiner, Joseph E.
   Kishore, Rani B.
   Levin, Barbara C.
   Albanetti, Thomas
   Boire, Nicholas
   Knipe, Ashley
   Helmerson, Kristian
   Deckman, Koren Holland
TI Detection of Heteroplasmic Mitochondrial DNA in Single Mitochondria
SO PLOS ONE
LA English
DT Article
ID standard reference material; mtdna genome; chromosome; disease; manipulation; organization; organelles; mutations; sequence
AB Background: Mitochondrial DNA (mtDNA) genome mutations can lead to energy and respiratory-related disorders like myoclonic epilepsy with ragged red fiber disease (MERRF), mitochondrial myopathy, encephalopathy, lactic acidosis and stroke (MELAS) syndrome, and Leber's hereditary optic neuropathy (LHON). It is not well understood what effect the distribution of mutated mtDNA throughout the mitochondrial matrix has on the development of mitochondrial-based disorders. Insight into this complex sub-cellular heterogeneity may further our understanding of the development of mitochondria-related diseases. Methodology: This work describes a method for isolating individual mitochondria from single cells and performing molecular analysis on that single mitochondrion's DNA. An optical tweezer extracts a single mitochondrion from a lysed human HL-60 cell. Then a micron-sized femtopipette tip captures the mitochondrion for subsequent analysis. Multiple rounds of conventional DNA amplification and standard sequencing methods enable the detection of a heteroplasmic mixture in the mtDNA from a single mitochondrion. Significance: Molecular analysis of mtDNA from the individually extracted mitochondrion demonstrates that a heteroplasmy is present in single mitochondria at various ratios consistent with the 50/50 heteroplasmy ratio found in single cells that contain multiple mitochondria.
C1 [Reiner, Joseph E.; Kishore, Rani B.; Helmerson, Kristian] NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA.
   [Levin, Barbara C.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA.
   [Albanetti, Thomas; Boire, Nicholas; Knipe, Ashley; Deckman, Koren Holland] Gettysburg Coll, Dept Chem, Gettysburg, PA 17325 USA.
C3 National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; Gettysburg College
RP Reiner, JE (corresponding author), NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA.
EM joseph.reiner@nist.gov
CR Agarwal A, 2007, ANAL CHEM, V79, P3589, DOI 10.1021/ac062049e
   Agarwal R, 2005, OPT EXPRESS, V13, P8906, DOI 10.1364/OPEX.13.008906
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0
   BERNS MW, 1989, P NATL ACAD SCI USA, V86, P4539, DOI 10.1073/pnas.86.12.4539
   Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1
   Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen Y, 2007, ELECTROPHORESIS, V28, P2406, DOI 10.1002/elps.200600628
   Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dahl HHM, 2001, AM J MED GENET, V106, P1, DOI 10.1002/ajmg.1427
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dufresne ER, 2001, REV SCI INSTRUM, V72, P1810, DOI 10.1063/1.1344176
   Fuller KM, 2003, CURR OPIN BIOTECH, V14, P35, DOI 10.1016/S0958-1669(02)00008-3
   Gertz EM, 2005, BLAST SCORING PARAMETERS, V0, P0
   Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888
   Jeffries GDM, 2007, NANO LETT, V7, P415, DOI 10.1021/nl0626784
   Kuroiwa T, 1996, PROTOPLASMA, V194, P275, DOI 10.1007/BF01882033
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Levin BC, 2003, MITOCHONDRION, V2, P387, DOI 10.1016/S1567-7249(03)00010-2
   Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nambiar R, 2002, OPT LETT, V27, P836, DOI 10.1364/OL.27.000836
   Niu H, 2010, PLOS PATHOG, V6, P0, DOI 10.1371/journal.ppat.1000774
   Pauzauskie PJ, 2006, NAT MATER, V5, P97, DOI 10.1038/nmat1563
   Poe BG, 2010, ANAL BIOANAL CHEM, V397, P3397, DOI 10.1007/s00216-010-3751-3
   Resnick A, 2010, J BIOMED OPT, V15, P0, DOI 10.1117/1.3316378
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Shelby JP, 2005, PHOTOCHEM PHOTOBIOL, V81, P994, DOI 10.1562/2005-02-02-RA-431R1.1
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   VOROBJEV IA, 1993, BIOPHYS J, V64, P533, DOI 10.1016/S0006-3495(93)81398-5
   Wang HW, 2004, J OPT A-PURE APPL OP, V6, P89, DOI 10.1088/1464-4258/6/1/016
   Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113
NR 38
TC 23
Z9 28
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD DEC 16
PY 2010
VL 5
IS 12
BP 
EP 
DI 10.1371/journal.pone.0014359
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 695OI
UT WOS:000285381200009
PM 21179558
DA 2024-11-01
ER

PT J
AU Parikh, S
AF Parikh, Sumit
TI THE NEUROLOGIC MANIFESTATIONS OF MITOCHONDRIAL DISEASE
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE mitochondria; mitochondrial disease; neurological; neuropathy; white matter; stroke; hearing loss; pigmentary retinopathy; Leigh syndrome; ataxia; Alper syndrome; POLG; epilepsia partialis continua-epilepsy; seizures; cerebellar degeneration; optic atrophy; myopathy; hypotonia; dysmotility
ID ribosomal-rna mutation; dna polymerase-gamma; oxidative-phosphorylation; oxidase deficiency; status epilepticus; polg mutations; leigh-syndrome; l-arginine; children; depletion
AB The nervous system contains some of the body's most metabolically demanding cells that are highly dependent on ATP produced via mitochondrial oxidative phosphorylation. Thus, the neurological system is consistently involved in patients with mitochondrial disease. Symptoms differ depending on the part of the nervous system affected. Although almost any neurological symptom can be due to mitochondrial disease, there are select symptoms that are more suggestive of a mitochondrial problem. Certain symptoms that have become sine qua non with underlying mitochondrial cytopathies can serve as diagnostic "red-flags." Here, the typical and atypical presentations of mitochondrial disease in the nervous system are reviewed, focusing on "red flag" neurological symptoms as well as associated symptoms that can occur in, but are not specific to, mitochondrial disease. The multitudes of mitochondria! syndromes are not reviewed in-depth, though a select few are discussed in some detail. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:120-128.
C1 Cleveland Clin, Cleveland, OH 44195 USA.
C3 Cleveland Clinic Foundation
RP Parikh, S (corresponding author), Cleveland Clin, 9500 Euclid Ave,S60, Cleveland, OH 44195 USA.
EM sumit.parikh@gmail.com
CR Arthur TM, 2007, MITOCHONDRION, V7, P279, DOI 10.1016/j.mito.2007.04.003
   Benarroch EE, 2010, NEUROLOGY, V74, P601, DOI 10.1212/WNL.0b013e3181d03762
   Blanco-Barca O, 2004, REV NEUROLOGIA, V39, P618
   Bough K, 2008, EPILEPSIA, V49, P91, DOI 10.1111/j.1528-1167.2008.01846.x
   Brown GK, 2005, J INHERIT METAB DIS, V28, P393, DOI 10.1007/s10545-005-7051-6
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Chitkara DK, 2003, AM J GASTROENTEROL, V98, P871, DOI 10.1016/S0002-0270(03)00049-2
   *CMG, 2002, GENET MED, V4, P162
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DEVRIES MC, 2008, J INHERIT METAB DIS, V0, P0
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elia M, 1996, BRAIN DEV-JPN, V18, P207, DOI 10.1016/0387-7604(95)00126-3
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Finsterer J, 2005, METAB BRAIN DIS, V20, P219, DOI 10.1007/s11011-005-7209-9
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4
   García-Cazorla A, 2007, DEV MED CHILD NEUROL, V49, P740, DOI 10.1111/j.1469-8749.2007.00740.x
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   KARTSOUNIS LD, 1992, ARCH NEUROL-CHICAGO, V49, P158, DOI 10.1001/archneur.1992.00530260058020
   Keng WT, 2003, DEV MED CHILD NEUROL, V45, P704
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   KOTAGAL S, 1988, PEDIATR NEUROL, V4, P241, DOI 10.1016/0887-8994(88)90038-0
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lachhwani DK, 2008, EPILEPSIA, V49, P223
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Morgan PG, 2002, ANESTHESIOLOGY, V96, P1268, DOI 10.1097/00000542-200205000-00036
   Muravchick S, 2006, ANESTHESIOLOGY, V105, P819, DOI 10.1097/00000542-200610000-00029
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G
   Nye JS, 2000, TERATOLOGY, V61, P165, DOI 10.1002/(SICI)1096-9926(200003)61:3<165::AID-TERA3>3.3.CO;2-5
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P184, DOI 10.1055/s-2007-991150
   Rose LVT, 2008, PEDIATR NEUROL, V38, P395, DOI 10.1016/j.pediatrneurol.2008.02.003
   Sadleir LG, 2004, EUR J NEUROL, V11, P103, DOI 10.1046/j.1351-5101.2003.00724.x
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Toribe Yasuhisa, 2007, NO TO HATTATSU, V39, P38
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020
   Weissman JR, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003815
   Willis TA, 2000, DEV MED CHILD NEUROL, V42, P414, DOI 10.1017/S0012162200000761
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zimmer V, 2009, NEUROGASTROENT MOTIL, V21, P627, DOI 10.1111/j.1365-2982.2009.01264.x
NR 74
TC 16
Z9 19
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PD JUN 15
PY 2010
VL 16
IS 2
BP 120
EP 128
DI 10.1002/ddrr.110
PG 9
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100004
PM 20818726
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Ferrero, I
   Foury, F
AF Baruffini, Enrico
   Ferrero, Iliana
   Foury, Francoise
TI <i>In vivo</i> analysis of mtDNA replication defects in yeast
SO METHODS
LA English
DT Article
DE mtDNA replication; Yeast Saccharomyces cerevisiae; rho(-)/rho(o); Petite frequency; mtDNA point mutability
ID progressive external ophthalmoplegia; mitochondrial-dna depletion; large ribosomal-rna; saccharomyces-cerevisiae; ribonucleotide reductase; resistance mutations; gene disruption; small-subunit; rib2 locus; polymerase
AB The yeast Saccharomyces cerevisiae has the capacity to survive large deletions or total loss of mtDNA (petite mutants), and thus in the last few years it has been used as a model system to study defects in mitochondrial DNA (mtDNA) maintenance produced by mutations in genes involved in mtDNA replication. In this paper we describe methods to obtain strains harboring mutations in nuclear genes essential for the integrity of mtDNA, to measure the frequency and the nature of petite mutants, to estimate the point mutation frequency in mtDNA and to determine whether a nuclear mutation is recessive or dominant and, in the latter case, the kind of dominance. (C) 2010 Published by Elsevier Inc.
C1 [Foury, Francoise] Inst Life Sci, B-1348 Louvain, Belgium.
   [Baruffini, Enrico; Ferrero, Iliana] Dept Genet, I-43124 Parma, Italy.
RP Foury, F (corresponding author), Inst Life Sci, Batiment Carnoy,Croix Sud 4-5-15, B-1348 Louvain, Belgium.
EM enrico.baruffini@nemo.unipr.it; iferrero@unipr.it; francoise.foury@uclouvain.be
FU Fondazione Telethon-Italy [GGP07019]; Belgian National Fund for Scientific Research; Belgian Science Policy; Association Francaise contre les Myopathies
CR BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2009, J BIOTECHNOL, V143, P247, DOI 10.1016/j.jbiotec.2009.08.007
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brachmann CB, 1998, YEAST, V14, P115
   Chatterjee A, 2001, NUCLEIC ACIDS RES, V29, P4935, DOI 10.1093/nar/29.24.4935
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CUI Z, 1989, CURR GENET, V16, P273, DOI 10.1007/BF00422114
   Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871
   Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497
   Dujon B, 1981, MOL BIOL YEAST SACCH, V0, P505
   ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740
   ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783
   EPHRUSSI B, 1949, UNITES BIOL DOUEES C, V0, P165
   FANGMAN WL, 1990, MOL CELL BIOL, V10, P10, DOI 10.1128/MCB.10.1.10
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Foury Francoise, 2007, METHODS MOL BIOL, V372, P167, DOI 10.1007/978-1-59745-365-3_12
   Fukuhara H, 1977, MITOCHONDRIA, V0, P123
   Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Gietz R Daniel, 2006, METHODS MOL BIOL, V313, P107
   GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391
   Hess DC, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000407
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   LISOWSKY T, 1988, MOL GEN GENET, V214, P218, DOI 10.1007/BF00337714
   MARMIROLI N, 1980, MOL GEN GENET, V177, P581
   Mathews S, 1977, MITOCHONDRIA, V0, P133
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   ORourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002
   OGUR M, 1956, J BACTERIOL, V72, P500, DOI 10.1128/JB.72.4.500-504.1956
   ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202
   Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000
   SHERMAN F, 1964, GENETICS, V49, P39
   Singh KK, 2001, NUCLEIC ACIDS RES, V29, P1381, DOI 10.1093/nar/29.6.1381
   SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   SOR F, 1982, NUCLEIC ACIDS RES, V10, P6571, DOI 10.1093/nar/10.21.6571
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040
   THOMAS BJ, 1989, GENETICS, V123, P725
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   WACH A, 1994, YEAST, V10, P1808
   Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114
   Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1
   Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644
   ZITOMER RS, 1992, MICROBIOL REV, V56, P1
NR 55
TC 49
Z9 51
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG 15
PY 2010
VL 51
IS 4
BP 426
EP 436
DI 10.1016/j.ymeth.2010.02.023
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 640KK
UT WOS:000281049900011
PM 20206271
DA 2024-11-01
ER

PT J
AU Zhou, XS
   Johansson, M
   Solaroli, N
   Rozell, B
   Grandien, A
   Karlsson, A
AF Zhou, Xiaoshan
   Johansson, Magnus
   Solaroli, Nicola
   Rozell, Bjorn
   Grandien, Alf
   Karlsson, Anna
TI Hematopoiesis in the thymidine kinase 2 deficient mouse model of mitochondrial DNA depletion syndrome
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID mtdna; triphosphate; specificity; association; myopathy; gene; mice
AB Mitochondria are important for normal blood-cell development, and several diseases linked to mitochondrial DNA (mtDNA) show hematological manifestations. We recently generated a mouse strain deficient in expression of the mitochondrial pyrimidine nucleoside kinase thymidine kinase 2 (Tk2), showing that these mice exhibit progressive mtDNA depletion in multiple organs. We used this mouse strain as a model for mtDNA depletion syndromes to investigate the effects of mtDNA depletion on hematopoiesis. MtDNA levels in spleen from the Tk2-deficient mice were decreased 50%, but in contrast to all other investigated organs, both thymus and peripheral blood leukocytes showed normal mtDNA levels. Analysis of peripheral blood and cell populations in spleen, thymus, and bone marrow showed normal findings in the Tk2-deficient mice. The total rates of thymidine phosphorylation-which also include phosphorylation catalyzed by cytosolic Tk 1-in both spleen and thymus from wild-type mice were > 50-fold higher than in liver, brain, and muscle. In summary, our data show that blood cells are less dependent on mitochondrial Tk2 compared with several other tissues and that these cells can synthesize deoxyribonucleotides required for mtDNA replication by alternative pathways such as phosphorylation of thymidine by cytosolic Tk1.
C1 [Zhou, Xiaoshan; Johansson, Magnus; Solaroli, Nicola; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, SE-14186 Stockholm, Sweden.
   [Rozell, Bjorn] Karolinska Univ Hosp Huddinge, Dept Lab Med, Clin Res Ctr, SE-14186 Stockholm, Sweden.
   [Grandien, Alf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, SE-14186 Stockholm, Sweden.
   [Grandien, Alf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Expt Hematol, SE-14186 Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital
RP Karlsson, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, SE-14186 Stockholm, Sweden.
EM anna.karlsson@ki.se
FU Swedish Cancer Society
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   ERIKSSON S, 1991, ADV EXP MED BIOL, V309, P239
   Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676
   FISCHELGHODSIAN N, 1992, PEDIATR RES, V31, P557, DOI 10.1203/00006450-199206000-00004
   Goel HC, 2007, MOL CELL BIOCHEM, V295, P93, DOI 10.1007/s11010-006-9277-5
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Leung TF, 1999, J INHERIT METAB DIS, V22, P86, DOI 10.1023/A:1005415802893
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261
   TOY G, 2010, P NATL ACAD SCI US, V0, P0
   Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001
   Wu C, 2009, GENOME BIOL, V10, P0, DOI 10.1186/gb-2009-10-11-r130
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 26
TC 4
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JUN 15
PY 2010
VL 33
IS 3
BP 231
EP 236
DI 10.1007/s10545-010-9102-x
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 602DV
UT WOS:000278119600004
PM 20440651
DA 2024-11-01
ER

PT J
AU Archer, SL
   Marsboom, G
   Kim, GH
   Zhang, HJ
   Toth, PT
   Svensson, EC
   Dyck, JRB
   Gomberg-Maitland, M
   Thébaud, B
   Husain, AN
   Cipriani, N
   Rehman, J
AF Archer, Stephen L.
   Marsboom, Glenn
   Kim, Gene H.
   Zhang, Hannah J.
   Toth, Peter T.
   Svensson, Eric C.
   Dyck, Jason R. B.
   Gomberg-Maitland, Mardi
   Thebaud, Bernard
   Husain, Aliya N.
   Cipriani, Nicole
   Rehman, Jalees
TI Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension A Basis for Excessive Cell Proliferation and a New Therapeutic Target
SO CIRCULATION
LA English
DT Article
DE epigenesis, genetic; gene silencing; hypoxia-inducible factor-1, alpha-subunit; hypertension, pulmonary; mitochondrial diseases; oxidation-reduction; superoxide dismutase 2
ID dna methyltransferase; sod2 expression; cancer; overexpression; methylation; pathway; dnmt3b
AB Background-Excessive proliferation and impaired apoptosis of pulmonary artery (PA) smooth muscle cells (PASMCs) contribute to vascular obstruction in patients and fawn-hooded rats (FHRs) with PA hypertension (PAH). Expression and activity of mitochondrial superoxide dismutase-2 (SOD2), the major generator of H2O2, is known to be reduced in PAH; however, the mechanism and therapeutic relevance of this are unknown. Methods and Results-SOD2 expression in PASMCs is decreased in PAH patients and FHRs with PAH. FHR PASMCs have higher proliferation and lower apoptosis rates than Sprague-Dawley rat PASMCs. Moreover, FHR PASMCs have hyperpolarized mitochondria, low H2O2 production, and reduced cytoplasmic and mitochondrial redox state. Administration of SOD2 small interfering RNA to normal PASMCs recapitulates the FHR PAH phenotype, hyperpolarizing mitochondria, decreasing H2O2, and inhibiting caspase activity. Conversely, SOD2 overexpression in FHR PASMCs or therapy with the SOD-mimetic metalloporphyrin Mn(III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) reverses the hyperproliferative PAH phenotype. Importantly, SOD-mimetic therapy regresses PAH in vivo. Investigation of the SOD2 gene revealed no mutation, suggesting a possible epigenetic dysregulation. Genomic bisulfite sequencing demonstrates selective hypermethylation of a CpG island in an enhancer region of intron 2 and another in the promoter. Differential methylation occurs selectively in PAs versus aortic SMCs and is reversed by the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine, restoring both SOD2 expression and the ratio of proliferation to apoptosis. Expression of the enzymes that mediate gene methylation, DNA methyltransferases 1 and 3B, is upregulated in FHR lungs. Conclusions-Tissue-specific, epigenetic SOD2 deficiency initiates and sustains a heritable form of PAH by impairing redox signaling and creating a proliferative, apoptosis-resistant PASMC. SOD augmentation regresses experimental PAH. The discovery of an epigenetic component to PAH may offer new therapeutic targets. (Circulation. 2010; 121: 2661-2671.)
C1 [Archer, Stephen L.; Marsboom, Glenn; Kim, Gene H.; Zhang, Hannah J.; Toth, Peter T.; Svensson, Eric C.; Gomberg-Maitland, Mardi; Rehman, Jalees] Univ Chicago, Dept Med, Chicago, IL 60637 USA.
   [Husain, Aliya N.; Cipriani, Nicole] Univ Chicago, Dept Pathol, Cardiol Sect, Chicago, IL 60637 USA.
   [Dyck, Jason R. B.] Univ Alberta, Dept Pharmacol, Alberta, ON, Canada.
   [Thebaud, Bernard] Univ Alberta, Dept Pediat, Alberta, ON, Canada.
C3 University of Chicago; University of Chicago; University of Alberta; University of Alberta
RP Archer, SL (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC6080, Chicago, IL 60637 USA.
EM sarcher@medicine.bsd.uchicago.edu
FU National Institutes of Health [RO1-HL071115, 1RC1HL099462-01]; American Heart Association; Roche Foundation for Anemia Research
CR Archer SL, 2008, AM J PHYSIOL-HEART C, V294, PH570, DOI 10.1152/ajpheart.01324.2007
   Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200
   Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200
   BelAiba RS, 2004, BIOL CHEM, V385, P249, DOI 10.1515/BC.2004.019
   Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC
   BRAVARD A, 1992, INT J CANCER, V51, P476, DOI 10.1002/ijc.2910510323
   Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200
   Elmedal B, 2004, BRIT J PHARMACOL, V141, P105, DOI 10.1038/sj.bjp.0705580
   Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721
   Harju T, 2004, EUR RESPIR J, V24, P765, DOI 10.1183/09031936.04.00121203
   Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005
   Hodge DR, 2005, CANCER RES, V65, P6255, DOI 10.1158/0008-5472.CAN-04-4482
   Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253
   Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051
   Hurt EM, 2007, BRIT J CANCER, V97, P1116, DOI 10.1038/sj.bjc.6604000
   Hurt EM, 2007, BLOOD, V109, P3953, DOI 10.1182/blood-2006-07-035162
   Kaewpila S, 2008, CANCER RES, V68, P2781, DOI 10.1158/0008-5472.CAN-07-2635
   Kim A, 2004, ANTIOXID REDOX SIGN, V6, P489, DOI 10.1089/152308604773934251
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J
   Martin RCG, 2007, CLIN CANCER RES, V13, P5176, DOI 10.1158/1078-0432.CCR-07-1152
   NGO VM, 1995, MOL CELL ENDOCRINOL, V108, P95, DOI 10.1016/0303-7207(94)03462-3
   Platoshyn O, 2001, AM J PHYSIOL-LUNG C, V280, PL801, DOI 10.1152/ajplung.2001.280.4.L801
   Razin A, 2005, PROG MOLEC, V38, P151
   Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291
   Rodríguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2
   Schröder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012
   Steinhorn RH, 2001, AM J RESP CRIT CARE, V164, P834, DOI 10.1164/ajrccm.164.5.2010104
   TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3
   Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Voelkel NF, 1998, CHEST, V114, P225S, DOI 10.1378/chest.114.3_Supplement.225S
   WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005
   Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002
   Zhao YD, 2006, AM J RESP CELL MOL, V35, P182, DOI 10.1165/rcmb.2005-0115OC
NR 38
TC 325
Z9 348
U1 0
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD JUN 22
PY 2010
VL 121
IS 24
BP 2661
EP U108
DI 10.1161/CIRCULATIONAHA.109.916098
PG 24
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 613MY
UT WOS:000278984600010
PM 20529999
DA 2024-11-01
ER

PT J
AU van der Westhuizen, FH
   Smet, J
   Levanets, O
   Meissner-Roloff, M
   Louw, R
   Van Coster, R
   Smuts, I
AF van der Westhuizen, Francois H.
   Smet, Joel
   Levanets, Oksana
   Meissner-Roloff, Madelein
   Louw, Roan
   Van Coster, Rudy
   Smuts, Izelle
TI Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthalmoplegia
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID brain magnetic-resonance; spectrophotometric assay; direct repeats; mr; subcomplexes; biogenesis; mutations; diagnosis; tissue; cells
AB A young, adult, African male patient presented with progressive proximal muscle weakness, external ophthalmoplegia and ptosis, as well as cardiac conduction abnormalities resembling Kearns-Sayre syndrome (KSS). Magnetic resonance imaging (MRI) of the brain revealed normal basal ganglia but bilateral well-circumscribed lesions in the cerebellar peduncles. Enzyme deficiencies in oxidative phosphorylation (OXPHOS) complexes I, IV and V was measured in muscle tissue. Blue native polyacrylamide gel electrophoresis (BN-PAGE) confirmed decreased protein content and activity of these complexes and revealed the presence of two catalytically active complex V sub-complexes. Upon investigation by molecular genetics, the mitochondrial DNA (mtDNA) copy number was found to be elevated and a novel deletion of 3431 bp was found in 80% of muscle mtDNA between positions 7115 and 10546, flanked by a 5 bp direct repeat sequence. In addition, it could also be concluded that the absence of mtDNA-encoded ATPase6 and ATPase8 genes in this patient clearly resulted in aberrant synthesis of ATP synthase.
C1 [van der Westhuizen, Francois H.; Levanets, Oksana; Meissner-Roloff, Madelein; Louw, Roan] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.
   [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Paediat, Div Paediat Neurol & Metab, Ghent, Belgium.
   [Smuts, Izelle] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat, ZA-0002 Pretoria, South Africa.
C3 North West University - South Africa; Ghent University; Ghent University Hospital; University of Pretoria
RP Smuts, I (corresponding author), POB 32781, ZA-0134 Totiusdal, South Africa.
EM Izelle.Smuts@up.ac.za
FU Medical Research Council of South Africa
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   CHRETIEN D, 1995, CLIN CHIM ACTA, V240, P129, DOI 10.1016/0009-8981(95)06145-6
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356
   Devreese B, 2002, ELECTROPHORESIS, V23, P2525, DOI 10.1002/1522-2683(200208)23:15<2525::AID-ELPS2525>3.0.CO;2-I
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   LEUTNER C, 1994, AM J NEURORADIOL, V15, P681
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/30.9.e36
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Selden RF, 1989, CURRENT PROTOCOLS MO, V0, P291
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Smet J, 2005, CELL BIOL LAB HDB, V4, P259
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 32
TC 9
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD DEC 15
PY 2010
VL 33
IS 
BP S55
EP S62
DI 10.1007/s10545-009-9020-y
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA V33ME
UT WOS:000209022100009
PM 20082143
DA 2024-11-01
ER

PT J
AU Souilem, S
   Kefi, M
   Mancuso, M
   Nesti, C
   Hentati, F
   Amouri, R
AF Souilem, Sihem
   Kefi, Mounir
   Mancuso, Michelangelo
   Nesti, Claudia
   Hentati, Faycal
   Amouri, Rim
TI A Novel Heteroplasmic tRNA<SUP>Ser(UCN)</SUP> mtDNA Point Mutation Associated With Progressive Ophthalmoplegia and Dysphagia
SO DIAGNOSTIC MOLECULAR PATHOLOGY
LA English
DT Article
DE PEO; tRNA(Ser(UCN)); mitochondrial DNA
ID external ophthalmoplegia; mitochondrial
AB We report a novel heteroplasmic mitochondrial DNA mutation in the tRNA(Ser(UCN)) gene at nucleotide 7458 (m.7458G>A) in a 26-year-old patient affected with sporadic progressive external ophthalmoplegia associated with dysphagia. Muscle biopsy showed a strong succinate dehydrogenase staining, ragged red fibers, and 15% of cytochrome c oxidase-negative fibers. Activities of mitochondrial respiratory chain complexes I+III and IV were reduced. The mutation was heteroplasmic (75%) in the muscle, but undetectable in accessible tissues from the patient and his maternal relatives. This report expands the molecular heterogeneity of progressive external ophthalmoplegia.
C1 [Souilem, Sihem; Kefi, Mounir; Hentati, Faycal; Amouri, Rim] Natl Inst Neurol, Dept Mol Neurobiol & Neuropathol Rabta, Tunis 1007, Tunisia.
   [Mancuso, Michelangelo; Nesti, Claudia] Univ Pisa, Neurol Clin, Dept Neurosci, I-56100 Pisa, Italy.
C3 Universite de Tunis-El-Manar; Institut National de Neurologie; University of Pisa
RP Souilem, S (corresponding author), Natl Inst Neurol, Dept Mol Neurobiol & Neuropathol Rabta, Tunis 1007, Tunisia.
EM sihemsouilem@yahoo.fr
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   BROWN MD, 1992, GENETICS, V130, P163
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chen B, 2008, AM J MED GENET A, V146A, P1248, DOI 10.1002/ajmg.a.32285
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Jones KJ, 1997, NEUROMUSCULAR DISORD, V7, P143, DOI 10.1016/S0960-8966(97)00447-1
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
NR 16
TC 3
Z9 6
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1052-9551
EI 1533-4066
J9 DIAGN MOL PATHOL
JI Diagn. Mol. Pathol.
PD MAR 15
PY 2010
VL 19
IS 1
BP 28
EP 32
DI 10.1097/PDM.0b013e3181b00f02
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pathology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pathology
GA 568LL
UT WOS:000275523700005
PM 20186009
DA 2024-11-01
ER

PT J
AU Weber, TA
   Reichert, AS
AF Weber, Tobias A.
   Reichert, Andreas S.
TI Impaired quality control of mitochondria: Aging from a new perspective
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
DE Aging; Mitochondrial dysfunction; Fusion; Fission; Autophagy; Mitophagy; Sirtuins; Longevity; ROS
ID m-aaa protease; dominant optic atrophy; caloric restriction; saccharomyces-cerevisiae; oxidative stress; life-span; skeletal-muscle; cell-survival; point mutations; dna mutations
AB Mitochondria fulfill a number of essential cellular functions and play a key role in the aging process. Reactive oxygen species (ROS) are predominantly generated in this organelle but next to inducing oxidative damage they act as signaling molecules. Autophagy is regulated by signaling ROS and is known to affect aging as well as neurodegenerative diseases. Many cellular components that influence autophagy are linked to longevity such as members of the sirtuin protein family. Recent studies further link mitochondrial dynamics to the removal of dysfunctional mitochondria by mitophagy, thereby representing a novel mechanism for the quality control of mitochondria. Here we summarize the current views on how mitochondrial function is linked to aging and we propose that quality control of mitochondria has a crucial role in counteracting the aging process. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Weber, Tobias A.; Reichert, Andreas S.] Goethe Univ Frankfurt, CEF Makromol Komplexe, Fachbereich Med, D-60590 Frankfurt, Germany.
C3 Goethe University Frankfurt
RP Reichert, AS (corresponding author), Goethe Univ Frankfurt, CEF Makromol Komplexe, Fachbereich Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM reichert@zbc.kgu.de
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961
   Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011
   Banks WA, 2003, J CLIN ENDOCR METAB, V88, P1234, DOI 10.1210/jc.2002-021695
   Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Brigelius-Flohé R, 2009, GENES NUTR, V4, P161, DOI 10.1007/s12263-009-0131-8
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108
   Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Davies KJA, 1995, BIOCHEM SOC SYMP, V0, PP1, DOI 10.1042/bss0610001
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   Díaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555
   Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Finlan LE, 2007, CELL CYCLE, V6, P1062, DOI 10.4161/cc.6.9.4162
   FLEMING JE, 1992, MUTAT RES, V275, P267, DOI 10.1016/0921-8734(92)90031-J
   Fontana L, 2010, AGE, V32, P97, DOI 10.1007/s11357-009-9118-z
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x
   Gispert S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005777
   Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145
   Juhász G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707
   Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kanki T, 2009, AUTOPHAGY, V5, P1201, DOI 10.4161/auto.5.8.9747
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kirkwood TBL, 2000, ANN NY ACAD SCI, V908, P14
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Levrero M, 2000, J CELL SCI, V113, P1661
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708
   Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200
   Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045
   Morley JE, 2010, CURR OPIN CLIN NUTR, V13, P40, DOI 10.1097/MCO.0b013e3283331384
   Morselli E, 2010, CELL DEATH DIS, V1, P0, DOI 10.1038/cddis.2009.8
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167
   Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   Okamoto K, 2009, AUTOPHAGY, V5, P1203, DOI 10.4161/auto.5.8.9830
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7
   Osiewacz HD, 2006, FREE RADICAL RES, V40, P1350, DOI 10.1080/10715760600921153
   Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05
   Parone PA, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003257
   Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Schäfer A, 2009, BIOL CHEM, V390, P707, DOI 10.1515/BC.2009.086
   Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008
   Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194
   Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110
   Steglich G, 1999, MOL CELL BIOL, V19, P3435
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200
   Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730
   TERAMOTO M, 2009, J SCI MED SPORT, V0, P0
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016
   Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 166
TC 97
Z9 104
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL-AUG 15
PY 2010
VL 45
IS 7-8
BP 503
EP 511
DI 10.1016/j.exger.2010.03.018
PG 9
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 619EU
UT WOS:000279412800006
PM 20451598
DA 2024-11-01
ER

PT J
AU Zheng, M
   Xiao, RP
AF Zheng, Ming
   Xiao, Rui-Ping
TI Role of mitofusin 2 in cardiovascular oxidative injury
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Review
DE Mitochondria; Mitofusin; Cardiovascular disease; Oxidative stress
ID muscle-cell apoptosis; mitochondrial fusion; skeletal-muscle; mfn2; mutations; neuropathy; dynamics; fission; complementation; dysfunction
AB Mitochondria are highly dynamic organelles with constant shape changes regulated by fusion and fission events. In addition to regulating mitochondrial morphology, mitochondrial fusion/fission is involved in fundamental mitochondrial biological processes, including mitochondrial metabolism, energization, respiration, mitochondrial membrane potential, and mtDNA stability. Dysfunction of mitochondrial dynamics has been implicated in various human diseases, especially in neurodegenerative diseases. Emerging evidence indicates that impaired expression of mitochondrial fusion proteins or their malfunction participates in oxidative stress-induced cardiovascular injury. This review will focus on recent advances of mitochondrial fusion in regulating various cellular processes in cardiovascular system.
C1 [Zheng, Ming; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
   [Xiao, Rui-Ping] Peking Univ, Sch Chem Biol & Biotechnol, Ctr Drug Discovery, Shenzhen Grad Sch, Shenzhen, Peoples R China.
C3 Peking University; Peking University
RP Xiao, RP (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
EM Xiaor@grc.nia.nih.gov
FU Major State Basic Research Development Program of China [2007CB512100]; National Natural Science Foundation of China [30770870, 30500182, 30971062]
CR Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161
   Chien KR, 2004, NAT CELL BIOL, V6, P807, DOI 10.1038/ncb0904-807
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316
   Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200
   Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029
   Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149
   Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479
   Santel A, 2001, J CELL SCI, V114, P867
   Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200
   Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 35
TC 12
Z9 14
U1 0
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2716
EI 
J9 J MOL MED
JI J. Mol. Med.
PD OCT 15
PY 2010
VL 88
IS 10
BP 987
EP 991
DI 10.1007/s00109-010-0675-5
PG 5
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 652ZT
UT WOS:000282052100005
PM 20824264
DA 2024-11-01
ER

PT J
AU Weihl, CC
   Pestronk, A
AF Weihl, Conrad C.
   Pestronk, Alan
TI Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Article
DE biomarkers; inclusion body myositis; inflammatory myopathies; proteostasis; TAR DNA binding protein-43
ID amyotrophic-lateral-sclerosis; valosin-containing protein; mitochondrial-dna deletions; muscle-fibers; skeletal-muscle; alzheimers-disease; inflammatory myopathy; frontotemporal dementia; tdp-43 accumulation; amyloid protein
AB Purpose of review The relevance of proteins that accumulate and aggregate in the muscle fibers of patients with sporadic inclusion body myositis (sIBM) is unknown. Many of these proteins also aggregate in other disorders, including Alzheimer's disease, leading to speculation that sIBM pathogenesis has similarities to neurodegenerative disorders. Our review will discuss current studies on these protein biomarkers and their utility in sIBM diagnosis. Recent findings Two 'classical' components of sIBM aggregates (amyloid beta and phospho-tau) have been re-evaluated. Three additional components of aggregates (TDP-43, p62, and LC3) have been identified. The sensitivity and specificity of these biomarkers has been explored. Two studies suggest that TDP-43 may have clinical utility in distinguishing sIBM from other inflammatory myopathies. Summary The fact that sIBM muscle accumulates multiple protein aggregates with no single protein appearing in every sIBM patient biopsy suggests that it is not presently possible to place pathogenic blame on any single protein (i.e. amyloid b or TDP-43). Instead changes in protein homeostasis may lead to the accumulation of different proteins that have a propensity to aggregate in skeletal muscle. Therapies aimed at improving protein homeostasis, instead of targeting a specific protein that may or may not accumulate in all sIBM patients, could be useful future strategies for this devastating and enigmatic disorder.
C1 [Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Washington University (WUSTL)
RP Weihl, CC (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.
EM weihlc@neuro.wustl.edu
FU NIH [R01AG031867, 5K08AG026271]; Muscular Dystrophy Association
CR ARAHATA K, 1995, MUSCLE NERVE, V0, PS56
   Askanas V, 2006, NEUROLOGY, V66, PS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2000, J NEUROPATH EXP NEUR, V59, P592, DOI 10.1093/jnen/59.7.592
   ASKANAS V, 1993, NEUROLOGY, V43, P1265, DOI 10.1212/WNL.43.6.1265-a
   ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006
   ASKANAS V, 1992, AM J PATHOL, V141, P31
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   CARPENTER S, 1978, NEUROLOGY, V28, P8, DOI 10.1212/WNL.28.1.8
   Chiesa R, 2001, NEUROBIOL DIS, V8, P279, DOI 10.1006/nbdi.2001.0400
   EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7
   ENGEL AG, 1990, RES P ARNMD, V68, P141
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Greenberg Steven A, 2009, BMJ, V339, Pb2680, DOI 10.1136/bmj.b2680
   Greenberg S, 2009, CURR NEUROL NEUROSCI, V9, P83, DOI 10.1007/s11910-009-0013-x
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376
   Kitazawa M, 2008, ANN NEUROL, V64, P15, DOI 10.1002/ana.21325
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Küsters B, 2009, ACTA NEUROPATHOL, V117, P209, DOI 10.1007/s00401-008-0471-2
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   Lünemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115
   Machado P, 2009, ACTA REUMATOL PORT, V34, P161
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   Mirabella M, 1996, J NEUROPATH EXP NEUR, V55, P774, DOI 10.1097/00005072-199607000-00003
   Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749
   Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olivé M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f
   Page LJ, 2009, P NATL ACAD SCI USA, V106, P11125, DOI 10.1073/pnas.0811753106
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Parker KC, 2009, MUSCLE NERVE, V39, P739, DOI 10.1002/mus.21230
   Pestronk A, 2006, ARTHRITIS RHEUM, V54, P1687, DOI 10.1002/art.21822
   Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292
   Salajegheh M, 2009, MUSCLE NERVE, V40, P520, DOI 10.1002/mus.21471
   Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386
   Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SARKOZI E, 1994, EXP NEUROL, V128, P27, DOI 10.1006/exnr.1994.1109
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014
   Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334
   Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037
   Wójcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6
NR 63
TC 41
Z9 46
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT 15
PY 2010
VL 23
IS 5
BP 482
EP 488
DI 10.1097/WCO.0b013e32833d3897
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 647LR
UT WOS:000281620500006
PM 20664349
DA 2024-11-01
ER

PT J
AU Wong, LJC
AF Wong, Lee-Jun C.
TI MOLECULAR GENETICS OF MITOCHONDRIAL DISORDERS
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE mitochondrial disorder; mtDNA mutation; mtDNA depletion; mtDNA deletion
ID progressive external ophthalmoplegia; comparative genomic hybridization; cytochrome-c-oxidase; sideroblastic anemia mlasa; coenzyme q(10) deficiency; dna depletion syndrome; polg mutations; liver-failure; leigh-disease; oxidative-phosphorylation
AB Mitochondrial respiratory chain (RC) disorders (RCDs) are a group of genetically and clinically heterogeneous diseases because of the fact that protein components of the RC are encoded by both mitochondrial and nuclear genomes and are essential in all cells. In addition, the biogenesis, structure, and function of mitochondria, including DNA replication, transcription, and translation, all require nuclear-encoded genes. In this review, primary molecular defects in the mitochondrial genome and major classes of nuclear genes causing mitochondrial RCDs, including genes underlying mitochondrial DNA (mtDNA) depletion syndrome, as well as genes encoding RC subunits, complex assembly genes, and translation factors, are described. Diagnostic methodologies used to detect common point mutations, large deletions, and unknown point mutations in the mtDNA and to quantify mutation heteroplasmy are also discussed. Finally, the selection of nuclear genes for gold standard sequence analysis, application of novel technologies including oligonucleotide array comparative genomic hybridization, and massive parallel sequencing of target genes are reviewed. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:154-162.
C1 Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
CR Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   BIANCHI MS, 1995, CYTOGENET CELL GENET, V71, P99, DOI 10.1159/000134072
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Bykhovskaya Y, 2007, MOL GENET METAB, V91, P148, DOI 10.1016/j.ymgme.2007.02.006
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200
   DiMauro S, 2004, MITOCHONDRION, V4, P799, DOI 10.1016/j.mito.2004.07.032
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Horton TM, 1996, GENE CHROMOSOME CANC, V15, P95, DOI 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Houstek J, 2009, BBA-BIOENERGETICS, V1787, P529, DOI 10.1016/j.bbabio.2008.11.013
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   Kenmochi N, 2000, J HUM GENET, V45, P290, DOI 10.1007/s100380070018
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   Lacbawan F, 2000, AM J MED GENET, V95, P266, DOI 10.1002/1096-8628(20001127)95:3<266::AID-AJMG13>3.3.CO;2-S
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Lutz RE, 2009, J PEDIATR GASTR NUTR, V49, P126, DOI 10.1097/MPG.0b013e31817d9cad
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mardis ER, 2009, GENOME MED, V1, P0, DOI 10.1186/gm40
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Shchelochkov OA, 2009, MOL GENET METAB, V96, P97, DOI 10.1016/j.ymgme.2008.11.167
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Tan DJ, 2002, CANCER RES, V62, P972
   Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Valente L, 2009, BBA-MOL BASIS DIS, V1792, P791, DOI 10.1016/j.bbadis.2009.06.002
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Wallace DC, 2001, THE METABOLIC AND MOLECULAR BASIS OF INHERITED DISEASE, V0, P2425
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 96
TC 49
Z9 55
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1940-5510
EI 
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PD JUN 15
PY 2010
VL 16
IS 2
BP 154
EP 162
DI 10.1002/ddrr.104
PG 9
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100008
PM 20818730
DA 2024-11-01
ER

PT J
AU Ahola-Erkkilä, S
   Carroll, CJ
   Peltola-Mjösund, K
   Tulkki, V
   Mattila, I
   Seppänen-Laakso, T
   Oresic, M
   Tyynismaa, H
   Suomalainen, A
AF Ahola-Erkkila, Sofia
   Carroll, Christopher J.
   Peltola-Mjosund, Katja
   Tulkki, Valtteri
   Mattila, Ismo
   Seppanen-Laakso, Tuulikki
   Oresic, Matej
   Tyynismaa, Henna
   Suomalainen, Anu
TI Ketogenic diet slows down mitochondrial myopathy progression in mice
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID deletions; biogenesis; twinkle; fat; dna
AB Mitochondrial dysfunction is a major cause of neurodegenerative and neuromuscular diseases of adult age and of multisystem disorders of childhood. However, no effective treatment exists for these progressive disorders. Cell culture studies suggested that ketogenic diet (KD), with low glucose and high fat content, could select against cells or mitochondria with mutant mitochondrial DNA (mtDNA), but proper patient trials are still lacking. We studied here the transgenic Deletor mouse, a disease model for progressive late-onset mitochondrial myopathy, accumulating mtDNA deletions during aging and manifesting subtle progressive respiratory chain (RC) deficiency. We found that these mice have widespread lipidomic and metabolite changes, including abnormal plasma phospholipid and free amino acid levels and ketone body production. We treated these mice with pre-symptomatic long-term and post-symptomatic shorter term KD. The effects of the diet for disease progression were followed by morphological, metabolomic and lipidomic tools. We show here that the diet decreased the amount of cytochrome c oxidase negative muscle fibers, a key feature in mitochondrial RC deficiencies, and prevented completely the formation of the mitochondrial ultrastructural abnormalities in the muscle. Furthermore, most of the metabolic and lipidomic changes were cured by the diet to wild-type levels. The diet did not, however, significantly affect the mtDNA quality or quantity, but rather induced mitochondrial biogenesis and restored liver lipid levels. Our results show that mitochondrial myopathy induces widespread metabolic changes, and that KD can slow down progression of the disease in mice. These results suggest that KD may be useful for mitochondrial late-onset myopathies.
C1 [Ahola-Erkkila, Sofia; Carroll, Christopher J.; Peltola-Mjosund, Katja; Tulkki, Valtteri; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Mattila, Ismo; Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.
C3 University of Helsinki; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, R C523B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Academy of Finland; Finnish Institute of Molecular Medicine; University of Helsinki; Helsinki Biomedical Graduate School
CR Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, PE1724, DOI 10.1152/ajpendo.00717.2006
   Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
NR 15
TC 147
Z9 160
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2010
VL 19
IS 10
BP 1974
EP 1984
DI 10.1093/hmg/ddq076
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 590PD
UT WOS:000277238200010
PM 20167576
DA 2024-11-01
ER

PT J
AU Tyynismaa, H
   Carroll, CJ
   Raimundo, N
   Ahola-Erkkilä, S
   Wenz, T
   Ruhanen, H
   Guse, K
   Hemminki, A
   Peltola-Mjosund, KE
   Tulkki, V
   Oresic, M
   Moraes, CT
   Pietiläinen, K
   Hovatta, I
   Suomalainen, A
AF Tyynismaa, Henna
   Carroll, Christopher J.
   Raimundo, Nuno
   Ahola-Erkkila, Sofia
   Wenz, Tina
   Ruhanen, Heini
   Guse, Kilian
   Hemminki, Akseli
   Peltola-Mjosund, Katja E.
   Tulkki, Valtteri
   Oresic, Matej
   Moraes, Carlos T.
   Pietilainen, Kirsi
   Hovatta, Iiris
   Suomalainen, Anu
TI Mitochondrial myopathy induces a starvation-like response
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; fibroblast growth factor-21; multiple deletions; skeletal-muscle; gene-expression; mtdna maintenance; mammalian-cells; ppar-alpha; mice; dna
AB Mitochondrial respiratory chain (RC) deficiency is among the most common causes of inherited metabolic disease, but its physiological consequences are poorly characterized. We studied the skeletal muscle gene expression profiles of mice with late-onset mitochondrial myopathy. These animals express a dominant patient mutation in the mitochondrial replicative helicase Twinkle, leading to accumulation of multiple mtDNA deletions and progressive subtle RC deficiency in the skeletal muscle. The global gene expression pattern of the mouse skeletal muscle showed induction of pathways involved in amino acid starvation response and activation of Akt signaling. Furthermore, the muscle showed induction of a fasting-related hormone, fibroblast growth factor 21 (Fgf21). This secreted regulator of lipid metabolism was also elevated in the mouse serum, and the animals showed widespread changes in their lipid metabolism: small adipocyte size, low fat content in the liver and resistance to high-fat diet. We propose that RC deficiency induces a mitochondrial stress response, with local and global changes mimicking starvation, in a normal nutritional state. These results may have important implications for understanding the metabolic consequences of mitochondrial myopathies.
C1 [Tyynismaa, Henna; Carroll, Christopher J.; Raimundo, Nuno; Ahola-Erkkila, Sofia; Ruhanen, Heini; Peltola-Mjosund, Katja E.; Tulkki, Valtteri; Hovatta, Iiris; Suomalainen, Anu] Biomedicum Helsinki, Res Program Mol Neurol, Helsinki 00290, Finland.
   [Wenz, Tina; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol & Cell Biol & Anat, Miami, FL 33136 USA.
   [Guse, Kilian; Hemminki, Akseli] Haartman Inst, Mol Canc Biol Program, Helsinki 00290, Finland.
   [Guse, Kilian; Hemminki, Akseli] Haartman Inst, Transplantat Lab, Helsinki 00290, Finland.
   [Guse, Kilian; Hemminki, Akseli] Finnish Inst Mol Med, Helsinki 00290, Finland.
   [Guse, Kilian; Hemminki, Akseli] HUSLAB, Helsinki 00290, Finland.
   [Guse, Kilian; Hemminki, Akseli] Univ Helsinki, Cent Hosp, Canc Gene Therapy Grp, FIN-00290 Helsinki, Finland.
   [Oresic, Matej; Suomalainen, Anu] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki 00290, Finland.
   [Oresic, Matej] VTT Tech Res Ctr Finland, Espoo 02044, Vtt, Finland.
   [Pietilainen, Kirsi] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res Unit, Helsinki 00290, Finland.
   [Hovatta, Iiris] Univ Helsinki, Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki 00271, Finland.
   [Hovatta, Iiris] Univ Helsinki, Dept Med Genet, Helsinki 00271, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00029, Finland.
C3 University of Helsinki; University of Miami; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Biomedicum Helsinki, Res Program Mol Neurol, RC523B,Haartmaninkatu 8, Helsinki 00290, Finland.
EM anu.wartiovaara@helsinki.fi
FU Helsinki Biomedical Graduate School; Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Helsinki
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06
   Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng015
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004
   Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168
   Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lauritzen HPMM, 2008, DIABETES, V57, P315, DOI 10.2337/db06-1578
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010
   Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2
   Sen P, 2003, MOL CELL BIOCHEM, V253, P241, DOI 10.1023/A:1026020101379
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 38
TC 240
Z9 258
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 15
PY 2010
VL 19
IS 20
BP 3948
EP 3958
DI 10.1093/hmg/ddq310
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 657UF
UT WOS:000282439700005
PM 20656789
DA 2024-11-01
ER

PT J
AU Krishnan, KJ
   Blackwood, JK
   Reeve, AK
   Turnbull, DM
   Taylor, RW
AF Krishnan, Kim J.
   Blackwood, John K.
   Reeve, Amy K.
   Turnbull, Douglass M.
   Taylor, Robert W.
TI Detection of Mitochondrial DNA Variation in Human Cells
SO GENETIC VARIATION: METHODS AND PROTOCOLS
LA English
DT Article; Book Chapter
DE Mitochondrial DNA; Variation; Mutations; mtDNA disease; Polymorphisms; Ageing; Real-time PCR
ID real-time pcr; substantia-nigra neurons; point mutations; common deletion; muscle-fibers; stem-cells; rapid identification; individual cells; skeletal-muscle; disease
AB The ability to detect mitochondrial DNA (mtDNA) variation within human cells is important not only to identify mutations causing mtDNA disease, but also as mtDNA mutations are being increasingly described in many ageing tissues and in complex diseases such as diabetes, neurodegeneration and cancer. In this review, we discuss the main molecular genetic techniques that can be applied to study the two main types of mtDNA mutation: point mutations and large-scale mtDNA rearrangements. We then describe in detail protocols routinely used within our laboratory to analyse mtDNA mutations in individual human cells such as single muscle fibres and individual neurons to study the relationship between mtDNA mutation load and respiratory chain dysfunction.
C1 [Krishnan, Kim J.; Blackwood, John K.; Reeve, Amy K.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK
RP Krishnan, KJ (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
FU Medical Research Council [G0700718] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline; MRC [G0700718] Funding Source: UKRI
CR Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177
   Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   *EM U CTR MOL MED, 2006, MITOMAP, V0, P0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   Pogozelski WK, 2003, MITOCHONDRION, V2, P415, DOI 10.1016/S1567-7249(03)00033-3
   POULTON J, 1989, LANCET, V1, P236
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, P0, DOI 10.1093/nar/28.20.e89
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
NR 47
TC 3
Z9 4
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PD JUN 15
PY 2010
VL 628
IS 
BP 227
EP 257
DI 10.1007/978-1-60327-367-1_13
PG 31
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BRC40
UT WOS:000282342500013
PM 20238085
DA 2024-11-01
ER

PT J
AU Koga, Y
   Povalko, N
   Nishioka, J
   Katayama, K
   Kakimoto, N
   Matsuishi, T
AF Koga, Yasutoshi
   Povalko, Nataliya
   Nishioka, Junko
   Katayama, Koujyu
   Kakimoto, Noriko
   Matsuishi, Toyojiro
TI MELAS and L-arginine therapy: pathophysiology of stroke-like episodes
SO MITOCHONDRIAL RESEARCH IN TRANSLATIONAL MEDICINE
LA English
DT Article; Proceedings Paper
DE MELAS; mitochondrial angiopathy; mitochondrial cytopathy; L-arginine; endothelial function
ID mitochondrial-dna mutation; cerebral-blood-flow; lactic-acidosis; protein-synthesis; myopathy; encephalopathy; patient; artery; encephalomyopathy; defects
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited multisystem mitochondrial disorder. Although many molecular and cellular mechanisms have been discovered leading to mitochondrial cytopathy, the pathogenic mechanism of stroke-like episodes seen in MELAS has not been clarified yet. According to the muscle and brain pathology and vascular physiology, mitochondrial angiopathy, or endothelial dysfunction, were proposed to play an important role for developing stroke-like episodes. Based on a hypothesis of mitochondrial angiopathy theory, we use L-arginine in MELAS patients and report its usefulness. This review aims to give a general idea on the actual knowledge about the possible pathogenic mechanism of stroke-like episodes, including clinical symptoms that lead to stroke-like episodes, muscle, or brain pathology, molecular cellular functions, neuroimagings including MRI, MRS, and SPECT, and the proposed site of action of L-arginine therapy on MELAS patients. Currently, L-arginine therapy may be the most promising for the treatment of stroke-like episodes in MELAS.
C1 [Koga, Yasutoshi; Povalko, Nataliya; Nishioka, Junko; Katayama, Koujyu; Kakimoto, Noriko; Matsuishi, Toyojiro] Kurume Univ, Dept Pediat & Child Hlth, Sch Med, Kurume, Fukuoka 8300011, Japan.
C3 Kurume University
RP Koga, Y (corresponding author), Kurume Univ, Dept Pediat & Child Hlth, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
EM yasukoga@med.kurume-u.ac.jp
FU Ministry of Culture and Education in Japan [19659271]; Ministry of Health, Labor and Welfare in Japan [20I-13]; Heiwa Memorial Foundation in Japan; Grants-in-Aid for Scientific Research [19659271] Funding Source: KAKEN
CR CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Gerriets T, 2004, BRAIN RES PROTOC, V12, P137, DOI 10.1016/j.brainresprot.2003.08.006
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Iizuka T, 2010, FUTUR NEUROL, V5, P61, DOI 10.2217/FNL.09.71
   Iizuka T, 2009, J NEUROL SCI, V278, P35, DOI 10.1016/j.jns.2008.11.016
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Jahangier Tafewchi RS, 2005, MUTAT RES, V578, P43
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KISHI M, 1988, J NEUROL SCI, V86, P31, DOI 10.1016/0022-510X(88)90005-6
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Koge Y, 1998, ANN NEUROL, V43, P835, DOI 10.1002/ana.410430620
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Moutaouakil F, 2009, REV NEUROL-FRANCE, V165, P482, DOI 10.1016/j.neurol.2008.08.006
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nariai R, 2001, J NEUROIMAGING, V11, P325, DOI 10.1111/j.1552-6569.2001.tb00057.x
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Stoquart-ElSankari S, 2008, J NEUROL, V255, P1593, DOI 10.1007/s00415-008-0968-6
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 39
TC 78
Z9 83
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
EI 
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PD JUN 15
PY 2010
VL 1201
IS 
BP 104
EP 110
DI 10.1111/j.1749-6632.2010.05624.x
PG 7
WC Cell Biology; Medicine, Research & Experimental; Multidisciplinary Sciences
SC Cell Biology; Research & Experimental Medicine; Science & Technology - Other Topics
GA BTN05
UT WOS:000287380500016
PM 20649546
DA 2024-11-01
ER

PT J
AU Schicks, J
   Synofzik, M
   Schulte, C
   Schöls, L
AF Schicks, Julia
   Synofzik, Matthis
   Schulte, Claudia
   Schoels, Ludger
TI <i>POLG</i>, but not <i>PEO1</i>, is a Frequent Cause of Cerebellar Ataxia in Central Europe
SO MOVEMENT DISORDERS
LA English
DT Article
DE ataxia; mitochondrial; genetics; epilepsy
ID progressive external ophthalmoplegia; recessive twinkle mutations; phenotypic spectrum; neuropathy; encephalopathy; depletion; disease; gene
AB Nuclear genes, in particular mitochondrial polymerase gamma (POLG) and PEO1, have been increasingly recognized to cause mitochondrial diseases. Both genes assume a complementary role as part of the mitochondrial DNA (mtDNA) replication fork and, accordingly, seem to present with largely overlapping phenotypical spectra. We assessed the frequency and phenotypic spectrum of PEO1 compared to POLG mutations in a cohort of 80 patients with cerebellar ataxia for which common repeat expansion diseases had been excluded. Patients were selected to present additional features previously described for PEO1 mutations, namely early age of onset, progressive external ophthalmoplegia (PEO), or epilepsy. Whereas PEO1 mutations were not found in our cohort, POLG frequently caused ataxia with PEO (47%), psychiatric comorbidities (20%) and, more rarely, with epilepsy (14%). Thus, PEO1 is rare in Central Europe even in those patients displaying characteristic phenotypic features. In contrast, POLG is rather common in Central European ataxia patients. It should be particularly considered in ataxia patients with PEO, psychiatric comorbidities, and/or sensory neuropathy, even if characteristic mitochondrial extra-CNS features are absent. (c) 2010 Movement Disorder Society
C1 [Schoels, Ludger] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.
   Univ Tubingen, German Res Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen
RP Schöls, L (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.
EM ludger.schoels@uni-tuebingen.de
FU German Ministry for Education and Research (BMBF) [01GM0864]; Movement Disorder Society; University of Tuebingen [1890-0-0]; Volkswagen Foundation (European platform); Santhera Pharmaceuticals; Deutsche Forschungsgemeinschaft [SCHO754/3-1, SCHO754/4-1]; German Research Council (BMBF) [01GM0864, 01GM0644, 01GM0603]; EU [LSHM-CT-2004-503304]; E-RARE program [01GM0807, 01GM0820]; HSP-Selbsthilfegruppe Deutschland eV.
CR Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P503, DOI 10.1136/jnnp.44.6.503
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 17
TC 26
Z9 26
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD NOV 15
PY 2010
VL 25
IS 15
BP 2678
EP 2682
DI 10.1002/mds.23286
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA 678FX
UT WOS:000284060600031
PM 20803511
DA 2024-11-01
ER

PT J
AU Brodsky, MC
AF Brodsky, Michael C.
TI Optic Atrophy in Children
SO PEDIATRIC NEURO-OPHTHALMOLOGY, SECOND EDITION
LA English
DT Article; Book Chapter
ID dominant cerebellar-ataxia; mitochondrial-dna mutations; infantile neuroaxonal dystrophy; lebers congenital amaurosis; hallervorden-spatz-syndrome; sensorineural hearing-loss; wolfram didmoad syndrome; central-nervous-system; progressive external ophthalmoplegia; pelizaeus-merzbacher disease
C1 Mayo Clin, Rochester, MN 55905 USA.
C3 Mayo Clinic
RP Brodsky, MC (corresponding author), Mayo Clin, Rochester, MN 55905 USA.
CR Abdel-Salam GMH, 2006, BRAIN DEV-JPN, V28, P529, DOI 10.1016/j.braindev.2006.01.009
   Abe T, 1997, ARCH OPHTHALMOL-CHIC, V115, P231, DOI 10.1001/archopht.1997.01100150233013
   Abrams LS, 1997, J PEDIAT OPHTH STRAB, V34, P223
   Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Serieh B, 2007, NEUROSURGERY, V60, P1039, DOI 10.1227/01.NEU.0000255456.12978.31
   Acaroglu Golge, 2001, INTERNATIONAL OPHTHALMOLOGY, V24, P349, DOI 10.1023/B:INTE.0000006855.48323.f1
   ADAMS RD, 1989, PRINCIPLES NEUROLOGY, V0, P804
   Adegbehingbe BO, 2007, AUST J RURAL HEALTH, V15, P269, DOI 10.1111/j.1440-1584.2007.00906.x
   Adeoti Caroline O, 2004, WEST AFR J MED, V23, P249
   AICARDI J, 1979, BRAIN, V102, P727, DOI 10.1093/brain/102.4.727
   Ajlouni K, 2002, AM J MED GENET, V115, P61, DOI 10.1002/ajmg.10345
   Al-Dirbashi OY, 2007, J INHERIT METAB DIS, V30, P612, DOI 10.1007/s10545-007-0635-6
   Al-Essa M, 1999, BRAIN DEV-JPN, V21, P24, DOI 10.1016/S0387-7604(98)00064-3
   Al-Essa M, 1999, CLIN PEDIATR, V38, P77, DOI 10.1177/000992289903800203
   Al-Merjan JI, 2005, OPHTHAL EPIDEMIOL, V12, P251, DOI 10.1080/09286580591005813
   Al-Sheyyab M, 2001, EUR J PEDIATR, V160, P243, DOI 10.1007/s004310000704
   Al-Till M, 2002, EUR J OPHTHALMOL, V12, P84, DOI 10.1177/112067210201200202
   ALDENHOVEL HBG, 1991, NEUROPEDIATRICS, V22, P103, DOI 10.1055/s-2008-1071426
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Allali F, 2004, SCAND J RHEUMATOL, V33, P362, DOI 10.1080/03009740410005980
   Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306
   ALVORD EC, 1988, J NEUROSURG, V68, P85, DOI 10.3171/jns.1988.68.1.0085
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   AMEMIYA T, 1994, OPHTHALMIC GENET, V15, P87, DOI 10.3109/13816819409098868
   Amitava AK, 2001, J PEDIAT OPHTH STRAB, V38, P229
   Anderson NE, 1999, NEUROLOGY, V52, P163, DOI 10.1212/WNL.52.1.163
   Andersson S, 2009, BRIT J OPHTHALMOL, V93, P526, DOI 10.1136/bjo.2008.142315
   ANGELINI L, 1992, J NEUROL, V239, P417, DOI 10.1007/BF00856805
   Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525
   ARAS C, 2000, INT OPHTHALMOL, V24, P147
   ARTS WFM, 1993, ANN NEUROL, V33, P535, DOI 10.1002/ana.410330519
   Ashworth JL, 2006, EYE, V20, P553, DOI 10.1038/sj.eye.6701921
   Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884
   Astle WE, 2006, J CATARACT REFR SURG, V32, P103, DOI 10.1016/j.jcrs.2005.11.028
   Atchaneeyasakul LO, 1998, AM J MED GENET, V80, P501, DOI 10.1002/(SICI)1096-8628(19981228)80:5<501::AID-AJMG12>3.0.CO;2-J
   Atmaca LS, 2004, JPN J OPHTHALMOL, V48, P386, DOI 10.1007/s10384-003-0069-0
   Aung T, 2003, BRIT J OPHTHALMOL, V87, P149, DOI 10.1136/bjo.87.2.149
   Awad AH, 1999, J AAPOS, V3, P40, DOI 10.1016/S1091-8531(99)70093-5
   AYSUN S, 1994, PEDIATR NEUROL, V10, P40, DOI 10.1016/0887-8994(94)90065-5
   Babalola E, 2003, BRIT J OPHTHALMOL, V87, P282, DOI 10.1136/bjo.87.3.282
   Babovic-Vuksanovic D, 1998, AM J MED GENET, V79, P383
   Badea N, 1991, OFTALMOLOGIA, V35, P63
   BAKER RH, 1990, OPHTHALMOLOGY, V97, P1176
   Bamashmus MA, 2004, EYE, V18, P257, DOI 10.1038/sj.eye.6700606
   Bandello F, 2002, EUR J OPHTHALMOL, V12, P556, DOI 10.1177/112067210201200620
   BANNA M, 1973, J PEDIATR-US, V83, P781, DOI 10.1016/S0022-3476(73)80369-5
   Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   Barbet F, 2003, EUR J HUM GENET, V11, P966, DOI 10.1038/sj.ejhg.5201070
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   BARKOVICH AJ, 2005, PEDIAT NEUROIMAGING, V0, P231
   BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6
   Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581
   Bartels MC, 2004, J CRANIOFAC SURG, V15, P1019, DOI 10.1097/00001665-200411000-00026
   BARTLETT JR, 1971, J NEUROL NEUROSUR PS, V34, P37, DOI 10.1136/jnnp.34.1.37
   Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69
   Baskan EB, 2006, J EUR ACAD DERMATOL, V20, P829, DOI 10.1111/j.1468-3083.2006.01655.x
   BASKIN DS, 1986, J NEUROSURG, V65, P22, DOI 10.3171/jns.1986.65.1.0022
   BEATTY RM, 1982, J NEUROL NEUROSUR PS, V45, P143, DOI 10.1136/jnnp.45.2.143
   BEHR C, 1909, KLIN MB AUGENHEILK, V47, P318
   Bekibele CO, 2003, INT J CLIN PRACT, V57, P14
   BELL RA, 1978, AM J OPHTHALMOL, V85, P538, DOI 10.1016/S0002-9394(14)75251-1
   Ben-Dov IZ, 2001, TRANSPLANTATION, V72, P958, DOI 10.1097/00007890-200109150-00037
   BENECKE R, 1983, J NEUROL, V230, P143, DOI 10.1007/BF00313625
   Bénichou OD, 2000, BONE, V26, P87, DOI 10.1016/S8756-3282(99)00244-6
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bennett JL, 2002, J NEURO-OPHTHALMOL, V22, P286, DOI 10.1097/00041327-200212000-00006
   BENNETT MJ, 1993, J INHERIT METAB DIS, V16, P831, DOI 10.1007/BF00714274
   BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84
   Berk AT, 2003, J PEDIAT OPHTH STRAB, V40, P272, DOI 10.3928/0191-3913-20030901-07
   Berker N, 2007, EUR J OPHTHALMOL, V17, P797, DOI 10.1177/112067210701700518
   Berker N, 2004, AM J OPHTHALMOL, V138, P879, DOI 10.1016/j.ajo.2004.05.068
   BERMAN JL, 1990, OPHTHALMOLOGY, V97, P1606
   BERNINGER TA, 1991, BRIT J OPHTHALMOL, V75, P49, DOI 10.1136/bjo.75.1.49
   Bhattacharyya P C, 1985, J ASSOC PHYSICIANS INDIA, V33, P674
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Bindu PS, 2006, BRAIN DEV-JPN, V28, P343, DOI 10.1016/j.braindev.2005.11.007
   Bindu PS, 2005, J NEUROL NEUROSUR PS, V76, P1698, DOI 10.1136/jnnp.2005.063776
   Biousse V, 1999, NEUROLOGY, V53, P1537, DOI 10.1212/WNL.53.7.1537
   BITOUN P, 1994, ANN GENET-PARIS, V37, P75
   Blazo MA, 2004, AM J MED GENET A, V127A, P224, DOI 10.1002/ajmg.a.20650
   Blohmé J, 2000, ACTA OPHTHALMOL SCAN, V78, P560, DOI 10.1034/j.1600-0420.2000.078005560.x
   Bodunde O T, 2006, NIGER J MED, V15, P291
   Boiko AN, 2000, J NEUROVIROL, V6, P0
   BORGNAPIGNATTI C, 1989, J PEDIATR-US, V114, P405, DOI 10.1016/S0022-3476(89)80558-X
   BORRETT D, 1985, BRAIN, V108, P367, DOI 10.1093/brain/108.2.367
   Borruat FX, 2005, AM J OPHTHALMOL, V139, P715, DOI 10.1016/j.ajo.2004.09.061
   BORRUAT FX, 1992, BRIT J OPHTHALMOL, V76, P571, DOI 10.1136/bjo.76.9.571
   BORRUAT FX, 1993, J CLIN NEURO-OPHTHAL, V13, P98
   Bosley TM, 2008, INVEST OPHTH VIS SCI, V49, P5250, DOI 10.1167/iovs.08-2193
   BOTHE N, 1991, KLIN MONATSBL AUGENH, V198, P509, DOI 10.1055/s-2008-1046023
   Bouhlal Y, 2005, ACTA MYOL, V24, P155
   BOWER SPC, 1992, LANCET, V339, P1427, DOI 10.1016/0140-6736(92)91257-9
   Bowman RJC, 2010, BRIT J OPHTHALMOL, V94, P146, DOI 10.1136/bjo.2009.160713
   Bozkurt B, 2002, CLIN EXP OPHTHALMOL, V30, P411, DOI 10.1046/j.1442-9071.2002.00570.x
   BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500
   Bremner FD, 1999, INVEST OPHTH VIS SCI, V40, P2528
   BRODSKY MC, 1988, J NEUROSURG, V68, P300, DOI 10.3171/jns.1988.68.2.0300
   BRODSKY MC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1562, DOI 10.1001/archopht.1990.01070130064032
   Brodsky MC, 2002, OPHTHALMOLOGY, V109, P85, DOI 10.1016/S0161-6420(01)00849-1
   BRODSKY MC, 1993, SURV OPHTHALMOL, V38, P213, DOI 10.1016/0039-6257(93)90104-F
   BRODSKY MC, 1988, J CLIN NEURO-OPHTHAL, V8, P67
   Brodsky MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P626
   Brookes JT, 2008, INT J PEDIATR OTORHI, V72, P121, DOI 10.1016/j.ijporl.2007.08.019
   Brown MD, 2004, MOVEMENT DISORD, V19, P235, DOI 10.1002/mds.10646
   Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   BROWN WF, 1990, STROKE, V21, P1700, DOI 10.1161/01.STR.21.12.1700
   BRUETON LA, 1990, J MED GENET, V27, P701, DOI 10.1136/jmg.27.11.701
   Brunette JR, 1969, PROGR NEUROOPHTHALMO, V0, P91
   BU XD, 1993, LANCET, V342, P598, DOI 10.1016/0140-6736(93)91416-J
   Buchfelder M, 1986, ZENTRALBL NEUROCHIR, V47, P89
   BUNCIC JR, 1991, CLIN PLAST SURG, V18, P315
   Buncic JR, 2004, OPHTHALMOLOGY, V111, P1935, DOI 10.1016/j.ophtha.2004.03.036
   Buono LM, 2005, SURV OPHTHALMOL, V50, P15, DOI 10.1016/j.survophthal.2004.10.005
   Burk K, 1996, BRAIN, V119, P1497, DOI 10.1093/brain/119.5.1497
   Burke J P, 1991, METAB PEDIATR SYST OPHTHALMOL (1985), V14, P12
   BURKE JP, 1989, BRIT J OPHTHALMOL, V73, P427, DOI 10.1136/bjo.73.6.427
   Buttner N, 1998, ARCH NEUROL-CHICAGO, V55, P1353, DOI 10.1001/archneur.55.10.1353
   BYRD DJ, 1989, EUR J PEDIATR, V148, P543, DOI 10.1007/BF00441554
   CABEZUDO JM, 1981, J NEUROSURG, V55, P127, DOI 10.3171/jns.1981.55.1.0127
   CABEZUDO JM, 1981, SURG NEUROL, V15, P422, DOI 10.1016/S0090-3019(81)80027-4
   Caines E, 2007, ACTA OPHTHALMOL SCAN, V85, P662, DOI 10.1111/j.1600-0420.2007.00905.x
   Çaksen H, 2003, GENET COUNSEL, V14, P343
   CALOGERO JA, 1971, J NEUROSURG, V34, P236, DOI 10.3171/jns.1971.34.2part1.0236
   CAMPANA G, 1987, OPHTHALMIC PAED GEN, V8, P125, DOI 10.3109/13816818709028528
   Campbell Carrie Lahnstein, 2003, OPTOMETRY, V74, P417
   Cano A, 2007, DIABETES CARE, V30, P2327, DOI 10.2337/dc07-0380
   CARANGO P, 1995, ANN NEUROL, V38, P610, DOI 10.1002/ana.410380409
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   Carroll AL, 2001, CLIN EXP OPHTHALMOL, V29, P38, DOI 10.1046/j.1442-9071.2001.00363.x
   CARROLL WM, 1980, BRAIN, V103, P413, DOI 10.1093/brain/103.2.413
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Cassidy L, 2000, MED PEDIATR ONCOL, V34, P43, DOI 10.1002/(SICI)1096-911X(200001)34:1<43::AID-MPO8>3.3.CO;2-8
   CASTEELS I, 1994, NEUROPEDIATRICS, V25, P265, DOI 10.1055/s-2008-1073034
   Castelnau P, 2001, PEDIATR NEUROL, V25, P170, DOI 10.1016/S0887-8994(01)00295-8
   Castro FJ, 2000, ACTA OPHTHALMOL SCAN, V78, P118, DOI 10.1034/j.1600-0420.2000.078001118.x
   CASTROGAGO M, 1993, ARCH FR PEDIATR, V50, P327
   Cerovski B, 2004, COLLEGIUM ANTROPOL, V28, P927
   Chan JW, 2003, SURV OPHTHALMOL, V48, P12, DOI 10.1016/S0039-6257(02)00416-2
   CHAN T, 1991, BRIT J OPHTHALMOL, V75, P524, DOI 10.1136/bjo.75.9.524
   Chang Chi-Wu, 2003, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, V19, P516
   Chansoria Maya, 2005, INDIAN JOURNAL OF PEDIATRICS, V72, P1047, DOI 10.1007/BF02724409
   CHELLURI L, 1988, RESUSCITATION, V16, P45, DOI 10.1016/0300-9572(88)90017-2
   Chen AS, 2000, GENET MED, V2, P283, DOI 10.1097/00125817-200009000-00003
   Chen Hsin-Yi, 1998, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, V14, P710
   Chen SQ, 2007, AM J OPHTHALMOL, V143, P186, DOI 10.1016/j.ajo.2006.06.049
   CHERNINKOVA S, 1990, OPHTHALMOLOGICA, V201, P201, DOI 10.1159/000310152
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   CHITAYAT D, 1992, AM J MED GENET, V43, P517, DOI 10.1002/ajmg.1320430304
   Christiansen SP, 2002, J PEDIAT OPHTH STRAB, V39, P157, DOI 10.3928/0191-3913-20020501-07
   Chronister Connie L, 2005, OPTOMETRY, V76, P302, DOI 10.1016/S1529-1839(05)70313-4
   Chuenkongkaew WL, 2005, J NEURO-OPHTHALMOL, V25, P173, DOI 10.1097/01.wno.0000176631.87234.49
   Chuenkongkaew WL, 2001, JPN J OPHTHALMOL, V45, P665, DOI 10.1016/S0021-5155(01)00423-3
   Chuenkongkaew WL, 2005, EUR J NEUROL, V12, P388, DOI 10.1111/j.1468-1331.2004.01060.x
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Chutorian AM, 2003, REV NEUROLOGIA, V36, P264, DOI 10.33588/rn.3603.2002178
   Chutorian AM, 2002, PEDIATR NEUROL, V26, P358, DOI 10.1016/S0887-8994(02)00398-3
   CILLINO S, 1989, GRAEF ARCH CLIN EXP, V227, P131, DOI 10.1007/BF02169784
   Coats DK, 2000, J AAPOS, V4, P110, DOI 10.1067/mpa.2000.103870
   COCKAYNE EA, 1946, ARCH DIS CHILD, V21, P52, DOI 10.1136/adc.21.105.52
   COGAN DG, 1980, AM J OPHTHALMOL, V90, P251, DOI 10.1016/S0002-9394(14)74863-9
   COHEN SM, 1992, AM J OPHTHALMOL, V95, P82
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Coleman P, 2007, OPHTHAL PHYSL OPT, V27, P547, DOI 10.1111/j.1475-1313.2007.00513.x
   COLLINS MLZ, 1990, OPHTHALMOLOGY, V97, P1445
   Colosimo A, 2003, HUM MUTAT, V21, P622, DOI 10.1002/humu.10215
   Comaish IF, 2002, DOCUMENTA OPHTHALMOLOGICA, V104, P195, DOI 10.1023/A:1014603229383
   Copeliovitch L, 2001, J PEDIATR ORTHOPED, V21, P512, DOI 10.1097/00004694-200107000-00018
   CORBETT JJ, 1986, SEMIN NEUROL, V6, P111, DOI 10.1055/s-2008-1041454
   CORDES FC, 1952, AM J OPHTHALMOL, V35, P1272, DOI 10.1016/0002-9394(52)91144-6
   Corona-Rivera JR, 2005, AM J MED GENET A, V135A, P69, DOI 10.1002/ajmg.a.30669
   COSTEFF H, 1989, NEUROLOGY, V39, P595, DOI 10.1212/WNL.39.4.595
   COSTEFF H, 1993, ANN NEUROL, V33, P103, DOI 10.1002/ana.410330117
   Costenbader FD, 1968, JOURNAL OF PEDIATRIC OPHTHALMOLOGY, V5, P77, DOI 10.3928/0191-3913-19680501-03
   Craig JE, 2006, BRIT J OPHTHALMOL, V90, P1420, DOI 10.1136/bjo.2006.099333
   CULLOM ME, 1993, ARCH OPHTHALMOL-CHIC, V111, P1482, DOI 10.1001/archopht.1993.01090110048021
   Curé JK, 2000, AM J NEURORADIOL, V21, P1110
   DArrigo S, 2005, J CHILD NEUROL, V20, P454, DOI 10.1177/08830738050200051801
   Dailey R, 1991, OPHTHALMOL CLIN N AM, V4, P519
   Damji KF, 2001, CAN J OPHTHALMOL, V36, P252, DOI 10.1016/S0008-4182(01)80018-1
   Dandona L, 2000, INDIAN J OPHTHALMOL, V48, P59
   Dandona R, 2002, OPHTHALMOLOGY, V109, P1871, DOI 10.1016/S0161-6420(02)01183-1
   Daneshvar H, 1999, OPHTHALMOLOGY, V106, P1792, DOI 10.1016/S0161-6420(99)90345-7
   David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65
   David LR, 2002, J CRANIOFAC SURG, V13, P676, DOI 10.1097/00001665-200209000-00015
   DAVIS PC, 1986, AM J NEURORADIOL, V7, P639
   de Vries L, 2003, J PEDIATR ENDOCR MET, V16, P703
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DeCarlo D K, 1999, J AM OPTOM ASSOC, V70, P647
   Deda G, 2003, GENET COUNSEL, V14, P253
   Defoort-Dhellemmes S, 2006, J PEDIATR ENDOCR MET, V19, P321
   Delague V, 2002, NEUROGENETICS, V4, P23, DOI 10.1007/s10048-001-0127-z
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125
   den Hollander AI, 2001, AM J HUM GENET, V69, P198
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Dhalla MS, 2006, CAN J OPHTHALMOL, V41, P38, DOI 10.1016/S0008-4182(06)80064-5
   Dharmaraj S R, 2000, OPHTHALMIC GENET, V21, P135
   Di Gennaro G, 1999, PEDIATR NEUROL, V21, P566, DOI 10.1016/S0887-8994(99)00030-2
   DIAMOND GA, 1987, AM J OPHTHALMOL, V104, P645, DOI 10.1016/0002-9394(87)90179-6
   Dillmann U, 1997, J NEUROL, V244, P562, DOI 10.1007/s004150050144
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Dimitratos SD, 1998, GENOMICS, V51, P308, DOI 10.1006/geno.1998.5404
   DINEEN J, 1982, EXP BRAIN RES, V47, P446
   Dogulu CF, 2001, EYE, V15, P183, DOI 10.1038/eye.2001.57
   DOHI MT, 1993, OPHTHAL PAEDIAT GENE, V14, P5
   DOLL R, 1992, AM J HUM GENET, V51, P161
   Dollfus H, 2000, ARCH OPHTHALMOL-CHIC, V118, P1386
   Domènech E, 2004, PRENATAL DIAG, V24, P787, DOI 10.1002/pd.982
   Domenech Enric, 2006, PEDIATR ENDOCRINOL REV, V3, P249
   Dörfler A, 2000, NEUROPEDIATRICS, V31, P151, DOI 10.1055/s-2000-7490
   DRACK AV, 1992, ARCH OPHTHALMOL-CHIC, V110, P712, DOI 10.1001/archopht.1992.01080170134041
   DREYER M, 1982, KLIN WOCHENSCHR, V60, P471, DOI 10.1007/BF01720362
   Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113
   DU JW, 2005, OPTOMETRY VISION SCI, V82, P1000
   DUBOIS LG, 1992, J CLIN NEURO-OPHTHAL, V12, P15
   Duman O, 2004, J CHILD NEUROL, V19, P552
   DURR A, 1995, CLIN NEUROSCI, V3, P12
   DUTTON JJ, 1994, SURV OPHTHALMOL, V38, P427, DOI 10.1016/0039-6257(94)90173-2
   DUTTON JJ, 1983, J CLIN NEURO-OPHTHAL, V3, P137
   Eckhardt SME, 1998, PEDIATR NEUROL, V19, P234, DOI 10.1016/S0887-8994(98)00042-3
   Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6
   Edwards TL, 2007, NEURO-OPHTHALMOLOGY, V31, P87, DOI 10.1080/01658100701501125
   Egan RA, 2005, AM J OPHTHALMOL, V140, P267, DOI 10.1016/j.ajo.2005.03.024
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   Eke T, 1997, BRIT MED J, V314, P180, DOI 10.1136/bmj.314.7075.180
   El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858
   ELAZAZI M, 1990, AM J OPHTHALMOL, V109, P1
   ELBERG H, 1994, HUM MOL GENET, V3, P977
   Eldevik OP, 1996, AM J NEURORADIOL, V17, P1427
   ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5
   Ells AL, 2003, J AAPOS, V7, P223, DOI 10.1016/S1091-8531(03)00005-3
   ELPELEG ON, 1994, DEV MED CHILD NEUROL, V36, P167
   ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445
   Ergür Ö, 2000, TURKISH J PEDIATR, V42, P48
   ERSAHIN Y, 1993, NEUROSURGERY, V33, P219, DOI 10.1097/00006123-199308000-00006
   Ersanli D, 2006, RETINA-J RET VIT DIS, V26, P32, DOI 10.1097/00006982-200601000-00006
   Esmaili N, 2007, OPHTHALMOLOGY, V114, P1773, DOI 10.1016/j.ophtha.2006.12.015
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Eustis H S, 1990, J PEDIATR OPHTHALMOL STRABISMUS, V27, P237
   Farber MD, 2003, OPHTHAL EPIDEMIOL, V10, P267, DOI 10.1076/opep.10.4.267.15910
   Fardet L, 2003, ACTA NEUROL SCAND, V108, P193, DOI 10.1034/j.1600-0404.2003.02178.x
   Farina L, 1999, NEURORADIOLOGY, V41, P376, DOI 10.1007/s002340050768
   Farukhi F, 2006, OPHTHALMIC GENET, V27, P89, DOI 10.1080/13816810600862626
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Fawzi AA, 2005, ARCH OPHTHALMOL-CHIC, V123, P486, DOI 10.1001/archopht.123.4.486
   Fazzi E, 2007, DEV MED CHILD NEUROL, V49, P503, DOI 10.1111/j.1469-8749.2007.00503.x
   Fein-Levy C, 1998, J PEDIAT HEMATOL ONC, V20, P577, DOI 10.1097/00043426-199811000-00015
   Felicio AC, 2008, PARKINSONISM RELAT D, V14, P370, DOI 10.1016/j.parkreldis.2007.08.008
   Feng XM, 2000, CHINESE MED J-PEKING, V113, P743
   Ferguson FR, 1928, J NEUROL PSYCHOPATHO, V9, P120
   FERNANDEZ GR, 1992, ACTA OPHTHALMOL, V70, P135
   Ferreira RC, 1997, AM J OPHTHALMOL, V123, P264, DOI 10.1016/S0002-9394(14)71051-7
   FERRER I, 1987, J NEUROL, V234, P416, DOI 10.1007/BF00314088
   Field MJ, 2003, AM J MED GENET A, V122A, P6, DOI 10.1002/ajmg.a.20216
   Filiano JJ, 2002, PEDIATR NEUROL, V26, P239, DOI 10.1016/S0887-8994(01)00377-0
   Finger PT, 2007, AM J OPHTHALMOL, V143, P335, DOI 10.1016/j.ajo.2006.09.014
   Fink JK, 2003, ARCH NEUROL-CHICAGO, V60, P1045, DOI 10.1001/archneur.60.8.1045
   Finsterer J, 2001, CAN J CARDIOL, V17, P464
   FLETCHER WA, 1986, J NEUROSURG, V65, P154, DOI 10.3171/jns.1986.65.2.0154
   FOLZ SJ, 1991, SURV OPHTHALMOL, V35, P353, DOI 10.1016/0039-6257(91)90185-I
   Fournier AV, 2001, OPHTHALMOLOGY, V108, P1595, DOI 10.1016/S0161-6420(01)00696-0
   FRAIOLI B, 1983, J NEUROSURG, V59, P590, DOI 10.3171/jns.1983.59.4.0590
   FRANCOIS J, 1966, J GENET HUM, V15, P147
   Francois J, 1979, ADV OPHTHALMOL, V39, P1
   FRANCOIS J, 1961, HEREDITARY OPHATHALM, V0, P508
   FREEMAN JW, 1980, ARCH NEUROL-CHICAGO, V37, P176, DOI 10.1001/archneur.1980.00500520074015
   FRIEDBERG EC, 1992, CELL, V128, P1233
   FRISEN L, 1984, OPHTHALMOLOGY, V91, P1342
   Fukuoka H, 2007, J HUM GENET, V52, P510, DOI 10.1007/s10038-007-0144-3
   Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299
   Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832
   Gamez J, 2001, AM J OPHTHALMOL, V131, P398, DOI 10.1016/S0002-9394(00)00799-6
   Ganesh A, 2005, J AAPOS, V9, P604, DOI 10.1016/j.jaapos.2005.05.001
   Ganesh SK, 2004, J CATARACT REFR SURG, V30, P2371, DOI 10.1016/j.jcrs.2004.02.091
   García-Silva MT, 2004, J INHERIT METAB DIS, V27, P591, DOI 10.1023/B:BOLI.0000042984.42433.d8
   Garcia-Valenzuela E, 1999, RETINA-J RET VIT DIS, V19, P424, DOI 10.1097/00006982-199909000-00010
   Gasch AT, 2002, OPHTHALMOLOGY, V109, P1477, DOI 10.1016/S0161-6420(02)01095-3
   GASCON GG, 1990, NEUROLOGY, V40, P1876, DOI 10.1212/WNL.40.12.1876
   GASCON GG, 1994, BRAIN DEV-JPN, V16, P94, DOI 10.1016/0387-7604(94)90102-3
   GASTON H, 1991, EYE (LONDON), V5, P279
   GAY C, 1991, ARCH FR PEDIATR, V48, P409
   GELBER SJ, 1992, J PEDIATR-US, V120, P931, DOI 10.1016/S0022-3476(05)81966-3
   Geneviève D, 2004, AM J MED GENET A, V129A, P64, DOI 10.1002/ajmg.a.30144
   Georgy BA, 1998, AM J NEURORADIOL, V19, P281
   Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689
   GHOSE S, 1983, T OPHTHAL SOC UK, V103, P217
   Gilles EE, 2003, J PEDIATR-US, V143, P494, DOI 10.1067/S0022-3476(03)00416-5
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Giuliano Fabienne, 2005, HUM MUTAT, V25, P99, DOI 10.1002/humu.9300
   Gnanaraj L, 2005, OPHTHAL PLAST RECONS, V21, P445, DOI 10.1097/01.iop.0000189222.20693.ff
   Goddey Nmorsi Onyebiguwa Patrick, 2001, JOURNAL OF COMMUNICABLE DISEASES, V33, P185
   Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x
   Goebel HH, 2004, BRAIN PATHOL, V14, P59, DOI 10.1111/j.1750-3639.2004.tb00498.x
   Goizet C, 2003, ANN GENET-PARIS, V46, P25, DOI 10.1016/S0003-3995(03)00003-0
   GOLDBERG MF, 1993, OPHTHALMOLOGY, V100, P1645
   GOLDBERG MF, 1970, AM J OPHTHALMOL, V69, P969, DOI 10.1016/0002-9394(70)91040-8
   Goldenberg-Cohen N, 2004, J AAPOS, V8, P20, DOI 10.1016/j.jaapos.2003.08.009
   GOOD W V, 1987, INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE, V28, P309
   GOODMAN SJ, 1975, ARCH OPHTHALMOL-CHIC, V93, P991
   Gordon N, 2001, EUR J PAEDIATR NEUROL, V5, P65, DOI 10.1053/ejpn.2001.0467
   Gordon Neil, 2002, EUR J PAEDIATR NEUROL, V6, P243, DOI 10.1053/ejpn.2002.0606
   Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341
   Gourie-Devi M, 2003, J NEUROL SCI, V209, P13, DOI 10.1016/S0022-510X(02)00458-6
   GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441
   GOUW LG, 1997, NAT GENET, V17, P65
   Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060
   Graham JM, 2001, AM J HUM GENET, V69, P291, DOI 10.1086/321295
   Granse Lotta, 2003, OPHTHALMIC GENET, V24, P233, DOI 10.1076/opge.24.4.233.17230
   GRANT WM, 1986, TOXICOLOGY EYE, V0, P1048
   Grattan-Smith PJ, 2001, J PAEDIATR CHILD H, V37, P81, DOI 10.1046/j.1440-1754.2001.00560.x
   Gray TL, 2005, OPHTHALMOLOGY, V112, P1129, DOI 10.1016/j.ophtha.2004.12.037
   Grazina MM, 2007, EUR J PAEDIATR NEURO, V11, P115, DOI 10.1016/j.ejpn.2006.11.015
   Greven CM, 2002, RETINA-J RET VIT DIS, V22, P575, DOI 10.1097/00006982-200210000-00007
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Gropman A L, 2001, CURR NEUROL NEUROSCI REP, V1, P185
   Gropman AL, 2004, MITOCHONDRION, V4, P503, DOI 10.1016/j.mito.2004.07.009
   Gücüyener K, 2001, NEUROPEDIATRICS, V32, P142, DOI 10.1055/s-2001-16616
   Gupta DK, 2006, CHILD NERV SYST, V22, P1194, DOI 10.1007/s00381-006-0055-1
   GUPTA S, 1993, DOC OPHTHALMOL, V83, P271, DOI 10.1007/BF01204328
   GUSTAVSON KH, 1993, AM J MED GENET, V45, P654, DOI 10.1002/ajmg.1320450527
   GUY J, 1991, J NEUROSURG, V74, P426, DOI 10.3171/jns.1991.74.3.0426
   HABERLAND C, 1972, ARCH NEUROL-CHICAGO, V26, P391, DOI 10.1001/archneur.1972.00490110025002
   Haddad MAO, 2007, J PEDIAT OPHTH STRAB, V44, P232, DOI 10.3928/01913913-20070701-04
   Haddad Maria Aparecida Onuki, 2006, CLINICS, V61, P239, DOI 10.1590/S1807-59322006000300009
   HADDAD R, 1976, ARCH OPHTHALMOL-CHIC, V94, P1927, DOI 10.1001/archopht.1976.03910040633011
   Hadidy AM, 2004, SAUDI MED J, V25, P638
   Haftel LT, 2000, J CHILD NEUROL, V15, P386, DOI 10.1177/088307380001500606
   HAGEMOSER K, 1989, AM J MED GENET, V33, P61, DOI 10.1002/ajmg.1320330108
   HAINES SJ, 1988, NEUROSURGERY, V23, P470, DOI 10.1227/00006123-198810000-00011
   HALTIA M, 1993, ACTA NEUROPATHOL, V85, P241
   HAMED LM, 1988, J CLIN NEURO-OPHTHAL, V8, P239
   HAMED LM, 1992, J CLIN NEURO-OPHTHAL, V12, P192
   HAMED LM, 1994, OPHTHALMOLOGY S, V101, P134
   Hamid R, 2007, MYMENSINGH MED J, V16, P123
   HAMILTON SR, 1990, ARCH OPHTHALMOL-CHIC, V108, P551, DOI 10.1001/archopht.1990.01070060099057
   HAMILTON SR, 1999, P N AM NEUR SOC SNOW, V0, P195
   Hammerstein W, 1991, FORTSCHR OPHTHALMOL, V88, P463
   HAMMOND EJ, 1983, ARCH NEUROL-CHICAGO, V40, P366, DOI 10.1001/archneur.1983.04050060066012
   Han J, 2006, GENET MED, V8, P217, DOI 10.1097/01.gim.0000214299.61930.c0
   Hanemann CO, 1996, J NEUROL, V243, P297, DOI 10.1007/BF00868531
   HANSEN E, 1992, ACTA OPHTHALMOL, V70, P597
   Hansen L, 2005, EUR J HUM GENET, V13, P1275, DOI 10.1038/sj.ejhg.5201491
   Hansen RM, 2008, VISION RES, V48, P325, DOI 10.1016/j.visres.2007.07.009
   Harding AR, 1984, THE HEREDITARY ATAXIAS AND RELATED DISORDERS, V0, P0
   HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1
   Harding GFA, 2000, NEUROLOGY, V55, P347, DOI 10.1212/WNL.55.3.347
   Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609
   HARLEY R D, 1970, TRANSACTIONS OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY AND OTO-LARYNGOLOGY, V74, P1011
   Harrison DA, 1998, OPHTHALMOLOGY, V105, P1886, DOI 10.1016/S0161-6420(98)91035-1
   HAYASAKA S, 1986, ARCH OPHTHALMOL-CHIC, V104, P1656
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   HEHER KL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1495, DOI 10.1001/archopht.1993.01090110061024
   Herman GE, 2003, HUM MOL GENET, V12, PR75, DOI 10.1093/hmg/ddg072
   Higgins JJ, 1996, NEUROLOGY, V46, P208, DOI 10.1212/WNL.46.1.208
   Hirai T, 2002, OPHTHALMOLOGY, V109, P1692, DOI 10.1016/S0161-6420(02)01171-5
   HO G, 2008, J INHERIT MED DIS, V0, P0
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   HOLMBERG M, 1995, HUM MOL GENET, V10, P89
   Houlden H, 2002, BRAIN, V125, P2681, DOI 10.1093/brain/awf270
   HOWELL N, 1994, AM J HUM GENET, V55, P219
   HOWELL N, 1993, AM J HUM GENET, V53, P959
   HOYT CS, 1979, AM J DIS CHILD, V133, P955, DOI 10.1001/archpedi.1979.02130090083017
   HOYT CS, 1980, OPHTHALMOLOGY, V87, P245
   HOYT CS, 1979, BRIT J OPHTHALMOL, V63, P191, DOI 10.1136/bjo.63.3.191
   HOYT CS, 1992, EYE, V6, P201, DOI 10.1038/eye.1992.39
   HOYT WF, 1990, INT CONGR SER, V882, P239
   HOYT WF, 1987, PROG EXP TUMOR RES, V30, P113
   HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P537, DOI 10.1136/bjo.56.7.537
   Hoyt WF, 1976, AUST J OPHTHALMOL, V4, P14, DOI 10.1111/j.1442-9071.1976.tb00846.x
   HUBER A, 1994, CURR OPIN NEUROL, V7, P65, DOI 10.1097/00019052-199402000-00012
   HUDSON G, 2006, AM J HUM GENET, V78, P564
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huisman TAGM, 2006, AM J NEURORADIOL, V27, P1555
   HULL BM, 1989, OPHTHAL PHYSL OPT, V9, P143, DOI 10.1111/j.1475-1313.1989.tb00834.x
   Huna-Baron R, 1999, PEDIATR NEUROSURG, V31, P322, DOI 10.1159/000028883
   Hung Hsiang-Ling, 2003, CHANG GUNG MED J, V26, P41
   Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670
   HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339
   HUR DJ, 2006, AM J MED GENET, V140, P1487
   Hussain IHMI, 1999, BRAIN DEV-JPN, V21, P229
   Hwang JM, 2000, PEDIATR NEUROSURG, V33, P328, DOI 10.1159/000055980
   HWANG TN, 2007, P FB WALSH SESS FEB, V0, P0
   Ianchulev T, 2003, OPHTHALMOLOGY, V110, P1850, DOI 10.1016/S0161-6420(03)00573-6
   ICHIYAMA T, 1993, BRAIN DEV-JPN, V15, P153, DOI 10.1016/0387-7604(93)90054-C
   Ilker SS, 1999, JPN J OPHTHALMOL, V43, P48, DOI 10.1016/S0021-5155(98)00058-6
   IMES RK, 1991, AM J OPHTHALMOL, V111, P729, DOI 10.1016/S0002-9394(14)76780-7
   IMES RK, 1986, BRIT J OPHTHALMOL, V70, P179, DOI 10.1136/bjo.70.3.179
   Ingelse J, 2001, OPTOMETRY, V72, P761
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Ishikawa K, 2005, JPN J OPHTHALMOL, V49, P121, DOI 10.1007/s10384-004-0166-8
   Ishikawa T, 2000, PEDIATR NEUROL, V22, P322, DOI 10.1016/S0887-8994(99)00147-2
   Ito S, 2007, AM J NEURORADIOL, V28, P305
   IWASHITA H, 1970, ARCH NEUROL-CHICAGO, V22, P357, DOI 10.1001/archneur.1970.00480220071010
   JACOBSON DM, 1990, NEUROLOGY, V40, P804, DOI 10.1212/WNL.40.5.804
   JACOBSON DM, 1991, J CLIN NEURO-OPHTHAL, V11, P152
   Jacobson L, 1997, ARCH OPHTHALMOL-CHIC, V115, P1263, DOI 10.1001/archopht.1997.01100160433007
   Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104
   JAKOBIEC FA, 1984, OPHTHALMOLOGY, V91, P137
   JAMPEL RS, 1962, ARCH OPHTHALMOL-CHIC, V67, P123, DOI 10.1001/archopht.1962.00960020125004
   JAN JE, 1977, DEV MED CHILD NEUROL, V19, P353
   JENSEN ME, 1990, RADIOGRAPHICS, V10, P53, DOI 10.1148/radiographics.10.1.2296697
   JENSEN PKA, 1987, AM J MED GENET, V28, P517, DOI 10.1002/ajmg.1320280234
   Ji Y H, 1999, KOREAN J OPHTHALMOL, V13, P52
   Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2
   JOHNS DR, 1993, AM J HUM GENET, V53, P916
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P1491, DOI 10.1001/archopht.1993.01090110057023
   JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   JOHNS DR, 1993, OPHTHALMOLOGY, V100, P981
   Johnson AB, 2002, INT J DEV NEUROSCI, V20, P391, DOI 10.1016/S0736-5748(02)00045-X
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1
   Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764
   Jonas JB, 2006, CLIN EXP OPHTHALMOL, V34, P654, DOI 10.1111/j.1442-9071.2006.01310.x
   Jonas JB, 2006, J GLAUCOMA, V15, P206, DOI 10.1097/01.ijg.0000212209.25642.01
   Jones M, 2005, FETAL PEDIATR PATHOL, V24, P191, DOI 10.1080/15227950500305843
   Junck L, 1996, NEUROLOGY, V46, P4, DOI 10.1212/WNL.46.1.4
   Jurkiewicz E, 2005, PEDIATR RADIOL, V35, P1027, DOI 10.1007/s00247-005-1498-3
   Kalman B, 1998, ACTA NEUROL SCAND, V98, P232, DOI 10.1111/j.1600-0404.1998.tb07301.x
   Kalviainen R, 2001, CNS DRUGS, V15, P217
   KAPLAN PW, 1995, ANN NEUROL, V37, P550, DOI 10.1002/ana.410370419
   Kardon R, 2006, OPHTHALMOLOGY, V113, P1345, DOI 10.1016/j.ophtha.2006.02.055
   Kasmann-Kellner B, 1999, OPHTHALMOLOGICA, V213, P200, DOI 10.1159/000027420
   Käsmann-Kellner B, 1999, OPHTHALMOLOGICA, V213, P63, DOI 10.1159/000027396
   Katz BJ, 2006, AM J MED GENET A, V140A, P2207, DOI 10.1002/ajmg.a.31455
   KAUL R, 1994, AM J HUM GENET, V55, P34
   Kaye LC, 2000, DEV MED CHILD NEUROL, V42, P704, DOI 10.1017/S0012162200001304
   Kazek B, 2007, J CHILD NEUROL, V22, P1256, DOI 10.1177/0883073807307092
   Keltner JL, 1999, J NEURO-OPHTHALMOL, V19, P71
   KENDALL BE, 1992, AM J NEURORADIOL, V13, P621
   Kenyon K R, 1976, BIRTH DEFECTS ORIG ARTIC SER, V12, P133
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6
   Khaliq S, 2003, EXP EYE RES, V76, P343, DOI 10.1016/S0014-4835(02)00304-4
   Khan R I, 2007, IR MED J, V100, P458
   KHODADOUST AA, 1968, AM J OPHTHALMOL, V66, P502, DOI 10.1016/0002-9394(68)91536-5
   Khong JJ, 2006, OPHTHALMOLOGY, V113, P347, DOI 10.1016/j.ophtha.2005.10.011
   Khong JJ, 2006, AM J OPHTHALMOL, V142, P328, DOI 10.1016/j.ajo.2006.02.046
   Kim CH, 2006, AM J OPHTHALMOL, V141, P398, DOI 10.1016/j.ajo.2005.08.071
   KIM I, 1980, CLIN NEUROL, V20, P264
   Kim JW, 2006, J NEURO-OPHTHALMOL, V26, P30, DOI 10.1097/01.wno.0000205980.32023.2d
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Kim TW, 2007, J GLAUCOMA, V16, P655, DOI 10.1097/IJG.0b013e31804d23aa
   Kimber J, 2003, J NEUROL NEUROSUR PS, V74, P654, DOI 10.1136/jnnp.74.5.654
   KINDER RSL, 1963, AM J DIS CHILD, V106, P331, DOI 10.1001/archpedi.1963.02080050333014
   KING KM, 1993, J PEDIATR OPHTHALMOL, V30, P84
   Kinjo S, 2004, ENDOCR J, V51, P473, DOI 10.1507/endocrj.51.473
   KINSLEY BT, 1992, IRISH MED J, V85, P34
   Kiratli H, 2002, AM J OPHTHALMOL, V133, P715, DOI 10.1016/S0002-9394(01)01429-5
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KJER P, 1956, DAN MED BULL, V3, P135
   KJER P, 1959, ACTA OPHTHALMOL SUPPL, V164, P1
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   KJER P, 1966, 18 ANN FC CORD EY SO, V0, P0
   Klein A, 2004, EUR J PAEDIATR NEURO, V8, P317, DOI 10.1016/j.ejpn.2004.08.006
   Kleta R, 2002, MOL GENET METAB, V76, P201, DOI 10.1016/S1096-7192(02)00047-1
   KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013
   Kobayashi K, 2005, JPN J OPHTHALMOL, V49, P306, DOI 10.1007/S10384-004-0204-6
   Kocur I, 2002, BRIT J OPHTHALMOL, V86, P716, DOI 10.1136/bjo.86.7.716
   Koeppen AH, 2002, J NEUROPATH EXP NEUR, V61, P747, DOI 10.1093/jnen/61.9.747
   Kotb AA, 2006, OPHTHAL EPIDEMIOL, V13, P1, DOI 10.1080/09286580500477317
   Koul R, 2001, ARCH DIS CHILD, V85, P469, DOI 10.1136/adc.85.6.469
   Krägeloh-Mann I, 1999, ACTA PAEDIATR, V88, P897
   KRAGELOHMANN I, 1992, PEDIATR NEUROL, V8, P60, DOI 10.1016/0887-8994(92)90055-4
   Krauss GL, 1998, NEUROLOGY, V50, P614, DOI 10.1212/WNL.50.3.614
   KRETZER FL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2000
   Kronenberg A, 2005, J AAPOS, V9, P169, DOI 10.1016/j.jaapos.2004.08.012
   Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P176, DOI 10.1159/000027415
   Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P48, DOI 10.1159/000027393
   Kumar R, 1999, ARCH DIS CHILD, V81, P221, DOI 10.1136/adc.81.3.221
   Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e
   Kurschel S, 2007, CHILD NERV SYST, V23, P901, DOI 10.1007/s00381-007-0355-0
   Kusuhara S, 2006, EYE, V20, P882, DOI 10.1038/sj.eye.6702013
   Lagunju I A, 2007, AFR J MED MED SCI, V36, P71
   LAMBERT SL, 1990, PEDIAT OPHTHALMOLOGY, V0, P507
   LAMBERT SR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1371
   Lana-Peixoto MA, 2001, ARQ NEURO-PSIQUIAT, V59, P311, DOI 10.1590/S0004-282X2001000300001
   Lapresle J, 1986, ADV NEUROL, V43, P265
   Larnaout A, 1998, ACTA NEUROL SCAND, V98, P452, DOI 10.1111/j.1600-0404.1998.tb07329.x
   Lavrov Arseni Y, 2002, EUR J PAEDIATR NEUROL, V6, P161, DOI 10.1053/ejpn.2002.0584
   LAWDEN MC, 1999, J NEUROL NEUROSUR PS, V67, P1784
   Lawthom C, 2009, OPHTHALMOLOGY, V116, P565, DOI 10.1016/j.ophtha.2008.09.047
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee AG, 1998, J NEURO-OPHTHALMOL, V18, P102
   Lee CW, 2003, YONSEI MED J, V44, P331, DOI 10.3349/ymj.2003.44.2.331
   Lee HBH, 2008, SURV OPHTHALMOL, V53, P543, DOI 10.1016/j.survophthal.2008.08.022
   LEES F, 1964, J NEUROL NEUROSUR PS, V27, P415, DOI 10.1136/jnnp.27.5.415
   LEEUWEN MA, 1949, BRAIN, V72, P340
   LEI SB, 2009, F WALSH SOC M FEBR 2, V0, P0
   LEINONEN MT, 1992, OPHTHALMOLOGICA, V204, P204, DOI 10.1159/000310295
   Lempert P, 2000, J AAPOS, V4, P258, DOI 10.1067/mpa.2000.106963
   Lesperance MM, 2003, ARCH OTOLARYNGOL, V129, P411, DOI 10.1001/archotol.129.4.411
   LESSELL S, 1977, ARCH NEUROL-CHICAGO, V34, P759, DOI 10.1001/archneur.1977.00500240047008
   WEERDT CJD, 1971, ACTA NEUROL SCAND, V47, P541, DOI 10.1111/j.1600-0404.1971.tb07507.x
   [Anonymous], 2007, OPHTHALMIC GENET, V28, P224, DOI 10.1080/13816810701663550
   Cano A, 2007, AM J MED GENET A, V143A, P1605, DOI 10.1002/ajmg.a.31809
   DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369
   LEUZZI V, 1992, J NEUROL NEUROSUR PS, V55, P16, DOI 10.1136/jnnp.55.1.16
   Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1
   LEVIN ML, 1986, J CLIN NEURO-OPHTHAL, V6, P1
   LEVIN PS, 1983, ARCH OPHTHALMOL-CHIC, V101, P1093
   Levy RL, 2006, ANN ACAD MED SINGAP, V35, P151
   LEWIS RA, 1984, OPHTHALMOLOGY, V91, P929
   Li CM, 2005, AM J MED GENET A, V138A, P208, DOI 10.1002/ajmg.a.30794
   Lieberman AP, 2000, MUSCLE NERVE, V23, P843, DOI 10.1002/(SICI)1097-4598(200006)23:6<843::AID-MUS2>3.0.CO;2-8
   Lin CH, 2004, J PEDIATR ENDOCR MET, V17, P1461
   Lin Ling, 2002, YAN KE XUE BAO, V18, P147
   Lindenbaum Y, 2001, EUR J PAEDIATR NEUROL, V5, P225, DOI 10.1053/ejpn.2001.0523
   Linhares SDC, 2006, ARQ NEURO-PSIQUIAT, V64, P222, DOI 10.1590/S0004-282X2006000200010
   LISTERNICK R, 1989, J PEDIATR-US, V114, P778, DOI 10.1016/s0022-3476(89)80137-4
   LIU GT, 1992, AM J OPHTHALMOL, V114, P193, DOI 10.1016/S0002-9394(14)73984-4
   Liu GT, 2001, SURV OPHTHALMOL, V46, P35, DOI 10.1016/S0039-6257(01)00225-9
   LIVINGSTONE IR, 1981, ARCH NEUROL-CHICAGO, V38, P75, DOI 10.1001/archneur.1981.00510020033003
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Loeffler J, 2002, PRENATAL DIAG, V22, P827, DOI 10.1002/pd.419
   Longman C, 2003, CLIN DYSMORPHOL, V12, P133, DOI 10.1097/00019605-200304000-00012
   Looi A, 2006, OPHTHAL PLAST RECONS, V22, P1, DOI 10.1097/01.iop.0000189820.02983.3a
   Losowska-Kaniewska D, 2007, ADV MED SCI, V52 Suppl 1, P176
   Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538
   Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415
   Luberichs J, 2002, GRAEF ARCH CLIN EXP, V240, P96, DOI 10.1007/s00417-001-0423-1
   Lynch DR, 2002, J NEURO-OPHTHALMOL, V22, P297, DOI 10.1097/00041327-200212000-00007
   Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028
   MACDERMOT KD, 1987, J NEUROL NEUROSUR PS, V50, P1342, DOI 10.1136/jnnp.50.10.1342
   Macedo-Souza LI, 2005, ANN NEUROL, V57, P730, DOI 10.1002/ana.20478
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   MacLaren RE, 2006, CLIN EXP OPHTHALMOL, V34, P233, DOI 10.1111/j.1442-9071.2006.01191.x
   MADREPERLA SA, 1993, OPHTHALMIC PAED GEN, V14, P61, DOI 10.3109/13816819309042904
   MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368
   MAFFEI L, 1985, EXP BRAIN RES, V59, P423
   Mahapatra A, 1992, J NEUROSURG SCI, V36, P79
   MAKHOUL J, 2002, B SOC BELG OPHTHALM, V286, P9
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MANCHESTER PT, 1958, ARCH OPHTHALMOL-CHIC, V60, P479
   MANTYJARVI MI, 1992, J CLIN NEURO-OPHTHAL, V12, P98
   MARGO CE, 1991, ARCH OPHTHALMOL-CHIC, V109, P1120, DOI 10.1001/archopht.1991.01080080080033
   MARSZAL E, 2004, NEUROL NEUROCHIR POL, V14, P388
   Martin-Kleiner I, 2006, COLLEGIUM ANTROPOL, V30, P171
   MARUYAMA K, 1989, EUR J PEDIATR, V148, P682, DOI 10.1007/BF00441534
   MARZAN KAB, 1994, PEDIATR NEUROL, V10, P247, DOI 10.1016/0887-8994(94)90033-7
   Mashima Y, 2002, JPN J OPHTHALMOL, V46, P660, DOI 10.1016/S0021-5155(02)00562-2
   Mashima Y, 1996, CLIN GENET, V50, P535
   MATSON DD, 1969, J NEUROSURG, V30, P377, DOI 10.3171/jns.1969.30.4.0377
   Matsuba CA, 2006, DEV MED CHILD NEUROL, V48, P508, DOI 10.1017/S0012162206001071
   MCADAMS HP, 1990, AM J NEURORADIOL, V11, P397
   MCCLUSKEY DJ, 1986, J CLIN NEURO-OPHTHAL, V6, P76
   MCCOMAS AJ, 1991, MUSCLE NERVE, V14, P585, DOI 10.1002/mus.880140702
   MCDONNELL JM, 1990, OPTHALMOLOGY, V97, P1445
   MCGINNITY FG, 1992, BRIT J OPHTHALMOL, V76, P520, DOI 10.1136/bjo.76.9.520
   McKusick VA, 1998, MENDELIAN INHERITANCE IN MAN: A CATALOG OF HUMAN GENES AND GENETIC DISORDERS, V0, P0
   MCKUSICK VA, 1965, MEDICINE, V44, P445, DOI 10.1097/00005792-196511000-00001
   Medlej R, 2004, J CLIN ENDOCR METAB, V89, P1656, DOI 10.1210/jc.2002-030015
   MEFTY O, 1988, J NEUROSURG, V68, P80
   Mégarbané A, 2001, AM J MED GENET, V101, P135, DOI 10.1002/1096-8628(20010615)101:2<135::AID-AJMG1134>3.0.CO;2-J
   Mégarbané A, 1999, J MED GENET, V36, P637
   Mégarbané A, 2003, AM J MED GENET A, V116A, P381, DOI 10.1002/ajmg.a.10023
   Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867
   MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861
   Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004
   MENKES JH, 1962, PEDIATRICS, V29, P764
   MENON V, 1992, ACTA OPHTHALMOL, V70, P725
   Meola G, 2000, MUSCLE NERVE, V23, P1789, DOI 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4
   Merchany SN, 2001, OTOL NEUROTOL, V22, P506, DOI 10.1097/00129492-200107000-00017
   Merrick Joav, 2004, INT J ADOLESC MED HEALTH, V16, P79
   Mets M B, 1999, TRANS AM OPHTHALMOL SOC, V97, P653
   METS MB, 1985, OPHTHALMIC PAED GEN, V5, P85, DOI 10.3109/13816818509007860
   Michelakakis HM, 2004, PEDIATR NEUROL, V31, P146, DOI 10.1016/j.pediatrneurol.2004.01.013
   MIKELBERG FS, 1993, CAN J OPHTHALMOL, V28, P69
   Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8
   MILLER NR, 1981, ARCH OPHTHALMOL-CHIC, V99, P1654
   Miller NR, 2004, CLIN EXP OPHTHALMOL, V32, P233, DOI 10.1111/j.1442-9071.2004.00809.x
   MILLER NR, 1991, AUST NZ J OPHTHALMOL, V19, P105, DOI 10.1111/j.1442-9071.1991.tb00636.x
   MILLER NR, 1982, CLIN NEUROOPHTHALMOL, V0, P329
   Mirdehghan SA, 2005, BRIT J OPHTHALMOL, V89, P612, DOI 10.1136/bjo.2004.050799
   MIYAKE Y, 1985, ARCH OPHTHALMOL-CHIC, V103, P1496
   Miyama S, 2000, NEUROPEDIATRICS, V31, P214, DOI 10.1055/s-2000-7462
   Mohamed MD, 2003, BRIT J OPHTHALMOL, V87, P473, DOI 10.1136/bjo.87.4.473
   Mohn A, 2004, MINERVA PEDIATR, V56, P115
   Moll Agnieszka, 2005, KLIN OCZNA, V107, P93
   MOLLER HU, 1992, OPHTHALMIC PAED GEN, V13, P31, DOI 10.3109/13816819209070051
   MOORE AT, 1985, OPHTHALMOLOGY, V92, P12
   Moorman CM, 1999, EYE, V13, P76, DOI 10.1038/eye.1999.15
   Morava E, 2006, AM J MED GENET A, V140A, P752, DOI 10.1002/ajmg.a.31117
   MORIYA N, 1995, AM J MED GENET, V58, P257, DOI 10.1002/ajmg.1320580312
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Morse LE, 2006, PEDIATR NEUROL, V35, P154, DOI 10.1016/j.pediatrneurol.2006.02.004
   MOSCHNER C, 1994, BRAIN, V117, P15, DOI 10.1093/brain/117.1.15
   Moser CL, 2002, BRIT J OPHTHALMOL, V86, P257, DOI 10.1136/bjo.86.3.257
   Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421
   Moura FC, 2007, OPHTHALMOLOGY, V114, P175, DOI 10.1016/j.ophtha.2006.06.045
   Mudgil AV, 2000, CLIN EXP OPHTHALMOL, V28, P34, DOI 10.1046/j.1442-9071.2000.00254.x
   MUKAI K, 1986, J NEURO-ONCOL, V4, P79, DOI 10.1007/BF02158007
   Mullaney PB, 1997, ARCH OPHTHALMOL-CHIC, V115, P940, DOI 10.1001/archopht.1997.01100160110028
   Muller U, 1997, GRAEF ARCH CLIN EXP, V235, P545, DOI 10.1007/BF00947081
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   Muthukumar N, 1998, BRIT J NEUROSURG, V12, P458
   Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2
   MWANZA JC, 2000, B SOC BELG OPHTHALM, V277, P75
   Nabi NU, 2003, J AAPOS, V7, P178, DOI 10.1016/S1091-8531(02)42005-8
   Nakamura M, 2006, OPHTHALMOLOGY, V113, P483, DOI 10.1016/j.ophtha.2005.10.054
   Nakamura M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1028, DOI 10.1001/archopht.121.7.1028
   NAKAMURA M, 1994, JPN J OPHTHALMOL, V38, P267
   Nakhla M, 2005, PEDIATR CLIN N AM, V52, P1637, DOI 10.1016/j.pcl.2005.07.005
   NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115
   Narula P, 2006, J PEDIATR GASTR NUTR, V43, P348, DOI 10.1097/01.mpg.0000221895.51748.44
   Neas K, 2005, J INHERIT METAB DIS, V28, P525, DOI 10.1007/s10545-005-0525-8
   Neetens A, 1982, BULL SOC BELGE OPHTALMOL, V203, P75
   NEETENS A, 1985, OPHTHALMIC PAED GEN, V5, P79, DOI 10.3109/13816818509007859
   NEETENS A, 1986, NEURO-OPHTHALMOLOGY, V6, P277, DOI 10.3109/01658108609053872
   NEUFELD EF, 1989, METABOLIC BASIS INHE, V2, P1565
   Newman NJ, 2005, WALSH HOYTS CLIN NEU, V0, P465
   Newman NJ, 1993, OPHTHALMOL CLIN N AM, V4, P431
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NEWMAN NJ, 1993, SURV OPHTHALMOL, V37, P273, DOI 10.1016/0039-6257(93)90010-5
   Newman S A, 1991, NEUROSURG CLIN N AM, V2, P587
   NEWMAN SA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1241, DOI 10.1001/archopht.1983.01040020243018
   Nguyen C, 2005, KLIN MONATSBL AUGENH, V222, P275, DOI 10.1055/s-2005-857981
   Nguyen TN, 2002, OPHTHALMOLOGY, V109, P520, DOI 10.1016/S0161-6420(01)00985-X
   Nicolaides P, 1996, J MED GENET, V33, P419, DOI 10.1136/jmg.33.5.419
   NIKOSKELAINEN E, 1985, LANCET, V1, P696
   NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011
   Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Nmorsi OPG, 2007, PARASITOL RES, V100, P1261, DOI 10.1007/s00436-006-0421-7
   Nmorsi OPG, 2002, SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, V33, P28
   Noguchi Y, 2005, ACTA OTO-LARYNGOL, V125, P1189, DOI 10.1080/00016480510044232
   Nomura S, 1999, PEDIATR NEUROSURG, V31, P213, DOI 10.1159/000028864
   NORTH KN, 1995, J PEDIATR-US, V126, P916, DOI 10.1016/S0022-3476(95)70208-3
   NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053
   Numabe H, 2001, RYOIKIBETSU SHOKOGUN SHIRIZU, V0, P382
   OHara CM, 2006, PEDIATR NEUROSURG, V42, P100, DOI 10.1159/000090463
   OKeefe M, 2001, BRIT J OPHTHALMOL, V85, P357, DOI 10.1136/bjo.85.3.357
   Ohata T, 1998, HUM GENET, V103, P470, DOI 10.1007/s004390050852
   Ohba N, 1976, MOD PROBL OPHTHALMOL, V17, P315
   Ohlenbusch A, 1998, NEUROPEDIATRICS, V29, P313, DOI 10.1055/s-2007-973584
   OHTSUKA Y, 1993, J CHILD NEUROL, V8, P366, DOI 10.1177/088307389300800414
   Okamoto K, 2003, AM J NEURORADIOL, V24, P1946
   Okuno T, 1985, PEDIATR NEUROL, V1, P311, DOI 10.1016/0887-8994(85)90036-0
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Oluleye TS, 2006, EUR J OPHTHALMOL, V16, P604, DOI 10.1177/112067210601600416
   Oluwole OSA, 2000, J NEUROL NEUROSUR PS, V69, P96, DOI 10.1136/jnnp.69.1.96
   Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175
   OPAL P, 2007, EMERY RIMOINS PRINCI, V3, P2755
   Orbak Z, 2002, J PEDIATR ENDOCR MET, V15, P865
   ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0
   OUVRIER RA, 1990, AUST NZ J OPHTHALMOL, V18, P375, DOI 10.1111/j.1442-9071.1990.tb01820.x
   Ozden Serap, 2002, OPHTHALMIC GENET, V23, P29, DOI 10.1076/opge.23.1.29.2208
   Ozer PA, 2007, J GLAUCOMA, V16, P685, DOI 10.1097/IJG.0b013e318073bd4d
   OZKAN H, 1991, TURKISH J PEDIATR, V33, P247
   Packwood EA, 2000, J AAPOS, V4, P321, DOI 10.1067/mpa.2000.106958
   Pakdemirli E, 2005, AUSTRALAS RADIOL, V49, P189, DOI 10.1111/j.1440-1673.2005.01420.x
   PALAN A, 1989, DOC OPHTHALMOL, V71, P77, DOI 10.1007/BF00155135
   Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   PARRAVANO JG, 1993, J COMPUT ASSIST TOMO, V17, P688, DOI 10.1097/00004728-199309000-00003
   Parsa CF, 2001, ARCH OPHTHALMOL-CHIC, V119, P516
   Patil CG, 2008, SPINE, V33, P1491, DOI 10.1097/BRS.0b013e318175d1bf
   Patton N, 2000, OPHTHALMIC GENET, V21, P151, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT151
   PAULI RM, 1984, CLIN GENET, V26, P383
   PAULUS W, 1993, J NEUROL, V240, P251, DOI 10.1007/BF00818714
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   PEARCE WG, 1985, OPHTHALMIC PAED GEN, V5, P99, DOI 10.3109/13816818509007862
   PENA SDJ, 1974, CLIN GENET, V5, P285
   Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906
   Perrault Isabelle, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9485
   Peters U, 2003, ANTICANCER RES, V23, P1249
   PETERSEN J R, 1990, UGESKRIFT FOR LAEGER, V152, P3865
   Pezzi PP, 1998, PEDIATR NEUROL, V19, P308, DOI 10.1016/S0887-8994(98)00060-5
   Phasukkijwatana N, 2006, J HUM GENET, V51, P1110, DOI 10.1007/s10038-006-0073-6
   PHILLIPS CI, 1993, OPHTHALMOLOGICA, V206, P89, DOI 10.1159/000310369
   Phillipson R, 1997, IMPACT, V1, P115
   PILLEY SFJ, 1976, BRIT J OPHTHALMOL, V60, P294, DOI 10.1136/bjo.60.4.294
   Pitz S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1353, DOI 10.1001/archopht.125.10.1353
   Pollack IF, 1996, PEDIATR NEUROSURG, V24, P202, DOI 10.1159/000121038
   POLLOCK SC, 1986, INT OPHTHALMOL CLIN, V26, P201, DOI 10.1097/00004397-198602640-00019
   POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95
   Pomeranz HD, 1999, ARCH OPHTHALMOL-CHIC, V117, P128
   POSNICK JC, 1993, PEDIATR NEUROSURG, V19, P260, DOI 10.1159/000120742
   Pott J W, 1999, STRABISMUS, V7, P97, DOI 10.1076/stra.7.2.97.648
   Poussaint TY, 1996, AM J NEURORADIOL, V17, P1907
   Prietsch V, 2002, J INHERIT METAB DIS, V25, P126, DOI 10.1023/A:1015628810892
   PROUD VK, 1992, AM J MED GENET, V43, P458, DOI 10.1002/ajmg.1320430169
   PRUZON J, 2005, N AM NEUR SOC FEB 12, V0, P0
   PTACEK LJ, 1995, CLIN NEUROSCI, V3, P28
   Pulzer F, 2007, ACTA PAEDIATR, V96, P353, DOI 10.1111/j.1651-2227.2007.00087.x
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   PUSEY E, 1987, AM J ROENTGENOL, V149, P383, DOI 10.2214/ajr.149.2.383
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015
   QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P841
   QUIGLEY HA, 1982, AM J OPHTHALMOL, V93, P689, DOI 10.1016/0002-9394(82)90461-5
   QUIGLEY HA, 1977, AM J OPHTHALMOL, V83, P709, DOI 10.1016/0002-9394(77)90138-6
   RAHMAN AM, 2009, EYE, V0, P0
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RAHN EK, 1968, AM J OPHTHALMOL, V66, P1143, DOI 10.1016/0002-9394(68)90825-8
   RAMAEKERS VT, 1993, NEUROPEDIATRICS, V24, P98, DOI 10.1055/s-2008-1071522
   Ramprasad VL, 2008, MOL VIS, V14, P481
   RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220
   Raney RB, 1999, MED PEDIATR ONCOL, V33, P362, DOI 10.1002/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I
   Ranjan P, 2003, NEURORADIOLOGY, V45, P277, DOI 10.1007/s00234-003-0958-4
   RAPID I, 1995, MERRITTS TXB NEUROLO, V0, P547
   RAPIN I, 1995, MERRITTS TXB NEUROLO, V0, P597
   Rathinam SR, 1998, OCUL IMMUNOL INFLAMM, V6, P155, DOI 10.1076/ocii.6.3.155.4041
   Reed UC, 1999, BRAIN DEV-JPN, V21, P274, DOI 10.1016/S0387-7604(98)00100-4
   Repka MX, 2002, MENT RETARD DEV D R, V8, P249, DOI 10.1002/mrdd.10045
   REPKA MX, 1989, OPHTHALMOLOGY, V96, P195
   REPKA MX, 1988, AM J OPHTHALMOL, V106, P191, DOI 10.1016/0002-9394(88)90833-1
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Ricci D, 2006, EARLY HUM DEV, V82, P591, DOI 10.1016/j.earlhumdev.2005.12.007
   RICHMOND IL, 1978, J NEUROSURG, V49, P163, DOI 10.3171/jns.1978.49.2.0163
   Riggs JE, 2001, NEUROLOGY, V56, P570, DOI 10.1212/WNL.56.4.570
   Riikonen R, 1999, EPILEPSIA, V40, P1642, DOI 10.1111/j.1528-1157.1999.tb02051.x
   Riikonen R, 2001, BRAIN DEV-JPN, V23, P765, DOI 10.1016/S0387-7604(01)00283-2
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Rizvi Raza, 2005, JPMA JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, V55, P502
   RIZZO JF, 1986, AM J OPHTHALMOL, V102, P463, DOI 10.1016/0002-9394(86)90074-7
   ROBB RM, 1984, AM J OPHTHALMOL, V97, P691, DOI 10.1016/0002-9394(84)90499-9
   ROGGEVEEN HCJ, 1985, OPHTHALMIC PAED GEN, V5, P103, DOI 10.3109/13816818509007863
   RON E, 1988, NEW ENGL J MED, V319, P1033, DOI 10.1056/NEJM198810203191601
   Roodhooft J M J, 2003, BULL SOC BELGE OPHTALMOL, V0, P45
   Rose AL, 1999, J CHILD NEUROL, V14, P123, DOI 10.1177/088307389901400211
   ROSENBERRN, 1967, NEUROLOGY, V17, P827, DOI 10.1212/WNL.17.9.827
   ROSENBERG RN, 1989, NEUROL CLIN, V7, P25, DOI 10.1016/S0733-8619(18)30826-0
   Rosenblatt DS, 1997, J INHERIT METAB DIS, V20, P528, DOI 10.1023/A:1005353530303
   Rothermel H, 2001, PEDIATRICS, V108, P477, DOI 10.1542/peds.108.2.477
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Ruberto G, 2006, INVEST OPHTH VIS SCI, V47, P484, DOI 10.1167/iovs.05-0529
   Rudanko SL, 2004, OPHTHALMOLOGY, V111, P2307, DOI 10.1016/j.ophtha.2004.05.033
   Rudanko SL, 2003, OPHTHALMOLOGY, V110, P1639, DOI 10.1016/S0161-6420(03)00498-6
   Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904
   Rutzen AR, 2007, OPHTHAL EPIDEMIOL, V14, P360, DOI 10.1080/01658100701436033
   RYAN SJ, 1971, AM J OPHTHALMOL, V71, P838, DOI 10.1016/0002-9394(71)90251-0
   SAATCI U, 1990, TURKISH JOURNAL OF PEDIATRICS, V32, P211
   SACHDEV M S, 1990, INDIAN JOURNAL OF OPHTHALMOLOGY, V38, P151
   Sadun A, 1998, TRANS AM OPHTHALMOL SOC, V96, P881
   SADUN AA, 1994, ARCH OPHTHALMOL-CHIC, V112, P691, DOI 10.1001/archopht.1994.01090170139037
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   SADUN AA, 1994, CLIN NEUROSCI, V2, P165
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Saeed P, 2003, OPHTHALMOLOGY, V110, P2019, DOI 10.1016/S0161-6420(03)00787-5
   SAFRAN AB, 1984, AM J OPHTHALMOL, V98, P494, DOI 10.1016/0002-9394(84)90138-7
   SALBERT BA, 1993, OPHTHALMOLOGICA, V206, P177, DOI 10.1159/000310387
   SALIH MAM, 1991, ACTA PAEDIATR SCAND, V80, P567, DOI 10.1111/j.1651-2227.1991.tb11908.x
   SALONEN R, 1991, CLIN GENET, V39, P287
   Sanchez RN, 2006, J NEURO-OPHTHALMOL, V26, P268, DOI 10.1097/01.wno.0000249320.27110.ab
   Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P149, DOI 10.1111/j.1600-0420.2006.00867.x
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Santucci M, 2001, EPILEPSIA, V42, P1074, DOI 10.1046/j.1528-1157.2001.0420081074.x
   SARKAR HR, 2007, MYMENSIGH M J L, V16, P123
   Sass JO, 2004, CLIN PEDIATR, V43, P837, DOI 10.1177/000992280404300908
   Sathasivam S, 2008, ORPHANET J RARE DIS, V3, P0, DOI 10.1186/1750-1172-3-9
   SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Savino PJ, 2009, J NEURO-OPHTHALMOL, V29, P245, DOI 10.1097/WNO.0b013e3181b1b3d7
   SAVOIARDO M, 1990, RADIOLOGY, V174, P693, DOI 10.1148/radiology.174.3.2305051
   Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x
   SAYLI BS, 1993, AM J MED GENET, V47, P342, DOI 10.1002/ajmg.1320470309
   Schimel AM, 2006, OPHTHALMIC GENET, V27, P9, DOI 10.1080/13816810500481758
   Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044
   Schollen E, 2005, EUR J MED GENET, V48, P153, DOI 10.1016/j.ejmg.2005.01.002
   SCHOR NF, 1992, J CHILD NEUROL, V7, P253, DOI 10.1177/088307389200700303
   Schramm P, 2005, ACTA NEUROCHIR, V147, P679, DOI 10.1007/s00701-005-0508-4
   Schröder JM, 2004, ACTA NEUROPATHOL, V108, P154, DOI 10.1007/s00401-004-0877-4
   Schuil J, 1998, NEUROPEDIATRICS, V29, P294, DOI 10.1055/s-2007-973580
   Schwankhaus JD, 1995, NEUROLOGY, V45, P2266, DOI 10.1212/WNL.45.12.2266
   Scolding NJ, 1996, ANN NEUROL, V39, P352, DOI 10.1002/ana.410390312
   Scott IU, 2005, OPHTHAL SURG LAS IM, V36, P374, DOI 10.3928/1542-8877-20050901-05
   Seiff S R, 1992, OPHTHALMOL CLIN NORTH AM, V5, P389
   SEIFF SR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1689, DOI 10.1001/archopht.1987.01060120087032
   SELLENFRMH, 1968, ARCH OPHTHALMOL-CHIC, V80, P718
   Semple P, 2007, CHILD NERV SYST, V23, P213, DOI 10.1007/s00381-006-0177-5
   SENANAYAKE N, 1992, J NEUROL, V239, P293
   SENER RN, 1993, PEDIATR RADIOL, V23, P321, DOI 10.1007/BF02010928
   Serdaroglu G, 2004, DEV MED CHILD NEUROL, V46, P733, DOI 10.1017/S0012162204001264
   Shah SA, 1995, PEDIATR RADIOL, V25, P0
   Shah VA, 2008, SURV OPHTHALMOL, V53, P403, DOI 10.1016/j.survophthal.2008.04.003
   Shaikh S, 2001, AM J OPHTHALMOL, V131, P143, DOI 10.1016/S0002-9394(00)00716-9
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5
   Shawky R M, 2001, EAST MEDITERR HEALTH J, V7, P981
   SHEDDEN AH, 1985, J CLIN NEURO-OPHTHAL, V5, P209
   SHEFFER RN, 1992, AM J OPHTHALMOL, V114, P494, DOI 10.1016/S0002-9394(14)71864-1
   Shimizu S, 2003, AM J OPHTHALMOL, V135, P256, DOI 10.1016/S0002-9394(02)01929-3
   Shimizu S, 2002, JPN J OPHTHALMOL, V46, P336, DOI 10.1016/S0021-5155(02)00484-7
   Shokunbi MT, 2002, EYE, V16, P739, DOI 10.1038/sj.eye.6700085
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   SHURIN SB, 1982, PEDIATRICS, V70, P288
   Simsek E, 2003, ACTA PAEDIATR, V92, P55
   Sinha S, 2004, SEIZURE-EUR J EPILEP, V13, P235, DOI 10.1016/S1059-1311(03)00163-8
   Sitorus RS, 2003, VISION RES, V43, P3087, DOI 10.1016/j.visres.2003.08.008
   SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302
   SMALL KW, 1988, AM J OPHTHALMOL, V106, P96, DOI 10.1016/S0002-9394(14)76398-6
   Smith CJA, 2004, DIABETES CARE, V27, P2003, DOI 10.2337/diacare.27.8.2003
   SMITH DP, 1972, AMER J OPT ARCH AM A, V49, P183
   SMITH DP, 1973, INVEST OPHTH VISUAL, V12, P608
   SMITH DP, 1972, AMER J OPT ARCH AM A, V49, P574
   SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X
   SMITH JL, 1973, ARCH OPHTHALMOL-CHIC, V90, P349
   SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022
   SOMER M, 1993, EPILEPSIA, V34, P727, DOI 10.1111/j.1528-1157.1993.tb00453.x
   SOMER M, 1993, AM J NEURORADIOL, V14, P861
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   SPALTON DJ, 1980, BRIT J OPHTHALMOL, V64, P726, DOI 10.1136/bjo.64.10.726
   SPERLI D, 1993, J MED GENET, V30, P877, DOI 10.1136/jmg.30.10.877
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Stannard C, 2002, INT J RADIAT ONCOL, V54, P1446, DOI 10.1016/S0360-3016(02)03756-2
   Stark KL, 1999, J AAPOS, V3, P366, DOI 10.1016/S1091-8531(99)70047-9
   Stavrou P, 2001, OCUL IMMUNOL INFLAMM, V9, P141, DOI 10.1076/ocii.9.3.141.3965
   Steinsapir KD, 2006, J NEURO-OPHTHALMOL, V26, P65, DOI 10.1097/01.wno.0000204646.94991.68
   STERN J, 1980, ARCH OPHTHALMOL-CHIC, V98, P505
   Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x
   Stöhr H, 1999, HUM GENET, V104, P99, DOI 10.1007/s004390050917
   Stojanov S, 2004, PEDIATRICS, V114, PE124, DOI 10.1542/peds.114.1.e124
   Stokkermans TJW, 1999, OPTOMETRY VISION SCI, V76, P444, DOI 10.1097/00006324-199907000-00019
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Straussberg R, 1998, NEUROPEDIATRICS, V29, P54, DOI 10.1055/s-2007-973537
   Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021
   STROMLAND K, 1982, BIRTH DEFECTS-ORIG, V18, P651
   Subramony SH, 2001, NEUROLOGY, V56, P287, DOI 10.1212/WNL.56.3.287
   SUGITA S, 1995, SURG NEUROL, V43, P154, DOI 10.1016/0090-3019(95)80127-3
   SULLIVAN TJ, 1994, AUST NZ J OPHTHALMOL, V22, P25, DOI 10.1111/j.1442-9071.1994.tb01691.x
   SULLIVAN TJ, 1992, J PEDIATR OPHTHALMOL, V29, P246
   Sullu Y, 2003, AM J OPHTHALMOL, V136, P367, DOI 10.1016/S0002-9394(03)00187-9
   SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029
   Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299
   SWEETMAN L, 1979, JAMA-J AM MED ASSOC, V242, P1048, DOI 10.1001/jama.242.10.1048
   SYLVESTER PE, 1958, ARCH DIS CHILD, V33, P217, DOI 10.1136/adc.33.169.217
   Szedelyova L, 1989, CESK OFTALMOL, V45, P440
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Tambe KA, 2003, EUR J PAEDIATR NEURO, V7, P77, DOI 10.1016/S1090-3798(03)00017-5
   Tarnaris A, 2005, J NEUROSURG, V102, P224, DOI 10.3171/jns.2005.102.2.0224
   Tay T, 2006, CLIN EXP OPHTHALMOL, V34, P434, DOI 10.1111/j.1442-9071.2006.01242.x
   TAYLOR D, 1982, BRIT J OPHTHALMOL, V66, P455, DOI 10.1136/bjo.66.7.455
   Taylor D, 1983, BULL SOC BELGE OPHTALMOL, V208 Pt 1, P405
   TEEBI AS, 1998, J MED GENET, V20, P143
   Tekgül H, 2000, TURKISH J PEDIATR, V42, P246
   Tekgül S, 1999, J UROLOGY, V161, P616, DOI 10.1016/S0022-5347(01)61982-7
   Terraciano Anthony J, 2002, CURR OPIN OPHTHALMOL, V13, P97, DOI 10.1097/00055735-200204000-00008
   Tessa A, 2001, HUM MUTAT, V17, P348, DOI 10.1002/humu.32
   Thieme H, 1999, GRAEF ARCH CLIN EXP, V237, P714, DOI 10.1007/s004170050301
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Thomas M, 2004, MOVEMENT DISORD, V19, P36, DOI 10.1002/mds.10650
   THOMAS PK, 1984, J NEUROL SCI, V64, P137, DOI 10.1016/0022-510X(84)90032-7
   Thomson APJ, 1999, J MED GENET, V36, P251
   Thuente DD, 2005, OPHTHALMOLOGY, V112, P724, DOI 10.1016/j.ophtha.2004.11.049
   TILL JS, 1987, J CLIN NEURO-OPHTHAL, V7, P40
   Timoney P, 2007, J AAPOS, V11, P291, DOI 10.1016/j.jaapos.2006.09.020
   Toker E, 2003, CORNEA, V22, P198, DOI 10.1097/00003226-200304000-00003
   Tong L, 2004, AM J OPHTHALMOL, V138, P160, DOI 10.1016/j.ajo.2004.02.026
   Towbin R, 1998, PEDIATR RADIOL, V28, P995, DOI 10.1007/s002470050518
   TRABOULSI EI, 1992, AM J OPHTHALMOL, V114, P579, DOI 10.1016/S0002-9394(14)74486-1
   TRABOULSI EI, 1988, ARCH OPHTHALMOL-CHIC, V106, P801, DOI 10.1001/archopht.1988.01060130871043
   TRABOULSI EI, 1992, AM J OPHTHALMOL, V113, P269, DOI 10.1016/S0002-9394(14)71578-8
   TRABOULSI EI, 1987, OPHTHALMOLOGY, V94, P47, DOI 10.1016/S0161-6420(87)33504-3
   Tranebjærg L, 2000, EUR J HUM GENET, V8, P464, DOI 10.1038/sj.ejhg.5200483
   Trautner C, 2003, INVEST OPHTH VIS SCI, V44, P1031, DOI 10.1167/iovs.02-0304
   TREFT RL, 1984, OPHTHALMOLOGY, V91, P908
   Trisciuzzi MTS, 2004, CLIN NEUROPHYSIOL, V115, P217, DOI 10.1016/S1388-2457(03)00282-7
   TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1040, DOI 10.1001/archopht.1980.01020031030003
   TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X
   Tsina EK, 2005, ARCH OPHTHALMOL-CHIC, V123, P1143, DOI 10.1001/archopht.123.8.1143
   Tugal-Tutkun I, 2003, AM J OPHTHALMOL, V136, P1114, DOI 10.1016/S0002-9394(03)00791-8
   Tugal-Tutkun Ilknur, 2007, INTERNATIONAL OPHTHALMOLOGY, V27, P117, DOI 10.1007/s10792-006-9001-1
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Tullu M S, 2000, INDIAN PEDIATR, V37, P939
   TUPPURAINEN K, 1993, GRAEF ARCH CLIN EXP, V231, P261, DOI 10.1007/BF00919102
   Turbin RE, 1998, J NEURO-OPHTHALMOL, V18, P242
   Tusa RJ, 1999, J CHILD NEUROL, V14, P621, DOI 10.1177/088307389901401001
   Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101
   TZEKOV C, 1992, PEDIATR NEUROSURG, V17, P317, DOI 10.1159/000120617
   Udar N, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9109
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   UNSOLD R, 1980, ARCH OPHTHALMOL-CHIC, V98, P1637, DOI 10.1001/archopht.1980.01020040489020
   Vaegan, 2006, OPTOMETRY VISION SCI, V83, P486, DOI 10.1097/01.opx.0000225920.97380.62
   Vaher U, 2001, BRAIN DEV-JPN, V23, P236, DOI 10.1016/S0387-7604(01)00184-X
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Van den Ouweland JMW, 2003, J MOL DIAGN, V5, P88, DOI 10.1016/S1525-1578(10)60457-6
   VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S
   VANDENBERGE JH, 1992, J NEUROSURG, V77, P545, DOI 10.3171/jns.1992.77.4.0545
   VANDENBERGH L, 1993, DOC OPHTHALMOL, V84, P119, DOI 10.1007/BF01206246
   Vanhatalo S, 2000, EPILEPSIA, V41, P705, DOI 10.1111/j.1528-1157.2000.tb00231.x
   Vanhatalo S, 2002, NEUROPEDIATRICS, V33, P100, DOI 10.1055/s-2002-32371
   Vedantham Vasumathy, 2007, INDIAN JOURNAL OF OPHTHALMOLOGY, V55, P113
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Verloes A, 2006, AM J MED GENET A, V140A, P1285, DOI 10.1002/ajmg.a.31270
   Verny C, 2005, REV NEUROL-FRANCE, V161, P451, DOI 10.1016/S0035-3787(05)85075-1
   Vijayalakshmi P, 2003, J AAPOS, V7, P91, DOI 10.1016/S1091-8531(02)42002-2
   VIKKI J, 1991, AM J HUM GENET, V48, P486
   Villanueva-Mendoza C, 2009, OPHTHALMIC GENET, V30, P45, DOI 10.1080/13816810802502962
   Vinkler C, 2003, AM J MED GENET A, V121A, P263, DOI 10.1002/ajmg.a.20238
   VOLKERDIEBEN HJM, 1974, DOC OPHTHALMOL, V37, P307, DOI 10.1007/BF00147264
   VOLPE IJ, 1987, NEUROLOGY NEWBORN, V0, P0
   VOLPE NJ, 1993, INT OPHTHALMOL CLIN, V33, P153, DOI 10.1097/00004397-199303320-00015
   Voo I, 2003, AM J OPHTHALMOL, V136, P670, DOI 10.1016/S0002-9394(03)00390-8
   Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48
   Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351
   Vougioukas VI, 2001, PEDIATR NEUROSURG, V35, P35, DOI 10.1159/000050383
   WAARDENBURG P J, 1957, ACTA GENET STAT MED, V7, P287
   WAJNTAL A, 1990, AM J MED GENET, V37, P213, DOI 10.1002/ajmg.1320370210
   WAKAI S, 1993, PEDIATR NEUROL, V9, P309, DOI 10.1016/0887-8994(93)90070-S
   WAKAKURA M, 1995, BRIT J OPHTHALMOL, V79, P442, DOI 10.1136/bjo.79.5.442
   WALSH FB, 1969, CLIN NEUROOPHTHALMOL, V1, P494
   Wang JY, 2008, J INT MED RES, V36, P544, DOI 10.1177/147323000803600320
   WANG PJ, 1995, PEDIATR NEUROL, V12, P47, DOI 10.1016/0887-8994(94)00124-K
   Warner RB, 2002, AM J OPHTHALMOL, V134, P918, DOI 10.1016/S0002-9394(02)01706-3
   WARNER TT, 2009, PRACTICAL NEUROGENET, V0, P92
   Webb C, 2008, ARCH PATHOL LAB MED, V132, P77, DOI 10.1043/1543-2165(2008)132[77:PPA]2.0.CO;2
   Weber P, 2004, DEV MED CHILD NEUROL, V46, P481, DOI 10.1017/S0012162204000799
   WEINER HL, 1994, NEUROSURGERY, V35, P1001, DOI 10.1227/00006123-199412000-00001
   WEISMAN JS, 1990, AM J OPHTHALMOL, V110, P244, DOI 10.1016/S0002-9394(14)76338-X
   WELEBER RG, 1992, ARCH OPHTHALMOL-CHIC, V110, P640, DOI 10.1001/archopht.1992.01080170062025
   Weleber RG, 1988, RETINAL DYSTROPHIES, V0, P233
   Weleber Richard G, 2002, OPHTHALMIC GENET, V23, P71, DOI 10.1076/opge.23.2.71.2214
   WERTENBAKER C, 1985, SURV OPHTHALMOL, V29, P297, DOI 10.1016/0039-6257(85)90153-5
   Westall CA, 2000, J AAPOS, V4, P295, DOI 10.1067/mpa.2000.107898
   WEYAND RD, 1952, P STAFF M MAYO CLIN, V27, P505
   Wild JM, 1999, EPILEPSIA, V40, P1784, DOI 10.1111/j.1528-1157.1999.tb01599.x
   Wilichowski E, 1998, NEUROPEDIATRICS, V29, P307, DOI 10.1055/s-2007-973583
   Wilkinson M E, 2001, OPTOMETRY, V72, P724
   Williams ZR, 2009, AM J OPHTHALMOL, V147, P929, DOI 10.1016/j.ajo.2008.12.024
   Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3
   WILSON J, 1963, BRAIN, V86, P347, DOI 10.1093/brain/86.2.347
   WILSON WB, 1981, NEUROOPHTHALMOLOGY, V1, P175
   WOLF B, 1981, J PEDIATR-US, V99, P835, DOI 10.1016/S0022-3476(81)80004-2
   Wolfram DJ, 1938, MAYO CLIN PROC, V1, P715, DOI 10.1186/1757-1626-2-9355
   Wong VCN, 2006, J CHILD NEUROL, V21, P462, DOI 10.1177/08830738060210061201
   WRAY SH, 1976, INVEST OPHTH VISUAL, V15, P128
   WRAY SH, 1976, AM J OPHTHALMOL, V82, P480, DOI 10.1016/0002-9394(76)90498-0
   WRIGHT JE, 1989, BRIT J OPHTHALMOL, V73, P967, DOI 10.1136/bjo.73.12.967
   WRIGHT JE, 1989, BRIT J OPHTHALMOL, V73, P960, DOI 10.1136/bjo.73.12.960
   Wu Horng-Jiun, 2000, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, V16, P422
   Yamada T, 2003, JPN J OPHTHALMOL, V47, P409, DOI 10.1016/S0021-5155(03)00056-X
   Yan Jianhua, 2004, ORBIT, V23, P245
   Yang MS, 2005, J FORMOS MED ASSOC, V104, P129
   Yang YL, 2007, J CHILD NEUROL, V22, P156, DOI 10.1177/0883073807300307
   Yen M Y, 2000, ZHONGHUA YI XUE ZA ZHI (TAIPEI), V63, P864
   Yen MY, 2004, INVEST OPHTH VIS SCI, V45, P1688, DOI 10.1167/iovs.03-0568
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Yen MY, 1999, JPN J OPHTHALMOL, V43, P196, DOI 10.1016/S0021-5155(99)00008-8
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   YOSHIOKA M, 1990, BRAIN DEV-JPN, V12, P423, DOI 10.1016/S0387-7604(12)80076-3
   Yuksel D, 2007, J CHILD NEUROL, V22, P1143, DOI 10.1177/0883073807306270
   Yun Yie-Min, 2005, KOREAN J OPHTHALMOL, V19, P68
   ZACHMANN M, 1979, J PEDIATR-US, V95, P86, DOI 10.1016/S0022-3476(79)80095-5
   Zafeiriou DI, 1999, PEDIATR NEUROL, V21, P843, DOI 10.1016/S0887-8994(99)00093-4
   Zervos A, 2002, EUR J OPHTHALMOL, V12, P253, DOI 10.1177/112067210201200401
   Zhou XT, 2006, BIOCHEM BIOPH RES CO, V340, P69, DOI 10.1016/j.bbrc.2005.11.150
   ZIMMERMAN CF, 1990, OPHTHALMOLOGY, V97, P585
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
   Zumrová A, 2005, NEUROENDOCRINOL LETT, V26, P213
NR 967
TC 0
Z9 1
U1 10
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 
EI 
J9 
PD JUN 15
PY 2010
VL 0
IS 
BP 155
EP 211
DI 10.1007/978-0-387-69069-8_4
PG 57
WC Clinical Neurology; Ophthalmology; Pediatrics
SC Neurosciences & Neurology; Ophthalmology; Pediatrics
GA BOO64
UT WOS:000277155200004
DA 2024-11-01
ER

PT J
AU Smits, P
   Mattijssen, S
   Morava, E
   van den Brand, M
   van den Brandt, F
   Wijburg, F
   Pruijn, G
   Smeitink, J
   Nijtmans, L
   Rodenburg, R
   van den Heuvel, L
AF Smits, Paulien
   Mattijssen, Sandy
   Morava, Eva
   van den Brand, Mariel
   van den Brandt, Frans
   Wijburg, Frits
   Pruijn, Ger
   Smeitink, Jan
   Nijtmans, Leo
   Rodenburg, Richard
   van den Heuvel, Lambert
TI Functional consequences of mitochondrial tRNA<SUP>Trp</SUP> and tRNA<SUP>Arg</SUP> mutations causing combined OXPHOS defects
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE combined OXPHOS defects; mitochondrial DNA; tRNA(Trp); tRNA(Arg); molecular mechanism
ID c-oxidase deficiency; transfer-rna genes; oxidative-phosphorylation; point mutation; dna mutation; mtdna; electrophoresis; encephalopathy; population; phenotypes
AB Combined oxidative phosphorylation (OXPHOS) system deficiencies are a group of mitochondrial disorders that are associated with a range of clinical phenotypes and genetic defects. They occur in approximately 30% of all OXPHOS disorders and around 4% are combined complex I, III and IV deficiencies. In this study we present two mutations in the mitochondrial tRNA(Trp) (MT-TW) and tRNA(Arg) (MT-TR) genes, m. 5556G>A and m. 10450A>G, respectively, which were detected in two unrelated patients showing combined OXPHOS complex I, III and IV deficiencies and progressive multisystemic diseases. Both mitochondrial tRNA mutations were almost homoplasmic in fibroblasts and muscle tissue of the two patients and not present in controls. Patient fibroblasts showed a general mitochondrial translation defect. The mutations resulted in lowered steady-state levels and altered conformations of the tRNAs. Cybrid cell lines showed similar tRNA defects and impairment of OXPHOS complex assembly as patient fibroblasts. Our results show that these tRNATrp and tRNAArg mutations cause the combined OXPHOS deficiencies in the patients, adding to the still expanding group of pathogenic mitochondrial tRNA mutations. European Journal of Human Genetics (2010) 18, 324-329; doi: 10.1038/ejhg.2009.169; published online 7 October 2009
C1 [Smits, Paulien; Morava, Eva; van den Brand, Mariel; van den Brandt, Frans; Smeitink, Jan; Nijtmans, Leo; Rodenburg, Richard; van den Heuvel, Lambert] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Mattijssen, Sandy; Pruijn, Ger] Radboud Univ Nijmegen, Inst Mol & Mat, Nijmegen Ctr Mol Life Sci, Dept Biomol Chem, NL-6500 HB Nijmegen, Netherlands.
   [Wijburg, Frits] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat G8 205, NL-1105 AZ Amsterdam, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam
RP van den Heuvel, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM B.vandenHeuvel@cukz.umcn.nl
FU European Union [LSHMCT-2004-005260]; Council for Chemical Sciences (NWO-CW)
CR AGRIS PF, 1986, BIOCHEMISTRY-US, V25, P5126, DOI 10.1021/bi00366a022
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   King M P, 1996, METHODS ENZYMOL, V264, P313, DOI 10.1016/S0076-6879(96)64030-0
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MITOMAP, 2009, MITOMAP HUM MIT GEN, V0, P0
   MKAOUARREBAI E, 2007, MITOMAP MTDNA SEQUEN, V0, P0
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
NR 36
TC 34
Z9 37
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAR 15
PY 2010
VL 18
IS 3
BP 324
EP 329
DI 10.1038/ejhg.2009.169
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 556OY
UT WOS:000274601800010
PM 19809478
DA 2024-11-01
ER

PT J
AU Chen, CT
   Hsu, SH
   Wei, YH
AF Chen, Chien-Tsun
   Hsu, Shu-Han
   Wei, Yau-Huei
TI Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article; Proceedings Paper
DE Stem cell differentiation; Mitochondria; Metabolic shift; Reactive oxygen species (ROS); Warburg effect
ID oxidative stress; gene-expression; in-vitro; embryonic-development; transcription factors; dna deletions; self-renewal; biogenesis; hypoxia; muscle
AB Stem cell research has received increasing attention due to their invaluable potentials in the clinical applications to cure degenerative diseases, genetic disorders and even cancers. A great number of studies have been conducted with an aim to elucidate the molecular mechanisms involved in the regulation of self-renewal of stem cells and the mysterious circuits guiding them to differentiate into all kinds of progenies that can replenish the cell pools. However, little effort has been made in studying the metabolic aspects of stem cells. Mitochondria play essential roles in mammalian cells in the generation of ATP, Ca2+ homeostasis, compartmentalization of biosynthetic pathways and execution of apoptosis. Considering the metabolic roles of mitochondria, they must be also critical in stem cells. This review is primarily focused on the biogenesis and bioenergetic function of mitochondria in the differentiation process and metabolic features of stem cells. In addition, the involvement of reactive oxygen species and hypoxic signals in the regulation of stem cell pluripotency and differentiation is also discussed. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chen, Chien-Tsun; Hsu, Shu-Han; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei 252, Taiwan.
C3 National Yang Ming Chiao Tung University; Mackay Medical College
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
EM d49303003@ym.edu.tw; lucihsu@gmail.com; joeman@ym.edu.tw
CR Annas GJ, 1999, NAT MED, V5, P1339, DOI 10.1038/70900
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403
   BAKEEVA LE, 1983, J MOL CELL CARDIOL, V15, P413, DOI 10.1016/0022-2828(83)90261-4
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bavister BD, 2006, REPROD FERT DEVELOP, V18, P829, DOI 10.1071/RD06111
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   BERTONCELLO I, 1985, EXP HEMATOL, V13, P999
   Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc
   Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   Chung Susan, 2007, NAT CLIN PRACT CARDIOVASC MED, V4 Suppl 1, PS60, DOI 10.1038/ncpcardio0766
   Chung S, 2008, ANN NY ACAD SCI, V1147, P254, DOI 10.1196/annals.1427.004
   Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102
   Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972
   Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158
   Gibson TC, 2005, MOL HUM REPROD, V11, P785, DOI 10.1093/molehr/gah227
   Gibson TC, 2006, REPROD BIOMED ONLINE, V12, P101, DOI 10.1016/S1472-6483(10)60987-X
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500
   Guo HW, 2008, J BIOMED OPT, V13, P0, DOI 10.1117/1.2990752
   Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092
   Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005
   HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E
   Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014
   Houten SM, 2004, CELL, V119, P5, DOI 10.1016/j.cell.2004.09.016
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823
   Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7
   KANAMURA S, 1990, J ELECTRON MICR TECH, V14, P92, DOI 10.1002/jemt.1060140204
   KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311
   Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073
   Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117
   Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, PC1220, DOI 10.1152/ajpcell.2000.279.4.C1220
   Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85
   Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467
   Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Leemhuis T, 1996, EXP HEMATOL, V24, P1215
   Lin Q, 2006, J BIOL CHEM, V281, P30678, DOI 10.1074/jbc.C600120200
   Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760
   Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641
   Ludwig TE, 2001, BIOL REPROD, V65, P1648, DOI 10.1095/biolreprod65.6.1648
   Mannella CA, 2008, ANN NY ACAD SCI, V1147, P171, DOI 10.1196/annals.1427.020
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, P0, DOI 10.1186/1477-7827-3-65
   Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, PC615, DOI 10.1152/ajpcell.00249.2006
   Moyes CD, 1998, J EXP BIOL, V201, P299
   Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, PC1345, DOI 10.1152/ajpcell.1997.272.4.C1345
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1
   Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521
   Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200
   Piccoli C, 2007, FEBS LETT, V581, P3111, DOI 10.1016/j.febslet.2007.05.077
   POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X
   Radley JM, 1999, EXP HEMATOL, V27, P365, DOI 10.1016/S0301-472X(98)00017-4
   Reyes JMG, 2006, STEM CELLS, V24, P1213, DOI 10.1634/stemcells.2004-0324
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   Siggins RW, 2008, INT J CLIN EXP MED, V1, P2
   Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354
   Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje
   Squirrell JM, 2003, MICROSC MICROANAL, V9, P190, DOI 10.1017/S1431927603030174
   St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141
   St John JC, 2006, METH MOL B, V331, P347
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stewart R, 2006, EUR J CANCER, V42, P1257, DOI 10.1016/j.ejca.2006.01.033
   Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005
   VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763
   Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   WOLF NS, 1993, EXP HEMATOL, V21, P614
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4
NR 92
TC 52
Z9 65
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAR 15
PY 2010
VL 1800
IS 3
BP 257
EP 263
DI 10.1016/j.bbagen.2009.09.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 574GP
UT WOS:000275977700008
PM 19747960
DA 2024-11-01
ER

PT J
AU Ali, N
   Woodward, CE
   Sweeney, M
   Phadke, R
   Holton, JL
   Acheson, J
   Plant, GT
   Bremner, FD
AF Ali, Nadeem
   Woodward, Catherine E.
   Sweeney, Mary
   Phadke, Rahul
   Holton, Janice L.
   Acheson, James
   Plant, Gordon T.
   Bremner, Fion D.
TI Pupillary Dysfunction in an Atypical Case of Mitochondrial Myopathy With Tubular Aggregates
SO JOURNAL OF NEURO-OPHTHALMOLOGY
LA English
DT Article
ID abnormal pupils
AB A 62-year-old man presented with diplopia, ocular ductional deficits, and sluggish pupils. Pupillometry demonstrated large hyporeactive pupils with no evidence of damage to the sympathetic or parasympathetic innervation, indicating a myopathy of the iris musculature. A single large deletion in mitochondrial DNA and characteristic histochemical features on muscle biopsy suggested a mitochondrial cytopathy. However, ultrastructural examination of skeletal muscle fibers showed tubular aggregates (TAs), a finding not reported in mitochondrial cytopathy. The combination of pupillary abnormalities and TAs suggests that mitochondrial dysfunction may not explain the full extent of abnormalities in this case.
C1 [Ali, Nadeem; Acheson, James; Plant, Gordon T.; Bremner, Fion D.] Natl Hosp Neurol & Neurosurg, Dept Neuroophthalmol, London WC1N 3BG, England.
   [Woodward, Catherine E.; Sweeney, Mary] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Phadke, Rahul; Holton, Janice L.] Natl Hosp Neurol & Neurosurg, Dept Neuropathol, London WC1N 3BG, England.
C3 University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Ali, N (corresponding author), Moorfields Eye Hosp, City Rd, London EC1V 2PD, England.
EM nadeem.ali@nhs.net
CR Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   Bremner F, 2006, J NEUROL NEUROSUR PS, V77, P1163, DOI 10.1136/jnnp.2006.092833
   Garrard P, 2002, J NEUROL NEUROSUR PS, V73, P207, DOI 10.1136/jnnp.73.2.207
   Jacques TS, 2002, J NEUROL NEUROSUR PS, V73, P324, DOI 10.1136/jnnp.73.3.324
   KLINE LB, 2003, NEUROOPHTHALMOLOGY R, V0, P0
   Loewenfeld IE, 1999, THE PUPIL: ANATOMY, V0, P0
   Miller N, 1998, WALSH HOYTS CLIN NEU, V5th, P0
   Müller HD, 2001, ACTA NEUROPATHOL, V102, P27
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Shahrizaila N, 2004, NEUROLOGY, V63, P1111, DOI 10.1212/01.WNL.0000138575.14424.5F
NR 14
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1070-8022
EI 
J9 J NEURO-OPHTHALMOL
JI J. Neuro-Ophthal.
PD JUN 15
PY 2010
VL 30
IS 2
BP 153
EP 156
DI 10.1097/WNO.0b013e3181dbfdcd
PG 4
WC Clinical Neurology; Ophthalmology
SC Neurosciences & Neurology; Ophthalmology
GA 605UL
UT WOS:000278372400010
PM 20414131
DA 2024-11-01
ER

PT J
AU Sacconi, S
   Trevisson, E
   Salviati, L
   Aymé, S
   Rigal, O
   Redondo, AG
   Mancuso, M
   Siciliano, G
   Tonin, P
   Angelini, C
   Auré, K
   Lombès, A
   Desnuelle, C
AF Sacconi, Sabrina
   Trevisson, Eva
   Salviati, Leonardo
   Ayme, Segolene
   Rigal, Odile
   Garcia Redondo, Alberto
   Mancuso, Michelangelo
   Siciliano, Gabriele
   Tonin, Paola
   Angelini, Corrado
   Aure, Karine
   Lombes, Anne
   Desnuelle, Claude
TI Coenzyme Q<sub>10</sub> is frequently reduced in muscle of patients with mitochondrial myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Coenzyme Q(10); Myopathy; Mitochondrial disease; Treatment
ID cerebellar-ataxia; respiratory-chain; ubiquinone deficiency; coq(10) deficiency; encephalomyopathy; mutations; supplementation; nephropathy; aprataxin; diagnosis
AB Coenzyme Q(10) (CoQ(10)) deficiency has been associated with an increasing number of clinical phenotypes. Whereas primary CoQ(10) defects are related to mutations in lubiquinone biosynthetic genes, which are now being unraveled, and respond well to CoQ(10) Supplementation. the etiologies, and clinical phenotypes related to secondary deficiencies are largely unknown. The purpose of this multicenter Study was to evaluate the frequency of muscle CoQ(10) deficiency in a cohort of 76 patients presenting with clinically heterogeneous mitochondrial phenotypes which included myopathy among their clinical features. A reliable diagnostic tool based oil HPLC quantification was employed to measure muscle CoQ(10) levels. A significant proportion of these patients (28 over 76) displayed CoQ(10) deficiency that was clearly secondary in mile patients, who harbored a pathogenic mutation of mitochondrial DNA. This study provides a rationale for future therapeutic trials on the effect of CoQ(10) supplementation in patients with mitochondrial diseases presenting with myopathy among clinical features. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sacconi, Sabrina] CHU Nice Archet 1, Nice Hosp, UMR 6543, Ctr Reference Malad Neuromusculaires,CNRS,Fac Med, F-06202 Nice 3, France.
   [Trevisson, Eva; Salviati, Leonardo] Univ Padua, Dept Pediat, Genet Unit, I-35100 Padua, Italy.
   [Ayme, Segolene] INSERM SC 11, Paris, France.
   [Rigal, Odile] Hop Robert Debre, Serv Biochim, F-75019 Paris, France.
   [Garcia Redondo, Alberto] Univ Hosp, Ctr Invest, Madrid, Spain.
   [Mancuso, Michelangelo; Siciliano, Gabriele] Dept Neurol, Pisa, Italy.
   [Tonin, Paola] Policlin GB Rossi, Neurol Clin, Verona, Italy.
   [Angelini, Corrado] Univ Padua, Dept Neurosci, Padua, Italy.
   [Aure, Karine; Lombes, Anne] Univ Paris 06, AP HP, GH Pitie Salpetriere, INSERM U 582, F-75013 Paris, France.
C3 CHU Nice; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); University of Padua; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Sacconi, S (corresponding author), CHU Nice Archet 1, Nice Hosp, UMR 6543, Ctr Reference Malad Neuromusculaires,CNRS,Fac Med, BP 3079, F-06202 Nice 3, France.
EM sacconi@unice.fr
FU Telethon [GTB07001D, GGP09207]; Eurobiobank [QLRI-CT-2002-02769]
CR Aeby A, 2007, J INHERIT METAB DIS, V30, P827, DOI 10.1007/s10545-007-0612-0
   Benoist JF, 2003, CLIN CHIM ACTA, V329, P147, DOI 10.1016/S0009-8981(02)00423-0
   Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9
   Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   CRANE FL, 1993, CLIN INVESTIGATOR, V71, P0
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Fernández-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009
   FOLKERS K, 1985, P NATL ACAD SCI USA, V82, P901, DOI 10.1073/pnas.82.3.901
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Müller T, 2003, NEUROSCI LETT, V341, P201, DOI 10.1016/S0304-3940(03)00185-X
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
NR 32
TC 72
Z9 80
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JAN 15
PY 2010
VL 20
IS 1
BP 44
EP 48
DI 10.1016/j.nmd.2009.10.014
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 558UG
UT WOS:000274772600006
PM 19945282
DA 2024-11-01
ER

PT J
AU Mercer, JR
   Cheng, KK
   Figg, N
   Gorenne, I
   Mahmoudi, M
   Griffin, J
   Vidal-Puig, A
   Logan, A
   Murphy, MP
   Bennett, M
AF Mercer, John R.
   Cheng, Kian-Kai
   Figg, Nichola
   Gorenne, Isabelle
   Mahmoudi, Melli
   Griffin, Julian
   Vidal-Puig, Antonio
   Logan, Angela
   Murphy, Michael P.
   Bennett, Martin
TI DNA Damage Links Mitochondrial Dysfunction to Atherosclerosis and the Metabolic Syndrome
SO CIRCULATION RESEARCH
LA English
DT Article
DE atherosclerosis; mitochondria; DNA damage; metabolic syndrome
ID smooth-muscle-cells; ataxia-telangiectasia; atherogenesis; disease; repair; mice; suppression; senescence; apoptosis; breakage
AB Rationale: DNA damage is present in both genomic and mitochondrial DNA in atherosclerosis. However, whether DNA damage itself promotes atherosclerosis, or is simply a byproduct of the risk factors that promote atherosclerosis, is unknown. Objective: To examine the effect of DNA damage on atherosclerosis, we studied apolipoprotein (Apo)E-/- mice that were haploinsufficient for the protein kinase ATM (ataxia telangiectasia mutated), which coordinates DNA repair. Methods and Results: ATM(-/-)/ApoE(-/-) mice developed accelerated atherosclerosis and multiple features of the metabolic syndrome, including hypertension, hypercholesterolemia, obesity, steatohepatitis, and glucose intolerance. Transplantation with ATM(+/+) bone marrow attenuated atherosclerosis but not the metabolic syndrome. ATM(+/-) smooth muscle cells and macrophages showed increased nuclear DNA damage and defective DNA repair signaling, growth arrest, and apoptosis. Metabolomic screening of ATM(+/-)/ApoE(-/-) mouse tissues identified metabolic changes compatible with mitochondrial defects, with increased beta-hydroxybutyrate but reduced lactate, reduced glucose, and alterations in multiple lipid species. ATM(+/-)/ApoE(-/-) mouse tissues showed an increased frequency of a mouse mitochondrial "common" deletion equivalent and reduced mitochondrial oxidative phosphorylation. Conclusions: We propose that failure of DNA repair generates defects in cell proliferation, apoptosis, and mitochondrial dysfunction. This in turn leads to ketosis, hyperlipidemia, and increased fat storage, promoting atherosclerosis and the metabolic syndrome. Prevention of mitochondrial dysfunction may represent a novel target in cardiovascular disease. (Circ Res. 2010;107:1021-1031.)
C1 [Mercer, John R.; Figg, Nichola; Gorenne, Isabelle; Mahmoudi, Melli; Bennett, Martin] Univ Cambridge, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England.
   [Cheng, Kian-Kai; Griffin, Julian] Univ Cambridge, Dept Biochem, Addenbrookes Hosp, Cambridge CB2 2QQ, England.
   [Vidal-Puig, Antonio] Univ Cambridge, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 2QQ, England.
   [Logan, Angela; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital
RP Bennett, M (corresponding author), Univ Cambridge, Div Cardiovasc Med, Addenbrookes Hosp, Box 110, Cambridge CB2 2QQ, England.
EM mrb@mole.bio.cam.ac.uk
FU British Heart Foundation (BHF) [RG08/009/25841, PG/05/08]; Diabetes and Wellness Foundation; Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust [072829/Z/03/Z]; Medical Research Council (MRC); Hepadip grants; European Vascular Genomics Network; Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre; MRC [MC_U105663142, G0802051] Funding Source: UKRI
CR Ambrose M, 2007, HUM MOL GENET, V16, P2154, DOI 10.1093/hmg/ddm166
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Catalano D, 2006, BMC BIOINFORMATICS, V7, P0, DOI 10.1186/1471-2105-7-36
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Dani Maria Angela C, 2004, GENET MOL RES, V3, P395
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004
   Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835
   Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007
   KirschVolders M, 1997, MUTAT RES-GEN TOX EN, V392, P19, DOI 10.1016/S0165-1218(97)00042-6
   Lee JW, 2005, J BIOL CHEM, V280, P39627, DOI 10.1074/jbc.M506112200
   Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146
   Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143
   Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca
   Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, PE70, DOI 10.1152/ajpendo.00259.2006
   Muscari C, 1996, AGING-CLIN EXP RES, V8, P429, DOI 10.1007/BF03339606
   OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X
   Puddu GM, 2005, J BIOMED SCI, V12, P839, DOI 10.1007/s11373-005-9024-z
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00
   Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200
NR 32
TC 190
Z9 211
U1 0
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD OCT 15
PY 2010
VL 107
IS 8
BP 1021
EP U159
DI 10.1161/CIRCRESAHA.110.218966
PG 19
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Hematology
GA 664MM
UT WOS:000282965300011
PM 20705925
DA 2024-11-01
ER

PT J
AU Berardo, A
   Çoku, J
   Kurt, B
   DiMauro, S
   Hirano, M
AF Berardo, Andres
   Coku, Jorida
   Kurt, Bulent
   DiMauro, Salvatore
   Hirano, Michio
TI A novel mutation in the tRNA<SUP>Ile</SUP> gene (<i>MTTI</i>) affecting the variable loop in a patient with chronic progressive external ophthalmoplegia (CPEO)
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA (mtDNA); Point mutation; tRNA(Ile); Chronic progressive external ophthalmoplegia (CPEO)
ID muscle mitochondrial-dna; point mutation; cardiomyopathy; deletions; encephalomyopathy; myopathy
AB We describe a 62-year-old woman with chronic progressive external ophthalmoplegia (CPEO), multiple lipomas, diabetes mellitus, and a novel mitochondrial DNA (mtDNA) mutation at nucleotide 4302 (4302A > G) of the tRNA(Ile) gene (MTTI). This is the first mutation at position 44 in the variable loop (V loop) of any mitochondrial tRNA. The muscle biopsy revealed 10% ragged-red/ragged-blue fibers and 25% cytochrome c oxidase (COX)deficient fibers. No deletions or duplications were detected by Southern blot analysis. The 4302A > G transition was present only in the patient's muscle and single-fiber analysis revealed significantly higher levels of the mutation in COX-deficient than in normal fibers. Like tRNA(Leu(UUR)), tRNA(Ile) appears to be a "hot spot" for mtDNA mutations causing CPEO. (c) 2010 Elsevier B.V. All rights reserved.
C1 [Berardo, Andres; Coku, Jorida; Kurt, Bulent; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NIH [HD32062]; Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF)
CR BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dirheimer G, 1995, P93, V0, P0
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7
   HART PE, 2002, MITOCHONDRIAL DISORD, V2, P235
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   ITO T, 1992, JPN CIRC J, V56, P1045, DOI 10.1253/jcj.56.1045
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Negro R, 2009, NEUROMUSCULAR DISORD, V19, P423, DOI 10.1016/j.nmd.2009.04.008
   SANAKER PS, 2009, ACTA NEUROL SCAND, V0, P0
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Smits BW, 2007, J NEUROL, V254, P1614, DOI 10.1007/s00415-007-0608-6
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
NR 22
TC 11
Z9 12
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAR 15
PY 2010
VL 20
IS 3
BP 204
EP 206
DI 10.1016/j.nmd.2010.01.006
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 584NK
UT WOS:000276759100009
PM 20149659
DA 2024-11-01
ER

PT J
AU Duchen, MR
   Szabadkai, G
AF Duchen, Michael R.
   Szabadkai, Gyorgy
TI Roles of mitochondria in human disease
SO ESSAYS IN BIOCHEMISTRY: MITOCHONDRIAL FUNCTION
LA English
DT Review; Book Chapter
ID permeability transition pore; pancreatic beta-cells; oxidative stress; dna mutations; cyclophilin-d; nitric-oxide; parkinsons-disease; muscle apoptosis; cancer-cells; down-regulation
AB The chapters throughout this volume illustrate the many contributions of mitochondria to the maintenance of normal cell and tissue function, experienced as the health of the individual. Mitochondria are essential for maintaining aspects of physiology as fundamental as cellular energy balance, the modulation of calcium signalling, in defining cellular redox balance, and they house significant biosynthetic pathways. Mitochondrial numbers and volume within cells are regulated and have an impact on their functional roles, while, especially in the CNS (central nervous system), mitochondrial trafficking is critical to ensure the cellular distribution and strategic localization of mitochondria, presumably driven by local energy demand. Maintenance of a healthy mitochondrial population involves a complex system of quality control, involving degrading misfolded proteins, while damaged mitochondria are renewed by fusion or removed by autophagy It seems evident that mechanisms that impair any of these processes will impair mitochondrial function and cell signalling pathways, leading to disordered cell function which manifests as disease. As gatekeepers of cell life and cell death, mitochondria regulate both apoptotic and necrotic cell death, and so at its most extreme, disturbances involving these pathways may trigger untimely cell death. Conversely, the lack of appropriate cell death can lead to inappropriate tissue growth and development of tumours, which are also characterized by altered mitochondrial metabolism. The centrality of mitochondrial dysfunction to a surprisingly wide range of major human diseases is slowly becoming recognized, bringing with it the prospect of novel therapeutic approaches to treat a multitude of unpleasant and pervasive diseases.
C1 [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.
   UCL, Consortium Mitochondrial Res, London WC1E 6BT, England.
C3 University of London; University College London; University of London; University College London
RP Duchen, MR (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.
FU Medical Research Council [MC_G1000735, G0601943] Funding Source: Medline; Parkinson&apos;s UK [G-0905] Funding Source: Medline; Wellcome Trust [089698] Funding Source: Medline; MRC [G0601943, MC_G1000735] Funding Source: UKRI
CR Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017
   Anoopkumar-Dukie S, 2009, BRIT J RADIOL, V82, P847, DOI 10.1259/bjr/35746067
   Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200
   Beltrán B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602
   Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127
   Bernardi P, 2009, BRAIN, V132, P0, DOI 10.1093/brain/awp021
   Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x
   Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017
   Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022
   Büeler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006
   Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001
   Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006
   Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023
   Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4
   Casley CS, 2002, NEUROBIOL DIS, V10, P258, DOI 10.1006/nbdi.2002.0516
   Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011
   Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892
   CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129
   Crichton PG, 2010, BIOSCIENCE REP, V30, P187, DOI 10.1042/BSR20090063
   Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8
   Da Cruz S, 2005, EXPERT REV PROTEOMIC, V2, P541, DOI 10.1586/14789450.2.4.541
   De Marchi U, 2009, BBA-BIOENERGETICS, V1787, P1425, DOI 10.1016/j.bbabio.2009.06.002
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   Deocaris C, 2008, BIOGERONTOLOGY, V9, P391, DOI 10.1007/s10522-008-9174-2
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790
   Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170
   Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0
   Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006
   Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104
   Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970
   Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104
   Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28
   Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x
   Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006
   Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0
   Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2
   Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986
   Grover GJ, 2008, CARDIOVASC THER, V26, P287, DOI 10.1111/j.1755-5922.2008.00065.x
   Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hicks D, 2009, BRAIN, V132, P147, DOI 10.1093/brain/awn289
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052
   Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509
   Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187
   King A, 2009, CURR OPIN CELL BIOL, V21, P885, DOI 10.1016/j.ceb.2009.09.009
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lacza Z, 2006, NITRIC OXIDE-BIOL CH, V14, P162, DOI 10.1016/j.niox.2005.05.011
   Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200
   Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006
   Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441
   Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108
   Mukheriee R, 2008, CELL CALCIUM, V44, P14, DOI 10.1016/j.ceca.2007.11.013
   Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327
   Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689
   Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P41271, DOI 10.1074/jbc.C400360200
   Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126
   Pan T, 2008, MED PHYS, V35, P4955, DOI 10.1118/1.2986145
   Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3
   Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993
   Rück A, 1998, FEBS LETT, V426, P97, DOI 10.1016/S0014-5793(98)00317-2
   Rugarli EI, 2006, TRENDS MOL MED, V12, P262, DOI 10.1016/j.molmed.2006.04.002
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/endo.141.6.7523
   Santos C, 2008, CURR TOP MED CHEM, V8, P1351, DOI 10.2174/156802608786141151
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102
   Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015
   Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0
   Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5
   Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634
   Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tatsuta T, 2009, J BIOCHEM, V146, P455, DOI 10.1093/jb/mvp122
   Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628
   Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070
   THEAUTHORS J, 2010, SOCIETY, V0, P0
   Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x
   Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Wallace DC, 2007, EMERY AND RIMOINS PRINCIPLES AND PRACTICE OF MEDICAL GENETICS, V5th, P194
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   WARBURG O, 1956, SCIENCE, V124, P269
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004
   Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004
   Wood-Kaczmar A, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002455
   Yaguchi T, 2007, ANN NY ACAD SCI, V1100, P306, DOI 10.1196/annals.1395.032
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 151
TC 131
Z9 141
U1 0
U2 36
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0071-1365
EI 1744-1358
J9 ESSAYS BIOCHEM
JI Essays Biochem.
PD JUN 15
PY 2010
VL 47
IS 
BP 115
EP 137
DI 10.1042/BSE0470115
PG 23
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BPO66
UT WOS:000279550900008
PM 20533904
DA 2024-11-01
ER

PT J
AU Bailey, CM
   Anderson, KS
AF Bailey, Christopher M.
   Anderson, Karen S.
TI A mechanistic view of human mitochondrial DNA polymerase γ: Providing insight into drug toxicity and mitochondrial disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Review
DE DNA polymerase gamma; Mitochondrial genome; Nucleoside analog toxicity; Progressive external ophthalmoplegia; Pre-steady-state kinetics
ID deoxyribonucleic-acid polymerase; transfer-rna synthetases; chronic hepatitis-b; accessory subunit; reverse-transcriptase; multiple deletions; nucleoside analog; antiretroviral therapy; catalytic subunit; crystal-structure
AB Mitochondrial DNA polymerase gamma (Pol gamma) is the sole polymerase responsible for replication of the mitochondrial genome. The study of human Pol gamma is of key importance to clinically relevant issues such as nucleoside analog toxicity and mitochondrial disorders such as progressive external ophthalmoplegia. The development of a recombinant form of the human Pol gamma holoenzyme provided an essential tool in understanding the mechanism of these clinically relevant phenomena using kinetic methodologies. This review will provide a brief history on the discovery and characterization of human mitochondrial DNA polymerase gamma, focusing on kinetic analyses of the polymerase and mechanistic data illustrating structure-function relationships to explain drug toxicity and mitochondrial disease. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Bailey, Christopher M.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.
C3 Yale University
RP Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.
EM karen.anderson@yale.edu
FU NIH [GM49551]
CR ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BRAHAMS D, 1994, LANCET, V343, P1494, DOI 10.1016/S0140-6736(94)92599-2
   BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787
   Carrodeguas JA, 2000, NUCLEIC ACIDS RES, V28, P1237, DOI 10.1093/nar/28.5.1237
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   CHAN SS, 2008, BIOCHIM BIOPHYS ACTA, V1787, P312
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   CHEN CH, 1991, MOL PHARMACOL, V39, P625
   CHERRINGTON JM, 1994, BIOCHEM PHARMACOL, V48, P1986, DOI 10.1016/0006-2952(94)90600-9
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   CHU CK, 1995, ANTIMICROB AGENTS CH, V39, P979, DOI 10.1128/AAC.39.4.979
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COLACINO JM, 1994, ANTIMICROB AGENTS CH, V38, P1997, DOI 10.1128/AAC.38.9.1997
   CUI LX, 1995, J CLIN INVEST, V95, P555, DOI 10.1172/JCI117698
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   EDENBERG HJ, 1978, J BIOL CHEM, V253, P3273
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Feng JY, 2001, J BIOL CHEM, V276, P23832, DOI 10.1074/jbc.M101156200
   Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004
   Feng JY, 1999, FASEB J, V13, P1511, DOI 10.1096/fasebj.13.12.1511
   Feng JY, 1999, BIOCHEMISTRY-US, V38, P55, DOI 10.1021/bi982340r
   Fowler JD, 2008, J BIOL CHEM, V283, P15339, DOI 10.1074/jbc.M800310200
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   FRY M, 1973, J BIOL CHEM, V248, P2678
   GEUSKENS M, 1981, NUCLEIC ACIDS RES, V9, P1599, DOI 10.1093/nar/9.7.1599
   GOODY RS, 1991, FEBS LETT, V291, P1, DOI 10.1016/0014-5793(91)81089-Q
   Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   GROVE KL, 1995, CANCER RES, V55, P3008
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hanes JW, 2007, J BIOL CHEM, V282, P25159, DOI 10.1074/jbc.M703972200
   HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   KALF GF, 1968, J BIOL CHEM, V243, P4904
   KEILBAUGH SA, 1991, BIOCHEM PHARMACOL, V42, PR5, DOI 10.1016/0006-2952(91)90672-R
   Kim BK, 2009, J HEPATOL, V51, P829, DOI 10.1016/j.jhep.2009.04.019
   KIM HO, 1992, TETRAHEDRON LETT, V33, P6899, DOI 10.1016/S0040-4039(00)60890-0
   KLECKER RW, 1994, MOL PHARMACOL, V46, P1204
   KNOPF KW, 1976, BIOCHEMISTRY-US, V15, P4540, DOI 10.1021/bi00665a032
   KUNKEL TA, 1988, J BIOL CHEM, V263, P4450
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Lee HR, 2007, J BIOL CHEM, V282, P31982, DOI 10.1074/jbc.M705392200
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   LEWIS W, 1994, BIOCHEMISTRY-US, V33, P14620, DOI 10.1021/bi00252a030
   Lewis W, 1996, P NATL ACAD SCI USA, V93, P3592, DOI 10.1073/pnas.93.8.3592
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702
   MEYER RR, 1968, P NATL ACAD SCI USA, V61, P130, DOI 10.1073/pnas.61.1.130
   Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   OLSON MW, 1995, J BIOL CHEM, V270, P28932, DOI 10.1074/jbc.270.48.28932
   OLSON MW, 1992, J BIOL CHEM, V267, P23136
   Pai SB, 1996, ANTIMICROB AGENTS CH, V40, P380, DOI 10.1128/AAC.40.2.380
   Parker WB, 1994, J. NATL. INST. HEALTH RES, V6, P57
   Pfeffer G, 2009, NEUROLOGY, V73, P71, DOI 10.1212/WNL.0b013e3181aae814
   Pinz KG, 2000, J BIOL CHEM, V275, P12509, DOI 10.1074/jbc.275.17.12509
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   STARNES MC, 1987, J BIOL CHEM, V262, P988
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   TABOR S, 1987, J BIOL CHEM, V262, P16212
   TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339
   Tak WY, 2009, HEPATOL RES, V39, P944, DOI 10.1111/j.1872-034X.2009.00515.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VANDERVLIET PC, 1981, BIOCHEMISTRY-US, V20, P2628, DOI 10.1021/bi00512a041
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yao GQ, 1996, BIOCHEM PHARMACOL, V51, P941, DOI 10.1016/0006-2952(96)00049-4
   YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZIMMERMANN W, 1980, J BIOL CHEM, V255, P1847
NR 120
TC 20
Z9 29
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD MAY 15
PY 2010
VL 1804
IS 5
BP 1213
EP 1222
DI 10.1016/j.bbapap.2010.01.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 584YB
UT WOS:000276789300016
PM 20083238
DA 2024-11-01
ER

PT J
AU Saneto, RP
   Naviaux, RK
AF Saneto, Russell P.
   Naviaux, Robert K.
TI POLYMERASE GAMMA DISEASE THROUGH THE AGES
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE polymerase gamma; mitochondrial disease; gene mutation; DNA; genetic inheritance; POLG spectrum disorders
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; sensory ataxic neuropathy; alpers-huttenlocher-syndrome; polg mutations; neuronal degeneration; autosomal-dominant; w748s mutation; reverse-transcriptase; genetic features
AB The most common group of mitochondrial disease is due to mutations within the mitochondrial DNA polymerase, polymerase gamma 1 (POLG). This gene product is responsible for replication and repair of the small mitochondrial DNA genome. The structure-function relationship of this gene product produces a wide variety of diseases that at times, seems to defy the common perceptions of genetics. The unique features of mitochondrial physiology are in part responsible, but POLG structure and function add to the conundrum of how one gene product can demonstrate autosomal recessive and autosomal dominant transmission, while also being responsible for pharmacogenetic disease, and exhibiting strong gene-environment interactions. The wide spectrum of clinical manifestations of POLG disease can arise from infancy to old age. The modulation of clinical findings relate in part to the molecular architecture of the POLG protein. POLG has three distinct molecular domains: exonuclease, linker, and polymerase domains. Most of the mutations leading to dominant forms of POLG disease are located in the Polymerase domain. Mutations leading to recessive inheritance are distributed in all three domains of the gene. Environmental factors like valproic acid and infection can unmask POLG disease, causing it to occur earlier in life than when not exposed to these factors. Other drugs like nucleoside reverse transcriptase inhibitors can produce genotype-specific POLG pharmacogenetic disease. Our current state of POLG understanding cannot account for many features of POLG disease. There is no answer for why the same mutation can give rise to varying diseases, disease severity, and age of onset. We introduce the term Ecogenetics in the context these features of POLG disease, to emphasize the important interactions between genes and environment in determining the expression of mitochondrial disease. In this article, we identify some of the key features that will help the reader understand POLG pathophysiology. When possible, we also identify genotype-phenotype relationships, give clues for diagnosis, and summarize the major clinical phenotypes in the spectrum of POLG disease presenting from birth to old age. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:163-174.
C1 [Saneto, Russell P.] Univ Washington, Seattle Children Hosp, Div Pediat Neurol, Seattle, WA 98105 USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
C3 Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego
RP Saneto, RP (corresponding author), Univ Washington, Seattle Children Hosp, Div Pediat Neurol, Mail Stop B-5552,4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
CR Aitken H, 2009, NEUROLOGY, V72, PE86, DOI 10.1212/WNL.0b013e3181a411b8
   Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brusco A, 2006, J ENDOCRINOL INVEST, V29, P1
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   GALLO RC, 1971, ACTA HAEMATOL-BASEL, V45, P136, DOI 10.1159/000208619
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gramstad A, 2009, EPILEPSY BEHAV, V16, P172, DOI 10.1016/j.yebeh.2009.01.014
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   KALF GF, 1968, J BIOL CHEM, V243, P4904
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   LEE HR, 2006, J BIOL CHEM, V276, P38090
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Malyarchuk BA, 2005, HUM BIOL, V77, P355, DOI 10.1353/hub.2005.0050
   MEYER RR, 1968, P NATL ACAD SCI USA, V61, P130, DOI 10.1073/pnas.61.1.130
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Naviaux RK, 1996, ANN NEUROL, V40, P29
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nowak R, 2005, ANN ONCOL, V16, P1211, DOI 10.1093/annonc/mdi205
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rubio-Gozalbo ME, 2000, HUM MUTAT, V15, P522, DOI 10.1002/1098-1004(200006)15:6<522::AID-HUMU4>3.0.CO;2-Y
   Sanderson S, 2006, ARCH DIS CHILD, V91, P896, DOI 10.1136/adc.2005.091637
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.1177/088307380101600214
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   TULINIUS MH, 1991, BRAIN DEV-JPN, V13, P167, DOI 10.1016/S0387-7604(12)80024-6
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Ulmer S, 2002, J COMPUT ASSIST TOMO, V26, P641, DOI 10.1097/00004728-200207000-00030
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   WEISSBACH A, 1975, SCIENCE, V190, P401, DOI 10.1126/science.1179222
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 117
TC 61
Z9 67
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PD JUN 15
PY 2010
VL 16
IS 2
BP 163
EP 174
DI 10.1002/ddrr.105
PG 12
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100009
PM 20818731
DA 2024-11-01
ER

PT J
AU Ma, YN
   Fang, F
   Cao, YY
   Yang, YL
   Zou, LP
   Zhang, Y
   Wang, ST
   Zhu, SN
   Xu, YF
   Pei, P
   Qi, Y
AF Ma, Yinan
   Fang, Fang
   Cao, Yanyan
   Yang, Yanling
   Zou, Liping
   Zhang, Ying
   Wang, Songtao
   Zhu, Sainan
   Xu, Yufeng
   Pei, Pei
   Qi, Yu
TI Clinical features of mitochondrial DNA m.3243A&gt;G mutation in 47 Chinese families
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrion; m.3243A > G mutation; MELAS; Urine; Family; China
ID lactic-acidosis; melas mutation; episodes melas; disease; encephalopathy; a3243g; presentations; phenotype; myopathy; cells
AB m.3243A>G mutation in mitochondrial DNA is the most common pathogenic point mutation, causing a variety of phenotypes. To further elucidate its clinical characteristics, we recruited 47 Chinese families carrying m.3243A>G mutation and analyzed their symptoms, disease history, inheritance, and mitochondria-related complications. In the probands, lactic acidosis, myopathy, seizures, short stature, weight loss and hirsutism were the most common clinical features. In their mothers, lactic acidosis, exercise intolerance, short stature and weight loss were the frequent manifestations, and normal phenotype was found in 59.6% mothers. m.3243A>G mutation was detected in 47 probands and 42 mothers. In the probands, the mutation ratio in blood was threefold higher and the ratio in urine was twofold higher than those of their mothers. m.3243A>G mutation ratio in mothers' urine and in their probands' blood were weakly correlated. In conclusion, (a) stroke-like episode induced by m.3243A>G mutation may be the symptom predominantly found in older patients; (b) m.3243A>G mutation ratio correlates with the severity of the disease; (c) m.3243A>G mutation ratio in mothers' urine may correlate to the ratio in blood in their offspring. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Ma, Yinan; Cao, Yanyan; Zhang, Ying; Wang, Songtao; Xu, Yufeng; Pei, Pei; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China.
   [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China.
   [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
   [Zou, Liping] Gen Hosp Peoples Liberat Army, Dept Pediat, Beijing 100853, Peoples R China.
   [Zhu, Sainan] Peking Univ, Hosp 1, Dept Stat, Beijing 100034, Peoples R China.
C3 Peking University; Capital Medical University; Peking University; Peking University
RP Qi, Y (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 Xishiku St, Beijing 100034, Peoples R China.
EM qiyu0724@yahoo.com
FU National Natural Science Foundation of China [30700912]; Peking University First Hospital
CR Asano T, 1999, DIABETOLOGIA, V42, P1439
   BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Gropman AL, 2004, MITOCHONDRION, V4, P503, DOI 10.1016/j.mito.2004.07.009
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
NR 20
TC 18
Z9 20
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2010
VL 291
IS 1-2
BP 17
EP 21
DI 10.1016/j.jns.2010.01.012
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 582UG
UT WOS:000276624200004
PM 20149394
DA 2024-11-01
ER

PT J
AU Friedman, SD
   Shaw, DWW
   Ishak, G
   Gropman, AL
   Saneto, RP
AF Friedman, Seth D.
   Shaw, Dennis W. W.
   Ishak, Gisele
   Gropman, Andrea L.
   Saneto, Russell P.
TI THE USE OF NEUROIMAGING IN THE DIAGNOSIS OF MITOCHONDRIAL DISEASE
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE lactate; magnetic resonance imaging (MRI); magnetic resonance spectroscopy (MRS); mitochondiral disease
ID magnetic-resonance-spectroscopy; complex-i deficiency; respiratory-chain disorders; proton mr spectroscopy; alpers-huttenlocher-syndrome; stroke-like episodes; leigh-syndrome; lactic-acidosis; brain mri; neurogastrointestinal encephalomyopathy
AB Mutations in nuclear and mitochondrial DNA impacting mitochondrial function result in disease manifestations ranging from early death to abnormalities in all major organ systems and to symptoms that can be largely confined to muscle fatigue. The definitive diagnosis of a mitochondrial disorder can be difficult to establish. When the constellation of symptoms is suggestive of mitochondrial disease, neuroimaging features may be diagnostic and suggestive, can help direct further workup, and can help to further characterize the underlying brain abnormalities. Magnetic resonance imaging changes may be nonspecific, such as atrophy (both general and involving specific structures, such as cerebellum), more suggestive of particular disorders such as focal and often bilateral lesions confined to deep brain nuclei, or clearly characteristic of a given disorder such as stroke-like lesions that do not respect vascular boundaries in mitochondria! myopathy, encephalopathy, lactic acidosis, and stroke-like episode (MELAS). White matter hyperintensities with or without associated gray matter involvement may also be observed. Across patients and discrete disease subtypes (e.g., MELAS, Leigh syndrome, etc.), patterns of these features are helpful for diagnosis. However, it is also true that marked variability in expression occurs in all mitochondrial disease subtypes, illustrative of the complexity of the disease process. The present review summarizes the role of neuroimaging in the diagnosis and characterization of patients with suspected mitochondrial disease. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:129-135.
C1 [Friedman, Seth D.; Shaw, Dennis W. W.; Ishak, Gisele] Univ Washington, Seattle Childrens Hosp, Div Radiol, Seattle, WA 98105 USA.
   [Gropman, Andrea L.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA.
   [Saneto, Russell P.] Univ Washington, Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA.
C3 University of Washington; University of Washington Seattle; Seattle Children's Hospital; Children's National Health System; Seattle Children's Hospital; University of Washington; University of Washington Seattle
RP Saneto, RP (corresponding author), Univ Washington, Seattle Childrens Hosp, Div Radiol, Mail Stop B-5552,4800 Sand Point Way,NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   ANTOZZI C, 1995, J NEUROL SCI, V129, P152, DOI 10.1016/0022-510X(94)00267-R
   Apostolova LG, 2005, ARCH NEUROL-CHICAGO, V62, P1154, DOI 10.1001/archneur.62.7.1154
   Barbiroli B, 1997, CELL MOL BIOL, V43, P741
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Boddaert N, 2008, MOL GENET METAB, V93, P85, DOI 10.1016/j.ymgme.2007.09.003
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Burgeois M, 1992, BRAIN DEV, V14, P404
   Cassandrini D, 2006, J CHILD NEUROL, V21, P983, DOI 10.1177/08830738060210111001
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Castro-Gago M, 1999, REV NEUROLOGIA, V29, P912, DOI 10.33588/rn.2910.99062
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Choi C, 2000, YONSEI MED J, V41, P676, DOI 10.3349/ymj.2000.41.5.676
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feng Feng, 2006, CHINESE MEDICAL SCIENCES JOURNAL, V21, P234
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P143, DOI 10.1017/S0317167100006508
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Goto Tamako, 2002, NIHON RINSHO, V60 Suppl 4, P236
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HATTEN HP, 1991, PEDIATR RADIOL, V21, P477, DOI 10.1007/BF02011716
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Isobe T, 2007, AUSTRALAS RADIOL, V51, P330, DOI 10.1111/j.1440-1673.2007.01745.x
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Jiang YW, 2002, J CHILD NEUROL, V17, P450, DOI 10.1177/088307380201700611
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kim JT, 2009, ACTA PAEDIATR, V98, P1825, DOI 10.1111/j.1651-2227.2009.01428.x
   Kimura S, 1997, BRAIN DEV-JPN, V19, P535, DOI 10.1016/S0387-7604(97)00074-0
   Kingsley PB, 2006, NMR BIOMED, V19, P435, DOI 10.1002/nbm.1039
   Kowalchuk JM, 2000, J APPL PHYSIOL, V89, P200, DOI 10.1152/jappl.2000.89.1.200
   Kumakura A, 2009, PEDIATR NEUROL, V41, P309, DOI 10.1016/j.pediatrneurol.2009.04.028
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Lin DDM, 2003, AM J NEURORADIOL, V24, P33
   Lincke CR, 1996, NEUROPEDIATRICS, V27, P216, DOI 10.1055/s-2007-973792
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Maricich SM, 2007, AM J NEURORADIOL, V28, P1602, DOI 10.3174/ajnr.A0602
   MATTHEWS PM, 1991, NEUROLOGY, V41, P1043, DOI 10.1212/WNL.41.7.1043
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Muñoz A, 1999, NEURORADIOLOGY, V41, P920
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Rohrbach M, 2009, FETAL DIAGN THER, V25, P177, DOI 10.1159/000209385
   Saitoh S, 1998, NEUROLOGY, V50, P531, DOI 10.1212/WNL.50.2.531
   Saneto RP, 2001, NEUROLOGY, V56, P0
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2006, J CHILD NEUROL, V21, P77, DOI 10.1177/08830738060210010601
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Takanashi J, 2003, AM J NEURORADIOL, V24, P1184
   Takanashi J, 1997, J NEUROL SCI, V145, P83, DOI 10.1016/S0022-510X(96)00248-1
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Timothy J, 2009, J CHILD NEUROL, V24, P1296, DOI 10.1177/0883073809333543
   TOSCANO A, 1995, J NEUROL, V242, P203, DOI 10.1007/BF00919592
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Weinstock A, 2002, J CHILD NEUROL, V17, P47, DOI 10.1177/088307380201700112
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Wolf NI, 2003, NEUROPEDIATRICS, V34, P156
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
   Yis U, 2009, EUR J PAEDIATR NEURO, V13, P550, DOI 10.1016/j.ejpn.2008.10.009
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Zafeiriou DI, 2008, NEUROPEDIATRICS, V39, P172, DOI 10.1055/s-0028-1093336
NR 91
TC 41
Z9 43
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PD JUN 15
PY 2010
VL 16
IS 2
BP 129
EP 135
DI 10.1002/ddrr.103
PG 7
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100005
PM 20818727
DA 2024-11-01
ER

PT J
AU Aniko, G
   Komlosi, K
   Anita, M
   Pentelenyi, K
   Remenyi, V
   Csaba, O
   Valikovics, A
   Peter, D
   Daniel, B
   Melegh, B
   Molnár, MJ
AF Aniko Gal
   Komlosi, Katalin
   Anita Maasz
   Pentelenyi, Klara
   Remenyi, Viktoria
   Csaba Ovary
   Valikovics, Attila
   Peter Dioszeghy
   Daniel Bereczki
   Melegh, Bela
   Molnar, Maria Judit
TI Analysis of mtDNA A3243G mutation frequency in Hungary
SO CENTRAL EUROPEAN JOURNAL OF MEDICINE
LA English
DT Article
DE Mitochondrial encephalomyopathy; Epidemiology; mtDNA; A3243G
ID type-2 diabetes-mellitus; progressive external ophthalmoplegia; mitochondrial-dna mutations; clinical-features; chinese patients; melas mutation; position 3243; gene; prevalence; population
AB The A3243G mutation in the mitochondrial tRNA(Leu (UUR)) gene is one of the most common causes of mitochondrial DNA related disorders. Originally it was described in MELAS syndrome (Mitochondrial Encephalomyopathy, Lactic acidosis, Stroke-like episodes), later it had been found to be associated with various phenotypes. In our study the mutation frequency of the A3243G mtDNA mutation was investigated in patients with maternal sensoneural hearing loss, stroke-like episodes, ataxia and myopathy with undetermined etiology. We screened 631 Hungarian patients in North-East, South-West and Central Hungary between 1999 and 2008 for this mutation. The mtDNA analysis was performed from blood and/or muscle tissue. The A3243G substitution was present in 6 patients in heteroplasmic form. The segregation analysis detected 8 further cases. The frequency of the A3243G mutation was 2.22% in the investigated patients. The A3243G mutation frequency in Hungary does not differ significantly from other countries using similar patient selection criteria, however in Finland a higher mutation rate was found. In studies investigated the mutation frequency of this mutation in diabetes mellitus similarly wide variety was detected as well. We conclude that the study design has a huge impact on the result of the genetic epidemiological investigation analyzing the mutation frequency of the A3243G mutation due to the broad clinical phenotype and the different mutation load in different tissues.
C1 [Aniko Gal; Pentelenyi, Klara; Remenyi, Viktoria; Daniel Bereczki; Molnar, Maria Judit] Semmelweis Univ, Dept Neurol, Ctr Mol Neurol, H-1083 Budapest, Hungary.
   [Komlosi, Katalin; Anita Maasz; Melegh, Bela] Univ Pecs, Dept Med Genet, H-7624 Pecs, Hungary.
   [Csaba Ovary] Natl Inst Neurosurg, Natl Stroke Ctr, H-1145 Budapest, Hungary.
   [Valikovics, Attila] Borsod Abauj Zemplen Cty Hosp, Dept Neurol, H-3526 Miskolc, Hungary.
   [Peter Dioszeghy] Josa Andras Cty Hosp, Dept Neurol, H-4400 Nyiregyhaza, Hungary.
C3 Semmelweis University; University of Pecs
RP Molnár, MJ (corresponding author), Semmelweis Univ, Dept Neurol, Ctr Mol Neurol, H-1083 Budapest, Hungary.
EM molnarmj@neur.sote.hu
FU National Health [ETT 179/2003]
CR Abad MM, 1997, METABOLISM, V46, P445, DOI 10.1016/S0026-0495(97)90064-0
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Francisco G, 2005, DIABETES METAB, V31, P621, DOI 10.1016/S1262-3636(07)70240-9
   Gal Aniko, 2008, ORVOSI HETILAP, V149, P1593, DOI 10.1556/OH.2008.28398
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Klemm T, 2001, EXP CLIN ENDOCR DIAB, V109, P283, DOI 10.1055/s-2001-16348
   Komlósi K, 2005, PATHOL ONCOL RES, V11, P82, DOI 10.1007/BF02893371
   Komlosi Katalin, 2004, ORVOSI HETILAP, V145, P1805
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   Malecki M, 2001, MED SCI MONITOR, V7, P246
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Martin-Kleiner I, 2004, ACTA DIABETOL, V41, P179, DOI 10.1007/s00592-004-0163-x
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nagata H, 2001, J HUM GENET, V46, P595, DOI 10.1007/s100380170027
   Ng MCY, 2000, CLIN ENDOCRINOL, V52, P557, DOI 10.1046/j.1365-2265.2000.00989.x
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   Rodríguez-Hernández M, 2000, REV NEUROLOGIA, V30, P1001, DOI 10.33588/rn.3011.2000037
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Salles JEN, 2007, ARQ BRAS ENDOCRINOL, V51, P559, DOI 10.1590/S0004-27302007000400009
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V251, P883, DOI 10.1006/bbrc.1998.9553
   Turner LF, 1998, EUR HEART J, V19, P1725, DOI 10.1053/euhj.1998.1125
   Wang Cai-ling, 2009, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V26, P74, DOI 10.3760/cma.j.issn.1003-9406.2009.01.017
   Wang Zhao-xia, 2008, ZHONGHUA YI XUE ZA ZHI, V88, P3254
   Zhang Xiu-ying, 2004, ZHONGHUA YI XUE YI CHUAN XUE ZA ZHI, V21, P168
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
   Zhao Jing, 2006, YICHUAN, V28, P1206, DOI 10.1360/yc-006-1206
NR 35
TC 3
Z9 3
U1 0
U2 13
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 1895-1058
EI 1644-3640
J9 CENT EUR J MED
JI Cent. Eur. J. Med.
PD JUN 15
PY 2010
VL 5
IS 3
BP 322
EP 328
DI 10.2478/s11536-009-0118-2
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 581GF
UT WOS:000276508900009
DA 2024-11-01
ER

PT J
AU Smigrodzki, R
   Portell, FR
AF Smigrodzki, Rafal
   Portell, Francisco R.
TI Mitochondrial Manipulation as a Treatment for Aging
SO FUTURE OF AGING: PATHWAYS TO HUMAN LIFE EXTENSION
LA English
DT Article; Book Chapter
ID amyloid-beta-peptide; targeted restriction-endonuclease; electron-transport chain; substantia-nigra neurons; mtdna deletion mutations; human skeletal-muscle; affecting complex-i; alzheimers-disease; dna mutations; oxidative stress
C1 [Smigrodzki, Rafal; Portell, Francisco R.] Gencia Inc, Charlottesville, VA USA.
RP Smigrodzki, R (corresponding author), Gencia Inc, Charlottesville, VA USA.
EM rafal@genciabiotech.com; francisco@genciabiotech.com
CR Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005
   ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210
   Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhat HK, 2004, J BIOCHEM MOL TOXIC, V18, P180, DOI 10.1002/jbt.20024
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   Boddapati SV, 2005, J LIPOSOME RES, V15, P49, DOI 10.1081/LPR-200064958
   Bonnefoy Nathalie, 2007, METHODS MOL BIOL, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771
   Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7
   Cervin C, 2004, DIABETES, V53, P1894, DOI 10.2337/diabetes.53.7.1894
   Cetica P, 2002, REPRODUCTION, V124, P675, DOI 10.1530/rep.0.1240675
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   DSouza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Davidson Michael H, 2006, METABOLIC SYNDROME AND RELATED DISORDERS, V4, P299, DOI 10.1089/met.2006.4.299
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101
   Godinot C, 2007, J BIOENERG BIOMEMBR, V39, P235, DOI 10.1007/s10863-007-9088-8
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   GRASSO DG, 1991, EUR J BIOCHEM, V199, P203, DOI 10.1111/j.1432-1033.1991.tb16110.x
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hong WK, 2007, NEUROCHEM RES, V32, P1483, DOI 10.1007/s11064-007-9336-7
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Kato Y, 2002, DIABETIC MED, V19, P784, DOI 10.1046/j.1464-5491.2002.00777.x
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lee HC, 2007, MITOCHONDRION, V7, P157, DOI 10.1016/j.mito.2006.11.016
   Lee M, 2007, J DRUG TARGET, V15, P115, DOI 10.1080/10611860600953555
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821
   Maassen JA, 2007, CURR OPIN CLIN NUTR, V10, P693, DOI 10.1097/MCO.0b013e3282f0b774
   MARK RJ, 1995, J NEUROSCI, V15, P6239
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Mori M, 2004, BRAIN DEV-JPN, V26, P453, DOI 10.1016/j.braindev.2003.12.009
   Mott JL, 1999, ANN NY ACAD SCI, V893, P353, DOI 10.1111/j.1749-6632.1999.tb07853.x
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001
   Oliveira-Sales EB, 2008, AM J HYPERTENS, V21, P98, DOI 10.1038/ajh.2007.12
   Pak JW, 2004, ANN NY ACAD SCI, V1019, P289, DOI 10.1196/annals.1297.049
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Perna NT, 1996, CURR BIOL, V6, P128, DOI 10.1016/S0960-9822(02)00441-4
   Pineau B, 2005, J BIOL CHEM, V280, P25994, DOI 10.1074/jbc.M500508200
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Przybylowski M, 2007, VACCINE, V25, P5013, DOI 10.1016/j.vaccine.2007.04.077
   Puddu P, 2007, CLIN EXP HYPERTENS, V29, P427, DOI 10.1080/10641960701613852
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sayre Lawrence M, 2005, ANN IST SUPER SANITA, V41, P143
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Schoeler S, 2005, BIOCHEM BIOPH RES CO, V332, P43, DOI 10.1016/j.bbrc.2005.04.086
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172
   Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Sun FZ, 2003, AM J HUM GENET, V72, P1515, DOI 10.1086/375656
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trounce IA, 2007, CURR TOP DEV BIOL, V77, P157, DOI 10.1016/S0070-2153(06)77006-5
   Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2
   VAN GG, 2002, ACTA NEUROL BELG, V102, P39
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   Yang Q, 2007, J HYPERTENS, V25, P2067, DOI 10.1097/HJH.0b013e328285a36e
   Yechoor VK, 2004, P NATL ACAD SCI USA, V101, P16525, DOI 10.1073/pnas.0407574101
   Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228
   Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, PH302, DOI 10.1152/ajpheart.00661.2004
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 106
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 
EI 
J9 
PD JUN 15
PY 2010
VL 0
IS 
BP 521
EP 541
DI 10.1007/978-90-481-3999-6_16
PG 21
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA BRL24
UT WOS:000283007100016
DA 2024-11-01
ER

PT J
AU Tuppen, HAL
   Blakely, EL
   Turnbull, DM
   Taylor, RW
AF Tuppen, Helen A. L.
   Blakely, Emma L.
   Turnbull, Douglass M.
   Taylor, Robert W.
TI Mitochondrial DNA mutations and human disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE mtDNA; Mitochondrial disease; Molecular mechanism; Diagnosis; Treatment
ID progressive external ophthalmoplegia; ragged-red fibers; anticodon wobble nucleotide; transfer-rna synthetase; random genetic drift; complex-i; mtdna mutation; protein-synthesis; lactic-acidosis; oxidative-phosphorylation
AB Mitochondrial disorders are a group of clinically heterogeneous diseases, commonly defined by a lack of cellular energy due to oxidative phosphorylation (OXPHOS) defects. Since the identification of the first human pathological mitochondrial DNA (mtDNA) mutations in 1988, significant efforts have been spent in cataloguing the vast array of causative genetic defects of these disorders. Currently, more than 250 pathogenic mtDNA mutations have been identified. An ever-increasing number of nuclear DNA mutations are also being reported as the majority of proteins involved in mitochondrial metabolism and maintenance are nuclear-encoded. Understanding the phenotypic diversity and elucidating the molecular mechanisms at the basis of these diseases has however proved challenging. Progress has been hampered by the peculiar features of mitochondrial genetics, an inability to manipulate the mitochondrial genome, and difficulties in obtaining suitable models of disease. In this review, we will first outline the unique features of mitochondrial genetics before detailing the diseases and their genetic causes, focusing specifically on primary mtDNA genetic defects. The functional consequences of mtDNA mutations that have been characterised to date will also be discussed, along with current and potential future diagnostic and therapeutic advances. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Tuppen, Helen A. L.; Blakely, Emma L.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Wellcome Trust; Muscular Dystrophy Campaign and SPARKS charity; UK National Commissioning Group
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Annunen-Rasila J, 2007, PROTEOMICS, V7, P2189, DOI 10.1002/pmic.200601031
   Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Baranowska I, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000499
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bonnefond L, 2008, RNA, V14, P641, DOI 10.1261/rna.938108
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cízková A, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-38
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447
   Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   El Meziane A, 1998, NAT GENET, V18, P350
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GREAVES LC, 2009, BIOCH BIOPHYS ACTA, V0, P0
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601
   Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5
   Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jacobs LJAM, 2006, HUM REPROD UPDATE, V12, P119, DOI 10.1093/humupd/dmi042
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kerscher S, 2004, BBA-BIOENERGETICS, V1659, P197, DOI 10.1016/j.bbabio.2004.07.006
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, PC658, DOI 10.1152/ajpcell.00224.2006
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li J, 2008, GENET MOL RES, V7, P1054, DOI 10.4238/vol7-4gmr480
   LIAO HX, 1991, J BIOL CHEM, V266, P20714
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marella M, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001433
   MARGULIS L, 1971, SCI AM, V225, P49
   McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Michikawa Y, 1997, NUCLEIC ACIDS RES, V25, P2455, DOI 10.1093/nar/25.12.2455
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   *MITOMAP, 2009, HUM MIT GEN DAT, V0, P0
   Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   MORAES CT, 1995, MUSCLE NERVE, V0, PS150
   MORAIS R, 1988, IN VITRO CELL DEV B, V24, P649, DOI 10.1007/BF02623602
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nagaike T, 2008, BBA-GENE REGUL MECH, V1779, P266, DOI 10.1016/j.bbagrm.2008.02.001
   Naini A, 2007, METHOD CELL BIOL, V80, P437, DOI 10.1016/S0091-679X(06)80022-1
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   OBRIEN TW, 1977, INT CELL BIOL, V0, P0
   Oefner PJ, 1995, AMERICAN JOURNAL OF HUMAN GENETICS, V57, P0
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013
   Rohou H, 2001, YEAST, V18, P219, DOI 10.1002/1097-0061(200102)18:3<219::AID-YEA651>3.0.CO;2-C
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305
   Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santos C, 2008, CURR TOP MED CHEM, V8, P1351, DOI 10.2174/156802608786141151
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Scheffler IE, 2008, MITOCHONDRIA, V0, P1
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z
   Serero A, 2003, J BIOL CHEM, V278, P52953, DOI 10.1074/jbc.M309770200
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tryoen-Tóth P, 2003, J BIOL CHEM, V278, P24314, DOI 10.1074/jbc.M301530200
   Tuppen HAL, 2008, J MED GENET, V45, P55, DOI 10.1136/jmg.2007.051185
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, P0, DOI 10.1093/nar/28.20.e89
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vempati UD, 2008, METHODS, V46, P241, DOI 10.1016/j.ymeth.2008.09.008
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   VILKKI J, 1990, AM J HUM GENET, V47, P95
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Woriax VL, 1995, BBA-GENE STRUCT EXPR, V1264, P347, DOI 10.1016/0167-4781(95)00176-X
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Yagi T, 2001, J BIOENERG BIOMEMBR, V33, P233, DOI 10.1023/A:1010787004053
   Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 256
TC 453
Z9 518
U1 0
U2 75
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD FEB 15
PY 2010
VL 1797
IS 2
BP 113
EP 128
DI 10.1016/j.bbabio.2009.09.005
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 556FD
UT WOS:000274574200001
PM 19761752
DA 2024-11-01
ER

PT J
AU Debray, FG
   Lambert, M
   Allard, P
   Mitchell, GA
AF Debray, Francois-Guillaume
   Lambert, Marie
   Allard, Pierre
   Mitchell, Grant A.
TI Low Citrulline in Leigh Disease: Still a Biomarker of Maternally Inherited Leigh Syndrome
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Leigh syndrome; mitochondrial disease; lactic acidosis; amino acids; citrulline
ID mitochondrial-dna mutations; mtdna mutation; hypocitrullinaemia; t8993g
AB Two siblings presented with encephalopathy, lactic acidosis, and hypocitrullinemia. Muscle and liver biopsies were considered for respiratory chain studies, but because of hypocitrullinemia, molecular analysis for maternally inherited Leigh syndrome was first performed, revealing in both siblings the mitochondrial DNA T8993G mutation (95% heteroplasmy), allowing to avoid tissue biopsies. Hypocitrullinemia, an occasional finding in mitochondrial diseases, has been specifically associated with T8993G mutation. However, only few patients have been reported, and the prevalence of hypocitrullinemia in 8993 mitochondrial DNA mutations is unknown. In a small series of 16 Leigh syndrome patients, sensitivity and specificity of hypocitrullinemia (<= 12 mu mol/L) for 8993 mitochondrial DNA mutations were 66% and 85%, respectively. Although studies in larger cohorts are necessary, we suggest considering T8993G mutation early in the diagnostic evaluation of infantile mitochondrial diseases with hypocitrullinemia, which minimizes the need for invasive procedures associated with a small but nonnegligible risk of complications and incorrect diagnosis.
C1 [Debray, Francois-Guillaume] CHU Sart Tilman, Dept Human Genet, B-4000 Liege, Belgium.
   [Debray, Francois-Guillaume] Univ Liege, Liege, Belgium.
   [Lambert, Marie; Allard, Pierre; Mitchell, Grant A.] Univ Montreal, Dept Pediat, Div Med Genet, CHU St Justine, Montreal, PQ H3C 3J7, Canada.
C3 University of Liege; University of Liege; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine
RP Debray, FG (corresponding author), CHU Sart Tilman, Dept Human Genet, Domaine Univ Sart Tilman,Bat B35, B-4000 Liege, Belgium.
EM fg.debray@chu.ulg.ac.be
CR Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Vázquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 9
TC 16
Z9 17
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 
J9 J CHILD NEUROL
JI J. Child Neurol.
PD AUG 15
PY 2010
VL 25
IS 8
BP 1000
EP 1002
DI 10.1177/0883073809351983
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 625PS
UT WOS:000279908100009
PM 20472868
DA 2024-11-01
ER

PT J
AU Palin, EJH
   Lesonen, A
   Farr, CL
   Euro, L
   Suomalainen, A
   Kaguni, LS
AF Palin, Eino J. H.
   Lesonen, Annamari
   Farr, Carol L.
   Euro, Liliya
   Suomalainen, Anu
   Kaguni, Laurie S.
TI Functional analysis of <i>H-sapiens</i> DNA polymerase γ spacer mutation W748S with and without common variant E1143G
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE DNA polymerase gamma; POLG; POLG1; Ataxia; MIRAS; Alpers
ID progressive external ophthalmoplegia; onset spinocerebellar ataxia; autosomal recessive ataxia; polg mutations; accessory subunit; mtdna depletion; alpers-syndrome; disease; twinkle; mitochondria
AB Mitochondrial DNA polymerase, POLG, is the sole DNA polymerase found in animal mitochondria. In humans, POLG alpha W748S in cis with an E1143G mutation has been linked to a new type of recessive ataxia. MIRAS, which is the most common inherited ataxia in Finland. We investigated the biochemical phenotypes of the W748S amino acid change, using recombinant human POLG. We measured processive and non-processive DNA polymerase activity, DNA binding affinity, enzyme processivity, and subunit interaction with recombinant POLG beta. In addition, we studied the effects of the W748S and E1143G mutations in primary human cell cultures using retroviral transduction. Here, we examined cell viability, mitochondrial DNA copy number, and products of mitochondrial translation. Our results indicate that the W748S mutant POLGa does not exhibit a clear biochemical phenotype, making it indistinguishable from wild type POLG alpha and as such, fail to replicate previously published results. Furthermore, results from the cell models were concurrent with the findings from patients, and support our biochemical findings. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
   [Palin, Eino J. H.; Lesonen, Annamari; Euro, Liliya; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
C3 Michigan State University; Michigan State University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM lskaguni@msu.edu
FU National Institutes of Health [GM45295]; Helsinki Biomedical Graduate School; Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Helsinki
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wang YX, 1999, J BIOL CHEM, V274, P28972, DOI 10.1074/jbc.274.41.28972
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 34
TC 8
Z9 9
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 15
PY 2010
VL 1802
IS 6
BP 545
EP 551
DI 10.1016/j.bbadis.2010.02.003
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 605AZ
UT WOS:000278321000006
PM 20153822
DA 2024-11-01
ER

PT J
AU Mimaki, M
   Hatakeyama, H
   Komaki, H
   Yokoyama, M
   Arai, H
   Kirino, Y
   Suzuki, T
   Nishino, I
   Nonaka, I
   Goto, Y
AF Mimaki, Masakazu
   Hatakeyama, Hideyuki
   Komaki, Hirofumi
   Yokoyama, Mina
   Arai, Hidee
   Kirino, Yohei
   Suzuki, Tsutomu
   Nishino, Ichizo
   Nonaka, Ikuya
   Goto, Yu-ichi
TI Reversible Infantile Respiratory Chain Deficiency: A Clinical and Molecular Study
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID c-oxidase deficiency; mitochondrial myopathy; lactic-acidosis; mutations; encephalopathy; mtdna; association; failure; defect; gene
AB Objective: To character ze the clinical features and clarify the pathogenicity of "benign cytochrome c oxidase deficiency myopathy." Methods: The study included 8 patients with the phenotype of this disease. Six patients underwent muscle biopsies and all the 8 underwent mitochondrial DNA analyses. To confirm the pathogenicity of the detected mitochondrial DNA mutation, we performed northern blot analysis, using muscle specimens, and blue native polyacrylamide gel electrophoresis and respiratory chain enzyme activity assay of transmitochondrial cell lines (cybrids). Results: Clinical symptoms were limited to skeletal muscle and improved spontaneously in all cases; however, 2 siblings had basal ganglia lesions. In all patients, we identified a homoplasmic m.14674T>C or m.14674T>G mitochondrial transfer RNA-glutamate mutation. Northern blot analysis revealed decreased levels of mitochondrial transfer RNA-glutamate molecules. Muscle specimens and cybrids derived from patients showed decreased activity of respiratory complexes IV, and/or I, III; however, this was normal in naive myoblasts. Interpretation: Identification of a novel m.14674T>G mutation in addition to m.14674T>C indicated the importance of this site for disease causation. Analyses of cybrids revealed the pathogenicity of m.14674T>C mutation, which resulted in defects of cytochrome c oxidase and multiple respiratory chain enzymes. Furthermore, patients with basal ganglia lesions provided new insights into this disease, in which only skeletal muscle was thought to be affected. Normal respiratory chain enzyme activities in naive myoblasts suggested the compensatory influence of nuclear factors, which may be clue to understanding the mechanisms of spontaneous recovery and low penetrance in families carrying the mutation. ANN NEUROL 2010;68:845-854
C1 [Mimaki, Masakazu; Hatakeyama, Hideyuki; Komaki, Hirofumi; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan.
   [Komaki, Hirofumi; Yokoyama, Mina; Nonaka, Ikuya; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo 1878502, Japan.
   [Kirino, Yohei; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.
   [Arai, Hidee] Chiba Childrens Hosp, Dept Neurol, Chiba, Japan.
   [Nishino, Ichizo; Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; University of Tokyo; Chiba Children's Hospital; National Center for Neurology & Psychiatry - Japan
RP Goto, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
EM goto@ncnp.go.jp
FU Ministry of Health, Labour, and Welfare of Japan [15B-4, 18A-5]; Ministry of Education, Culture, Sports, Science and Technology [17790738]; Japan Health Sciences Foundation [KHD2207]; Grants-in-Aid for Scientific Research [17790738] Funding Source: KAKEN
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   DAurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025
   Goto YI, 1996, BIOCHEM BIOPH RES CO, V222, P215, DOI 10.1006/bbrc.1996.0724
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   JERUSALEM F, 1973, ARCH NEUROL-CHICAGO, V29, P162, DOI 10.1001/archneur.1973.00490270044007
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   NONAKA I, 1988, ACTA NEUROPATHOL, V77, P152
   OLDFORS A, 1989, ACTA NEUROPATHOL, V77, P267, DOI 10.1007/BF00687578
   Pallanck Leo, 1995, P371, V0, P0
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   SERVIDEI S, 1988, CLIN NEUROPATHOL, V7, P209
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   SUZUKI M, 1989, NO TO HATTATSU, V21, P543
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Wada Hiroko, 1996, NO TO HATTATSU, V28, P443
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   ZEVIANI M, 1987, NEUROLOGY, V37, P64, DOI 10.1212/WNL.37.1.64
NR 36
TC 28
Z9 32
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD DEC 15
PY 2010
VL 68
IS 6
BP 845
EP 854
DI 10.1002/ana.22111
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 703DE
UT WOS:000285953500012
PM 21194154
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Sitarz, KS
   Samuels, DC
   Griffiths, PG
   Reeve, AK
   Bindoff, LA
   Horvath, R
   Chinnery, PF
AF Yu-Wai-Man, Patrick
   Sitarz, Kamil S.
   Samuels, David C.
   Griffiths, Philip G.
   Reeve, Amy K.
   Bindoff, Laurence A.
   Horvath, Rita
   Chinnery, Patrick F.
TI <i>OPA1</i> mutations cause cytochrome <i>c</i> oxidase deficiency due to loss of wild-type mtDNA molecules
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID mitochondrial transcription factor; dominant optic atrophy; skeletal-muscle; factor-a; external ophthalmoplegia; dna mutations; apoptosis; expression; deletions; exercise
AB Pathogenic OPA1 mutations cause autosomal dominant optic atrophy (DOA),a condition characterized by the preferential loss of retinal ganglion cells and progressive optic nerve degeneration. Approximately 20% of affected patients will also develop more severe neuromuscular complications, an important disease subgroup known as DOA(+). Cytochrome c oxidase (COX)-negative fibres and multiple mitochondrial DNA (mtDNA) deletions have been identified in skeletal muscle biopsies from patients manifesting both the pure and syndromal variants, raising the possibility that the accumulation of somatic mtDNA defects contribute to the disease process. In this study, we investigated the mtDNA changes induced by OPA1 mutations in skeletal muscle biopsies from 15 patients with both pure DOA and DOA(+) phenotypes. We observed a 2-to 4-fold increase in mtDNA copy number at the single-fibre level, and patients with DOA(+) features had significantly greater mtDNA proliferation in their COX-negative skeletal muscle fibres compared with patients with isolated optic neuropathy. Low levels of wild-type mtDNA molecules were present in COX-deficient muscle fibres from both pure DOA and DOA(+) patients, implicating haplo-insufficiency as the mechanism responsible for the biochemical defect. Our findings are consistent with the 'maintenance of wild-type' hypothesis, the secondary mtDNA deletions induced by OPA1 mutations triggering a compensatory mitochondrial proliferative response in order to maintain an optimal level of wild-type mtDNA genomes. However, when deletion levels reach a critical level, further mitochondrial proliferation leads to replication of the mutant species at the expense of wild-type mtDNA, resulting in the loss of respiratory chain COX activity.
C1 [Yu-Wai-Man, Patrick; Sitarz, Kamil S.; Griffiths, Philip G.; Reeve, Amy K.; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick; Griffiths, Philip G.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Samuels, David C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN USA.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Chinnery, Patrick F.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Vanderbilt University; University of Bergen; University of Bergen; Haukeland University Hospital; Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
EM P.F.Chinnery@ncl.ac.uk
FU Clinical Research Fellowship [G0701386]; Parkinson's Disease Society (UK); Medical Research Council Translational Muscle Centre; UK NIHR Biomedical Research Centre in Ageing and Age related disease; NIH/NIGMS [R01GM073744]; Helse Vest (RHF); Norwegian Research Council; Academy of Medical Sciences; Deutsche Forschungsgemeinschaft [HO 2505/2-1]; Wellcome Trust; MRC [G0700718, G0701386] Funding Source: UKRI
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bengtsson J, 2001, PFLUG ARCH EUR J PHY, V443, P61, DOI 10.1007/s004240100628
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Davies V, 2006, EXP EYE RES, V83, P1003, DOI 10.1016/j.exer.2005.11.021
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JOHNSON MA, 1996, HDB MUSCLE DIS, V0, P61
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013
   LJUBICIC V, 2009, BIOCHIM BIOPHYS ACTA, V1800, P223, DOI 10.1111/J.1474-9726.2009.00483.X
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   Norrbom J, 2010, ACTA PHYSIOL, V198, P71, DOI 10.1111/j.1748-1716.2009.02030.x
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   YUWAIMAN P, 2010, OPHTHALMOLOGY 0422, V0, P0
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 46
TC 81
Z9 85
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 1
PY 2010
VL 19
IS 15
BP 3043
EP 3052
DI 10.1093/hmg/ddq209
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 633HA
UT WOS:000280491200011
PM 20484224
DA 2024-11-01
ER

PT J
AU García, E
   Macarrón, JL
   de la Maza, L
   Jiménez, S
   Cabello, A
   Martín, MA
   Ruíz, E
AF Garcia, Elena
   Macarron, Jesus Luis
   de la Maza, Laura
   Jimenez, Sara
   Cabello, Ana
   Martin, Miguel Angel
   Ruiz, Enrique
TI Diabetes and Mitochondrial Encephalomyopathy
SO ENDOCRINOLOGIST
LA English
DT Article
DE mitochondrial diabetes; sensorineural deafness; epilepsy; MELAS syndrome
ID stroke-like episodes; 3243a-greater-than-g mutation; oxidative stress; lactic-acidosis; dna mutation; mellitus; deafness; a3243g; damage; cells
AB The identification of patients with monogenic forms of diabetes is challenging. Nonetheless, the importance of identifying such individuals has been underscored by the different therapeutic and prognostic implications. The mutation m3243 A>G in the mitochondrial DNA tRNA(Leu)(UUR) gene has been found to be associated with the syndrome of maternally inherited diabetes and deafness. In the presence of higher levels of mutant mitochondrial DNA, the phenotypic presentation consists of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome and epilepsy. We report a family with mitochondrial diabetes and the mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome.
C1 [Garcia, Elena; de la Maza, Laura; Ruiz, Enrique] Dept Endocrinol, Burgos, Spain.
   [Macarron, Jesus Luis] Dept Neurol, Burgos, Spain.
   [Jimenez, Sara; Martin, Miguel Angel] CIBERER, U723, Madrid, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP García, E (corresponding author), Complejo Hosp Burgos, Secc Endocrinol, Paseo Comendadores S-N, Burgos 09001, Spain.
EM elenagarciafer@hotmail.com
FU ISCIII (Ministry of Health) [PI060547, PI0690088]
CR Aggarwal P, 2000, HUM HERED, V51, P114
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bonakdar RA, 2005, AM FAM PHYSICIAN, V72, P1065
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HAMAZAKI S, 1993, ACTA PATHOL JAPON, V43, P187
   Hosono T, 2001, J MATERN FETAL MED, V10, P355, DOI 10.1080/714052760
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   LORENZI M, 1986, J CLIN INVEST, V77, P322, DOI 10.1172/JCI112295
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MAJAMAAVOLTTI L, 2002, BMC CARDIOVASC DISOR, V2, P12
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   SILVESTREAILLAUD P, 1995, DIABETOLOGIA, V38, P1485
   Suzuki S, 2004, ANN NY ACAD SCI, V1011, P185, DOI 10.1196/annals.1293.019
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   VANDAM PS, 1995, DIABETES METAB REV, V11, P181, DOI 10.1002/dmr.5610110303
   Whittaker RG, 2007, DIABETES CARE, V30, P2238, DOI 10.2337/dc07-0466
NR 31
TC 0
Z9 0
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1051-2144
EI 1539-9192
J9 ENDOCRINOLOGIST
JI Endocrinologist
PD MAY-JUN 15
PY 2010
VL 20
IS 3
BP 105
EP 108
DI 10.1097/TEN.0b013e3181dfdb01
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 597QL
UT WOS:000277773900006
DA 2024-11-01
ER

PT J
AU Liu, S
   Xie, SZ
   Lee, YF
   Chang, CS
AF Liu, Su
   Xie, Shaozhen
   Lee, Yi-Fen
   Chang, Chawnshang
TI PHYSIOLOGICAL FUNCTIONS OF TR2 AND TR4 ORPHAN NUCLEAR RECEPTOR
SO NUCLEAR RECEPTORS: CURRENT CONCEPTS AND FUTURE CHALLENGES
LA English
DT Article; Book Chapter
ID direct repeat 4; mitochondrial diseases; gene; expression; mice; exercise; muscle; diagnosis; member; transactivation
AB The human testicular receptor 2 and 4 (TR2 and TR4) are two evolutionarily related orphan nuclear receptors belonging to the same nuclear receptor subfamily (Lee et al. 2002, J Steroid Biochem Mol Biol 81(4-5), 291-308). They regulate gene expression by binding to DNA as homodimers or a heterodimer with each other. TR4 may also cross-talk with other nuclear receptors, to control its target genes. In vitro and in vivo studies have identified several TR4 target genes, including ciliary neurotrophic factor alpha (CNTFR alpha) (Young et al. 1997, J Biol Chem 272(5), 3109-3116), apolipoprotein E (ApoE) (Kim et al. 2003, J Biol Chem 278(47), 46919-46926) and phosphenolpyruvate carboxykinase (PEPCK) (Liu et al. 2007, Diabetes 56(12), 2901-2909). Recent studies using TR4 knockout (TR4(-/-)) mice suggested that TR4 may play essential roles in growth, development, and metabolism (Zhang et al. 2007, Mol Endocrinol 21(4), 908-920; Kim et al. 2005, Biochem Biophys Res Commun 328(1), 85-90; Chen et al. 2005, Mol Cell Biol 25(7), 2722-2732; Mu et al. 2004, Mol Cell Biol 24(13), 58875899; Collins et al. 2004, Proc Natl Acad Sci USA 101(42), 15058-15063). Mice with a germline deletion of TR4 are viable but have high early postnatal mortality, growth retardation, and profound reduction in body weight. Further studies showed that TR4 plays essential roles in the development and functioning in the central nervous system (Chen et al. 2005, Mol Cell Biol 25(7), 2722-2732), such as proper myelination and oligodendrocyte differentiation (Zhang et al. 2007, Mol Endocrinol 21(4), 908-920). Studies also showed that TR4 is important for spermatogenesis in male mice (Mu et al. 2004, Mol Cell Biol 24(13), 5887-5899) and folliculogenesis in female mice (Chen et al. 2008, Mol Endocrinol 22,858-867). In addition, TR4 might be involved in skeletal muscle function and bone remodeling. TR4 and TR2 also regulate embryonic and fetal globin gene transcription (Tanabe et al. 2002, EMBO J 21(13), 3434-3442; Tanabe et al. 2007, EMBO J 26(9). 2295-2306). Surprisingly, mice lacking TR2 are viable and have no serious developmental defects. Thus, TR2 may either not be important in spermatogenesis and testis development, or its roles may be compensated by other closely related proteins such as TR4. Therefore, this chapter will focus on the in vivo roles of TR4.
C1 [Liu, Su; Xie, Shaozhen; Lee, Yi-Fen; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA.
   [Liu, Su; Xie, Shaozhen; Lee, Yi-Fen; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA.
C3 University of Rochester; University of Rochester
RP Liu, S (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA.
EM chang@urmc.rochester.edu
CR Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049
   Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326
   CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040
   Chen LM, 2008, MOL ENDOCRINOL, V22, P858, DOI 10.1210/me.2007-0181
   Chen YT, 2008, CEREBELLUM, V7, P9, DOI 10.1007/s12311-008-0006-3
   Chen YT, 2007, BRAIN RES, V1168, P72, DOI 10.1016/j.brainres.2007.06.069
   Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005
   Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832
   Cohen P, 2004, J NUTR, V134, P2455S, DOI 10.1093/jn/134.9.2455S
   Cohen Paul, 2003, CURRENT DRUG TARGETS - IMMUNE ENDOCRINE AND METABOLIC DISORDERS, V3, P271, DOI 10.2174/1568008033340117
   Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101
   Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Downey PA, 2006, PHYS THER, V86, P77, DOI 10.1093/ptj/86.1.77
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Gartland A, 2005, BONE, V37, P530, DOI 10.1016/j.bone.2005.04.034
   Gellerich FN, 2004, MOL CELL BIOCHEM, V256, P391, DOI 10.1023/B:MCBI.0000009885.34498.e6
   Giguère V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689
   Giguère Y, 2000, CLIN GENET, V57, P161, DOI 10.1034/j.1399-0004.2000.570301.x
   Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9
   Harada H, 1998, ENDOCRINOLOGY, V139, P204, DOI 10.1210/en.139.1.204
   HIROSE T, 1995, BIOCHEM BIOPH RES CO, V211, P83, DOI 10.1006/bbrc.1995.1781
   Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012
   Hwang SB, 1998, ENDOCRINE, V8, P169, DOI 10.1385/ENDO:8:2:169
   Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285
   Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014
   Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803
   Kim E, 2005, BIOCHEM BIOPH RES CO, V328, P85, DOI 10.1016/j.bbrc.2004.12.146
   Kim E, 2003, J BIOL CHEM, V278, P46919, DOI 10.1074/jbc.M304088200
   Kinugawa S, 2005, CIRCULATION, V111, P1480, DOI 10.1161/01.CIR.0000159261.11520.63
   Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757
   Koritschoner NP, 2001, CELL GROWTH DIFFER, V12, P563
   Langman CB, 2005, PEDIATR NEPHROL, V20, P352, DOI 10.1007/s00467-004-1687-6
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lee CH, 1998, J BIOL CHEM, V273, P25209, DOI 10.1074/jbc.273.39.25209
   LEE HJ, 1995, J BIOL CHEM, V270, P30129
   Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8
   Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437
   Lee YF, 1999, J BIOL CHEM, V274, P16198, DOI 10.1074/jbc.274.23.16198
   Lee YF, 1997, J BIOL CHEM, V272, P12215, DOI 10.1074/jbc.272.18.12215
   Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359
   Massett MP, 2005, AM J PHYSIOL-REG I, V288, PR1006, DOI 10.1152/ajpregu.00476.2004
   McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004
   Mulder JE, 2006, NAT CLIN PRACT ENDOC, V2, P670, DOI 10.1038/ncpendmet0325
   MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049
   Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303
   Popov VM, 2007, STEROIDS, V72, P221, DOI 10.1016/j.steroids.2006.12.001
   Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7
   Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758
   Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247
   Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0
   Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8
   Shyr CR, 2002, J BIOL CHEM, V277, P14622, DOI 10.1074/jbc.M110051200
   Shyr CR, 2002, MOL CELL BIOL, V22, P4661, DOI 10.1128/MCB.22.13.4661-4666.2002
   Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340
   Tanabe O, 2007, GENE DEV, V21, P2832, DOI 10.1101/gad.1593307
   Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Willson TM, 2002, MOL ENDOCRINOL, V16, P1135, DOI 10.1210/me.16.6.1135
   Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948
   Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050
   Yoshikawa T, 1996, ENDOCRINOLOGY, V137, P1562, DOI 10.1210/en.137.5.1562
   Young WJ, 1998, J BIOL CHEM, V273, P20877, DOI 10.1074/jbc.273.33.20877
   Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109
   Zebaze RMD, 2003, OSTEOPOROSIS INT, V14, P301, DOI 10.1007/s00198-002-1356-1
   Zhang G, 2007, RAPID COMMUN MASS SP, V21, P920, DOI 10.1002/rcm.2914
NR 76
TC 1
Z9 2
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1567-2530
EI 
J9 PROTEINS CELL REGUL
JI Proteins Cell Regul.
PD JUN 15
PY 2010
VL 8
IS 
BP 327
EP 343
DI 10.1007/978-90-481-3303-1_13
PG 17
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BOH92
UT WOS:000276683200013
DA 2024-11-01
ER

